# EDGAR Filing Document

**Accession Number:** 0001496454
**File Stem:** 0001496454-23-000001
**Filing Date:** 2023-3
**Character Count:** 558122
**Document Hash:** 10bb3bf15bea6af9f89a42db5f06b9e3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001496454-23-000001.hdr.sgml**: 20230310

**ACCESSION NUMBER**: 0001496454-23-000001

**CONFORMED SUBMISSION TYPE**: 10-K

**PUBLIC DOCUMENT COUNT**: 107

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230310

**DATE AS OF CHANGE**: 20230310

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CNL Healthcare Properties, Inc.
- **CENTRAL INDEX KEY:** 0001496454
- **STANDARD INDUSTRIAL CLASSIFICATION:** REAL ESTATE INVESTMENT TRUSTS [6798]
- **IRS NUMBER:** 272876363
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-54685
- **FILM NUMBER:** 23723372

**BUSINESS ADDRESS:**
- **STREET 1:** 450 SOUTH ORANGE AVENUE
- **CITY:** ORLANDO
- **STATE:** FL
- **ZIP:** 32801
- **BUSINESS PHONE:** (407) 650-1000

**MAIL ADDRESS:**
- **STREET 1:** 450 SOUTH ORANGE AVENUE
- **CITY:** ORLANDO
- **STATE:** FL
- **ZIP:** 32801

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CNL Healthcare Trust, Inc.
- **DATE OF NAME CHANGE:** 20120209

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CNL Properties Trust, Inc.
- **DATE OF NAME CHANGE:** 20110301

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CNL Diversified Lifestyle Properties, Inc.
- **DATE OF NAME CHANGE:** 20100713

?xml version="1.0" ? chth-20221231

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

---

| | |
|:---|:---|
| **FORM 10-K** | **FORM 10-K** |
| ☒ | **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |

---

**For the fiscal year ended December 31, 2022**

**OR**

**☐** **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from ______ to ______**

**Commission file number: 000-54685**

**CNL Healthcare Properties, Inc.**<br>**(Exact name of registrant as specified in its charter)**<br>

---

| | |
|:---|:---|
| **Maryland** | **27-2876363** |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(I.R.S. Employer**<br>**Identification No.)** |
| **CNL Center at City Commons**<br>**450 South Orange Avenue**<br>**Orlando, Florida** | **32801** |
| **(Address of principal executive offices)** | **(Zip Code)** |
| **Registrant's telephone number, including area code (407) 650-1000** | **Registrant's telephone number, including area code (407) 650-1000** |

---

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| None | N/A | N/A |

---

**Securities registered pursuant to Section 12(g) of the Act:** Common Stock, $0.01 par value per share<br>

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Large accelerated filer | ☐ | Accelerated filer | ☐ |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-accelerated filer | ☒ | Smaller reporting company | ☐ |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Emerging growth company | ☐ | | |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

There is currently no established public market for the registrant's shares of common stock. Based on the Company's $7.37 net asset value ("NAV") per share as of June 30, 2022 (the last business day of the registrant's most recently completed second fiscal quarter), the aggregate market value of the stock held by non-affiliates of the registrant on such date was approximately $1.3 billion.

**The number of shares of common stock of the registrant outstanding as of March 8, 2023 was 173,960,540.**

DOCUMENTS INCORPORATED BY REFERENCE

None

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Contents**

---

| | | |
|:---|:---|:---|
| | | Page |
| <u>[PART I.](#i7aa20ec61c924cc0a7c3ac74d325237b_10)</u> |  |  |
|  | <u>[Statement Regarding Forward Looking Statements](#i7aa20ec61c924cc0a7c3ac74d325237b_13)</u> | [2](#i7aa20ec61c924cc0a7c3ac74d325237b_13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 1.](#i7aa20ec61c924cc0a7c3ac74d325237b_16) | <u>[Business](#i7aa20ec61c924cc0a7c3ac74d325237b_16)</u> | [2](#i7aa20ec61c924cc0a7c3ac74d325237b_16) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 1A.](#i7aa20ec61c924cc0a7c3ac74d325237b_19) | <u>[Risk Factors](#i7aa20ec61c924cc0a7c3ac74d325237b_19)</u> | [24](#i7aa20ec61c924cc0a7c3ac74d325237b_19) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 1B.](#i7aa20ec61c924cc0a7c3ac74d325237b_22) | <u>[Unresolved Staff Comments](#i7aa20ec61c924cc0a7c3ac74d325237b_22)</u> | [37](#i7aa20ec61c924cc0a7c3ac74d325237b_22) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 2.](#i7aa20ec61c924cc0a7c3ac74d325237b_25) | <u>[Properties](#i7aa20ec61c924cc0a7c3ac74d325237b_25)</u> | [38](#i7aa20ec61c924cc0a7c3ac74d325237b_25) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 3.](#i7aa20ec61c924cc0a7c3ac74d325237b_28) | <u>[Legal Proceedings](#i7aa20ec61c924cc0a7c3ac74d325237b_28)</u> | [41](#i7aa20ec61c924cc0a7c3ac74d325237b_28) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 4.](#i7aa20ec61c924cc0a7c3ac74d325237b_31) | <u>[Mine Safety Disclosures](#i7aa20ec61c924cc0a7c3ac74d325237b_31)</u> | [41](#i7aa20ec61c924cc0a7c3ac74d325237b_31) |
| <u>[PART II.](#i7aa20ec61c924cc0a7c3ac74d325237b_34)</u> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 5.](#i7aa20ec61c924cc0a7c3ac74d325237b_37) | <u>[Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](#i7aa20ec61c924cc0a7c3ac74d325237b_37)</u> | [42](#i7aa20ec61c924cc0a7c3ac74d325237b_37) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 6.](#i7aa20ec61c924cc0a7c3ac74d325237b_40) | <u>[Reserved](#i7aa20ec61c924cc0a7c3ac74d325237b_40)</u> | [44](#i7aa20ec61c924cc0a7c3ac74d325237b_40) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 7.](#i7aa20ec61c924cc0a7c3ac74d325237b_43) | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i7aa20ec61c924cc0a7c3ac74d325237b_43)</u> | [45](#i7aa20ec61c924cc0a7c3ac74d325237b_43) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 7A.](#i7aa20ec61c924cc0a7c3ac74d325237b_100) | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i7aa20ec61c924cc0a7c3ac74d325237b_100)</u> | [65](#i7aa20ec61c924cc0a7c3ac74d325237b_100) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 8.](#i7aa20ec61c924cc0a7c3ac74d325237b_103) | <u>[Financial Statements and Supplementary Data](#i7aa20ec61c924cc0a7c3ac74d325237b_103)</u> | [67](#i7aa20ec61c924cc0a7c3ac74d325237b_103) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 9.](#i7aa20ec61c924cc0a7c3ac74d325237b_190) | <u>[Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](#i7aa20ec61c924cc0a7c3ac74d325237b_190)</u> | [104](#i7aa20ec61c924cc0a7c3ac74d325237b_190) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 9A.](#i7aa20ec61c924cc0a7c3ac74d325237b_193) | <u>[Controls and Procedures](#i7aa20ec61c924cc0a7c3ac74d325237b_193)</u> | [104](#i7aa20ec61c924cc0a7c3ac74d325237b_193) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 9B.](#i7aa20ec61c924cc0a7c3ac74d325237b_196) | <u>[Other Information](#i7aa20ec61c924cc0a7c3ac74d325237b_196)</u> | [104](#i7aa20ec61c924cc0a7c3ac74d325237b_196) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 9C.](#i7aa20ec61c924cc0a7c3ac74d325237b_199) | <u>[Disclosure Regarding Foreign Jurisdictions that Prevent Inspections](#i7aa20ec61c924cc0a7c3ac74d325237b_199)</u> | [104](#i7aa20ec61c924cc0a7c3ac74d325237b_199) |
| <u>[PART III.](#i7aa20ec61c924cc0a7c3ac74d325237b_202)</u> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 10.](#i7aa20ec61c924cc0a7c3ac74d325237b_205) | <u>[Directors, Executive Officers and Corporate Governance](#i7aa20ec61c924cc0a7c3ac74d325237b_205)</u> | [105](#i7aa20ec61c924cc0a7c3ac74d325237b_205) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 11.](#i7aa20ec61c924cc0a7c3ac74d325237b_208) | <u>[Executive Compensation](#i7aa20ec61c924cc0a7c3ac74d325237b_208)</u> | [111](#i7aa20ec61c924cc0a7c3ac74d325237b_208) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 12.](#i7aa20ec61c924cc0a7c3ac74d325237b_211) | <u>[Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](#i7aa20ec61c924cc0a7c3ac74d325237b_211)</u> | [113](#i7aa20ec61c924cc0a7c3ac74d325237b_211) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 13.](#i7aa20ec61c924cc0a7c3ac74d325237b_214) | <u>[Certain Relationships and Related Transactions, and Director Independence](#i7aa20ec61c924cc0a7c3ac74d325237b_214)</u> | [113](#i7aa20ec61c924cc0a7c3ac74d325237b_214) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 14.](#i7aa20ec61c924cc0a7c3ac74d325237b_217) | <u>[Principal Accountant Fees and Services](#i7aa20ec61c924cc0a7c3ac74d325237b_217)</u> | [114](#i7aa20ec61c924cc0a7c3ac74d325237b_217) |
| <u>[PART IV.](#i7aa20ec61c924cc0a7c3ac74d325237b_220)</u> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 15.](#i7aa20ec61c924cc0a7c3ac74d325237b_223) | <u>[Exhibits and Financial Statement Schedules](#i7aa20ec61c924cc0a7c3ac74d325237b_223)</u> | [115](#i7aa20ec61c924cc0a7c3ac74d325237b_223) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Item 16.](#i7aa20ec61c924cc0a7c3ac74d325237b_226) | <u>[Form 10-K Summary](#i7aa20ec61c924cc0a7c3ac74d325237b_226)</u> | [115](#i7aa20ec61c924cc0a7c3ac74d325237b_226) |
| <u>[Signatures](#i7aa20ec61c924cc0a7c3ac74d325237b_229)</u> |  | [120](#i7aa20ec61c924cc0a7c3ac74d325237b_229) |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**PART I**

**STATEMENT REGARDING FORWARD LOOKING INFORMATION**

For further information regarding risks and uncertainties associated with the Company's business and important factors that could cause the Company's actual results to vary materially from those expressed or implied in its forward-looking statements, please refer to the factors listed and described under "Management's Discussion and Analysis of Financial Condition and Results of Operations" and the "Risk Factors" sections of the Company's documents filed from time to time with the U.S. Securities and Exchange Commission ("SEC" or "the Commission"), including, but not limited to, this Annual Report and the Company's quarterly reports on Form 10-Q, copies of which may be obtained from the Company's website at www.cnlhealthcareproperties.com.

All written and oral forward-looking statements attributable to the Company or persons acting on its behalf are qualified in their entirety by this cautionary note. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to, and expressly disclaims any obligation to, publicly release the results of any revisions to its forward-looking statements to reflect new information, changed assumptions, the occurrence of unanticipated subsequent events or circumstances, or changes to future operating results over time, except as otherwise required by law.

**Item 1. BUSINESS**

**General**

CNL Healthcare Properties, Inc. is a Maryland corporation that elected to be taxed as a REIT for U.S. federal income tax purposes. We have been and intend to continue to be organized and operate in a manner that allows us to remain qualified as a REIT for U.S. federal income tax purposes. The terms "us," "we," "our," "Company" and "CNL Healthcare Properties" include CNL Healthcare Properties, Inc. and each of its subsidiaries.

Substantially all of our assets are held by, and all operations are conducted, either directly or indirectly, through: (1) CHP Partners LP ("Operating Partnership") in which we are the sole limited partner and our wholly owned subsidiary, CHP GP, LLC, is the sole general partner; (2) a wholly owned taxable REIT subsidiary ("TRS"), CHP TRS Holding, Inc.; (3) property owner subsidiaries and lender subsidiaries, which are single purpose entities; and (4) investments in joint ventures.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

We completed our public offerings ("Offerings") and in October 2015, we deregistered the unsold shares of our common stock under our previous registration statement on Form S-11, except for 20 million shares that we registered on Form S-3 under the Securities Exchange Act of 1933 with the SEC for the sale of additional shares of common stock through our distribution reinvestment plan ("Reinvestment Plan"). As part of moving forward with the consideration of Possible Strategic Alternatives, as described below under "Possible Strategic Alternatives," effective July 11, 2018, we suspended our Reinvestment Plan and, effective with the suspension of our Reinvestment Plan, stockholders who were participants in our Reinvestment Plan now receive cash distributions instead of additional shares of our common stock.

Our offices are located at 450 South Orange Avenue within the CNL Center at City Commons in Orlando, Florida, 32801, and our telephone number is (407) 650-1000.

**Advisor and Property Manager**

We are externally managed and advised by CNL Healthcare Corp. ("Advisor"), an affiliate of CNL Financial Group, LLC ("Sponsor"). The Sponsor is an affiliate of CNL Financial Group, Inc. ("CNL"). Our Advisor has responsibility for our day-to-day operations, serving as our consultant in connection with policy decisions to be made by our board of directors, and for identifying, recommending and executing on Possible Strategic Alternatives and dispositions on our behalf pursuant to an advisory agreement. In May 2022, we extended the advisory agreement with our Advisor through June 2023. For additional information on our Advisor, its affiliates or other related parties, as well as the fees and reimbursements we pay, see Item 8. "Financial Statements and Supplementary Data – Note 12. Related Party Arrangements."

**Seniors Housing Investment Focus and Strategy**

As of December 31, 2022, our investment portfolio consisted of interests in 70 properties, comprised of 69 seniors housing communities and one vacant land parcel. The types of seniors housing properties that we own include independent and assisted living facilities, continuing care retirement communities and Alzheimer's/memory care facilities. Our strategy is to manage our seniors housing portfolio in a way that will allow us to provide stockholders with cash distributions; preserve, protect and return stockholders' invested capital; and explore liquidity opportunities. We had previously invested in 70 properties consisting of 63 medical office buildings, acute care and post-acute care properties and seven skilled nursing facilities. As part of executing under Possible Strategic Alternatives, we sold 69 of these properties between April 2019 and January 2021, and completed the sale of the last property in 2022. The exploration of liquidity opportunities, such as the sale of either the Company or our assets, a potential merger, or the listing of our common shares on a national securities exchange, as further described below under "Possible Strategic Alternatives."

We have primarily leased our seniors housing properties to wholly owned TRS entities and engaged independent third-party managers under management agreements to operate the properties as permitted under the REIT Investment Diversification and Empowerment Act of 2007 ("RIDEA"). We have also leased certain of our seniors housing properties to third-party tenants under triple-net or similar lease structures, where the tenant bears all or substantially all of the costs (including cost increases, for real estate taxes, utilities, insurance and ordinary repairs). In addition, most of our investments are wholly owned, although, to a lesser extent, we invested through partnerships with other entities where we believed it was appropriate and beneficial.

**COVID-19**

In March 2020, the World Health Organization declared the outbreak of the novel coronavirus ("COVID-19") as a pandemic around the globe and we operated our communities through the disruptions and uncertainties of the pandemic, including disruptions from new variants of the virus during 2021. Refer to [Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations – COVID-19"](#i7aa20ec61c924cc0a7c3ac74d325237b_49) for further discussions on the impact of the COVID-19 pandemic on our financial position and results of operations.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Possible Strategic Alternatives**

In 2017, we began evaluating possible strategic alternatives to provide liquidity to our stockholders. In April 2018, our board of directors formed a special committee consisting solely of our independent directors ("Special Committee") to consider possible strategic alternatives, including, but not limited to (i) the listing of our or one of our subsidiaries' common stock on a national securities exchange; (ii) an orderly disposition of our assets or one or more of our asset classes and the distribution of the net sale proceeds thereof to our stockholders; and (iii) a potential business combination or other transaction with a third-party or parties that provides our stockholders with cash and/or securities of a publicly traded company (collectively, among other options, "Possible Strategic Alternatives"). Since 2018, the Special Committee has engaged KeyBanc Capital Markets Inc. to act as its financial advisor in connection with exploring our Possible Strategic Alternatives.

In connection with our consideration of the Possible Strategic Alternatives, our board of directors suspended both our Reinvestment Plan and our Redemption Plan effective July 11, 2018. In addition, as part of executing on Possible Strategic Alternatives, our board of directors committed to a plan to sell 70 properties which included medical office buildings, post-acute care facilities and acute care hospitals across the US, collectively (the "MOB/Healthcare Portfolio") plus several skilled nursing facilities. Through December 31, 2021, we sold 69 properties, received net sales proceeds of approximately $1.4497 billion and used the net sales proceeds to: (1) repay indebtedness secured by the properties; (2) strategically rebalance other corporate borrowings; (3) make a special cash distribution in May 2019 of approximately $347.9 million (or $2.00 per share) to our stockholders and (4) retained net sales proceeds for other corporate purposes, because we were focused on maintaining balance sheet strength and liquidity during COVID-19 to enhance financial flexibility. In April 2022, we sold the last property, the Hurst Specialty Hospital, to an unrelated third party, received net sales proceeds of approximately $8.3 million and retained these net sales proceeds to continue our focus to maintain a strong balance sheet and liquidity.

During the COVID-19 pandemic, we shifted our focus away from the pursuit of larger strategic alternatives to provide further liquidity to our stockholders due to the market and industry disruptions in the seniors housing sector from COVID-19. However, our Special Committee continued working and continues to work with our financial advisor to carefully study market data. We remain fully committed to our readiness, active study and pursuit of additional strategic opportunities to provide incremental liquidity to our stockholders as the economic and transactional environments permit.

**Portfolio Overview**

We believe demographic trends and compelling supply and demand indicators present a strong case for an investment focus on seniors housing real estate assets and real estate-related assets. Our seniors housing investment portfolio is geographically diversified with properties in 26 states. The map below shows our seniors housing investment portfolio across geographic regions as of March 8, 2023:

![chth-20221231_g1.jpg](chth-20221231_g1.jpg)

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

The following table summarizes our remaining healthcare portfolio by asset class and investment structure as of March 8, 2023:

---

| | | | |
|:---|:---|:---|:---|
| **Type of Investment** | **Number of<br>Investments** | **Amount of<br>Investments<br>(in millions)** | **Percentage <br>of Total<br>Investments** |
| *Consolidated investments:* |  |  |  |
| &nbsp;&nbsp;&nbsp;Seniors housing leased <sup>(1)</sup> | 15 | $311.0 | 17.8% |
| &nbsp;&nbsp;&nbsp;Seniors housing managed <sup>(2)</sup> | 54 | 1427.6 | 82.1% |
| &nbsp;&nbsp;&nbsp;Vacant land | 1 | 1.1 | 0.1% |
|  | 70 | $1739.7 | 100.0% |

---

_______________

**FOOTNOTES:**

<sup>(1)</sup> Properties that are leased to third-party tenants for which we report rental income and related revenues.

<sup>(2)</sup> Properties that are leased to TRS entities and managed pursuant to third-party management contracts (i.e. RIDEA structure) where we report resident fees and services, and the corresponding property operating expenses.

Refer to Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" for information on how we evaluate our seniors housing portfolio, our significant tenants and operators as well as our lease expirations.

**Dispositions** 

The determination of when a particular investment should be sold or otherwise disposed of may be made after considering all relevant factors, including overall strategic alternatives, tax considerations as well as prevailing and projected economic and market conditions (including whether the value of the property or other investment is anticipated to decline substantially). The net proceeds, after payment of debt, received from any disposition may be retained for corporate purposes or distributed to stockholders. Refer to Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" for additional information on dispositions.

**Share Price Valuation**

We have adopted a valuation policy designed to follow recommendations of the Investment Program Association ("IPA"), an industry trade group, in the IPA Practice Guideline 2013-01, Valuations of Publicly Registered Non-Listed REITs, which was adopted by the IPA effective May 1, 2013 ("IPA Valuation Guideline"). The purpose of our valuation policy is to establish guidelines to be followed in determining the NAV per share of our common stock for regulatory and investor reporting and on-going evaluation of investment performance. NAV means the fair value of real estate, real estate-related investments and all other assets less the fair value of total liabilities. Our NAV will be determined based on the fair value of our assets less liabilities under market conditions existing as of the time of valuation and assuming the allocation of the resulting net value among our stockholders after any adjustments for incentive, preferred or special interests, if applicable.

In accordance with our valuation policy and as recommended by the IPA Valuation Guideline, we expect to produce an estimated NAV per share at least annually as of December 31 and disclose such amount as soon as possible after year-end. The audit committee of our board of directors, comprised of our independent directors ("Valuation Committee"), oversees our valuation process and engages one or more third-party valuation advisors to assist in the process of determining the estimated NAV per share of our common stock.

To assist our board of directors in its determination of the estimated NAV per share of our common stock, our board of directors engaged an independent third-party valuation firm, Robert A. Stanger & Co., Inc. ("Stanger"), to provide property-level and aggregate valuation analyses of the Company and a range for the NAV per share of our common stock and to consider other information provided by our Advisor.

For a detailed discussion of the determination of the estimated NAV per share of our common stock, including our valuation process and methodology, see Item 5. "Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities–Market Information."

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Distributions**

In order to qualify as a REIT, we are required to make distributions, other than capital gain distributions, to our stockholders each year in the amount of at least 90% of our taxable income. We may make distributions in the form of cash or other property, including distributions of our own securities. While we generally expect to pay distributions from cash flows provided by operating activities, we have covered, and may in the future cover, periodic shortfalls between distributions paid and cash flows provided by operating activities from other sources; such as from cash flows provided by financing activities ("Other Sources"), a component of which could include borrowings, whether collateralized by our properties or unsecured, or net sales proceeds from the sale of real estate. We have not established any limit on the extent to which we may use borrowings to pay distributions, and there is no assurance we will be able to sustain distributions at any level. Refer to Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" for a table that presents total regular and special cash distributions declared and issued, and cash flows provided by operating activities for each quarter in the years ended December 31, 2022 and 2021.

**Borrowings**

We have borrowed funds to acquire properties, to make loans and other permitted investments and to pay certain related fees. We may borrow money, whether collateralized by our assets or unsecured, to pay distributions to stockholders, for working capital and/or for other corporate purposes. We are subject to certain customary covenants and limitations in connection with our borrowings. The aggregate amount of long-term financing is not expected to exceed 60% of the carrying value of our total assets on an annual basis.

There is no limitation on the amount we can borrow. Our board of directors has adopted a policy to generally limit our aggregate borrowings to approximately 75% of the aggregate value of our assets, unless substantial justification exists that borrowing a greater amount is in our best interests. Refer to Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations–Sources of Liquidity and Capital Resources–Borrowings" for further discussions of our borrowings, repayments and aggregate debt leverage ratios.

**Competition**

Our tenants and operators compete with other properties that provide comparable services in their local markets. Tenants and operators compete for residents based on a variety of factors including, but not limited to: quality of care, reputation, location, service offerings, staff and price. Throughout the COVID-19 pandemic, seniors housing operators have experienced broad-based occupancy declines and as a result, we expect competition to continue in 2023 and beyond as operators attempt to fill unoccupied units.

**Human Capital**

We are externally managed and as such we do not have any employees. All of our executive officers are employees of the Advisor or one of its affiliates. We do not directly compensate our executive officers for services rendered to us.

**Government Regulations**

Our business is subject to various federal, state and local laws, ordinances and regulations, including, among other things, the Americans with Disabilities Act of 1990, healthcare regulatory matters, environmental regulations, and zoning regulations and land use controls. Changes in these laws and regulations, or their interpretation by agencies and courts, occur frequently. We did not make any material capital expenditures in connection with these regulations during the year ended December 31, 2022 and we do not expect that we will be required to make any such material capital expenditures during 2023.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***Americans with Disabilities Act***

Under the Americans with Disabilities Act of 1990, or ADA, all public accommodations and commercial facilities are required to meet certain federal requirements related to access and use by disabled persons. These requirements became effective in 1992. Complying with the ADA requirements could require us to remove access barriers. Failing to comply could result in the imposition of fines by the federal government or an award of damages to private litigants. Although we own properties that substantially comply with these requirements, we may incur additional costs to comply with the ADA. In addition, a number of additional federal, state, and local laws may require us to modify any properties we own, or may restrict further renovations thereof, with respect to access by disabled persons. Additional legislation could impose financial obligations or restrictions with respect to access by disabled persons. Although we believe that these costs will not have a material adverse effect on us, if required changes involve a greater amount of expenditures than we currently anticipate, our ability to make expected distributions could be adversely affected.

***Healthcare Regulatory Matters***

Ownership and operation of certain senior housing properties are subject, directly and indirectly, to substantial federal, state and local government healthcare laws and regulations. The failure by our tenants or operators to comply with these laws and regulations could adversely affect the successful operation of our properties. For example, most senior housing facilities are subject to state licensing and registration laws. In granting and renewing these licenses, the state regulatory agencies consider numerous factors relating to a property's physical plant and operations, including, but not limited to, admission and discharge standards, staffing, and training. A decision to grant or renew a license is also affected by a property owner's record with respect to patient and consumer rights, medication guidelines, and rules. In addition, the Health Insurance Portability and Accountability Act of 1996, or HIPAA, requires the use of uniform electronic data transmission standards for certain healthcare claims and payment transactions submitted or received electronically. Compliance with these regulations is mandatory for healthcare providers, such as, in some cases, our tenants and operators. The cost of compliance with these regulations may have a material adverse effect on the business, financial condition or results of operations of our tenants or operators and, therefore, may adversely affect us. We intend for all of our business activities and operations, as well as the business activities and operations of our tenants and operators, to conform in all material respects with all applicable laws and regulations, including healthcare laws, regulations and licensing requirements.

***Environmental Regulations***

As an owner of real property, we are subject to various federal, state and local laws and regulations regarding environmental, health and safety matters. These laws and regulations address, among other things, asbestos, polychlorinated biphenyls, fuel, oil management, wastewater discharges, air emissions, radioactive materials, medical wastes, and hazardous wastes, and in certain cases, the costs of complying with these laws and regulations and the penalties for non-compliance can be substantial. Even with respect to properties that we do not operate or manage, we may be held liable, primarily or jointly and severally, for costs relating to the investigation and clean-up of any property from which there is or has been an actual or threatened release of a regulated material and any other affected properties, regardless of whether we knew of or caused the release. Such costs typically are not limited by law or regulation and could exceed the property's value. In addition, we may be liable for certain other costs, such as governmental fines and injuries to persons, property or natural resources, as a result of any such actual or threatened release.

Under the terms of our lease and management agreements, we generally have a right to indemnification by the tenants or operators of our properties for any contamination caused by them. However, we cannot assure you that our tenants or operators will have the financial capability or willingness to satisfy their respective indemnification obligations to us, and any such inability or unwillingness to do so may require us to satisfy the underlying environmental claims.

**Financial Information about Industry Segments**

We have determined that we operate in one business segment, real estate ownership, which consists of owning, managing, leasing, acquiring, developing, investing in, and as conditions warrant, disposing of real estate assets. We internally evaluate all of our real estate assets as one operating segment and, accordingly, we do not report segment information.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Taxation** 

The following summary of the U.S. federal income taxation of the Company and the material U.S. federal income tax consequences to the holders of our equity securities is for general information only and is not tax advice. This summary does not address all aspects of taxation that may be relevant to certain types of holders of securities (including, but not limited to, insurance companies, tax-exempt entities, financial institutions or broker-dealers, persons holding our securities as part of a hedging, integrated conversion, or constructive sale transaction or a straddle, persons subject to special tax accounting rules under Section 451(b) of the Code (as hereinafter defined), persons subject to alternative minimum tax, traders in securities that use a mark-to-market method of accounting for their securities, investors in pass-through entities and foreign corporations and persons who are not citizens or residents of the U.S.).

This summary does not discuss all of the aspects of U.S. federal income taxation that may be relevant in light of a particular investment or other circumstances. In addition, this summary does not discuss any state or local income taxation or foreign income taxation or other tax consequences. This summary is based on current U.S. federal income tax law. Subsequent developments in U.S. federal income tax law, including changes in law or differing interpretations, which may be applied retroactively, could have a material effect on the U.S. federal income tax consequences of purchasing, owning and disposing of our securities as set forth in this summary.

***General.*** We elected to be taxed as a REIT under the U.S. Internal Revenue Code of 1986, as amended ("Code") beginning with our taxable year ended December 31, 2012. We believe that, commencing with such taxable year, we have been organized and have operated in a manner so as to qualify as a REIT for U.S. federal income tax purposes.

Qualification and taxation as a REIT has depended upon, and will continue to depend upon, our ability to meet on a continuing basis, through actual operating results, distribution levels, diversity of share ownership and various qualification requirements imposed upon REITs by the Code. Our ability to qualify as a REIT also requires that we satisfy certain asset tests (discussed below), some of which depend upon the fair market values of assets directly or indirectly owned by us. Such values may not be susceptible to a precise determination. While we intend to continue to operate in a manner that will allow us to qualify as a REIT, no assurance can be given that the actual results of our operations for any taxable year will satisfy such requirements for qualification and taxation as a REIT.

As a REIT, we generally will not be subject to U.S. federal corporate income taxes on that portion of our ordinary income or capital gain we distribute currently to our stockholders, because the REIT provisions of the Code generally allow a REIT to deduct distributions, which are taxable dividends, paid to its stockholders. This substantially eliminates the U.S. federal double taxation on earnings (taxation at both the corporate level and stockholder level) that usually results from an investment in a corporation. With limited exceptions, dividends from us or from other entities that are taxed as REITs are generally not eligible for the capital gain rate and will continue to be taxed at rates applicable to ordinary income. Commencing with taxable years beginning on or after January 1, 2018 and continuing through 2025, the effective tax rate on ordinary REIT dividends (i.e., dividends other than capital gain dividends and dividends attributable to certain qualified dividend income received by us) is reduced for U.S. stockholders (as hereinafter defined) of our common stock that are individuals, estates or trusts by permitting such stockholders to claim a deduction in determining their taxable income equal to 20% of any such dividends they receive. Such deduction results in a maximum effective rate of regular U.S. federal income tax on ordinary REIT dividends of 29.6% through 2025 (as compared to the 20% maximum U.S. federal income tax rate applicable to qualified dividend income received from a non-REIT corporation).

Any net operating losses ("NOLs"), foreign tax credits and other tax attributes generally do not pass through to our stockholders, subject to special rules for certain items such as the capital gains that we recognize.

Effective for taxable years beginning on or after January 1, 2018, our domestic TRSs are subject to U.S. federal income tax on their taxable income at a rate of 21% (as well as applicable state and local income tax), but NOL carryforwards of a TRS arising in taxable years beginning after December 31, 2020 may be deducted only to the extent of 80% of TRS taxable income in the carryforward year (computed without regard to the NOL deduction).

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

Commencing in taxable years beginning after December 31, 2017, section 163(j) of the Code limits the deductibility of net interest expense paid or accrued on debt properly allocable to a trade or business to 30% of "adjusted taxable income," subject to certain exceptions. Any deduction in excess of the limitation is carried forward and may be used in a subsequent year, subject to the 30% limitation in such subsequent year. "Adjusted taxable income" is determined without regard to certain deductions, including those for net interest expense, NOL carryforwards and, for taxable years beginning before January 1, 2022, depreciation, amortization and depletion. Provided the taxpayer makes a timely election (which is irrevocable), the limitation based on adjusted taxable income does not apply to a "real property trade or business" within the meaning of section 469(c)(7)(C) of the Code, which generally includes real property development, redevelopment, construction, reconstruction, rental, operation, acquisition, conversion, disposition, management, leasing or brokerage trade or business. If this election is made, depreciable real property (including certain improvements) held by the relevant trade or business must be depreciated under the alternative depreciation system ("ADS") under the Code, which is generally less favorable than the generally applicable system of depreciation under the Code. Under guidance issued by the U.S. Department of the Treasury, our leasing, management and operation of our healthcare facilities and buildings should constitute a real property trade or business, and as of the taxable year beginning on January 1, 2018, we elected not to have the interest deduction limitation apply to our trade or business. Thus, we currently are not subject to the foregoing limitation on deductibility of net interest expense. However, we must depreciate depreciable real property (and certain improvements) under ADS. If, however, the election is determined not to be available with respect to all or certain of our business activities, the new interest deduction limitation could result in us having more REIT taxable income and thus increasing the amount of distributions we must make to comply with the REIT requirements and avoid incurring corporate level tax.

Even if we qualify for taxation as a REIT, however, we will be subject to U.S. federal income taxation as follows:

• We will be taxed at the regular corporate rate on our undistributed taxable income, including undistributed net capital gains.

• If we have net gain for tax purposes from prohibited transactions (which are, in general, sales or other dispositions of property, other than foreclosure property, held primarily for sale to customers in the ordinary course of business), such gain will be subject to a 100% tax.

• If we elect to treat property that we acquire in connection with a foreclosure of a mortgage loan or certain leasehold terminations as "foreclosure property," we may avoid the 100% tax on gain from a sale of that property (if the sale would otherwise constitute a prohibited transaction), but the income from the sale or operation of the property may be subject to corporate income tax at the highest applicable rate.

• If we should fail to satisfy the asset test other than certain de minimis violations or other requirements applicable to REITs, as described below, yet nonetheless maintain our qualification as a REIT because there is reasonable cause for the failure and other applicable requirements are met, we may be subject to an excise tax. In that case, the amount of the tax will be at least $50,000 per failure, and, in the case of certain asset test failures, will be determined as the amount of net income generated by the assets in question multiplied by the highest corporate tax rate if that amount exceeds $50,000 per failure.

• If we fail to satisfy either of the 75% or the 95% income tests (discussed below) but have nonetheless maintained our qualification as a REIT because certain conditions have been met, we will be subject to a 100% tax on an amount based on the magnitude of the failure, as adjusted to reflect the profit margin associated with our gross income.

• If we fail to distribute during each year at least the sum of (i) 85% of our REIT ordinary income for the year, (ii) 95% of our REIT capital gain net income for such year, and (iii) any undistributed taxable income from prior periods, then we will be subject to a 4% excise tax on the excess of the required distribution over the sum of (A) the amounts actually distributed, plus (B) retained amounts on which corporate level tax is paid by us.

• We may elect to retain and pay tax on our net long-term capital gains. In that case, a U.S. stockholder would be taxed on its proportionate share of our undistributed long-term capital gains and would receive a credit or refund for its proportionate share of the tax we paid.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

• If we acquire an appreciated asset from a C corporation that is not a REIT (i.e., a corporation generally subject to corporate level tax) in a transaction in which the C corporation would not normally be required to recognize any gain or loss on disposition of the asset and we subsequently recognize gain on the disposition of the asset during the five-year period beginning on the date on which we acquired the asset, then a portion of the gain may be subject to tax at the regular corporate rate, unless the C corporation made an election to treat the asset as if it were sold for its fair market value at the time of our acquisition of such asset. We will also be required to distribute prior non-REIT earnings and profits ("E&P").

• We may be required to pay monetary penalties to the U.S. Internal Revenue Service ("IRS") in certain circumstances, including if we fail to meet record keeping requirements intended to monitor our compliance with rules relating to the composition of a REIT's stockholders.

• The earnings of our TRSs are subject to U.S. federal corporate income tax. In addition, a 100% excise tax will be imposed on the REIT and a corporate level tax on the TRS for transactions between a TRS and the REIT that are deemed not to be conducted on an arm's length basis.

In addition, we and our subsidiaries may be subject to a variety of taxes, including state and local property and other taxes, on our assets and operations. We could also be subject to tax in situations and on transactions not presently contemplated.

***Requirements for Qualification as a REIT.*** Our qualification as a REIT has depended upon and will continue to depend upon our meeting and continuing to meet the requirements discussed below relating to our organization, sources of income, nature of assets and distributions of income to our stockholders.

*Organizational Requirements.* In order to qualify for taxation as a REIT under the Code we must meet tests regarding our income and assets described below and we must (i) be a corporation, trust or association that would be taxable as a domestic corporation but for the REIT provisions of the Code; (ii) be managed by one or more trustees or directors; (iii) have our beneficial ownership evidenced by transferable shares; (iv) not be a financial institution or an insurance company subject to special provisions of the U.S. federal income tax laws; (v) use a calendar year for U.S. federal income tax purposes; (vi) have at least 100 stockholders for at least 335 days of each taxable year of 12 months or during a proportionate part of a taxable year of less than 12 months; and (vii) not be closely held, as defined for purposes of the REIT provisions of the Code.

We would be treated as closely held if, during the last half of any taxable year, more than 50% in value of our outstanding capital shares is owned, directly or indirectly through the application of certain attribution rules, by five or fewer individuals, as defined in the Code to include certain entities. Items (vi) and (vii) above do not apply until after the first taxable year for which we elect to be taxed as a REIT. If we comply with the U.S. Department of the Treasury regulations ("Treasury Regulations") that provide procedures for ascertaining the actual ownership of our common stock for each taxable year and we did not know, and with the exercise of reasonable diligence could not have known, that we failed to meet item (vii) above for a taxable year, we will be treated as having met item (vii) for that year.

We have elected to be taxed as a REIT commencing with our taxable year ended December 31, 2012, and we intend to satisfy the other requirements described in items (i) through (v) above at all times during each of our taxable years. In addition, our charter contains restrictions regarding ownership and transfer of shares of our common stock that are intended to assist us in continuing to satisfy the share ownership requirements in items (vi) and (vii) above.

For purposes of the requirements described herein, any corporation that is a qualified REIT subsidiary of ours will not be treated as a corporation separate from us for U.S. federal income tax purposes and all assets, liabilities and items of income, deduction and credit of our qualified REIT subsidiaries will be treated as our assets, liabilities and items of income, deduction and credit for such purposes. A qualified REIT subsidiary is a corporation, other than a TRS (described below under "— Operational Requirements — Asset Tests"), of which all of its capital shares are owned by a REIT.

In the case of a REIT that is a partner in an entity treated as a partnership for U.S. federal income tax purposes, the REIT is treated as owning its proportionate share, based on its capital interest, of the assets of the partnership and as earning its allocable share of the gross income of the partnership for purposes of the requirements described herein. In addition, the character of the assets and gross income of the partnership will retain the same character in the hands of the REIT for purposes of the REIT requirements, including the asset and income tests described below. As a result, our proportionate share, based on our capital interest, of the assets, liabilities and items of income any partnership and of any other partnership, joint venture, limited liability company or other entity treated as a partnership for U.S. federal income tax purposes in which we or the operating partnership have an interest, will be treated as our assets, liabilities and items of income.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

The operating partnership since its formation has been treated as an entity disregarded as separate from us for U.S. federal income tax purposes. Thus, all of the operating partnership's assets, liabilities and activities are treated as our assets, liabilities and activities for U.S. federal income tax purposes. It is not anticipated that additional interests in the operating partnership will be issued to a third party in a manner that would cause the operating partnership to cease being treated as an entity disregarded as separate from us for U.S. federal income tax purposes.

The Code provides relief from violations of the REIT gross income requirements, as described below under "— Operational Requirements — Gross Income Tests," in cases where a violation is due to reasonable cause and not willful neglect, and other requirements are met, including the payment of a penalty tax that is based upon the magnitude of the violation. In addition, the Code includes provisions that extend similar relief in the case of certain violations of the REIT asset requirements (see "— Operational Requirements — Asset Tests" below) and other REIT requirements, again provided that the violation is due to reasonable cause and not willful neglect, and other conditions are met, including the payment of a penalty tax. If we fail to satisfy any of the various REIT requirements, there can be no assurance that these relief provisions would be available to enable us to maintain our qualification as a REIT. If relief provisions are available, the amount of any resultant penalty tax could be substantial.

*Operational Requirements — Gross Income Tests.* To maintain our qualification as a REIT, we must satisfy annually two gross income requirements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• At least 75% of our gross income, excluding gross income from prohibited transactions, for each taxable year must be derived directly or indirectly from investments relating to real property or mortgages on real property and from other specified sources, including qualified temporary investment income, as described below. Gross income includes "rents from real property" (as defined in the Code) and, in some circumstances, interest, but excludes gross income from dispositions of property held primarily for sale to customers in the ordinary course of a trade or business. These dispositions are referred to as "prohibited transactions." This is the "75% Income Test."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• At least 95% of our gross income, excluding gross income from prohibited transactions, for each taxable year must be derived from the real property investments described above and generally from dividends and interest and gains from the sale or disposition of shares of common stock or securities or from any combination of the foregoing. This is the "95% Income Test."

The rents we will receive or be deemed to receive will qualify as "rents from real property" for purposes of satisfying the gross income requirements for a REIT only if the following conditions are met:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The amount of rent received from a tenant must not be based in whole or in part on the income or profits of any Person; however, an amount received or accrued generally will not be excluded from the term "rents from real property" solely by reason of being based on a fixed percentage or percentages of gross receipts or sales.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In general, neither we nor an owner of 10% or more of our common stock may directly or constructively own 10% or more of a tenant, which we refer to as a "Related Party Tenant," or a subtenant of the tenant (in which case only rent attributable to the subtenant is disqualified).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Rent attributable to personal property leased in connection with a lease of real property cannot be greater than 15% of the total rent received under the lease, as determined based on the average of the fair market values as of the beginning and end of the taxable year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We normally must not operate or manage the property or furnish or render services to tenants, other than through an "independent contractor" (as defined in the Code) who is adequately compensated and from whom we do not derive any income or through a TRS (discussed below). However, a REIT may provide services with respect to its properties, and the income derived therefrom will qualify as "rents from real property" if the services are "usually or customarily rendered" in connection with the rental of space only and are not otherwise considered "rendered to the occupant". Even if the services provided by us with respect to a property are impermissible customer services, the income derived therefrom will qualify as "rents from real property" if such income does not exceed 1% of all amounts received or accrued with respect to that property.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

Interest income constitutes qualifying mortgage interest for purposes of the 75% Income Test to the extent that the obligation upon which such interest is paid is secured by a mortgage on real property. If we receive interest income with respect to a mortgage loan that is secured by both real property and other property, and the highest principal amount of the loan outstanding during a taxable year exceeds the fair market value of the real property on the date that we acquired or originated the mortgage loan, the interest income will be apportioned between the real property and the other collateral, and our income from the arrangement will qualify for purposes of the 75% Income Test only to the extent that the interest is allocable to the real property. Even if a loan is not secured by real property, or is under-secured, the income that it generates may nonetheless qualify for purposes of the 95% Income Test.

To the extent the terms of a loan provide for contingent interest that is based on the cash proceeds realized upon the sale of the property securing the loan, income attributable to the participation feature will be treated as gain from sale of the underlying real property, which generally will be qualifying income for purposes of both the 75% Income Test and 95% Income Test, provided that such property is not held as inventory or dealer property or primarily for sale to customers in the ordinary course of business. Similar to the treatment of contingent rents from real property (discussed above), to the extent that we derive interest income from a mortgage loan where all or a portion of the amount of interest or rental income payable is contingent, such income generally will qualify for purposes of the 75% Income Test and 95% Income Test only if it is based upon the gross receipts or sales and not on the net income or profits of the borrower.

We may, from time to time, enter into hedging transactions with respect to interest rate exposure. Any such hedging transactions could take a variety of forms, including the use of derivative instruments such as interest rate swap contracts, interest rate cap or floor contracts, futures or forward contracts, and options. To the extent that we or a pass-through subsidiary enters into a hedging transaction (i) to reduce interest rate risk on indebtedness incurred to acquire or carry real estate assets, or (ii) for taxable years beginning after December 31, 2015, new hedging transactions entered into to hedge the income or loss from prior hedging transactions, where the property or indebtedness which was the subject of the prior hedging transaction was extinguished or disposed of, and the instrument is properly identified as a hedge along with the risk it hedges within prescribed time periods, any periodic income from the instrument, or gain from the disposition of such instrument, would be excluded altogether from the 95% Income Test or the 75% Income Test.

To the extent that we hedge in certain other situations, the resultant income will be treated as income that does not qualify under the 75% Income Test or the 95% Income Test, provided that certain requirements are met. We intend to structure any hedging transactions in a manner that does not jeopardize our status as a REIT. We may conduct some or all of our hedging activities through a TRS or other corporate entity, the income from which may be subject to federal, state, and/or local income tax, rather than by participating in the arrangements directly or through pass-through subsidiaries. No assurance can be given, however, that our hedging activities will not give rise to income that does not qualify for purposes of either or both of the REIT income tests, or that our hedging activities will not adversely affect our ability to satisfy the REIT qualification requirements.

With regard to rental income, our leases generally are, and we expect them generally to continue to be, for fixed rentals with annual CPI or similar adjustments and that none of the rentals under our leases will be based on the income or profits of any Person. Rental leases may provide for payments based on gross receipts, which are generally permissible under the REIT income tests. In addition, none of our tenants are expected to be "Related Party Tenants" and the portion of the rent attributable to personal property is not expected to exceed 15% of the total rent to be received under any lease. The services to be performed with respect to our real properties generally are, and we expect them generally to continue to be, performed by our property manager, and such services are expected to be those usually or customarily rendered in connection with the rental of real property and not rendered to the occupant of such real property. Finally, we anticipate any non-customary services will be provided by a TRS or, alternatively, by an independent contractor that is adequately compensated and from whom we derive no income. However, we can give no assurance that the actual sources of our gross income will allow us to satisfy the 75% Income Test and the 95% Income Test described above.

Notwithstanding our failure to satisfy one or both of the 75% Income and the 95% Income Tests for any taxable year, we may still qualify as a REIT for that year if we are eligible for relief under specific provisions of the Code. These relief provisions generally will be available if:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our failure to meet these tests was due to reasonable cause and not due to willful neglect; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• following our identification of the failure, we file a schedule with a description of each item of gross income that caused the failure in accordance with Treasury Regulations.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

It is not possible, however, to state whether, in all circumstances, we would be entitled to the benefit of these relief provisions. In addition, as discussed above, even if these relief provisions apply, a tax would be imposed with respect to the excess net income.

*Operational Requirements — Prohibited Transactions.* A "prohibited transaction" is a sale by a REIT of real property or other assets held primarily for sale in the ordinary course of the REIT's trade or business (i.e., real property or other assets that are not held for investment but are held as inventory for sale by the REIT). A 100% penalty tax is imposed on any gain realized by a REIT from a prohibited transaction (including our distributive share of any such gain realized by our operating partnership). Under existing law, whether property is held as inventory or primarily for sale to customers in the ordinary course of a trade or business is a question of fact that depends on all the facts and circumstances surrounding the particular transaction. We do not presently intend to acquire or hold or allow the operating partnership to acquire or hold any property that represents inventory or other property held primarily for sale to customers in the ordinary course of our or the operating partnership's trade or business.

A safe harbor to the characterization of the sale of property by a REIT as a prohibited transaction and the 100% prohibited transaction tax is available if the following requirements are met:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the REIT has held the property for not less than two years;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the aggregate expenditures made by the REIT, or any partner of the REIT, during the two-year period preceding the date of the sale that are includable in the basis of the property do not exceed 30% of the net selling price of the property;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• either (i) during the year in question, the REIT did not make more than seven sales of property other than foreclosure property or like-kind exchanges under section 1031 of the Code, or (ii) the aggregate adjusted bases of the non-foreclosure property sold by the REIT during the year did not exceed 20% of the aggregate bases of all of the assets of the REIT at the beginning of such year, or (iii) the fair market value of the non-foreclosure property sold by the REIT during the year did not exceed 20% of the fair market value of all the assets of the REIT at the beginning of such year (10% for both aggregate basis and fair market value determinations beginning with taxable years beginning before December 18, 2015);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the REIT has held the property for at least two years for the production of rental income; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• if the REIT has made more than seven sales of non-foreclosure property during the year, substantially all of the marketing and development expenditures with respect to the property were made through an independent contractor from whom the REIT derives no income.

For purposes of the limitation on the number of sales that a REIT may complete in any given year, the sale of more than one property to one buyer will be treated as one sale.

The failure of a sale to fall within the safe harbor does not alone cause such sale to be a prohibited transaction and subject to the 100% prohibited transaction tax. In that event, the particular facts and circumstances of the transaction must be analyzed to determine whether it is a prohibited transaction.

*Operational Requirements — Asset Tests.* At the close of each quarter of our taxable year, starting with the taxable year ending December 31, 2012 (i.e., starting with the quarter ending March 31, 2012), we also must satisfy four tests, which we refer to as "Asset Tests," relating to the nature and diversification of our assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• First, at least 75% of the value of our total assets must be represented by real estate assets, cash, cash items and government securities. The term "real estate assets" includes real property, mortgages on real property, shares of common stock in other qualified U.S. REITs, property attributable to the temporary investment of new capital as described above and a proportionate share of any real estate assets owned by a partnership in which we are a partner or of any qualified REIT subsidiary of ours. For taxable years beginning after December 31, 2015, the term "real estate assets" also includes debt instruments of publicly offered REITs, personal property securing a mortgage secured by both real property and personal property if the fair market value of such personal property does not exceed 15% of the total fair market value of all such property, and personal property leased in connection with a lease of real property for which the rent attributable to personal property is not greater than 15% of the total rent received under the lease.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Second, no more than 25% of our total assets may be represented by securities other than those in the 75% asset class.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Third, of the investments included in the 25% asset class, the value of any one issuer's securities that we own may not exceed 5% of the value of our total assets. Additionally, we may not own more than 10% of the voting power or value of any one issuer's outstanding securities. Such asset tests do not apply to securities of a TRS. The term "securities" also does not include the equity or debt securities of a qualified REIT subsidiary of ours or an equity interest in any entity treated as a partnership for U.S. federal income tax purposes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fourth, no more than 20% (25% for our taxable years beginning before December 31, 2017) of the value of our total assets may consist of the securities of one or more TRSs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fifth, for taxable years beginning after December 31, 2015, not more than 25% of the value of our total assets may be represented by debt instruments of publicly offered REITs to the extent those debt instruments would not be real estate assets but for the inclusion of debt instruments of publicly offered REITs in the meaning of real estate assets effective for taxable years beginning after December 31, 2015, as described above.

Independent appraisals are not necessarily obtained by us to support our conclusions as to the value of our total assets or the value of any particular security or securities for purposes of these operational requirements. Moreover, values of some assets may not be susceptible to a precise determination, and values are subject to change in the future. Furthermore, the proper classification of an instrument as debt or equity for U.S. federal income tax purposes may be uncertain in some circumstances, which could affect the application of the REIT asset requirements. Accordingly, there can be no assurance that the IRS will not contend that our interests in our subsidiaries or in the securities of other issuers will not cause a violation of the REIT asset tests.

The Asset Tests must generally be met for each quarter. Upon full investment of the Net Offering Proceeds, most of our assets have consisted of "real estate assets" and we therefore expect to satisfy the Asset Tests.

If we meet the Asset Tests at the close of any quarter, we maintain our qualification as a REIT despite a failure to satisfy the Asset Tests at the end of a later quarter in which we have not acquired any securities or other property if such failure occurs solely because of changes in asset values. If our failure to satisfy the Asset Tests results from an acquisition of securities or other property during a quarter, we can cure the failure by disposing of a sufficient amount of non-qualifying assets within 30 days after the close of that quarter. We intend to maintain adequate records of the value of our assets to ensure compliance with the Asset Tests and to take other action within 30 days after the close of any quarter as may be required to cure any noncompliance. If that does not occur, we may nonetheless qualify for one of the relief provisions described below.

The Code contains a number of provisions applicable to REITs, including relief provisions that allow REITs to satisfy the asset requirements, or to maintain REIT qualification notwithstanding certain violations of the asset and other requirements.

One such provision allows a REIT which fails one or more of the asset requirements to nevertheless maintain its REIT qualification if (i) it provides the IRS with a description of each asset causing the failure; (ii) the failure is due to reasonable cause and not willful neglect; (iii) the REIT pays a tax equal to the greater of (A) $50,000 per failure; or (B) the product of the net income generated by the assets that caused the failure multiplied by the highest applicable corporate tax rate; and (iv) the REIT either disposes of the assets causing the failure within six months after the last day of the quarter in which it identifies the failure, or otherwise satisfies the relevant asset tests within that time frame.

A second relief provision applies to de minimis violations of the 10% and 5% asset tests. A REIT may maintain its qualification despite a violation of such requirements if (i) the value of the assets causing the violation do not exceed the lesser of 1% of the REIT's total assets and $10,000,000, or (ii) the REIT either disposes of the assets causing the failure within six months after the last day of the quarter in which it identifies the failure, or the relevant tests are otherwise satisfied within that time frame.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

The Code also provides that certain securities will not cause a violation of the 10% value test described above. Such securities include instruments that constitute "straight debt," which includes securities having certain contingency features. A security cannot qualify as "straight debt" if a REIT (or a controlled TRS) owns other securities in the issuer of that security which do not qualify as straight debt, unless the value of those other securities constitutes, in the aggregate, 1% or less of the total value of that issuer's outstanding securities. In addition to straight debt, the Code provides that certain other securities will not violate the 10% value test. Such securities include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any loan made to an individual or an estate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• certain rental agreements in which one or more payments are to be made in subsequent years (other than agreements between a REIT and certain Persons related to the REIT);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any obligation to pay rents from real property;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• securities issued by governmental entities that are not dependent in whole or in part on the profits of (or payments made by) a non-governmental entity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any security issued by another REIT; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any debt instrument issued by a partnership if the partnership's income is of a nature that it would satisfy the 75% Income Test described above under "— Operational Requirements — Gross Income Tests."

In addition, when applying the 10% value test, a debt security issued by a partnership is not taken into account to the extent, if any, of the REIT's proportionate equity interest in that partnership.

*Operational Requirements — Annual Distribution Requirement.* In order to be taxed as a REIT, we are required to make cash or taxable property distributions, other than capital gain distributions, to our stockholders each year in the amount of at least 90% of our taxable income (computed without regard to the dividends paid deduction and our net capital gain and subject to certain other potential adjustments) for all tax years. While we must generally make distributions in the taxable year to which they relate, we may also make distributions in the following taxable year if (i) they are declared before we timely file our U.S. federal income tax return for the taxable year in question and (ii) they are paid on or before the first regular distribution payment date after the declaration.

Even if we satisfy the foregoing distribution requirement and, accordingly, continue to qualify as a REIT for tax purposes, we will still be subject to U.S. federal income tax on the excess of our net capital gain and our REIT taxable income, as adjusted, over the amount of distributions to stockholders.

In addition, if we fail to distribute during each calendar year at least the sum of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 85% of our ordinary income for that year;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 95% of our capital gain net income other than the capital gain net income which we elect to retain and pay tax on for that year; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any undistributed taxable income from prior periods,

then we will be subject to a 4% non-deductible excise tax on the excess of the amount of the required distributions over the sum of (i) the amounts actually distributed plus (ii) retained amounts on which corporate level tax is paid by us.

We intend to make timely distributions sufficient to satisfy this requirement; however, it is possible we may experience timing differences between (i) the actual receipt of income and payment of deductible expenses, and (ii) the inclusion of that income and deduction of those expenses for purposes of computing our taxable income. Further, income generally must be accrued for U.S. federal income tax purposes no later than the taxable year in which such income is take into account as revenue in our financial statements, which could create a mismatch between our taxable income and the actual receipt of cash attributable to such income. It is also possible we may be allocated a share of net capital gain attributable to the sale of depreciated property by any partnership in which we own an interest, that exceeds our allocable share of cash attributable to that sale. In those circumstances, we may have less cash than is necessary to meet our annual distribution requirement or to avoid income or excise taxation on undistributed income.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

We may find it necessary in those circumstances to arrange for financing, raise funds through the issuance of additional shares of our common stock or to make a taxable stock distribution in order to meet our distribution requirements. If we fail to satisfy the distribution requirement for any taxable year by reason of a later adjustment to our taxable income made by the IRS, we may be able to pay "deficiency dividends" (as defined in the Code) in a later year and include such distributions in our deductions for dividends paid for the earlier year. In that event, we may be able to avoid the disqualification of our REIT status or being taxed on amounts distributed as deficiency dividends, but we would be required to pay interest and a penalty to the IRS based upon the amount of any deduction taken for deficiency dividends for the earlier year.

As noted above, we may also elect to retain, rather than distribute, some or all of our net long-term capital gains. The effect of such an election would be as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We would be required to pay the U.S. federal income tax on the undistributed gains;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Taxable U.S. stockholders, while required to include their proportionate share of the undistributed long-term capital gains in income, would receive a credit or refund for their share of the tax paid by the REIT; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The basis of the stockholder's shares of our common stock would be increased by the difference between the designated amount included in the stockholder's long-term capital gains and the tax deemed paid with respect to such shares of common stock.

In computing our taxable income, we use the accrual method of accounting and depreciate depreciable property under the ADS. We are required to file an annual U.S. federal income tax return, which, like other corporate returns, is subject to examination by the IRS. Because the tax law requires us to make many judgments regarding the proper treatment of a transaction or an item of income or deduction, it is possible that the IRS will challenge positions we take in computing our taxable income and our distributions.

Challenges could arise, for example, with respect to the allocation of the purchase price of real properties between depreciable or amortizable assets and non-depreciable or non-amortizable assets such as land and the current deductibility of fees paid to our Advisor or its affiliates. If the IRS were to successfully challenge our characterization of a transaction or determination of our taxable income, we could be found to have failed to satisfy a requirement for qualification as a REIT. If we are determined to have failed to satisfy the distribution requirements for a taxable year, we would be disqualified as a REIT, unless we were permitted to pay a deficiency dividend to our stockholders and pay interest thereon to the IRS, as provided by the Code.

*Operational Requirement — Recordkeeping.* We must maintain certain records as set forth in Treasury Regulations in order to avoid the payment of monetary penalties to the IRS. Such Treasury Regulations require that we request, on an annual basis, certain information designed to disclose the ownership of shares of our outstanding common stock. We intend to comply with these requirements. See "— Statement of Share Ownership" below.

*Taxable REIT Subsidiaries.* A TRS is any corporation in which a REIT directly or indirectly owns stock, provided that the REIT and that corporation make a joint election to treat the corporation as a TRS. The election can be revoked at any time as long as the REIT and the TRS revoke such election jointly. In addition, if a TRS holds, directly or indirectly, more than 35% of the securities of any other corporation (by vote or by value), then that other corporation also is treated as a TRS. A corporation can be a TRS with respect to more than one REIT. We may form one or more TRSs for the purpose of owning and selling properties that do not meet the requirements of the "prohibited transactions" safe harbor. See "— Requirements for Qualification as a REIT — Operational Requirements — Prohibited Transactions" above.

To the extent of its taxable income, a TRS is subject to U.S. federal income tax at the regular corporate rate and also may be subject to state and local taxation. Any distributions paid or deemed paid by any one of our TRSs also will be subject to tax, either (i) to us if we do not pay the distributions received to our stockholders as distributions, or (ii) to our stockholders if we do pay out the distributions received to our stockholders. Further, the rules impose a 100% excise tax on transactions between a TRS and its parent REIT or to the REIT's tenants that are not conducted on an arm's-length basis. We may hold more than 10% of the stock of a TRS without jeopardizing our qualification as a REIT notwithstanding the rule described above under "— Requirements for Qualification as a REIT — Operational Requirements — Asset Tests" that generally precludes ownership of more than 10% (by vote or value) of any issuer's securities.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

However, as noted below, in order for us to qualify as a REIT, the non-mortgage securities (both debt and equity) of all of the TRSs in which we have invested either directly or indirectly may not represent more than 20% (25% for our taxable years beginning before December 31, 2017) of the total value of our assets. We expect that the aggregate value of all of our interests in TRSs will continue to represent less than 20% of the total value of our assets. We cannot, however, assure you that we will always satisfy the 20% value limit or that the IRS will agree with the value we assign to our TRSs.

We may engage in activities indirectly through a TRS as necessary or convenient to avoid receiving the benefit of income or services that would jeopardize our REIT status if we engaged in the activities directly. In particular, in addition to the ownership of certain of our properties as noted above, we would likely use TRSs for providing services that are non-customary or that might produce income that does not qualify under the gross income tests described above. We may also use TRSs to satisfy various lending requirements with respect to special-purpose bankruptcy-remote entities.

Finally, while a REIT is generally limited in its ability to earn rents that qualify as "rents from real property" from a related party as defined by the Code, a REIT can earn "rents from real property" from the lease of a qualified healthcare property to a TRS (even a wholly owned TRS) if an eligible independent contractor operates the facility. Generally, a qualified healthcare property means a property which is a healthcare facility or is necessary or incidental to the use of a healthcare facility. A qualified healthcare facility is defined as a hospital, nursing facility, assisted living facility, congregate care facility, qualified continuing care facility or other licensed facility which extends medical or nursing or ancillary services to patients operated by a provider of such services which was eligible for participation in the Medicare program under title XVIII of the Social Security Act with respect to such facility. For these purposes, a contractor qualifies as an "eligible independent contractor" if it is less than 35% affiliated with the REIT and, at the time the contractor enters into the agreement with the TRS to operate the qualified healthcare property, that contractor or any Person related to that contractor is actively engaged in the trade or business of operating qualified healthcare properties for Persons unrelated to the TRS or its affiliated REIT. For these purposes, an otherwise eligible independent contractor is not disqualified from that status on account of the TRS bearing the expenses for the operation of the qualified healthcare property, the TRS receiving the revenues from the operation of the qualified healthcare property, net of expenses for that operation and fees payable to the eligible independent contractor, or the REIT receiving income from the eligible independent contractor pursuant to a preexisting or otherwise grandfathered lease of another property.

***Failure to Qualify as a REIT.*** If we fail to qualify as a REIT for any reason in a taxable year and applicable relief provisions do not apply, then we will be subject to tax on our taxable income at the regular corporate rate. We will not be able to deduct dividends paid to our stockholders in any year in which we fail to qualify as a REIT. In addition, if we fail to qualify as a REIT, all distributions to stockholders will be taxable as regular corporate dividends to the extent of current or accumulated E&P. In this event, stockholders taxed as individuals will be taxed on these dividends at the preferential income tax rates currently in effect for qualified dividends received from taxable C corporations and corporate distributees may be eligible for the dividends received deduction. We also will be disqualified for the four taxable years following the year during which qualification was lost unless we are entitled to relief under specific statutory provisions. It is not possible to state whether we would be entitled to this statutory relief.

***Sale-Leaseback Transactions.*** We normally intend to treat our property leases as true leases for U.S. federal income tax purposes. However, depending on the terms of any specific transaction, the IRS might take the position that the transaction is not a true lease but is more properly treated in some other manner. If such re-characterization were successful, we would not be entitled to claim the depreciation deductions available to an owner of the property. In addition, the re-characterization of one or more of these transactions might cause us to fail to satisfy the Asset Tests or the REIT income tests described above based upon the asset we would be treated as holding or the income we would be treated as having earned and such failure could result in our failing to qualify as a REIT.

Alternatively, the amount or timing of income inclusion or the loss of depreciation deductions resulting from the re-characterization might cause us to fail to meet the distribution requirement described above for one or more taxable years absent the availability of the deficiency dividend procedure or might result in a larger portion of our dividends being treated as ordinary income to our stockholders.

**Taxation of Taxable U.S. Stockholders** 

***Definition.*** In this section, the phrase "U.S. stockholder" means a holder of our common stock that for U.S. federal income tax purposes is:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a citizen or resident of the U.S.;

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a corporation or other entity treated as a corporation for U.S. federal income tax purposes created or organized in or under the laws of the U.S. or of any political subdivision thereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a trust, if a U.S. court is able to exercise primary supervision over the administration of the trust and one or more U.S. Persons have the authority to control all substantial decisions of the trust.

If a partnership, including for this purpose any entity that is treated as a partnership for U.S. federal income tax purposes, holds our common stock, the tax treatment of a partner in the partnership will generally depend upon the status of the partner and the activities of the partnership. An investor that is a partnership and the partners in such partnership should consult their tax advisors about the U.S. federal income tax consequences of the acquisition, ownership and disposition of our common stock.

For any taxable year for which we qualify for taxation as a REIT, amounts distributed to, and gains realized by, taxable U.S. stockholders with respect to our common stock generally will be taxed for U.S. federal income tax purposes as described below.

***Distributions Generally.*** Distributions paid to U.S. stockholders, other than capital gain distributions discussed below, made out of our current or accumulated E&P will be taxable to the stockholders as ordinary income for U.S. federal income tax purposes. These distributions are not eligible for the dividends received deduction generally available to corporations. In addition, with limited exceptions, these distributions are not eligible for taxation at the preferential income tax rates currently in effect for qualified dividends received by U.S. stockholders that are individuals, trusts and estates from taxable C corporations. However, non-corporate stockholders may generally deduct 20% of the aggregate amount of ordinary REIT dividends distributed by us (other than "capital gain dividends" or "qualified dividend income") for taxable years beginning after December 31, 2017 and before January 1, 2026, thereby reducing the maximum effective tax rate applicable to REIT ordinary dividends to 29.6% (assuming the current maximum individual income tax rate of 37% applies). Stockholders that are individuals, trusts or estates however, may be taxed at the preferential rates currently in effect (assuming the relevant holding periods have been met) on dividends designated by and received from us to the extent that the dividends are attributable to (i) income retained by us in the prior taxable year on which we were subject to corporate level income tax (less the amount of tax), (ii) dividends received by us from taxable C corporations, including any dividends we may receive from a TRS, or (iii) income in the prior taxable year from the sales of "built-in gain" property acquired by us from C corporations in carryover basis transactions (less the amount of corporate tax on such income).

To the extent we make a distribution in excess of our current and accumulated E&P, the distribution will be treated first as a tax-free return of capital, reducing the tax basis in a U.S. stockholder's shares of common stock, and the amount of each distribution in excess of a U.S. stockholder's tax basis in its shares of common stock will be taxable as gain realized from the sale of its shares of common stock. Dividends we declare in October, November or December of any year payable to a stockholder of record on a specified date in any of these months will be treated as both paid by us and received by the stockholder on December 31 of the year, provided that we actually pay the dividends during January of the following calendar year.

To the extent we have available NOLs (after application of the 80% limitation described above) and capital losses carried forward from prior tax years, such losses may reduce the amount of distributions we must make in order to comply with the REIT distribution requirements. See "— Requirements for Qualification as a REIT — Operational Requirements — Annual Distribution Requirement." Such losses, however, are not passed through to stockholders and do not offset income of stockholders from other sources, nor would such losses affect the character of any distributions that we make, which are generally subject to tax in the hands of stockholders to the extent that we have current or accumulated E&P.

We will be treated as having sufficient E&P to treat as a dividend any distribution by us up to the amount required to be distributed in order to avoid imposition of the 4% excise tax discussed above. Moreover, any "deficiency distribution" will be treated as an ordinary or capital gain distribution, as the case may be, regardless of our E&P. As a result, stockholders may be required to treat as taxable some distributions that would otherwise result in a tax-free return of capital.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

Distributions to U.S. stockholders that we properly designate as capital gain distributions normally will be treated as long-term capital gains to the extent they do not exceed our actual net capital gain for the taxable year without regard to the period for which the U.S. stockholder has held his or her shares of common stock and, for taxable years beginning after December 31, 2015, may not exceed our distributions paid for the taxable year, including distributions paid the following year that are treated as paid in the current year. A corporate U.S. stockholder might be required to treat up to 20% of some capital gain distributions as ordinary income. Long-term capital gains are generally taxable at preferential rates in the case of stockholders who are individuals, estates, and trusts. Capital gains attributable to the sale of depreciable real property held for more than 12 months are subject to a 25% maximum U.S. federal income tax rate for taxpayers who are individuals, to the extent of previously claimed depreciation deductions (unrecaptured Section 1250 gains). See "— Requirements for Qualification as a REIT — Operational Requirements — Annual Distribution Requirement" for the treatment by U.S. stockholders of net long-term capital gains that we elect to retain and pay tax on.

***Certain Dispositions of Our Common Stock.*** In general, capital gains recognized by individuals upon the sale or disposition of shares of our common stock will be subject to tax at the U.S. federal capital gains rate if such shares of common stock are held for more than 12 months, and will be taxed at ordinary income rates if such shares of common stock are held for 12 months or less. Gains recognized by stockholders that are corporations are subject to U.S. federal income tax at a current flat rate of 21%, whether or not classified as long-term capital gains. Capital losses recognized by a stockholder upon the disposition of a share of our common stock held for more than one year at the time of disposition will be considered long-term capital losses, and are generally available only to offset capital gain income of the stockholder but not ordinary income (except in the case of individuals, trusts and estates who may offset up to $3,000 of ordinary income each year). In addition, any loss upon a sale or exchange of shares of common stock by a stockholder who has held such shares of common stock for six months or less, after applying holding period rules, will be treated as a long-term capital loss to the extent of distributions received from us that are required to be treated by the stockholder as long-term capital gain. In addition, under the so-called "wash sale" rules (as defined in the Code), all or a portion of any loss that a stockholder realizes upon a taxable disposition of shares of common stock may be disallowed if the stockholder purchases (including through our Reinvestment Plan) other shares of our stock (or stock substantially similar to our stock) within 30 days before or after the disposition.

If an investor recognizes a loss upon a subsequent disposition of our stock or other securities in an amount that exceeds a prescribed threshold, it is possible that the provisions of Treasury Regulations involving "reportable transactions" (as defined in the Code) could apply, with a resulting requirement to separately disclose the loss-generating transaction to the IRS. These regulations, though directed towards tax shelters, are broadly written and apply to transactions that would not typically be considered tax shelters. The Code imposes significant penalties for failure to comply with these requirements.

You should consult your tax advisor concerning any possible disclosure obligation with respect to the receipt or disposition of our stock or securities or transactions that we might undertake directly or indirectly. Moreover, you should be aware that we and other participants in the transactions in which we are involved (including their advisors) might be subject to disclosure or other requirements pursuant to these regulations, and that the failure to make such disclosures would result in substantial penalties.

Distributions we make and gain arising from the sale or exchange by a U.S. stockholder of our stock will not be treated as passive activity income. As a result, stockholders will not be able to apply any passive losses against income or gain relating to our stock. To the extent distributions we make do not constitute a return of capital or a long-term capital gain (unless you elect otherwise), they will be treated as investment income for purposes of computing the investment interest limitation.

***Additional Medicare Contribution Tax.*** An additional tax of 3.8% generally will be imposed on the "net investment income" of U.S. stockholders who meet certain requirements and are individuals, estates or certain trusts. Among other items, "net investment income" generally includes gross income from dividends and net gain attributable to the disposition of certain property, such as shares of our common stock. In the case of individuals, this tax will only apply to the extent such individual's modified adjusted gross income exceeds $200,000 ($250,000 for married couples filing a joint return and surviving spouses, and $125,000 for married individuals filing a separate return). U.S. stockholders should consult their tax advisors regarding the possible applicability of this additional tax in their particular circumstances.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***Information Reporting Requirements and Backup Withholding for U.S. Stockholders.*** As required, we will report to U.S. stockholders of our common stock and to the IRS the amount of distributions made or deemed made during each calendar year and the amount of tax withheld, if any. Under some circumstances, U.S. stockholders may be subject to backup withholding on payments made with respect to, or cash proceeds of a sale or exchange of, our common stock. Backup withholding will apply only if the stockholder:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fails to furnish its taxpayer identification number (which, for an individual, would typically be his or her Social Security number);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Furnishes an incorrect taxpayer identification number;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Is notified by the IRS that the stockholder has failed to properly report payments of interest or dividends and is subject to backup withholding; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Under some circumstances, fails to certify, under penalties of perjury, that it has furnished a correct taxpayer identification number and has not been notified by the IRS that the stockholder is subject to backup withholding for failure to report interest and dividend payments or has been notified by the IRS that the stockholder is no longer subject to backup withholding for failure to report those payments.

Backup withholding will not apply with respect to payments made to some stockholders, such as corporations in certain circumstances and tax-exempt organizations. Backup withholding is not an additional tax. Rather, the amount of any backup withholding with respect to a payment to a U.S. stockholder will be allowed as a credit against the U.S. stockholder's U.S. federal income tax liability and may entitle the U.S. stockholder to a refund, provided that the required information is furnished to the IRS. U.S. stockholders should consult their tax advisors regarding their qualification for exemption from backup withholding and the procedure for obtaining an exemption.

***Cost Basis Reporting.*** Treasury Regulations require us to report the cost basis and gain or loss to a stockholder upon the sale or liquidation of "covered" shares. For purposes of these Treasury Regulations, all shares acquired by non-tax-exempt stockholders through the Reinvestment Plan will be considered "covered" shares and will be subject to the applicable reporting requirements.

Upon the sale or liquidation of "covered" shares, a broker must report both the cost basis of the shares and the gain or loss recognized on the sale of those shares to the stockholder and to the IRS on Form 1099-B. In addition, stockholders that are S-corporations are no longer exempt from Form 1099-B reporting and shares purchased by an S-corporation are "covered" shares under the Treasury Regulations. If we take an organizational action such as a stock split, merger, or acquisition that affects the cost basis of "covered" shares, we will report to each stockholder and to the IRS via our website a description of any such action and the quantitative effect of that action on the cost basis on an information return.

We have elected the first in, first out (FIFO) method as the default for calculating the cost basis and gain or loss upon the sale or liquidation of "covered" shares. A non-tax-exempt stockholder may elect a different method of computation until the settlement date of the sold or liquidated shares. We suggest that you consult with your tax advisor to determine the appropriate method of accounting for your investment.

**Treatment of Tax-Exempt Stockholders** 

Tax-exempt entities, including employee pension benefit trusts and individual retirement accounts, generally are exempt from U.S. federal income taxation. These entities are subject to taxation, however, on any UBTI, as defined in the Code. The IRS has issued a published ruling that distributions from a REIT to a tax-exempt pension trust do not constitute UBTI. Although rulings are merely interpretations of law by the IRS and may be revoked or modified, based on this analysis, indebtedness incurred by us or by our operating partnership in connection with the acquisition of a property should not cause any income derived from the property to be treated as UBTI upon the distribution of those amounts as dividends to a tax-exempt U.S. stockholder of our common stock. A tax-exempt entity that incurs indebtedness to finance its purchase of our common stock, however, will be subject to UBTI under the debt-financed income rules.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

In certain circumstances, a pension trust that owns more than 10% of our stock could be required to treat a percentage of the dividends as UBTI if we are a "pension-held REIT." We will not be a pension-held REIT unless (i) we are required to look through one or more of our pension trust stockholders in order to satisfy the REIT "closely-held" test, and (ii) either (A) one pension trust owns more than 25% of the value of our stock, or (B) one or more pension trusts, each individually holding more than 10% of the value of our stock, collectively owns more than 50% of the value of our stock. Certain restrictions on ownership and transfer of our stock generally should prevent a tax-exempt entity from owning more than 10% of the value of our stock and generally should prevent us from becoming a pension-held REIT. Tax-exempt stockholders are urged to consult their tax advisors regarding the U.S. federal, state, local and foreign income and other tax consequences of owning our common stock.

For social clubs, voluntary employee benefit associations, supplemental unemployment benefit trusts and qualified group legal services plans exempt from U.S. federal income taxation under sections 501(c)(7), (c)(9), (c)(17) and (c)(20) of the Code, respectively, income from an investment in our shares will generally constitute UBTI unless the stockholder in question is able to deduct amounts set aside or placed in reserve for certain purposes so as to offset the UBTI generated. Any such organization that is a prospective stockholder should consult its own tax advisor concerning these set aside and reserve requirements, and regarding the treatment of distributions to such organization.

**Special Tax Considerations for Non-U.S. Stockholders** 

The rules governing U.S. federal income taxation of non-resident alien individuals, foreign corporations and other foreign stockholders, which we refer to collectively as "Non-U.S. stockholders," are complex. The following discussion is intended only as a summary of these rules. Non-U.S. stockholders should consult with their own tax advisors to determine the impact of U.S. federal, state and local income tax laws on an investment in our common stock, including any reporting requirements as well as the tax treatment of the investment under the tax laws of their home country.

***Ordinary Dividends.*** The portion of distributions received by Non-U.S. stockholders payable out of our E&P which are not attributable to our capital gains and which are not effectively connected with a U.S. trade or business of the Non-U.S. stockholder will be subject to U.S. withholding tax at the rate of 30%, unless reduced or eliminated by treaty.

In general, Non-U.S. stockholders will not be considered to be engaged in a U.S. trade or business solely as a result of their ownership of our common stock. In cases where the distribution income from a Non-U.S. stockholder's investment in our common stock is, or is treated as, effectively connected with the Non-U.S. stockholder's conduct of a U.S. trade or business, the Non-U.S. stockholder generally will be subject to U.S. federal income tax at graduated rates, in the same manner as U.S. stockholders are taxed with respect to such distributions, such income must generally be reported on a U.S. federal income tax return filed by or on behalf of the Non-U.S. stockholder, and the income may also be subject to the 30% branch profits tax in the case of a Non-U.S. stockholder that is a corporation.

***Non-Dividend Distributions.*** Unless our common stock constitutes a U.S. real property interest ("USRPI"), distributions by us which are not distributions out of our E&P will not be subject to U.S. federal income tax. If it cannot be determined at the time at which a distribution is made whether or not the distribution will exceed current and accumulated E&P, the distribution will be subject to withholding at the rate applicable to distributions. However, the Non-U.S. stockholder may seek a refund from the IRS of any amounts withheld if it is subsequently determined that the distribution was, in fact, in excess of our current and accumulated E&P. If our common stock constitutes a USRPI, as described below, distributions by us in excess of the sum of our E&P plus the stockholder's basis in shares of our common stock will be taxed under the Foreign Investment in Real Property Tax Act of 1980 ("FIRPTA") at the rate of tax, including any applicable capital gains rates, that would apply to a U.S. stockholder of the same type (e.g., an individual or a corporation, as the case may be), and the collection of the tax will be enforced by a refundable withholding at a rate of 15% of the amount by which the distribution exceeds the stockholder's share of our E&P.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***Capital Gain Distributions.*** Under FIRPTA, subject to the following exception, distributions that are sourced from capital gains from dispositions of USRPIs will be treated as income that is effectively connected with a U.S. trade or business of the Non-U.S. stockholder without regard to whether the distribution is designated as a capital gain distribution and shall be subject to a 21% withholding tax. As an exception, a distribution sourced from capital gains from dispositions of USRPIs will generally not be treated as income that is effectively connected with a U.S. trade or business, and will instead be treated the same as an ordinary distribution from us (see "— Special Tax Considerations for Non-U.S. Stockholders — Ordinary Dividends"), if (i) the capital gain distribution is received with respect to a class of stock that is regularly traded on an established securities market located in the U.S., and (ii) the recipient Non-U.S. stockholder does not own more than 10% of that class of stock at any time during the taxable year in which the capital gain distribution is received. We do not anticipate our common stock satisfying the "regularly traded" requirement, and in such cases distributions that are sourced from capital gains from dispositions in USRPIs generally would be taxable to a Non-U.S. stockholder under FIRPTA. Distributions subject to FIRPTA may also be subject to a 30% branch profits tax in the hands of a Non-U.S. stockholder that is a corporation. A distribution is not a USRPI capital gain if we held the underlying asset solely as a creditor. Capital gain distributions received by a Non-U.S. stockholder from a REIT that are not USRPI capital gains are generally not subject to U.S. federal income tax, but may be subject to U.S. federal withholding tax. Distributions, to "qualified foreign pension funds" or entities all of the interests of which are held by "qualified foreign pension funds" are exempt from U.S. federal income tax under FIRPTA. Non-U.S. stockholders should consult their tax advisors regarding the application of these rules.

***Estate Tax.*** If our stock is owned or treated as owned by an individual who is not a citizen or resident (as specially defined for U.S. federal estate tax purposes) of the U.S. at the time of such individual's death, the stock will be includable in the individual's gross estate for U.S. federal estate tax purposes, unless an applicable estate tax treaty provides otherwise, and may therefore be subject to U.S. federal estate tax.

***Dispositions of Our Common Stock.*** Unless our common stock constitutes a USRPI, a sale of our common stock by a Non-U.S. stockholder generally will not be subject to U.S. federal income tax under FIRPTA. Our common stock will not be treated as a USRPI if less than 50% of our assets throughout a prescribed testing period consist of interests in real property located within the U.S., excluding, for this purpose, interests in real property solely in a capacity as a creditor.

Even if the foregoing test is not met, our common stock nonetheless will not constitute a USRPI if we are a "domestically controlled REIT." A "domestically controlled REIT" is a REIT in which, at all times during a specified testing period, less than 50% in value of its shares of common stock is held directly or indirectly by Non-U.S. stockholders. If we are a domestically controlled REIT, the sale of our common stock should not be subject to taxation under FIRPTA. We cannot assure you that we are or will continue to be a domestically controlled REIT. Non-U.S. stockholders should consult their tax advisors regarding the application of these rules.

If we were not a domestically controlled REIT, whether a Non-U.S. stockholder's sale of our common stock would be subject to tax under FIRPTA as a sale of a USRPI would depend on whether our common stock were "regularly traded" on an established securities market and on the size of the selling stockholder's interest in us.

In addition, even if we are a domestically controlled REIT, upon disposition of our common stock (subject to the exception applicable to "regularly traded" stock described above), a Non-U.S. stockholder may be treated as having gain from the sale or exchange of a USRPI if the Non-U.S. stockholder (i) disposes of our common stock within a 30-day period preceding the ex-dividend date of distribution, any portion of which, but for the disposition, would have been treated as gain from the sale or exchange of a USRPI and (ii) acquires, or enters into a contract or option to acquire, other shares of our common stock within 30 days after such ex-dividend date.

If the gain on the sale of shares of common stock were subject to taxation under FIRPTA, a Non-U.S. stockholder would be subject to the same treatment as a U.S. stockholder with respect to the gain, subject to any applicable alternative minimum tax and a special alternative minimum tax in the case of non-resident alien individuals.

Gain from the sale of our common stock that would not otherwise be subject to FIRPTA will nonetheless be taxable in the U.S. to a Non-U.S. stockholder in two cases: (i) if the Non-U.S. stockholder's investment in our common stock is effectively connected with a U.S. trade or business conducted by such Non-U.S. stockholder, the Non-U.S. stockholder will be subject to the same treatment as a U.S. stockholder with respect to such gain; or (ii) if the Non-U.S. stockholder is a nonresident alien individual who was present in the U.S. for 183 days or more during the taxable year and has a "tax home" (as defined in the Code) in the U.S., the nonresident alien individual will be subject to a 30% U.S. federal tax on the individual's capital gain.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***Information Reporting Requirements and Backup Withholding for Non-U.S. Holders.*** Non-U.S. stockholders should consult their tax advisors with regard to U.S. information reporting and backup withholding requirements under the Code. We will provide you with an annual Form 1042-S, if required, by March 15 following the end of our fiscal year.

**Statement of Share Ownership** 

We are required to demand annual written statements from the record holders of designated percentages of our common stock disclosing the actual owners of the shares of common stock. Any record stockholder who, upon our request, does not provide us with required information concerning actual ownership of the shares of common stock is required to include specified information relating to his or her shares of common stock in his or her U.S. federal income tax return. We also must maintain, within the Internal Revenue District in which we are required to file our U.S. federal income tax return, permanent records showing the information we have received about the actual ownership of our common stock and a list of those Persons failing or refusing to comply with our demand.

**Other Tax Considerations** 

***Payments to Certain Foreign Financial Entities and Other Foreign Entities.*** U.S. federal withholding tax at a rate of 30% will be imposed on certain payments to you or certain foreign financial institutions (including investment funds) and other non-U.S. entities receiving payments on your behalf, including distributions in respect of shares of our stock, if you or such institutions fail to comply with certain due diligence and other reporting rules as set forth in Treasury Regulations. Accordingly, the entity through which shares of our stock are held will affect the determination of whether such withholding is required. Withholding currently applies to payments of dividends and the IRS has advised that future guidance may provide that certain other payments made to or by certain foreign financial institutions may be subject to a 30% U.S. federal withholding tax. Stockholders that are otherwise eligible for an exemption from, or reduction of, U.S. federal withholding taxes with respect to such dividends will be required to seek a refund from the IRS to obtain the benefit of such exemption or reduction. Additional requirements and conditions may be imposed pursuant to an intergovernmental agreement, if and when entered into, between the U.S. and such institution's home jurisdiction. We will not pay any additional amounts to any stockholders in respect of any amounts withheld. You are encouraged to consult with your tax advisor regarding U.S. federal withholding taxes and the application of the Treasury Regulations in light of your particular circumstances.

***Partnership Audit Rules.*** Generally effective for partnership tax years beginning after December 31, 2017, for U.S. federal income tax purposes, subject to certain exceptions, any audit adjustment to items of income, gain, loss, deduction, or credit of a partnership (and any partner's distributive share thereof) generally is determined, and taxes, interest, or penalties attributable thereto are assessed and collected, at the partnership level. It is possible that this rule could result in partnerships in which we directly or indirectly invest being required to pay additional taxes, interest and penalties as a result of an audit adjustment, and we, as a direct or indirect partner of these partnerships, could be required to bear the economic burden of those taxes, interest, and penalties even though we, as a REIT, may not otherwise have been required to pay additional corporate-level taxes as a result of the related audit adjustment.

***Legislative or Other Actions Affecting REITs.*** Current and prospective holders of our stock should recognize the present U.S. federal income tax treatment of an investment in our stock may be modified by legislative, judicial or administrative action at any time and that any such action may affect investments and commitments previously made. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the IRS and the U.S. Department of the Treasury. Changes to the U.S. federal tax laws and interpretations thereof could adversely affect an investment in our stock.

***U.S. State and Local Taxes.*** We and our subsidiaries and stockholders may be subject to U.S. state and local taxation in various jurisdictions including those in which we or they transact business, own property or reside. We own properties located in numerous jurisdictions within the U.S., and may be required to file tax returns in some or all of those jurisdictions. Our U.S. state and local tax treatment and that of our stockholders may not conform to the U.S. federal income tax treatment discussed above.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Available Information**

CNL Financial Group, LLC ("Sponsor" or "CNL") maintains a web site at www.cnlhealthcareproperties.com containing additional information about our business, and a link to the SEC web site (www.sec.gov). We make available free of charge on our web site, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and, if applicable, amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practical after we file such material, or furnish it to, the SEC. The SEC also maintains a web site (www.sec.gov) where you can search for annual, quarterly and current reports, proxy and information statements, and other information regarding us and other public companies.

The contents of our web site are not incorporated by reference in, or otherwise a part of, this report.

**Item 1A. RISK FACTORS**

The events and consequences discussed in these risk factors could, in circumstances where the Company may not be able to accurately predict, recognize or control, have a material adverse effect on the Company's business, growth, reputation, prospects, financial condition, operating results, cash flows, liquidity, and ability to pay distributions.

**Risks Related to The Company's Business**

**The ongoing COVID-19 pandemic has had an adverse effect on, and likely will continue to adversely affect, the Company's business, results of operations and financial condition.**

The COVID-19 pandemic has resulted in a decline in occupancy, resident fees, and revenues, and coupled with an increase in COVID-19 operating expenses, has had a negative impact on results of operations and cash flow from operations at the Company's senior communities. The magnitude of impact of COVID-19 on the Company's business, results from operations, financial condition, liquidity and cash flows will depend on many factors, many of which cannot be foreseen given the ongoing and dynamic nature of the circumstances surrounding the COVID-10 pandemic, including: the ultimate duration of the pandemic; the severity of COVID-19 on seniors generally and those living in seniors housing communities specifically; the continued emergence of additional variants; continued issues with the supply chain and availability and cost of goods; and consumer sentiment regarding the safety of seniors housing communities during and after the pandemic which may impact demand for seniors housing communities.

The COVID-19 pandemic and other actions taken by the governments, businesses and individuals in response to the COVID-19 pandemic has subjected and could further subject the Company's business, operations, and financial condition to a number of risks, including, but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's ability to collect rents;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• occupancy rates in the Company's facilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's and its operators' ability to evict residents for non-payment and for other reasons;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's ability to repay existing debt and to secure new debt financing if needed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's ability to collect unpaid rent and to exercise other rights and remedies in bankruptcy proceedings involving tenant, operator, borrow, manager and other obligors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's ability to find replacement tenants as needed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's ability to control incremental costs associated with COVID-19, including increased costs resulting from higher inflation and insurance costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• continued staffing shortages resulting from the COVID-19 pandemic and other actions taken by local and national governments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• potential litigation expenses and increased reputational risk; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's ability to pay distributions at expected levels or at all.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

Given the ongoing and dynamic nature of the circumstances surrounding the COVID-19 pandemic, it remains challenging to predict the ultimate impact of the COVID-19 pandemic on the global economy, the Company's residents and operators, or for how long disruptions are likely to continue. The COVID-19 pandemic also may have the effect of heightening many of the other risks described below.

***If the Company does not successfully implement a liquidity event, investors may have to hold an investment for an indeterminate period of time.***

In April 2018, the Company's board of directors formed a special committee consisting solely of independent directors ("Special Committee") to consider possible strategic alternatives to provide liquidity to the Company's stockholders. In connection with its consideration of Possible Strategic Alternatives, the board of directors suspended both the Company's Reinvestment Plan and Redemption Plan effective July 11, 2018 and committed to a plan to sell 70 properties consisting of medical office buildings, acute-care properties, post-acute care properties and skilled nursing facilities.

Between April 2019 and December 31, 2021, the Company sold 69 of these properties resulting in net proceeds to the Company of approximately $1.4497 billion. The Company used the net sales proceeds to: (1) repay indebtedness secured by or allocated to the sold properties; (2) strategically rebalance other corporate borrowings; (3) make a special cash distribution of $347.9 million to stockholders and (4) for other corporate purposes. In March 2022, the Company entered into a purchase and sale agreement for the last property in its MOB/Healthcare Portfolio, the remaining specialty hospital ("Hurst Specialty Hospital"), with an unrelated third party and in April 2022, sold it and received net sales proceeds of approximately $8.3 million. As of December 31, 2022, the Company's investment portfolio consisted of interests in 70 properties, comprising of 69 seniors housing communities and one vacant land parcel.

Our Special Committee continues to actively work with our financial advisor to identify potential strategic options, which may include other transactions to provide stockholders with liquidity for their investment. The COVID-19 pandemic and general macroeconomic conditions have adversely affected the real estate market for properties like those currently owned by the Company. Valuations of properties have declined as a result of changes in operating income, lower estimates of earnings growth, and an expansion of capitalization rates. Additionally, rising interest rates in a high inflation environment may adversely impact the valuation of the Company's assets as debt capital available to potential buyers becomes more expensive. As a result, the Company may have to own and operate its remaining properties if and until market conditions improve. Even if the Company consummates a liquidity event, the Company cannot guarantee that the Company will be able to liquidate all of the Company's remaining assets on favorable terms, if at all. The timing of the sale of assets will depend on real estate and financial markets, economic conditions in areas in which its investments are located and federal income tax effects on stockholders that may prevail in the future.

If the Company is unable to consummate a liquidity event or delays such a transaction due to market conditions, the Company's common stock may continue to be illiquid and investors may, for an indeterminate period of time, be unable to convert investor shares to cash easily, if at all, and could suffer losses on an investment in the Company's shares.

***In determining the Company's estimated NAV per share, the Company primarily relied upon a valuation of the Company's portfolio of properties and debt as of December 31, 2022. Valuations and appraisals of the Company's properties and outstanding debt are estimates of fair value and may not necessarily correspond to realizable value upon the sale of such properties. Therefore, the Company's estimated NAV per share may not reflect the amount that would be realized upon a sale of each of the Company's properties.***

For the purposes of calculating the Company's estimated NAV per share, the Company retained an independent third-party valuation firm as valuation expert to determine the Company's estimated NAV per share and the value of the Company's properties and debt as of December 31, 2022. The valuation methodologies used to estimate the NAV of the Company's shares as well as the value of the Company's properties and outstanding debt involved certain subjective judgments, including but not limited to, discounted cash flow analyses and the direct capitalization approach for wholly owned and partially owned properties. Ultimate realization of the value of an asset depends to a great extent on economic and other conditions beyond the Company's control. Further, valuations do not necessarily represent the price at which an asset would sell, since market prices of assets can only be determined by negotiation between a willing buyer and seller. Therefore, the valuations of the Company's properties and the Company's investments in real estate-related assets may not correspond to the realizable value upon a sale of those assets. In addition, reduced occupancy levels at the Company's properties, as well as disruptions in the financial markets or deteriorating economic conditions that differ from what the Company anticipated at the time the Company acquired the properties could result in decreased values for such properties. As a result, the value of the Company's real estate investments could decrease below the amounts the Company paid for the investments and also adversely affect NAV.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

The Company's valuation procedures and its NAV are not subject to accounting principles generally accepted in the United States, or GAAP, and will not be subject to independent audit. The Company's NAV may differ from equity (net assets) reflected on the Company's audited financial statements, even if the Company is required to adopt a fair value basis of accounting for GAAP financial statement purposes.

***Seniors housing properties in the Company's portfolio may not be readily adaptable to other uses.***

Seniors housing properties are specific-use properties that have limited alternative uses. Therefore, if the operations of any of the Company's properties become unprofitable for the Company's tenant or operator or for the Company due to industry competition, a general deterioration of the applicable industry or otherwise, then the Company may have great difficulty re-leasing the property or developing an alternative use for the property and the liquidation value of the property may be substantially less than would be the case if the property were readily adaptable to other uses. Should any of these events occur, the Company's income and cash available for distribution and the value of the Company's property portfolio could be reduced.

***The financial condition of our operators and tenants can impact the Company's operating revenue.***

Although the Company's operating lease agreements provide it with the right to evict a tenant, demand immediate payment of rent and exercise other remedies, the bankruptcy and insolvency laws afford certain rights to a party that has filed for bankruptcy or reorganization. A tenant, operator, borrower, manager, or other obligor in bankruptcy or subject to insolvency proceedings may be able to limit or delay the Company's ability to collect unpaid rent and to exercise other rights and remedies. In addition, if a lease is rejected in a tenant bankruptcy, the Company's claim against the tenant may be limited by applicable provisions of the bankruptcy law. The Company may be required to fund certain expenses (e.g., real estate taxes and maintenance) to preserve the value of an investment property, avoid the imposition of liens on a property and/or transition a property to a new tenant. If the Company has terminated its lease with a tenant, the Company may not be able to find another tenant under current conditions due to the country's current economic conditions, including impacts to the industry and other macroeconomic effects of the COVID-19 pandemic. If the Company cannot transition a leased property to a new tenant, the Company may take possession of that property, which may expose it to certain successor liabilities. Publicity about the operator's financial condition and insolvency proceedings may also negatively impact their and the Company's reputations, decreasing customer demand and revenues. Should such events occur, the Company's revenue and operating cash flow may be adversely affected.

***Events which adversely affect the ability of seniors to afford the Company's daily resident fees could cause the occupancy rates, resident fee revenues and results of operations of the Company's seniors housing properties to decline.***

Costs to seniors associated with certain types of the seniors housing properties the Company acquires generally are not reimbursable under government reimbursement programs such as Medicaid and Medicare. A significant majority of the resident fee revenues generated by the Company's properties are derived from private payment sources consisting of income or assets of residents or their family members. Only seniors with income or assets meeting or exceeding certain standards can typically afford to pay the Company's daily resident and service fees and, in some cases, entrance fees. Economic downturns such as the one recently experienced in the U.S., reductions, or declining growth of government entitlement programs, such as social security benefits, inflation, or stock market volatility could adversely affect the ability of seniors to afford the fees for the Company's seniors housing properties. If the Company's tenants or managers are unable to attract and retain seniors with sufficient income, assets or other resources required to pay the fees associated with assisted and independent living services, the occupancy rates, resident fee revenues and results of operations for these properties could decline, which, in turn, could have a material adverse effect on the Company's business.

***Inflation could adversely impact the operating expenses of our tenants and operators.***

Recent increases and continuing increases in the rate of inflation, both real and anticipated, as well as any resulting governmental policies, could adversely affect the economy and the costs of labor, goods and services to our tenants and operators. Increased operating costs could have an adverse impact if operating expenses exceed the pace of increases in revenue at our operating properties. Similarly, if increases in tenants' operating expenses exceed increases in their revenue, this may adversely affect our tenants' ability to pay rent owed to us. An increase in our tenants' expenses and a failure of their revenues to increase at least with inflation could adversely impact our tenants' and our financial condition and our results of operations.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***Inflation could rise at rates that outpace contractual or actual increases in rental income.***

Our long-term leases typically contain provisions, such as rent escalators, designed to mitigate the adverse impact of inflation. If the contractual or actual increases in rental income we receive from our operators do not keep pace with a rise in inflation, our financial condition and our results of operations could be adversely impacted. Inflation could erode the value of long-term leases that do not contain indexed escalation provisions, or contain fixed annual rent escalation provisions that are at rates lower than the rate of inflation, and increase expenses including those that cannot be passed through under our leases. Increased inflation could also increase our general and administrative expenses and, as a result of an increase in market interest rate in response to higher than anticipated inflation rate, increase our mortgage and debt interest costs, and these costs could increase at a rate higher than our rent increases.

***There can be no assurance that the Company will be able to achieve expected cash flows necessary to pay or maintain distributions at any particular level or that distributions will continue over time.***

There are many factors that can affect the availability and timing of distributions to stockholders. Distributions generally will be based upon such factors as the amount of cash available or anticipated to be available from real estate investments, current and projected cash requirements and tax considerations. Distributions may be limited in whole or in part by covenants of the Company's Revolving Credit Facility or other loans. Because the Company receives income from property operations and interest or rents at various times during the Company's fiscal year, distributions paid may not reflect the Company's income earned in that particular distribution period. The amount of cash available for distributions is affected by many factors, such as the income from the Company's real estate investments, the Company's operating expense levels and many other variables. Actual cash available for distribution may vary substantially from estimates. The Company's actual results may differ significantly from the assumptions used by the Company's board of directors in establishing the distribution rates to be paid on its shares.

The Company cannot assure investors that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• rents or operating income from the Company's properties will remain stable or increase; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• tenants will not default under or terminate their leases.

Many of the factors that can affect the availability and timing of cash distributions to stockholders are beyond the Company's control, and a change in any one factor could adversely affect the Company's ability to pay distributions. For instance:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash available for distributions may decrease if the Company is required to spend money to correct defects or to make improvements to properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Federal income tax laws require REITs to distribute at least 90% of their taxable income to stockholders each year. The Company has elected to be treated as a REIT for tax purposes, and this limits the earnings that the Company may retain for corporate growth, such as asset acquisition, development or expansion, and will make the Company more dependent upon additional debt or equity financing than corporations that are not REITs. If the Company borrows more funds in the future, more of the Company's operating cash will be needed to make debt payments and cash available for distributions may decrease.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The payment of principal and interest required to service the debt resulting from the Company's policy to use leverage to acquire assets may leave the Company with insufficient cash to pay distributions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Because the Company has elected to be taxed as a REIT, the Company may pay distributions to the Company's stockholders to comply with the distribution requirements of the Code, and to eliminate, or at least minimize, exposure to federal income taxes and the nondeductible REIT excise tax. Differences in timing between the receipt of income and the payment of expenses, and the effect of required debt payments, could require the Company to borrow funds on a short-term basis to meet the distribution requirements that are necessary to achieve the tax benefits associated with qualifying as a REIT.

In addition, subject to the applicable REIT rules, the Company's board of directors, in its discretion, may retain any portion of the Company's cash on hand for capital needs and other corporate purposes. Future distribution levels are subject to adjustment based upon any one or more of the risk factors set forth in this Annual Report, as well as other factors that the Company's board of directors may, from time to time deem relevant to consider when determining an appropriate common stock distribution.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***An investment return may be reduced if the Company is required to register as an investment company under the Investment Company Act.***

The Company is not registered and does not intend to register the Company or any of its subsidiaries, as an investment company under the Investment Company Act. If the Company or any of its subsidiaries becomes obligated to register as an investment company, the registered entity would have to comply with a variety of substantive requirements under the Investment Company Act imposing, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• limitations on capital structure;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• restrictions on specified investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• prohibitions on transactions with affiliates; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• compliance with reporting, record keeping, voting, proxy disclosure and other rules and regulations that would significantly change the Company's operations.

The Company believes it conducts its operations, directly and through the Company's wholly and majority owned subsidiaries, so that neither the Company nor any of its subsidiaries will be an investment company and, therefore, will not be required to register as an investment company under the Investment Company Act. Under Section 3(a)(1)(A) of the Investment Company Act, a company is deemed to be an "investment company" if it is, or holds itself out as being, engaged primarily, or proposes to engage primarily, in the business of investing, reinvesting or trading in securities. Under Section 3(a)(1)(C) of the Investment Company Act, a company is deemed to be an "investment company" if it is engaged, or proposes to engage, in the business of investing, reinvesting, owning, holding or trading in securities and owns or proposes to acquire "investment securities" having a value exceeding 40% of the value of its total assets (exclusive of government securities and cash items) on an unconsolidated basis, which the Company refers to as the "40% Test."

Since the Company is primarily engaged in the business of acquiring real estate, the Company believes that the Company and most, if not all, of the Company's wholly and majority-owned subsidiaries will not be considered investment companies under either Section 3(a)(1)(A) or Section 3(a)(1)(C) of the Investment Company Act. If the Company or any of the Company's wholly or majority-owned subsidiaries would ever inadvertently fall within one of the definitions of "investment company," the Company intends to rely on the exception provided by Section 3(c)(5)(C) of the Investment Company Act. Under Section 3(c)(5)(C), a company generally must maintain at least 55% of its assets directly in what are deemed "qualifying" real estate assets and at least 80% of the entity's assets in such qualifying assets and in a broader category of what are deemed "real estate-related" assets to qualify for this exception.

If the Company were required to register as an investment company but failed to do so, it would be prohibited from engaging in the Company's business, and criminal and civil actions could be brought against the Company. In addition, the Company's contracts would be unenforceable unless a court required enforcement, and a court could appoint a receiver to take control of the Company and liquidate its business.

***Cyber security risks and cyber incidents could adversely affect the Company's business and disrupt operations.***

Cyber incidents can result from deliberate attacks or unintentional events. These incidents can include, but are not limited to, gaining unauthorized access to digital systems for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. The result of these incidents could include, but are not limited to, disrupted operations, misstated financial data, liability for stolen assets or information, increased cyber security protection costs, litigation and reputational damage adversely affecting customer or investor confidence.

***Damage from catastrophic weather and other natural events and climate change could result in losses to us.***

Certain of our properties are located in areas that may experience catastrophic weather and other natural events from time to time, including hurricanes or other severe weather, flooding, fires, snow or ice storms, windstorms or, earthquakes. These adverse weather and natural events could cause substantial damages or losses to our properties which could exceed our insurance coverage. In the event of a loss in excess of insured limits, we could lose our capital invested in the affected property, as well as anticipated future revenue from that property. We could also continue to be obligated to repay any mortgage indebtedness or other obligations related to the property.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

To the extent that significant changes in the climate occur, we may experience extreme weather and changes in precipitation and temperature and rising sea levels, all of which may result in physical damage to or a decrease in demand for properties located in these areas or affected by these conditions. The impact of climate change may be material in nature, including destruction of our properties, or occur for lengthy periods of time.

Growing public concern about climate change has resulted in the increased focus of local, state, regional, national and international regulatory bodies on greenhouse gas ("GHG") emissions and climate change issues. Legislation to regulate GHG emissions has periodically been introduced in the U.S. Congress, and there has been a wide-ranging policy debate, both in the U.S. and internationally, regarding the impact of these gases and possible means for their regulation. Federal, state or foreign legislation or regulation on climate change could result in increased capital expenditures to improve the energy efficiency of our existing properties or to protect them from the consequence of climate change and could also result in increased compliance costs or additional operating restrictions that could adversely impact the businesses of our tenants and their ability to pay rent.

***Discovery of previously undetected environmentally hazardous conditions may adversely affect our operating results.***

Under various federal, state and local environmental laws, ordinances and regulations, a current or previous owner or operator of real property may be liable for the cost of removal or remediation of hazardous or regulated substances on, under, in or about such property. The costs of investigation, removal or remediation of such substances could be substantial. Those laws may impose liability whether or not the owner or operator knew of, or was responsible for, the presence of the substances.

Environmental laws also may impose restrictions on the manner in which property may be used or businesses may be operated, and compliance with those restrictions may require substantial expenditures. Environmental laws provide for sanctions in the event of noncompliance and may be enforced by governmental agencies or, in certain circumstances, by private parties. Certain environmental laws and common law principles govern the presence, maintenance, removal and disposal of certain building materials, including mold, asbestos and lead-based paint.

The cost of defending against such claims of liability, of compliance with environmental requirements, of remediating any contaminated property, or of paying personal injury claims could materially adversely affect our business, assets or results of operations and, consequently, the amounts available for distribution to our stockholders.

We cannot assure our stockholders that properties which we acquired will not have any material environmental conditions, liabilities or compliance concerns. Accordingly, we have no way of determining at this time the magnitude of any potential liability to which we may be subject arising out of environmental conditions or violations with respect to the properties we own.

**Risks Related to Conflicts of Interest and the Company's Relationships with Its Advisor and Its Affiliates**

***The Advisor and its affiliates, including all of the Company's executive officers and affiliated directors, face conflicts of interest as a result of their compensation arrangements with the Company, which could result in actions that are not in the best interest of the Company's stockhold****ers.*

The Company pays its Advisor and its affiliates substantial fees. These fees could influence their advice to the Company, as well as the judgment of affiliates of the Advisor performing services for the Company. Among other matters, these compensation arrangements could affect their judgment with respect to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the continuation, renewal, or enforcement of the Company's agreements with its Advisor and its affiliates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• property sales, which may entitle the Advisor to disposition fees;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• property acquisitions from third parties, which entitle the Advisor to an investment services fee;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• borrowings to acquire assets, which increase the investment services fees and asset management fees payable to the Advisor and which entitle the Advisor or its affiliates to receive other acquisition fees in connection with assisting in obtaining financing for assets if approved by the Company's board of directors, including a majority of the Company's independent directors;

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• whether the Company seeks to internalize its management functions, which could result in it retaining some of the Advisor's and its affiliates' key officers for compensation that is greater than that which they currently earn or which could require the Company to make additional payments to the Advisor or its affiliates to purchase the assets and operations of the Advisor and its affiliates performing services for the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the listing of, or other liquidity event with respect to, the Company's shares, which may entitle the Advisor to a subordinated incentive fee.

The fees the Advisor receives in connection with transactions involving the purchase and management of the Company's assets are not necessarily based on the quality of the investment or the quality of the services rendered to the Company. The basis upon which fees are calculated may influence the Advisor to recommend riskier transactions to the Company.

***None of the agreements with the Advisor or any other affiliates were negotiated at arm's length.***

Agreements with the Advisor or any other affiliates may contain terms that would not otherwise apply if the Company entered into agreements negotiated at arm's length with third parties.

***If the Company internalizes the Company's management functions, an interest in the Company could be diluted, the Company could incur other significant costs associated with being self-managed, and the Company may not be able to retain or replace key personnel and may have increased exposure to litigation.***

The Company may internalize management functions provided by the Advisor and its affiliates. The Company's board of directors may decide in the future to acquire assets and personnel from the Advisor or its affiliates for consideration that would be negotiated at that time. However, as a result of the non-solicitation clause in the advisory agreement, generally the acquisition of Advisor personnel would require the prior written consent of the Advisor. There can be no assurances that the Company will be successful in retaining the Advisor's key personnel in the event of an internalization transaction. In the event the Company acquires the Advisor, the Company cannot be sure of the form or amount of consideration or other terms relating to any such acquisition, which could take many forms, including cash payments, promissory notes, and shares of the Company's stock. The payment of such consideration could reduce the percentage of the Company's shares owned by the Company's current stockholders and could reduce the net income per share and FFO per share attributable to their current stockholdings.

In addition, the Company may issue equity awards to officers and consultants, which would reduce the percentage of the Company's shares owned by the Company's current stockholders, increase operating expenses and decrease net income and FFO. The Company cannot reasonably estimate the amount of fees to the Advisor and other affiliates the Company would save, and the costs it would incur, if the Company acquired these entities. If the expenses the Company assumes as a result of an internalization are higher than the expenses the Company avoids paying to the Advisor and other affiliates, its net income per share and FFO per share would be lower than they otherwise would have been had the Company not internalized management functions.

Additionally, if the Company internalizes its management functions, the Company could have difficulty integrating these functions. Currently, the officers of the Advisor and its affiliates perform asset management and general and administrative functions, including accounting and financial reporting, for multiple entities. The Company may fail to properly identify the appropriate mix of personnel and capital needs to operate as a stand-alone entity. An inability to manage an internalization transaction effectively could result in the Company's incurring additional costs and divert its management's attention from effectively managing the Company's properties and overseeing other real estate-related assets.

Internalization transactions have been the subject of stockholder litigation. Stockholder litigation can be costly and time-consuming, and there can be no assurance that any litigation expenses the Company might incur would not be significant or that the outcome of litigation would be favorable to the Company. Any amounts the Company is required to expend defending any such litigation will reduce the amount of funds available for investment by the Company in properties or other investments.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***The Company is not in privity of contract with service providers that may be engaged by the Advisor to perform advisory services and they may be insulated from liabilities to the Company, and the Advisor has minimal assets with which to remedy any liabilities to the Company.***

The Advisor sub-contracts with affiliated or unaffiliated service providers for the performance of substantially all of its advisory services. The Advisor has engaged affiliates of the Sponsor to perform certain services on its behalf pursuant to agreements to which the Company is not a party. As a result, the Company is not in privity of contract with any such service provider and, therefore, such service provider has no direct duties, obligations, or liabilities to the Company. In addition, the Company has no right to any indemnification to which the Advisor may be entitled under any agreement with a service provider. The service providers the Advisor may subcontract with may be insulated from liabilities to the Company for services they perform but may have certain liabilities to the Advisor. The Advisor has minimal assets with which to remedy liabilities to the Company resulting under the advisory agreement.

**Financing Related Risks**

***The Company may enter into agreements with lenders which restrict the Company's ability to pay distributions to investors****.*

The Company's Revolving Credit Facility contains limitations on distributions and the extent of allowable distributions. The Company's Revolving Credit Facility requires that allowable distributions not exceed 95% of adjusted FFO (as defined in the Revolving Credit Facility agreement) and limits the minimum amount of distributions required to maintain the Company's REIT status. These and other similar restrictions in loan agreements the Company may enter into impact the Company's ability to pay distributions to investors.

***Mortgage indebtedness and other borrowings will increase the Company's business risks.***

The Company has incurred and may increase the Company's mortgage debt by obtaining loans collateralized by some or all of the Company's assets to obtain funds to acquire additional investments or to pay distributions to the Company's stockholders. If necessary, the Company also may borrow funds to satisfy the requirement that the Company distribute at least 90% of the Company's annual taxable income, or otherwise as is necessary or advisable to assure that the Company maintain the Company's qualification as a REIT for federal income tax purposes.

The Company's charter provides that it may not borrow more than 300% of the value of the Company's net assets without the approval of a majority of the Company's independent directors and the borrowing must be disclosed to the Company's stockholders in the Company's first quarterly report after such approval. Borrowing may be risky if the cash flow from the Company's properties and other real estate-related investments is insufficient to meet the Company's debt obligations. In addition, the Company's lenders may seek to impose restrictions on future borrowings, distributions and operating policies, including with respect to capital expenditures and asset dispositions. If the Company mortgages assets or pledges equity as collateral and the Company cannot meet the Company's debt obligations, then the lender could take the collateral, and the Company would lose the asset or equity and the income the Company were deriving from the asset.

***The Company uses credit facilities to finance the Company's investments, which may require the Company to provide additional collateral and significantly impact its liquidity position*.** 

Some of the Company's credit facilities contain mark-to-market provisions providing that if the market value of the commercial real estate debt or securities pledged by the Company declines in value due to credit quality deterioration, the Company may be required by the Company's lenders to provide additional collateral or pay down a portion of the Company's borrowings. In a weak economic environment, the Company would generally expect credit quality and the value of the commercial real estate debt or securities that serve as collateral for the Company's credit facilities to decline, and in such a scenario it is likely that the terms of the Company's credit facilities would require partial repayment from the Company, which could be substantial. Posting additional collateral to support the Company's credit facilities could significantly reduce the Company's liquidity and limit its ability to leverage its assets. In the event the Company does not have sufficient liquidity to meet such requirements, the Company's lenders can accelerate the Company's borrowings, which could have a material adverse effect on its business and operations.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***Financing arrangements involving balloon payment obligations may adversely affect the Company's ability to make distributions.***

The Company sometimes enters into fixed-term financing arrangements which require it to make "balloon" payments at maturity. The Company's ability to pay or refinance such obligations at maturity is uncertain and may depend upon the Company's ability to obtain additional financing or sell a particular property. At the time the balloon payment is due, the Company may not be able to raise equity or refinance the balloon payment on terms as favorable as the original loan or sell the property at a price sufficient to make the balloon payment. These refinancing or property sales could negatively impact the rate of return to stockholders and the timing of disposition of the Company's assets. In addition, payments of principal and interest may leave the Company with insufficient cash to pay the distributions that the Company is required to pay to maintain its qualification as a REIT.

***The Company may acquire various financial instruments for purposes of "hedging" or reducing the Company's risks which may be costly and/or ineffective and will reduce the Company's cash available for distribution to its stockholders.***

The Company may engage in hedging transactions to manage the risk of changes in interest rates, price changes or currency fluctuations with respect to borrowings made or to be made, or ordinary obligations incurred or to be incurred, by the Company. The Company may use derivative financial instruments for this purpose, collateralized by the Company's assets and investments. Derivative instruments may include interest rate swap contracts, interest rate cap or floor contracts, futures or forward contracts, options or repurchase agreements. The Company's actual hedging decisions will be determined in light of the facts and circumstances existing at the time of the hedge and may differ from time to time. Hedging activities may be costly or become cost-prohibitive and the Company may have difficulty entering into hedging transactions.

To the extent that the Company uses derivative financial instruments to hedge against exchange rate and interest rate fluctuations, the Company will be exposed to credit risk, basis risk and legal enforceability risks. In this context, credit risk is the failure of the counterparty to perform under the terms of the derivative contract. If the fair value of a derivative contract is positive, the counterparty owes the Company, which creates credit risk for the Company. Basis risk occurs when the index upon which the contract is based is more or less variable than the index upon which the hedged asset or liability is based, thereby making the hedge less effective. Finally, legal enforceability risks encompass general contractual risks, including the risk that the counterparty will breach the terms of, or fail to perform its obligations under, the derivative contract. The Company may be unable to manage these risks effectively.

**Regulation**

***The Company's failure or the failure of the tenants and managers of the Company's properties to comply with licensing and certification requirements, the requirements of governmental programs, fraud and abuse regulations or new legislative developments may materially adversely affect the operations of the Company's seniors housing properties.***

The operations of the Company's seniors housing properties are subject to numerous federal, state, and local laws and regulations that are subject to frequent and substantial changes resulting from legislation, adoption of rules and regulations, and administrative and judicial interpretations of existing laws. The ultimate timing or effect of any changes in these laws and regulations cannot be predicted. Failure to obtain licensure or loss or suspension of licensure or certification may prevent a facility from operating or result in a suspension of certain revenue sources until all licensure or certification issues have been resolved. Properties may also be affected by changes in accreditation standards or procedures of accrediting agencies that are recognized by governments in the certification process. State laws may require compliance with extensive standards governing operations and agencies administering those laws regularly inspect such properties and investigate complaints. Failure to comply with all regulatory requirements could result in the loss of the ability to provide or bill and receive payment for healthcare services at the Company's seniors housing properties. Additionally, transfers of operations of certain facilities are subject to regulatory approvals not required for transfers of other types of commercial operations and real estate. The Company has no direct control over the tenant's or manager's ability to meet regulatory requirements and failure to comply with these laws, regulations and requirements may materially adversely affect the operations of these properties.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

In addition, if the Company leases a seniors housing property to the Company's TRS rather than leasing the property to a third-party tenant, the Company's TRS will generally be the license holder and become subject to state licensing requirements and certain operating risks that apply to facility operators, including regulatory violations and third-party actions for negligence or misconduct. The TRS will have increased liability resulting from events or conditions that occur at the facility, including, for example, injuries to residents and deaths of residents at the facility. In the event the TRS incurs liability and a successful claim is made that the separate legal status of the TRS should be ignored for equitable or other reasons (i.e. a corporate veil piercing claim), the Company may also become liable for such matters. Insurance may not cover all such liabilities. Any negative publicity resulting from lawsuits related to the Company's TRS status as a licensee could adversely affect the Company's business reputation and ability to attract and retain residents in the Company's leased properties, the Company's ability to obtain or maintain licenses at the affected facility and other facilities, and the Company's ability to raise additional capital.

***Termination of resident lease agreements could adversely affect the Company's revenues and earnings for seniors housing properties providing assisted living services.***

Applicable regulations governing assisted living properties generally require written resident lease agreements with each resident. Most of these regulations also require that each resident have the right to terminate the resident lease agreement for any reason on reasonable notice or upon the death of the resident. The operators of seniors housing properties cannot contract with residents to stay for longer periods of time, unlike typical apartment leasing arrangements with terms of up to one year or longer. In addition, the resident turnover rate in the Company's properties may be difficult to predict. If a large number of resident lease agreements terminate at or around the same time, and if the Company's units remained unoccupied, then the Company's tenant's ability to make scheduled rent payments to the Company or, with respect to certain of the Company's seniors housing properties lease to TRS entities, the Company's operating results, the Company's revenues and the Company's earnings could be adversely affected.

***Legislation and government regulation may adversely affect the operations of the Company's properties.***

Certain of the operations conducted on the Company's properties require permits, licenses, and approvals from certain federal, state, and local authorities. Material permits, licenses or approvals may be terminated, not renewed, or renewed on terms or interpreted in ways that are materially less favorable to the Company. Furthermore, laws and regulations that the Company or the Company's operators are subject to may change in ways that are difficult to predict. There can be no assurance that the application of laws, regulations or policies, or changes in such laws, regulations and policies, will not occur in a manner that could have a detrimental effect on any property the Company may acquire, the operations of such property and the amount of rent it receives from the tenant of such property.

**Tax Related Risks** 

***Failure to qualify as a REIT would adversely affect the Company's operations and the Company's ability to pay distributions to investors.***

The Company believes it operates as a REIT under the Code and believes the Company will continue to operate as a REIT in such manner. However, qualification as a REIT involves the application of highly technical and complex Code provisions for which there are only limited judicial and administrative interpretations. The determination of various factual matters and circumstances not entirely within the Company's control may also affect the Company's ability to remain qualified as a REIT. If the Company fails to qualify as a REIT for any taxable year, (i) the Company will be subject to federal and state income tax on the Company's taxable income for that year at regular corporate rates, (ii) for taxable years beginning before December 31, 2017, the Company may be subject to alternative minimum tax on the Company's taxable income for that year at regular corporate rates, (iii) unless entitled to relief under relevant statutory provisions, the Company would generally be disqualified from taxation as a REIT for the four taxable years following the year of disqualification as a REIT; and (iv) distributions to stockholders would no longer qualify for the dividends paid deduction in computing the Company's taxable income. If the Company does not qualify as a REIT, the Company would not be required to make distributions to stockholders as a non-REIT is not required to pay dividends to stockholders in order to maintain REIT status or avoid an excise tax. The additional income tax liability the Company would incur as a result of failing to qualify as a REIT would reduce the Company's net earnings available for distributions to stockholders and also reduce the funds available for satisfying the Company's obligations in general. If the Company fails to qualify as a REIT, the Company may be required to borrow funds or liquidate some investments in order to pay the applicable tax. As a result of all these factors, the Company's failure to qualify as a REIT also could impair the Company's ability to implement its business strategy and would adversely affect the value of its stock.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***The Company's leases may be re-characterized as financings which would eliminate depreciation deductions with respect to the Company's properties.***

The Company believes that it would be treated as the owner of properties where the Company would own the underlying real estate, except with respect to leases structured as "financing leases," which would constitute financings for federal income tax purposes. If the lease of a property does not constitute a lease for federal income tax purposes and is re-characterized as a secured financing by the IRS, then the Company believes the lease should be treated as a financing arrangement and the income derived from such a financing arrangement should satisfy the 75% and the 95% gross income tests for REIT qualification as it would be considered to be interest on a loan collateralized by real property. Nevertheless, the re-characterization of a lease in this fashion may have adverse tax consequences for the Company. In particular, the Company would not be entitled to claim depreciation deductions with respect to the property (although the Company should be entitled to treat part of the payments the Company would receive under the arrangement as the repayment of principal and not rent). In such event, in some taxable years the Company's taxable income, and the corresponding obligation to distribute 90% of such income, would be increased. With respect to leases structured as "financing leases," the Company will report income received as interest income and will not take depreciation deductions related to the real property. Any increase in the Company's distribution requirements may limit the Company's ability to invest in additional properties and to make additional mortgage loans. No assurance can be provided that the IRS would re-characterize such transactions as financings that would qualify under the 95% and 75% gross income tests.

***The Company may have to borrow funds or sell assets to meet the Company's distribution requirements.***

Subject to some adjustments that are unique to REITs, a REIT generally must distribute 90% of its taxable income to its stockholders. For the purpose of determining taxable income, the Company may be required to accrue interest, rent and other items treated as earned for tax purposes, but that it has not yet received. In addition, the Company may be required not to accrue as expenses for tax purposes some items which actually have been paid, or some of the Company's deductions might be subject to certain disallowance rules under the Code. As a result, the Company could have taxable income in excess of cash available for distribution. If this occurs, the Company may have to borrow funds or liquidate some of its assets in order to meet the distribution requirements applicable to a REIT.

***Even as a REIT, the Company remains subject to various taxes which would reduce operating cash flow if and to the extent certain liabilities are incurred.***

Even as a REIT, the Company is or could be subject to federal, foreign and state and local taxes on the Company's income and property that could reduce operating cash flow, including but not limited to: (i) tax on any undistributed taxable income; (ii) for taxable years beginning before December 31, 2017, alternative minimum tax on the Company's items of tax preference; (iii) certain state income taxes (because not all states treat REITs the same as they are treated for federal income tax purposes); (iv) a tax equal to 100% of net gain from "prohibited transactions"; (v) tax on net gains from the sale of certain "foreclosure property"; (vi) tax on gains of sale of certain "built-in gain" properties; and (vii) certain taxes and penalties if the Company fails to comply with one or more REIT qualification requirements, but nevertheless qualifies to maintain the Company's status as a REIT. Foreclosure property includes property with respect to which the Company acquires ownership by reason of a borrower default on a loan or possession by reason of a tenant's default on a lease. The Company may elect to treat certain qualifying property as "foreclosure property," in which case, the gross revenue and net gain from such property will be treated as qualifying income under the 75% and 95% gross income tests for three years following such acquisition. To qualify for such treatment, the Company must satisfy additional requirements, including that the Company operate the property through an independent contractor after a short grace period. The Company will be subject to tax on the Company's net income from foreclosure property. Such net income generally means the excess of any gain from the sale or other disposition of foreclosure property and income derived from foreclosure property that otherwise does not qualify for the 75% gross income test, over the allowable deductions that relate to the production of such income. Any such tax incurred will reduce the amount of cash available for distribution.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***The Company's investment strategy may cause the Company to incur penalty taxes, fail to maintain the Company's REIT status or own and sell properties through TRSs, each of which would diminish the return to the Company's stockholders.***

The sale of one or more of the Company's properties may be considered a prohibited transaction under the Code. Any "inventory-like" sales would almost certainly be considered such a prohibited transaction. If the Company is deemed to have engaged in a "prohibited transaction" (i.e., the Company sells a property held by the Company primarily for sale in the ordinary course of the Company's trade or business), all net gain that the Company derives from such sale would be subject to a 100% penalty tax. The Code sets forth a safe harbor for REITs that wish to sell property without risking the imposition of the 100% penalty tax. The principal requirements of the safe harbor are that: (i) the REIT must hold the applicable property for not less than two years for the production of rental income prior to its sale; (ii) the aggregate expenditures made by the REIT, or any partner of the REIT, during the two-year period preceding the date of sale which are includible in the basis of the property do not exceed 30% of the net selling price of the property; and (iii) the REIT does not make more than seven sales of property during the taxable year, the aggregate adjusted bases of property sold during the taxable year does not exceed 20% of the aggregate bases of all of the REIT's assets as of the beginning of the taxable year or the fair market value of property sold during the taxable year does not exceed 20% of the fair market value of all of the REIT's assets as of the beginning of the taxable year (this percentage threshold was 10% of the aggregate bases or fair market value of all of the REIT's assets, as the case may be, for taxable years beginning before December 18, 2015). Given the Company's investment strategy, the sale of one or more of its properties may not fall within the prohibited transaction safe harbor.

If the Company desires to sell a property pursuant to a transaction that does not fall within the safe harbor, the Company may be able to avoid the prohibited transaction tax if the Company acquired the property through a TRS, or acquired the property and transferred it to a TRS for a non-tax business purpose prior to the sale (i.e., for a reason other than the avoidance of taxes). The Company may decide to forego the use of a TRS in a transaction that does not meet the safe harbor based on the Company's own internal analysis, the opinion of counsel or the opinion of other tax advisors that the disposition will not be subject to the prohibited transaction tax. In cases where a property disposition is not effected through a TRS, the IRS could successfully assert that the disposition constitutes a prohibited transaction, in which event all of the net gain from the sale of such property will be payable as a tax which will have a negative impact on cash flow and the ability to make cash distributions.

As a REIT, the value of the Company's ownership interests held in the Company's TRSs may not exceed 20% of the value of all of the Company's assets at the end of any calendar quarter (25% for taxable years beginning before December 31, 2017). If the IRS were to determine that the value of the Company's interests in all of the Company's TRSs exceeded 20% of the value of the Company's total assets at the end of any calendar quarter, then the Company would fail to qualify as a REIT. If the Company determines it to be in its best interest to own a substantial number of the Company's properties through one or more TRSs, then it is possible that the IRS may conclude that the value of the Company's interests in the Company's TRSs exceeds 20% of the value of the Company's total assets at the end of any calendar quarter and therefore cause the Company to fail to qualify as a REIT. Additionally, as a REIT, no more than 25% of the Company's gross income with respect to any year may be from sources other than real estate. Distributions paid to the Company from a TRS are considered to be non-real estate income. Therefore, the Company may fail to qualify as a REIT if distributions from all of the Company's TRSs, when aggregated with all other non-real estate income with respect to any one year, are more than 25% of the Company's gross income with respect to such year.

***The Company's TRS structure subjects the Company to the risk that the leases with the Company's TRSs do not qualify for tax purposes as arm's-length, which would expose the Company to potentially significant tax penalties.***

The Company's TRSs generally will incur taxes or accrue tax benefits consistent with a "C" corporation for federal income tax purposes. If the leases between the Company and the Company's TRSs were deemed by the IRS to not reflect an arm's-length transaction as that term is defined by tax law, the Company may be subject to significant tax penalties as the lessor that would adversely impact the Company's profitability and the Company's cash flows.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***If the Company's operating partnership fails to maintain its status as a partnership, the operating partnership's income may be subject to taxation, which would reduce the cash available to the Company for distribution to its stockholders.***

The Company maintains the status of its operating partnership as either a disregarded entity or an entity taxable as a partnership for federal income tax purposes. However, if the IRS were to successfully challenge the status of the operating partnership as a disregarded entity or an entity taxable as a partnership, the Company's operating partnership would be taxable as a corporation. In such event, this would reduce the amount of distributions that the operating partnership could make to the Company. Additionally, this could also result in the Company's failure to qualify as a REIT and becoming subject to a corporate level tax on the Company's taxable income. This would substantially reduce the cash available to the Company to pay distributions and the return on an investment. In addition, if any of the partnerships or limited liability companies through which the Company's operating partnership owns its properties, in whole or in part, loses its characterization as a partnership or disregarded entity for federal income tax purposes, it would be subject to taxation as a corporation, thereby reducing distributions to the Company's operating partnership. Such a re-characterization of an underlying property owner could also threaten the Company's ability to maintain REIT status.

***The lease of qualified health care properties to a TRS is subject to special requirements.***

The Company leases certain qualified health care properties to TRSs (or limited liability companies of which the TRSs are members), which lessees then contract with managers (or related parties) to manage the health care operations at these properties. The rents from this TRS lessee structure are treated as qualifying rents from real property if (1) they are paid pursuant to an arm's-length lease of a qualified health care property with a TRS and (2) the manager qualifies as an eligible independent contractor (as defined in the Code). If any of these conditions are not satisfied, then the rents will not be qualifying rents and the Company might fail to meet the 95% and 75% gross income tests.

***If the Company's assets are deemed "plan assets" for the purposes of the Employee Retirement Income Security Act ("ERISA"), the Company could be subject to excise taxes on certain prohibited transactions.***

The Company believes that the Company's assets will not be deemed to be "plan assets" for purposes of ERISA and/or the Code, but the Company has not requested an opinion of counsel to that effect, and no assurances can be given that the Company's assets will never constitute "plan assets." If the Company's assets were deemed to be "plan assets" for purposes of ERISA and/or the Code, among other things, (a) certain of the Company's transactions could constitute "prohibited transactions" under ERISA and the Code, and (b) ERISA's prudence and other fiduciary standards would apply to the Company's investments (and might not be met). Among other things, ERISA makes plan fiduciaries personally responsible for any losses resulting to the plan from any breach of fiduciary duty, and the Code imposes nondeductible excise taxes on prohibited transactions. If such excise taxes were imposed on the Company, the amount of funds available for the Company to make distributions to stockholders would be reduced.

**Risks Related to the Company's Organizational Structure**

***The limit on the percentage of shares of the Company's stock that any person may own may discourage a takeover or business combination that may benefit the Company's stockholders****.*

The Company's charter restricts the direct or indirect ownership by one person or entity to no more than 9.8%, by number or value, of any class or series of the Company's equity securities (which includes common stock and any preferred stock the Company may issue). This restriction may deter individuals or entities from making tender offers for shares of the Company's common stock on terms that might be financially attractive to stockholders or which may cause a change in the Company's management. This ownership restriction may also prohibit business combinations that would have otherwise been approved by the Company's board of directors and stockholders and may also decrease stockholders' ability to sell their shares of the Company's common stock.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***The Company's board of directors can take many actions without stockholder approval which could have a material adverse effect on the distributions investors receive from the Company and/or could reduce the value of the Company's assets.***

The Company's board of directors has overall authority to conduct the Company's operations. This authority includes significant flexibility. For example, the Company's board of directors can: (i) list the Company's stock on a national securities exchange or include its stock for quotation on the National Market System of the NASDAQ Stock Market without obtaining stockholder approval; (ii) prevent the ownership, transfer and/or accumulation of shares in order to protect the Company's status as a REIT or for any other reason deemed to be in the best interests of the stockholders; (iii) authorize and issue additional shares of any class or series of stock without obtaining stockholder approval, which could dilute an ownership interest; (iv) change the Company's Advisor's compensation, and employ and compensate affiliates; (v) direct the Company's investments toward those that will not appreciate over time, such as loans and building-only properties, with the land owned by a third-party; and (vi) establish and change minimum creditworthiness standards with respect to tenants. Any of these actions could reduce the value of the Company's assets without giving investors, as stockholders, the right to vote.

***The Company's use of an operating partnership structure may result in potential conflicts of interest with limited partners other than the Company, if any, whose interests may not be aligned with those of the Company's stockholders.***

Limited partners other than the Company, if any, in the Company's operating partnership will have the right to vote on certain amendments to the operating partnership agreement, as well as on certain other matters. Persons holding such voting rights may exercise them in a manner that conflicts with the interests of the Company's stockholders. As general partner of the Company's operating partnership, the Company is obligated to act in a manner that is in the best interest of all partners of the Company's operating partnership. Circumstances may arise in the future when the interests of other limited partners in the operating partnership may conflict with the interests of the Company's stockholders. These conflicts may be resolved in a manner that stockholders do not believe is in their best interest.

**Item 1B. UNRESOLVED STAFF COMMENTS**

None.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Item 2. PROPERTIES**

As of December 31, 2022, we had investments in 70 real estate investment properties, as described in Item 1. "Business––Seniors Housing Investment Focus and Strategy." The following tables set forth details on our consolidated healthcare investment portfolio by asset class (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name and Location** | **Structure** | **Date Acquired** | **Encumbrance at 12/31/2022** | **Investment Amount** |
| **Seniors Housing (Leased)** | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primrose Retirement Community of Casper <br>Casper, WY | Triple-net Lease | 2/16/2012 | $— | $19.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sweetwater Retirement Community <br>Billings, MT | Triple-net Lease | 2/16/2012 |  | 16.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primrose Retirement Community of Grand Island <br>Grand Island, NE | Triple-net Lease | 2/16/2012 |  | 13.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primrose Retirement Community of Mansfield <br>Mansfield, OH | Triple-net Lease | 2/16/2012 |  | 18.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primrose Retirement Community of Marion <br>Marion, OH | Triple-net Lease | 2/16/2012 |  | 17.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primrose Retirement Community of Lima <br>Lima, OH | Triple-net Lease | 12/19/2012 |  | 18.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primrose Retirement Community of Zanesville <br>Zanesville, OH ("Columbus") | Triple-net Lease | 12/19/2012 |  | 19.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primrose Retirement Community of Decatur <br>Decatur, IL | Triple-net Lease | 12/19/2012 |  | 18.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primrose Retirement Community of Council Bluffs <br>Council Bluffs, IA ("Omaha") | Triple-net Lease | 12/19/2012 |  | 12.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primrose Retirement Community Cottages <br>Aberdeen, SD | Triple-net Lease | 12/19/2012 |  | 4.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primrose Retirement Community of Anderson <br>Anderson, IN ("Muncie") | Triple-net Lease | 5/29/2015 |  | 21.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primrose Retirement Community of Lancaster <br>Lancaster, OH ("Columbus") | Triple-net Lease | 5/29/2015 |  | 25.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Primrose Retirement Community of Wausau <br>Wausau, WI ("Green Bay") | Triple-net Lease | 5/29/2015 |  | 20.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wellmore of Tega Cay <br>Tega Cay, SC ("Charlotte") | Triple-net Lease | 2/7/2014 |  | 32.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wellmore of Lexington<br>Lexington, SC ("Columbia") | Triple-net Lease | 9/14/2015 |  | 53.7 |
| **Senior Housing (Managed)** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Brookridge Heights Assisted Living & Memory Care<br>Marquette, MI | Managed | 12/21/2012 |  | 18.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Curry House Assisted Living & Memory Care<br>Cadillac, MI | Managed | 12/21/2012 |  | 13.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Symphony Manor<br>Baltimore, MD | Managed | 12/21/2012 |  | 24.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Woodholme Gardens Assisted Living & Memory Care<br>Pikesville, MD ("Baltimore") | Managed | 12/21/2012 |  | 17.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tranquillity at Fredericktowne<br>Frederick, MD | Managed | 12/21/2012 |  | 23.3 |
| &nbsp;&nbsp;&nbsp;HarborChase of Villages Crossing<br> Lady Lake, FL ("The Villages") | Managed | 8/29/2012 |  | 19.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HarborChase of Jasper<br>Jasper, AL | Managed | 8/1/2013 |  | 7.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HarborChase of Plainfield<br>Plainfield, IL | Managed | 3/28/2014 |  | 26.5 |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name and Location** | **Structure** | **Date Acquired** | **Encumbrance at 12/31/2022** | **Investment Amount** |
| **Senior Housing (Managed) - continued** | | | | |
| &nbsp;&nbsp;&nbsp;HarborChase of Shorewood<br> Shorewood, WI ("Milwaukee") | Managed | 7/8/2014 | $— | $23.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Raider Ranch<br>Lubbock, TX | Managed | 8/29/2013 |  | 72.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Town Village<br>Oklahoma City, OK | Managed | 8/29/2013 |  | 23.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MorningStar of Billings<br>Billings, MT | Managed | 12/2/2013 |  | 48.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MorningStar of Boise<br>Boise, ID | Managed | 12/2/2013 |  | 40.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MorningStar of Idaho Falls<br>Idaho Falls, ID | Managed | 12/2/2013 |  | 44.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MorningStar of Sparks<br>Sparks, NV ("Reno") | Managed | 12/2/2013 |  | 55.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living Arbor Place<br>Medford, OR | Managed | 12/2/2013 |  | 15.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living Beaverton Hills<br>Beaverton, OR ("Portland") | Managed | 12/2/2013 |  | 12.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living Five Rivers<br>Tillamook, OR | Managed | 12/2/2013 |  | 16.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living High Desert<br>Bend, OR | Managed | 12/2/2013 |  | 13.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living Huntington Terrace<br>Gresham, OR ("Portland") | Managed | 12/2/2013 |  | 15.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living Orchard Heights<br>Salem, OR | Managed | 12/2/2013 |  | 17.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living Riverwood<br>Tualatin, OR ("Portland") | Managed | 12/2/2013 |  | 9.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living Southern Hills<br>Salem, OR | Managed | 12/2/2013 |  | 12.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living Auburn Meadows<br>Auburn, WA ("Seattle") | Managed | 2/3/2014 |  | 21.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living Bridgewood<br>Vancouver, WA ("Portland") | Managed | 2/3/2014 |  | 22.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living Monticello Park<br>Longview, WA | Managed | 2/3/2014 |  | 27.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living Rosemont<br>Yelm, WA | Managed | 2/3/2014 |  | 16.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prestige Senior Living West Hills<br>Corvallis, OR | Managed | 3/3/2014 |  | 15.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Isle at Cedar Ridge<br>Cedar Park, TX ("Austin") | Managed | 2/28/2014 |  | 22.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legacy Ranch Alzheimer's Special Care Center<br>Midland, TX | Managed | 3/28/2014 |  | 12.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Springs Alzheimer's Special Care Center<br>San Angelo, TX | Managed | 3/28/2014 |  | 10.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Isle at Watercrest - Bryan<br>Bryan, TX | Managed | 4/21/2014 |  | 50.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Isle at Watercrest - Mansfield<br>Mansfield, TX ("Dallas/Fort Worth") | Managed | 5/5/2014 |  | 31.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Watercrest at Mansfield <sup>(1)</sup><br>Mansfield, TX ("Dallas/Fort Worth") | Managed | 6/30/2014 | 22.9 | 49.0 |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name and Location** | **Structure** | **Date Acquired** | **Encumbrance at 12/31/2022** | **Investment Amount** |
| **Senior Housing (Managed) - continued** | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Watercrest at Katy <sup>(2)</sup><br>Lubbock, TX | Managed | 6/27/2014 | $21.2 | $37.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fairfield Village of Layton<br>Layton, UT ("Salt Lake City") | Managed | 11/20/2014 |  | 68.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Superior Residences of Panama City<br>Panama City Beach, FL | Managed | 7/15/2015 |  | 20.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parc at Duluth<br>Duluth, GA ("Atlanta") | Managed | 7/31/2015 |  | 52.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parc at Piedmont<br>Marietta, GA ("Atlanta") | Managed | 7/31/2015 |  | 50.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Pavilion at Great Hills<br>Austin, TX | Managed | 7/31/2015 |  | 35.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Hampton at Meadows Place<br>Meadows Place, TX ("Houston") | Managed | 7/31/2015 |  | 28.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Beacon at Gulf Breeze<br>Gulf Breeze, FL ("Pensacola") | Managed | 7/31/2015 |  | 28.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Waterstone on Augusta<br>Greenville, SC | Managed | 8/31/2015 |  | 26.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Palmilla Senior Living<br>Albuquerque, NM | Managed | 9/30/2015 |  | 47.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cedar Lake Assisted Living and Memory Care<br>Lake Zurich, IL ("Chicago") | Managed | 9/30/2015 |  | 30.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Shores of Lake Phalen<br>Maplewood, MN ("St. Paul") | Managed | 11/10/2015 |  | 29.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Dogwood Forest of Grayson<br>Grayson, GA | Managed | 11/24/2015 |  | 25.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Park Place Senior Living at WingHaven<br>O'Fallon, MO ("St Louis") | Managed | 12/17/2015 |  | 54.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hearthside Senior Living of Collierville<br>Collierville, TN ("Memphis") | Managed | 12/29/2015 |  | 17.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Windsor Manor of Vinton <sup>(3)</sup><br>Vinton, IA | Managed | 8/31/2012 | 2.7 | 5.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Windsor Manor of Webster City <sup>(3)</sup><br>Webster City, IA | Managed | 8/31/2012 | 2.4 | 5.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Windsor Manor of Nevada <sup>(3)</sup><br>Nevada, IA | Managed | 8/31/2012 | 5.4 | 5.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Windsor Manor of Indianola <sup>(3)</sup><br>Indianola, IA | Managed | 4/2/2013 | 2.1 | 4.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Windsor Manor of Grinnell <sup>(3)</sup><br>Grinnell, IA | Managed | 4/2/2013 | 5.2 | 5.5 |
| **Vacant Land** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Albuquerque NM, Land Owner<br>Albuquerque, NM | Managed | 9/7/2017 |  | 1.1 |
|  |  |  | $61.9 | $1739.7 |

---

_______________

**FOOTNOTES:**

(1)The encumbrance collateralized by this property was repaid in March 2023.

(2)Property owned through a consolidated joint venture in which we hold a 95% controlling interest.

(3)As of December 31, 2021, we owned this real estate property through a 75% interest in Windsor Manor Joint Venture, an unconsolidated joint venture. Effective January 1, 2022, we acquired the remaining 25% interest in the Windsor Manor Joint Venture from our joint venture partner and currently own a 100% interest in the Windsor Manor Joint Venture.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Item 3. LEGAL PROCEEDINGS**

From time to time, we may be a party to legal proceedings in the ordinary course of, or incidental to the normal course of, our business, including proceedings to enforce our contractual or statutory rights. While we cannot predict the outcome of these legal proceedings with certainty, based upon currently available information, we do not believe the final outcome of any pending or threatened legal proceeding will have a material adverse effect on our results of operations or financial condition.

**Item 4. MINE SAFETY DISCLOSURES**

None.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**PART II**

**Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES**

**Market Information** 

There is no established public trading market for our common stock. Therefore, there is a risk that a stockholder may not be able to sell shares at a time or price acceptable to the stockholder, or at all. Unless and until our shares are listed on a national securities exchange, it is not expected that a public market for the shares will develop.

Our board of directors has adopted a valuation policy substantially consistent with the IPA Valuation Guideline. The valuation process used by the Valuation Committee and the board of directors to determine the estimated NAV per share was designed to follow recommendations in the IPA Valuation Guideline and our valuation policy.

During the year ended December 31, 2022, our board of directors initiated a process to estimate the Company's NAV per share as of December 31, 2022 ("Valuation Date") and engaged Stanger to provide a report containing, among other things, a range for the estimated NAV per share of our common stock as of the Valuation Date ("Valuation Report"). The engagement of Stanger was based on a number of factors including Stanger's experience in the valuation of assets similar to those we own. Upon receipt of the Valuation Report from Stanger, which contained, among other information, a range for the estimated NAV per share for our common stock, our Valuation Committee considered the reasonableness of the range of per share values in order to make a recommendation to our board of directors. On March 8, 2023, our board of directors accepted the recommendation of our Valuation Committee and approved an estimated NAV as of December 31, 2022 of $6.92 per share, which includes deductions for estimated transaction costs (the "2022 NAV"). The Company previously announced an estimated NAV of $7.37 per share as of December 31, 2021 (the "2021 NAV") and also previously announced an estimated NAV of $7.38 per share as of December 31, 2020 (the "2020" NAV").

For additional information on the determination of our estimated NAV, please refer to our Current Report on Form 8-K filed with the SEC on March 9, 2023.

**Stockholder Information** 

As of December 31, 2022, we had 46,343 stockholders of record. The number of stockholders is based on the records of DST Systems, Inc., who serves as our transfer agent.

**Redemption Plan**

Our Redemption Plan, through its suspension in July 2018, as further discussed below, was designed to provide eligible stockholders with limited interim liquidity by enabling them to sell shares back to us prior to any liquidity event. Proceeds from our Reinvestment Plan were the primary source of available funds for redemption requests under the Redemption Plan on a quarterly basis with additional sources for excess redemption requests determined by our board of directors in accordance with our Redemption Plan.

In July 2018, in light of the Company's decision to proceed with the exploration of Possible Strategic Alternatives, our board of directors suspended our Reinvestment Plan and our Redemption Plan. Approximately $16.4 million (1.6 million shares) of unsatisfied redemptions requests were placed in a redemption requests queue effective with the suspension of our Redemption Plan. The unsatisfied redemption requests placed in the redemption queue will remain there until such time, if at all, that our board of directors reinstates our Redemption Plan. Unless our Redemption Plan is reinstated by our board of directors, we will not as a general matter accept or otherwise process any additional redemption requests received after July 11, 2018. There can be no guarantee that our Redemption Plan will be reinstated by our board of directors.

No requests for redemptions have been accepted subsequent to the July 2018 suspension of the Redemption Plan.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Distributions**

Distributions to our stockholders are governed by the provisions of our articles of incorporation. We intend to continue paying distributions to our stockholders on a quarterly basis until such provisions are terminated or amended by our board of directors. The amount or basis of distributions declared to our stockholders will be determined by our board of directors and is dependent upon a number of factors, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• sources of cash available for distribution such as current year and inception to date cumulative cash flows from operating activities, FFO and MFFO, as well as expected future long-term cash flows, FFO and MFFO;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of the disruptions from the COVID-19 pandemic on occupancy and our cash flows from operations in determining the level of distributions going forward;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• limitations and restrictions contained in the terms of our current and future indebtedness concerning the payment of distributions; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• other factors, including but not limited to, the avoidance of distribution volatility, our objective of continuing to qualify as a REIT, capital requirements, inflation levels, rising interest rates, the general economic environment and other factors.

The table in Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations–Liquidity and Capital Resources–Uses of Capital Resources–Distributions" presents total regular cash distributions declared and issued, and cash flows provided by operating activities for each quarter in the years ended December 31, 2022 and 2021. On March 21, 2022, our Board approved $0.0256 per share as the first quarter 2022 distribution (the "First Quarter Distribution"). The First Quarter Distribution represents a fifty percent (50%) discount from the previous quarter's declared cash distribution. The First Quarter Distribution rate is the result of various factors including, without limitation, the continued COVID-19 impact on industry performance, inflation, a rising interest rate environment and volatility in the credit markets. We, along with our Board, will continue to monitor our cash flow and operating proceeds as well as our strategic alternatives process and make no assurances regarding future quarterly cash distributions.

The tax composition of our distributions declared for years ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** |
| Ordinary income | 0.00% | 43.82% |
| Return of capital | 100.00% | 56.18% |

---

Due to a variety of factors, the characterization of distributions declared for the year ended December 31, 2022 may not be indicative of the characterization of distributions that may be expected for the year ending December 31, 2023. In determining the apportionment between taxable income and return of capital, the amounts distributed to stockholders (other than amounts designated as capital gains dividends) in excess of current or accumulated E&P are treated as a return of capital to the stockholders. E&P is a statutory calculation which is derived from net income and determined in accordance with the Code. It is not intended to be a measure of the REIT's performance, nor do we consider it to be an absolute measure or indicator of our source or ability to pay distributions to stockholders. No amounts distributed to stockholders for the years ended December 31, 2022 and 2021 were required to be or have been treated as return of capital for purposes of calculating the stockholders' return on their invested capital as described in our advisory agreement.

**Unregistered Sales of Equity Securities** 

None.

**Securities Authorized for Issuance under Equity Compensation Plans**

None.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Secondary Sales of Registered Shares between Investors** 

During years ended December 31, 2022, 2021 and 2020, there were approximately 936,000 shares, 743,000 shares and 482,000 shares transferred between investors, respectively, at an average sales price per share of approximately $4.77, $4.13 and $4.73, respectively. We are not aware of any other trades of our shares, other than previous purchases made in our Offerings and/or redemptions of shares by us.

**Item 6. RESERVED**

The selected financial data previously required by Item 301 of Regulation S-K has been omitted in reliance on SEC Release No. 33-10890.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

**Overview**

CNL Healthcare Properties, Inc. is a Maryland corporation that elected to be taxed as a REIT for U.S. federal income tax purposes. We have and intend to continue to be organized and operate in a manner that allows us to remain qualified as a REIT for federal income tax purposes. The terms "us," "we," "our," "Company" and "CNL Healthcare Properties" include CNL Healthcare Properties, Inc. and each of its subsidiaries. The discussion of our financial condition and results of operations for the year ended December 31, 2020 included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2021 as filed on March 23, 2022 is incorporated by reference herein.

Substantially all of our assets are held by, and all operations are conducted, either directly or indirectly, through: (1) the Operating Partnership in which we are the sole limited partner and our wholly owned subsidiary, CHP GP, LLC, is the sole general partner; (2) a wholly owned TRS, CHP TRS Holding, Inc.; (3) property owner subsidiaries and lender subsidiaries, which are single purpose entities; and (4) investments in joint ventures.

We are externally managed and advised by CNL Healthcare Corp. (the "Advisor"). Our Advisor has responsibility for our day-to-day operations, serving as our consultant in connection with policy decisions to be made by our board of directors, and for identifying, recommending and executing on Possible Strategic Alternatives (as described below under "Possible Strategic Alternatives"), and dispositions on our behalf pursuant to an advisory agreement. In May 2022, we extended the advisory agreement with the Advisor through June 2023. For additional information on our Advisor, its affiliates or other related parties, as well as the fees and reimbursements we pay, see Item 8. "Financial Statements and Supplementary Data–Note 12. Related Party Arrangements."

As of December 31, 2022, our seniors housing investment portfolio consisted of interests in 70 properties, consisting of a geographically diversified portfolio of 69 seniors housing communities and one vacant land parcel. The types of seniors housing properties that we own include independent and assisted living facilities, continuing care retirement communities and Alzheimer's/memory care facilities. Five of our 69 seniors housing properties were previously owned through an unconsolidated joint venture and became wholly-owned effective January 1, 2022.

**Market Conditions**

During the last half of 2021, we began to experience the operational impacts of a challenging labor market. Labor costs increased at an accelerated rate during the last half of 2021 due to increases throughout all wage classifications within our communities and an increased focus on attracting and retaining staff at our communities. The "great resignation" resulted in an increase in the number of vacant positions at our communities and COVID-19 staff infections contributed to staff absences due to quarantine requirements under CDC guidelines. These factors led to an increase in the usage of temporary agency labor which led to incremental, measurable labor costs beginning in the middle of 2021. Since the beginning of 2022, our intensified focus of hiring and filling some of the vacant staff roles, as well as a decline in absences from lower COVID staff infections and more relaxed CDC quarantine requirements, have resulted in ongoing reductions in our reliance on temporary agency labor. However, historically low unemployment rates, wage pressures, overtime pay and some continued reliance on temporary agency labor resulted in high labor costs that impacted net operating income ("NOI") margins during 2022 and could continue to impact margins in 2023.

In addition, during the last half of 2021, we began to experience the impact of higher inflation levels in the form of higher food costs and virtually all other operating expenses. This contributed to property NOI margin compressions during 2022 in our managed seniors housing communities. We anticipate that operating expenses will continue to remain at elevated levels which could result in continued operating margin compressions during 2023.

Macro-economic and geopolitical events around the globe have contributed to volatile credit markets. As part of its effort to reduce the rising levels of inflation, the Federal Reserve enacted several interest rate increases during 2022 and additional rate increases are expected to continue into 2023. The interest rate increases to date and any further interest rate increases will contribute to higher interest expense on our unhedged variable rate debt. We have interest rate caps in place for interest rate protection on a portion of our variable rate debt and continue to monitor opportunities to further protect the remaining unhedged variable rate debt.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**COVID-19**

Since the onset of the coronavirus ("COVID-19") pandemic in March 2020 and throughout 2021, we operated our communities through the disruptions and uncertainties of the pandemic, including disruptions from new variants of the virus. Average occupancy declined from the second half of March 2020 through February 2021, and since March 2021, we have experienced marginal occupancy gains, initially attributed to the availability of vaccines and lifted or relaxed regulatory move-in restrictions. The positive marginal occupancy gains continued through 2022 and have resulted in increases in resident fees and revenues. We anticipate continued marginal occupancy improvements in 2023.

As of December 31, 2022, our 69 seniors housing communities were located throughout the United States in 26 states. Of our 69 senior housing communities, we owned 15 properties leased to two separate third party tenants under triple-net leases ("NNN"), and the remaining 54 properties were managed through third party operators. During 2020, we provided assistance to the tenant of two properties under NNN leases with $0.9 million in rent relief and in December 2021, we provided another $1.4 million in rent relief, each in the form of rent deferral agreements. We did not grant any rent concessions as part of any rent deferral provided to this tenant and through February 2022, we had deferred an aggregate of $2.3 million in rents under these rent deferral agreements. We began collecting amounts deferred in January 2023 in accordance with the installment schedule under the rent deferral agreements and as of March 8, 2023, had collected 100% of all amounts due in accordance with the terms of the tenant's lease agreements and deferral agreements. As of March 8, 2023, we had collected 100% of all rental amounts due from our other tenant of 13 properties under NNN leases in accordance with their lease agreements.

Since March 13, 2020, there have been a number of federal, state and local government initiatives to manage the spread of the virus and its impact on the economy, financial markets and continuity of businesses of all sizes and industries. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law which provided, among other things, for the establishment of a Provider Relief Fund under the direction of the Department of Health and Human Services ("HHS"). During the years ended December 31, 2022 and 2021, we received or recognized provider relief funds under the CARES Act, which are deemed governmental grants provided that the recipient attests to and complies with certain terms and conditions, and we recorded approximately $4.3 million and $0.5 million, respectively, as other income in the accompanying consolidated statements of operations as all conditions of the grant had been met.

**Possible Strategic Alternatives**

In 2017, we began evaluating possible strategic alternatives to provide liquidity to our stockholders. In April 2018, our board of directors formed a special committee consisting solely of our independent directors ("Special Committee") to consider possible strategic alternatives, including, but not limited to (i) the listing of our or one of our subsidiaries' common stock on a national securities exchange; (ii) an orderly disposition of our assets or one or more of our asset classes and the distribution of the net sale proceeds thereof to our stockholders; and (iii) a potential business combination or other transaction with a third-party or parties that provides our stockholders with cash and/or securities of a publicly traded company (collectively, among other options, "Possible Strategic Alternatives"). Since 2018, the Special Committee has engaged KeyBanc Capital Markets Inc. to act as its financial advisor in connection with exploring our Possible Strategic Alternatives.

In connection with our consideration of the Possible Strategic Alternatives, our board of directors suspended both our Reinvestment Plan and our Redemption Plan effective July 11, 2018. In addition, as part of executing on Possible Strategic Alternatives, our board of directors committed to a plan to sell 70 properties which included medical office buildings, post-acute care facilities and acute care hospitals across the US, collectively (the "MOB/Healthcare Portfolio") plus several skilled nursing facilities. Through December 31, 2021, we sold 69 properties, received net sales proceeds of approximately $1.4497 billion and used the net sales proceeds to: (1) repay indebtedness secured by the properties; (2) strategically rebalance other corporate borrowings; (3) make a special cash distribution in May 2019 of approximately $347.9 million (or $2.00 per share) to our stockholders and (4) retained net sales proceeds for other corporate purposes, because we were focused on maintaining balance sheet strength and liquidity during COVID-19 to enhance financial flexibility. In April 2022, we sold the last property, the Hurst Specialty Hospital, to an unrelated third party and received net sales proceeds of approximately $8.3 million.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

During the COVID-19 pandemic, we shifted our focus away from the pursuit of larger strategic alternatives to provide further liquidity to our stockholders due to the market and industry disruptions in the seniors housing sector from COVID-19. However, our Special Committee continued working and continues to work with our financial advisor to carefully study market data. We remain fully committed to our readiness, active study and pursuit of additional strategic opportunities to provide incremental liquidity to our stockholders as the economic and transactional environments permit.

**Seniors Housing Portfolio** 

Our remaining investment focus is in seniors housing communities. We have invested in or developed the following types of seniors housing properties:

*Independent Living Facilities*. Independent living facilities are age-restricted, multi-family rental or ownership (condominium) housing with central dining facilities that provide residents, as part of a monthly fee, meals and other services such as housekeeping, linen service, transportation, social and recreational activities.

*Assisted Living Facilities*. Assisted living facilities are usually state-regulated rental properties that provide the same services as independent living facilities, but also provide, in a majority of the units, supportive care from trained employees to residents who are unable to live independently and require assistance with activities of daily living. The additional services may include assistance with bathing, dressing, eating, and administering medications.

*Memory Care/Alzheimer's Facilities.* Those suffering from the effects of Alzheimer's disease or other forms of memory loss need specialized care. Memory care/Alzheimer's centers provide the specialized care for this population including residential housing and assistance with the activities of daily living.

**Portfolio Overview**

As of December 31, 2022, our healthcare investment portfolio consisted of interests in 70 properties, comprising 69 seniors housing communities and one vacant land parcel.

We believe demographic trends and compelling supply and demand indicators present a strong case for an investment focus on seniors housing real estate and real estate-related assets. Our seniors housing investment portfolio is geographically diversified with properties in 26 states. The map below shows our seniors housing investment portfolio across geographic regions as of March 8, 2023:

![chth-20221231_g1.jpg](chth-20221231_g1.jpg)

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

The following table summarizes our seniors housing investment portfolio by investment structure as of March 8, 2023:

---

| | | | |
|:---|:---|:---|:---|
| **Type of Investment** | **Number of<br>Investments** | **Amount of<br>Investments<br>(in millions)** | **Percentage <br>of Total<br>Investments** |
| *Consolidated investments:* |  |  |  |
| &nbsp;&nbsp;&nbsp;Seniors housing leased <sup>(1)</sup> | 15 | $311.0 | 17.8% |
| &nbsp;&nbsp;&nbsp;Seniors housing managed <sup>(2)</sup> | 54 | 1427.6 | 82.1 |
| &nbsp;&nbsp;&nbsp;Vacant land | 1 | 1.1 | 0.1 |
|  | 70 | $1739.7 | 100.0% |

---

_______________

**FOOTNOTES:**

(1)Properties that are leased to third-party tenants for which we report rental income and related revenues.

(2)Properties that are leased to TRS entities and managed pursuant to third-party management contracts (i.e. RIDEA structure) where we report resident fees and services, and the corresponding property operating expenses.

**Portfolio Evaluation**

While we are not directly impacted by the performance of the underlying properties leased to third-party tenants, we believe that the financial and operational performance of our tenants provides an indication about the stability of our tenants and their ability to pay rent. To the extent that our tenants, managers or joint venture partners experience operating difficulties and become unable to generate sufficient cash to make rent payments to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. Our tenants and managers are generally contractually required to provide this information to us in accordance with their respective lease, management and/or joint venture agreements. Therefore, in order to mitigate the aforementioned risk, we monitor our investments through a variety of methods determined by the type of property.

We monitor the credit of our tenants to stay abreast of any material changes in credit quality. We monitor credit quality by (1) reviewing financial statements that are publicly available or that are required to be delivered to us under the applicable lease, (2) direct interaction with onsite property managers, (3) monitoring news and rating agency reports regarding our tenants (or their parent companies) and their underlying businesses, (4) monitoring the timeliness of rent collections and (5) monitoring lease coverage.

When evaluating the performance of our seniors housing portfolio, management reviews property-level operating performance versus budgeted expectations, conducts periodic operational review calls with operators and conducts periodic property inspections or site visits. Management also reviews occupancy levels and monthly revenue per occupied unit, which we define as total revenue divided by average number of occupied units. Similarly, when evaluating the performance of our third-party operators, management reviews monthly financial statements, property-level operating performance versus budgeted expectations, conducts periodic operational review calls with operators and conducts periodic property inspections or site visits. All of the aforementioned operating and statistical metrics assist us in determining the ability of our properties or operators to achieve market rental rates, to assess the overall performance of our diversified healthcare portfolio, and to review compliance with leases, debt, licensure, real estate taxes, and other collateral.

**Significant Tenants and Operators** 

Our real estate portfolio of 69 seniors housing properties is operated by a mix of national or regional operators and the following represents the significant tenants and operators that lease or manage 10% or more of our rentable space as of March 8, 2023, excluding the vacant land parcel:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Tenants** | **Number of<br>Properties** | **Rentable<br>Square Feet<br>(in thousands)** | **Percentage <br>of Rentable<br>Square Feet** | **Lease<br>Expiration<br>Year** |
| TSMM Management, LLC | 13 | 1261 | 77.5% | 2025 |
| Wellmore, LLC | 2 | 366 | 22.5 | 2031-2032 |
|  | 15 | 1627 | 100.0% |  |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Operators** | **Number of<br>Properties** | **Rentable<br>Square Feet<br>(in thousands)** | **Percentage <br>of Rentable<br>Square Feet** | **Operator<br>Expiration<br>Year** |
| Integrated Senior Living, LLC | 7 | 1948 | 30.8% | 2023-2024 |
| Prestige Senior Living, LLC | 13 | 895 | 14.2 | 2023-2024 |
| Morningstar Senior Management, LLC | 4 | 834 | 13.2 | 2023 |
| Other operators <sup>(1)</sup> | 30 | 2645 | 41.8 | 2023-2029 |
|  | 54 | 6322 | 100.0% |  |

---

_______________

**FOOTNOTE:**

(1)Comprised of various operators each of which comprise less than 10% of our consolidated rentable square footage.

**Tenant Lease Expirations**

As of December 31, 2022, we owned 15 seniors housing properties that were leased to third party tenants under triple-net operating leases. During the year ended December 31, 2022, our rental income from continuing operations represented approximately 8.3% of our total revenues from continuing operations.

Under the terms of our triple-net lease agreements, each tenant is responsible for payment of property taxes, general liability insurance, utilities, repairs and maintenance, including structural and roof expenses. Each tenant is expected to pay real estate taxes directly to the taxing authorities. However, if the tenant does not pay the real estate taxes, we are liable.

We work with our tenants in advance of the lease expirations or renewal period options in order for us to maintain a balanced lease rollover schedule and high occupancy levels, as well as to enhance the value of our properties through extended lease terms. Certain amendments or modifications to the terms of existing leases could require lender approval.

The following table lists, on an aggregate basis, scheduled expirations for the next 10 years and thereafter on our consolidated seniors housing portfolio, assuming that none of the tenants exercise any of their renewal options (in thousands, except for number of properties and percentages):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Year of Expiration** <sup>(1)</sup> | **Number of<br>Properties** | **Expiring<br>Leased<br>Square Feet** | **Expiring**<br>**Annualized**<br>**Base Rents** <sup>(2)</sup> | **Percentage<br>of Expiring<br>Annual<br>Base Rents** |
| 2023 |  |  | $— | —% |
| 2024 |  |  |  |  |
| 2025 | 13 | 1261 | 17941 | 68.1 |
| 2026 |  |  |  |  |
| 2027 |  |  |  |  |
| 2028 |  |  |  |  |
| 2029 |  |  |  |  |
| 2030 |  |  |  |  |
| 2031 | 1 | 137 | 3602 | 13.7 |
| 2032 | 1 | 229 | 4793 | 18.2 |
| Thereafter |  |  |  |  |
| Total | 15 | 1627 | $26336 | 100.0% |
| **Weighted Average Remaining Lease Term:** <sup>(3)</sup> | **Weighted Average Remaining Lease Term:** <sup>(3)</sup> | **Weighted Average Remaining Lease Term:** <sup>(3)</sup> | 4.7 years |  |

---

_______________

**FOOTNOTES:**

(1)Represents current lease expiration and does not take into consideration lease renewals available under existing leases at the option of the tenants.

(2)Represents the current base rent, excluding tenant reimbursements and the impact of future rent increases included in leases, multiplied by 12 and included in the year of expiration.

(3)Weighted average remaining lease term is the average remaining term weighted by annualized current base rents.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Operator Expirations**

As of December 31, 2022, we had 54 seniors housing properties managed by third-party operators. All of our management agreements have been in place for multiple years and many include auto-renewal clauses ranging from one to five years, which are effective unless a notice of termination is provided by either party. We work with our operators in advance of management agreement expirations or renewal period options in order for us to maintain a balanced operator rollover schedule, which provides us flexibility to execute on possible strategic alternatives, minimize potential early termination fees and align with the broader industry. The management agreements of 38 of our managed seniors housing properties were scheduled to expire within one year or less as of December 31, 2022, all of which are scheduled to be renewed under the renewal provisions of the agreements.

**Liquidity and Capital Resources**

*General*

Our ongoing primary source of capital is proceeds from operating cash flows. Our primary uses of capital include the payment of distributions, payment of operating expenses, funding capital improvements to existing properties and payment of debt service. Generally, we expect to meet short-term working capital needs from our cash flows from operations. Our ongoing sources and uses of capital have been and will continue to be impacted by the rate of occupancy recovery from the COVID-19 pandemic, and by rising interest rates and rising inflation levels. As necessary, we may use financings or other sources of capital in the event of unforeseen significant capital expenditures or to cover periodic shortfalls between distributions paid and cash flows from operating activities.

Despite the marginal increases in occupancy beginning in March 2021 as described above in "COVID-19", we began to experience and during 2022 continued to experience compression in property level NOI margins due to increases in operating expenses. Labor costs increased due to increased wages in a tight labor market. The "great resignation" resulted in an increase in the number of vacant positions at our communities, which led to increased reliance on temporary agency personnel to temporarily fill vacancies. Since the beginning of 2022, our intensified focus of hiring and filling some of the vacant staff roles, as well as a decline in absences from lower COVID staff infections and more relaxed CDC quarantine requirements, resulted in ongoing reductions in our reliance on temporary agency labor. Rising inflation levels surfaced in the form of higher food costs and other operating expenses, which also contributed to margin compressions. We implemented rate increases at our properties as part of ongoing resident lease renewals in 2022 which resulted in an increase in revenues. Rental rate increases during 2022 contributed favorably to operating margins, however, increased labor costs and operating expenses resulted in downward pressure on the rate of operating margin recovery during 2022. We expect that increases in occupancy and some moderate rate increases will increase revenue streams during 2023. However, even though we anticipate less reliance on agency labor and anticipate lower inflation levels, we anticipate that labor costs and operating expenses will continue at elevated levels throughout 2023 and could impact the rate of margin recovery in 2023.

As of December 31, 2022, we had approximately $210.9 million of liquidity (consisting of $69.5 million cash on hand, $24.4 million invested in short term securities and $117.0 million in undrawn availability under the Revolving Credit Facility). We remain focused on maintaining liquidity and financial flexibility and continue to monitor developments as we continue to recover from the disruptions in occupancy from COVID-19, continue to navigate through rising labor costs during a tight labor market, increased operating expenses from current inflation levels and the increase in interest costs from a rising interest rate environment. The extent of the continued impact of COVID-19, a tight labor market, inflation, the volatility in the credit markets and a rising interest rate environment on our financial condition, results of operations and cash flows is uncertain and cannot be predicted at the current time as it depends on the timing and speed of economic recovery.

We have pledged certain of our properties in connection with our borrowings and may continue to strategically leverage our real estate and use debt financing as a means of providing additional funds for the payment of distributions to stockholders, working capital and for other corporate purposes. Our ability to increase our borrowings could be adversely affected by credit market conditions, inflation and rising interest rates, which could result in lenders reducing or limiting funds available for loans, including loans collateralized by real estate. We may also be negatively impacted by rising interest rates on our unhedged variable rate debt or the timing of when we seek to refinance existing debt. As part of our variable debt hedging strategy, we have purchased interest rate caps for interest rate protection. We continue to monitor the credit markets and continue to evaluate the need and the timing for additional interest rate protection in the form of interest rate swaps or caps on unhedged variable rate debt or variable rate debt with interest rate protection scheduled to mature.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

Our cash flows from operating and investing activities as described within "Sources of Liquidity and Capital Resources" and "Uses of Liquidity and Capital Resources" represent cash flows from continuing operations and exclude the results of one property that was classified as discontinued operations, which was sold in January 2021.

**Sources of Liquidity and Capital Resources** 

*Proceeds from Sale of Real Estate – Continuing Operations*

During the year ended December 31, 2022, we closed on the sale of the Hurst Specialty Hospital, the last of the 70 properties for which we had committed to a plan to sell and received net sales proceeds of approximately $8.3 million. Additionally, our co-venture partner exercised its option to purchase the Fieldstone at Pear Orchard property (a seniors housing property owned through a consolidated joint venture) and also provided an unsolicited offer to purchase the Fieldstone Memory Care property, an adjacent property (collectively, the "Fieldstone Properties"). We completed the sale of the Fieldstone Properties and received net sales proceeds of approximately $28.4 million. We used approximately $2.0 million of the net sales proceeds from the sale of the Fieldstone at Pear Orchard property to pay distributions to our co-venture partner in accordance with the terms of the joint venture agreement, as described below. We retained the remaining net sales proceeds from the Hurst Specialty Hospital and the Fieldstone Properties to maintain a strong balance sheet and liquidity. We did not sell any properties from continuing operations during the year ended December 31, 2021.

*Proceeds from Sale of Real Estate – Discontinued Operations*

As part of executing under our Possible Strategic Alternatives, during the year ended December 31, 2021, we closed on the sale of one acute care property and received net sales proceeds of approximately $7.4 million. We did not sell any properties from discontinued operations during the year ended December 31, 2022.

*Borrowings*

During the year ended December 31, 2022, we borrowed $45.0 million from our Revolving Credit Facility to refinance approximately $44.5 million of secured indebtedness in advance of its September 2022 maturity and paid fees of approximately $0.3 million to unrelated third parties. In February 2023, we purchased a short-term interest rate cap with a notional value of $420.0 million and a strike of 3.5%, to hedge the majority of our Credit Facilities. The interest rate cap matures on August 15, 2023.

In September 2021, we entered into a new term loan agreement which provided for an additional $150 million senior unsecured term loan facility (the "2021 Term Loan Facility") to complement and become part of our existing Credit Facilities. The 2021 Term Loan Facility has an initial term that is co-terminus with the Credit Facilities, maturing May 15, 2024, subject to one 12-month extension, and through September 2022, bore interest based on 30-day LIBOR plus a spread that varies with the Company's leverage ratio. The 2021 Term Loan Facility is pre-payable at any time in whole or part without fees or penalties, has a borrowing availability calculation that is subject to a similar borrowing base calculation as the Credit Facilities and contains similar affirmative, negative and financial covenants as the covenants in the Credit Facilities. We paid fees totaling approximately $0.9 million to unrelated third parties and a refinancing fee to the Advisor of approximately $1.5 million. See Item 8. "Financial Statements and Supplementary Data–Note 12. Related Party Arrangements" for additional information regarding the refinancing fee.

In October 2021, we borrowed $238.0 million, which consisted of $88 million drawn on our unsecured Revolving Credit Facility and $150.0 million available under the unsecured 2021 Term Loan Facility to refinance approximately $238.0 million of secured indebtedness in advance of its January 2022 maturity. See "Liquidity and Capital Resources – Uses of Liquidity and Capital Resources – Debt Repayments" below for additional information regarding debt repayments during the years ended December 31, 2022 and 2021.

We may borrow money to fund enhancements to our portfolio, as well as to cover periodic shortfalls between distributions paid and cash flows from operating activities to the extent impacted by compressed property NOI margins from rising labor costs, inflationary pressures on other operating expenses and an increased interest rate environment.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

*Net Cash Provided by Operating Activities – Continuing Operations*

Cash flows from operating activities for the years ended December 31, 2022 and 2021 were approximately $43.8 million and $46.4 million, respectively. The change in cash flows from operating activities for the year ended December 31, 2022 as compared to the same period in 2021 was primarily the result of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a decline in NOI, primarily due to reduced rent related to new leases which commenced February 2022 at five seniors housing properties, increased operating expenses at our managed properties primarily driven by inflation and labor shortages, and the sale of three properties during 2022, which was partially offset by the consolidation of the Windsor Manor properties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• higher interest expense due to the rising interest rate environment; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• unfavorable changes in assets and liabilities; partially offset by

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• $4.3 million received in provider relief funds under the CARES Act.

*Lease Renewals and Extensions*

We entered into new leases covering five of our properties that expired in February 2022. The new leases with the same tenant commenced in February 2022 and will expire in February 2025. We do not have any leases expiring until 2025.

*Tenant Financial Difficulties*

The tenant of the Hurst Specialty Hospital had experienced financial difficulties. During the year ended December 31, 2021, we collected approximately $2.2 million in rental amounts from the tenant and we paid approximately $0.2 million in real estate taxes which were not reimbursed by the tenant. We did not collect any rental amounts and we did not pay any real estate taxes during the year ended December 31, 2022. We sold the Hurst Specialty Hospital in April 2022. Refer to "Results of Operations — Impairment Provision" for further discussion on the impairment recorded related to this property during the year ended December 31, 2021.

*Distributions from Unconsolidated Entities*

As of December 31, 2021, we had an investment in five unconsolidated properties through a 75% interest in an unconsolidated joint venture (the "Windsor Manor Joint Venture"). Pursuant to the joint venture agreement, we were entitled to receive quarterly preferred cash distributions to the extent there was cash available to distribute. These distributions were generally received within 45 days after each quarter end. For the year ended December 31, 2021, we received approximately $0.7 million of operating distributions from our investment in these unconsolidated entities. Effective January 1, 2022, we acquired the remaining 25% interest in the Windsor Manor Joint Venture for approximately $3.3 million and currently own a 100% interest in the Windsor Manor Joint Venture. Effective January 1, 2022 we began consolidating the revenues and expenses of the five properties in the Windsor Manor Joint Venture and ceased recording distributions from unconsolidated joint ventures.

*Amended and Restated Expense Support Agreement*

We have entered into an amended and restated expense support agreement with our Advisor (the "Amended and Restated Expense Support Agreement"). Pursuant to the Amended and Restated Expense Support Agreement, our Advisor agreed to provide expense support through forgoing the payment of fees in cash and acceptance of restricted forfeitable stock for services in an amount equal to the positive excess, if any, of (a) Aggregate Stockholder Cash Distributions declared for the applicable year, over (b) our aggregate modified funds from operations over the same period (as defined in the Amended and Restated Expense Support Agreement).

Under the terms of the Amended and Restated Expense Support Agreement with our Advisor, for each quarter within a calendar expense support year, we will record a proportional estimate of the cumulative year-to-date period based on an estimate of expense support amounts for the calendar expense support year. Moreover, in exchange for services rendered and in consideration of the expense support provided under the expense support agreement, we will issue, within 90 days following the determination date, a number of shares of forfeitable restricted common stock ("Restricted Stock") equal to the quotient of the expense support amounts provided by our Advisor for the preceding calendar year divided by our then-current NAV per share of common stock. The terms of the Amended and Restated Expense Support Agreement automatically renew for consecutive one-year periods, subject to the right of our Advisor to terminate upon 30 days' written notice. We did not recognize any expense support for the years ended December 31, 2022 or 2021. See Item 8. "Financial Statements and Supplementary Data — Note 12. Related Party Arrangements" for additional information.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Uses of Liquidity and Capital Resources** 

*Acquisition of Joint Venture Interest*

As of December 31, 2021, we indirectly owned five properties through a 75% interest in the Windsor Manor Joint Venture, an unconsolidated equity method investment. Effective January 1, 2022, we acquired the remaining 25% interest from our joint venture partner for approximately $3.3 million and we currently own a 100% controlling interest in the Windsor Manor Joint Venture.

*Capital Expenditures*

We paid approximately $17.8 million and $14.2 million in capital expenditures during the years ended December 31, 2022 and 2021, respectively. We have increased our investment in capital improvements to maintain and improve our properties.

*Purchase of Held-to-Maturity Securities*

During the year ended December 31, 2022, we used approximately $24.2 million of available cash to purchase held-to-maturity securities to enhance the yield earned on cash on hand. We did not purchase held-to-maturity securities during the year ended December 31, 2021.

*Debt Repayments*

During the year ended December 31, 2022, we repaid approximately $46.3 million of indebtedness, which included $1.8 million of scheduled repayments on our mortgages and other notes payable and the June 2022 refinance of approximately $44.5 million of secured indebtedness, consisting of debt collateralized by five properties. We refinanced the debt maturity, added the five properties to the borrowing base of our unsecured Credit Facilities and used $45.0 million from amounts available under the unsecured Revolving Credit Facility to repay our secured indebtedness. In September 2022, we amended the agreements of our Credit Facilities to transition the benchmark rate from LIBOR to SOFR.

During the year ended December 31, 2021, we paid approximately $247.8 million, which included $9.8 million of scheduled repayments on our mortgages and other notes payable and the October 2021 refinance of approximately $238.0 million of secured indebtedness, consisting of debt collateralized by 22 properties, in advance of its scheduled maturity of January 2022. We added the 22 properties to the borrowing base of our unsecured Credit Facilities and used $88 million from amounts available under the unsecured Revolving Credit Facility and $150 million available under the new unsecured 2021 Term Loan to repay our secured indebtedness.

On an ongoing basis, we monitor our debt maturities, engage in dialogue with third-party lenders about various financing scenarios and analyze our overall portfolio borrowings in advance of scheduled maturity dates of the debt obligations to determine the optimal borrowing strategy.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

The following table provides details of the Company's indebtedness as of December 31, 2022 and 2021 (in thousands):

---

| | | |
|:---|:---|:---|
| | **As of December 31,** | **As of December 31,** |
| | **2022** | **2021** |
| Mortgages payable and other notes payable: |  |  |
| &nbsp;&nbsp;&nbsp;Fixed rate debt<sup>(1)</sup> | $44082 | $89766 |
| &nbsp;&nbsp;&nbsp;Variable rate debt<sup>(1)(2)(3)</sup> | 17859 |  |
| &nbsp;&nbsp;&nbsp;Premium<sup>(4)</sup> | 17 | 59 |
| &nbsp;&nbsp;&nbsp;Loan costs, net | (185) | (425) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total mortgages and other notes payable, net | 61773 | 89400 |
| Credit facilities: |  |  |
| &nbsp;&nbsp;Revolving Credit Facility<sup>(6)(7)</sup> | 133000 | 88000 |
| &nbsp;&nbsp;Term Loan Facility<sup>(5)(6)(7)</sup> | 265000 | 265000 |
| &nbsp;&nbsp;2021 Term Loan Facility<sup>(5)(6)(7)</sup> | 150000 | 150000 |
| &nbsp;&nbsp;Loan costs, net related to Term Loan Facilities | (1900) | (3272) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total credit facilities, net | 546100 | 499728 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total indebtedness, net | $607873 | $589128 |

---

_______________

**FOOTNOTES:** 

(1)As of December 31, 2022 and 2021, our mortgages and other notes payable were collateralized by seven properties, with a total carrying value of approximately $92.7 million and $135.4 million, respectively.

(2)In connection with the acquisition of the 25% interest in the Windsor Manor Joint Venture, we consolidated the net assets of the joint venture effective January 1, 2022, including the debt associated with the properties, at fair value. The debt collateralized by the five Windsor Manor properties accrues interest at a rate of 2.50% plus 30-day LIBOR and matures in February 2024. The 30-day LIBOR was approximately 4.39% as of December 31, 2022.

(3)As of December 31, 2022, we had interest rate protection through an interest rate cap with a notional amount of $15.0 million. Refer to Item 8. "Financial Statements and Supplementary Data – Note 13. Derivative Financial Instruments" for additional information.

(4)Premium is reflective of recording mortgage note payables assumed at fair value on the respective acquisition dates.

(5)As of December 31, 2021 and during the year ended December 31, 2022, we had interest rate protection through interest rate caps with notional amounts of $355.0 million. The interest rate caps expired on December 31, 2022. Refer to Item 7A. "Quantitative and Qualitative Disclosures About Market Risks" and Item 8. "Financial Statements and Supplementary Data – Note 13. Derivative Financial Instruments" for additional information.

(6)As of December 31, 2022 and 2021, we had undrawn availability under the applicable revolving credit facility of approximately $117.0 million and $14.1 million, respectively, based on the value of the properties in the unencumbered pool of assets supporting the loan.

(7)Term SOFR (as defined by the agreements governing our Credit Facilities) was approximately 4.46% as of December 31, 2022. The 30-day LIBOR was approximately 0.10% as of December 31, 2021.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

As of December 31, 2022, we had approximately $210.9 million of liquidity (consisting of $69.5 million of cash on hand, $24.4 million invested in short term securities and $117.0 million available under the Revolving Credit Facility) and we believe we are well positioned to manage our near-term debt maturities. We had $133.0 million outstanding under our Revolving Credit Facility that was scheduled to mature in May 2023, with a one-year extension option. In January 2023, we exercised our one-year extension option which extended the maturity date to May 2024.

The following is a schedule of future principal payments for our total indebtedness for the next five years and thereafter, in the aggregate, and reflects the extension of the maturity date of our Revolving Credit Facility (in thousands):

---

| | |
|:---|:---|
| 2023 | $24054 |
| 2024 | 585887 |
| 2025 |  |
| 2026 |  |
| 2027 |  |
| Thereafter |  |
|  | $609941 |

---

As of December 31, 2022, we had $24.1 million of scheduled principal payments coming due during the year ending December 31, 2023, which included a mortgage loan maturing in June 2023 of $22.7 million. We repaid this loan in March 2023 before its scheduled maturity using cash on hand, to reduce interest expense in 2023.

The aggregate amount of long-term financing is not expected to exceed 60% of our gross asset values (as defined in our Credit Facilities) on an annual basis. As of December 31, 2022 and 2021, we had aggregate debt leverage ratios of approximately 31.9% and 31.8%, respectively, of the aggregate carrying value of our assets.

Generally, the loan agreements for our mortgage loans contain customary financial covenants and ratios; including (but not limited to) the following: debt service coverage ratio, minimum occupancy levels, limitations on incurrence of additional indebtedness, etc. The loan agreements also contain customary performance criteria and remedies for the lenders. As of December 31, 2022, we were in compliance with all financial covenants related to our mortgage loans.

The Credit Facilities contain affirmative, negative, and financial covenants which are customary for loans of this type, including (but not limited to): (i) maximum leverage, (ii) minimum fixed charge coverage ratio, (iii) minimum consolidated net worth, (iv) restrictions on payments of cash distributions except if required by REIT requirements, (v) maximum secured indebtedness, (vi) maximum secured recourse debt, (vii) minimum unsecured interest coverage, (viii) maximum unsecured indebtedness ratio and (ix) limitations on certain types of investments and with respect to the pool of properties supporting borrowings under the Credit Facilities, minimum weighted average occupancy, and remaining lease terms, as well as property type, MSA, operator, and asset value concentration limits. The limitations on distributions generally include a limitation on the extent of allowable distributions, which are not to exceed the greater of 95% of adjusted FFO (as defined per the Credit Facilities) and the minimum amount of distributions required to maintain the Company's REIT status. As of December 31, 2022, we were in compliance with all financial covenants related to our Credit Facilities.

*Distributions*

In order to qualify as a REIT, we are required to make distributions, other than capital gain distributions, to our stockholders each year in the amount of at least 90% of our taxable income. We may make distributions in the form of cash or other property, including distributions of our own securities. While we generally expect to pay distributions from cash flows provided by operating activities, we have and may continue to cover periodic shortfalls between distributions paid and cash flows from operating activities with proceeds from other sources such as from cash flows provided by financing activities, a component of which could include borrowings, whether collateralized by our properties or unsecured, or net sales proceeds from the sale of real estate.

In March 2022, our board of directors reduced our quarterly distributions to $0.0256 per share effective with the first quarter 2022 distribution. The decrease in the quarterly distribution rate was the result of various factors including, without limitation, the continued COVID-19 impact on industry performance, inflation rates and volatility in the credit markets. Our management team and our board of directors will continue to monitor our results of operations and operating cash flows, as well as our strategic alternatives process and make no assurances regarding future quarterly cash distributions.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

The following table presents total cash distributions declared, distributions reinvested and cash distributions per share on a quarterly basis for the years ended December 31, 2022 and 2021 (in thousands, except per share data):

---

| | | | |
|:---|:---|:---|:---|
| **Periods** | **Cash<br>Distributions<br>per Share** | **Total Cash**<br>**Distributions**<br>**Declared** <sup>(1)</sup> | **Cash Flows**<br>**Provided by**<br>**Operating**<br>**Activities** <sup>(2)</sup> |
| <u>2022 Quarters</u> |  |  |  |
| &nbsp;&nbsp;&nbsp;First | $0.02560 | $4453 | $8236 |
| &nbsp;&nbsp;&nbsp;Second | 0.02560 | 4453 | 15840 |
| &nbsp;&nbsp;&nbsp;Third | 0.02560 | 4454 | 10318 |
| &nbsp;&nbsp;&nbsp;Fourth | 0.02560 | 4454 | 9452 |
| Total | $0.10240 | $17814 | $43846 |
| <u>2021 Quarters</u> |  |  |  |
| &nbsp;&nbsp;&nbsp;First | $0.05120 | $8907 | $12633 |
| &nbsp;&nbsp;&nbsp;Second | 0.05120 | 8906 | 11560 |
| &nbsp;&nbsp;&nbsp;Third | 0.05120 | 8907 | 8719 |
| &nbsp;&nbsp;&nbsp;Fourth | 0.05120 | 8907 | 13450 |
| Total | $0.20480 | $35627 | $46362 |

---

_______________

**FOOTNOTES:** 

(1)For the years ended December 31, 2022 and 2021, our net loss attributable to common stockholders was approximately $(1.5) million and $(22.9) million, respectively, while cash distributions declared for each of the periods were approximately $17.8 million and $35.6 million, respectively. For the years ended December 31, 2022 and 2021, 100% of regular cash distributions declared to stockholders were considered to be funded with cash provided by operating activities as calculated on a quarterly basis for GAAP purposes.

(2)Amounts herein include cash flows from discontinued operations. Cash flows from operating activities calculated in accordance with GAAP are not necessarily indicative of the amount of cash available to pay distributions and as such our board of directors uses other measures such as FFO and MFFO in order to evaluate the level of distributions.

*Distributions to Noncontrolling Interests*

During the year ended December 31, 2022, our consolidated joint ventures paid distributions of approximately $2.2 million to co-venture partners, which included $2.0 million representing the pro rata share of net sales proceeds from the sale of one of the Fieldstone Properties owned by one of the consolidated joint ventures, and the balance represented their pro rata share of operating cash flows. During the year ended December 31, 2021, our consolidated joint ventures paid distributions of approximately $0.2 million to co-venture partners, representing their pro rata share of operating cash flows.

**Results of Operations**

Except for the impact of elevated labor costs, inflation and a rising interest rate environment, we are not aware of other material trends or uncertainties, favorable or unfavorable, that may be reasonably anticipated to have a material impact on either capital resources or the revenues or income to be derived from the operation of properties, other than those referred to in the risk factors identified in "Part I, Item 1A" of this report.

The following discussion and analysis should be read in conjunction with the accompanying consolidated financial statements and the notes thereto.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***Fiscal year ended December 31, 2022 as compared to the fiscal year ended December 31, 2021***

As of December 31, 2022, excluding our vacant land and including the five properties consolidated from the Windsor Manor Joint Venture effective January 1, 2022, we owned 69 consolidated operating investment properties and owned 67 properties as of December 31, 2021.

---

| | | |
|:---|:---|:---|
| | **Investment count as of December 31,** | **Investment count as of December 31,** |
|<br>**Consolidated operating investment types:** | **2022** | **2021** |
| Seniors housing leased | 15 | 15 |
| Seniors housing managed | 54 | 51 |
| Acute care leased |  | 1 |
|  | 69 | 67 |

---

*Rental Income and Related Revenues.* Rental income and related revenues were approximately $26.9 million and $30.1 million for the years ended December 31, 2022 and 2021, respectively. The decrease in revenue during the year ended December 31, 2022, was primarily due to reduced rent related to new leases in February 2022 at five seniors housing properties, as well as the sale of the Hurst Specialty Hospital in April 2022.

*Resident Fees and Services.* Resident fees and services income was approximately $295.8 million and $265.3 million for the years ended December 31, 2022 and 2021, respectively. The increase in revenue during the year ended December 31, 2022, was primarily due to an increase in average occupancy and increases in rates charged to our residents. Average occupancy was lower during the year ended December 31, 2021, due to move-in restrictions, intensified screening and other measures enacted at our communities to address the spread of COVID-19. The increase in resident fees and services was also partially due to the acquisition of the remaining 25% interest in the Windsor Manor Joint Venture and the subsequent consolidation of the Windsor Manor revenues from five properties effective January 1, 2022. Refer to Item 8. "Financial Statements and Supplemental Data – Note 4. Acquisition" for additional information. The increase was partially offset by the sale of the Fieldstone Properties in August 2022.

*Property Operating Expenses.* Property operating expenses were approximately $226.8 million and $197.6 million for the years ended December 31, 2022 and 2021, respectively. Property operating expenses increased during the year ended December 31, 2022, primarily due to an increase in average occupancy as well as the consolidation of our Windsor Manor expenses, as described above. In addition, property expenses were higher due to increased labor costs driven by higher wages and usage of agency labor in a tight labor market and an increase in operating expenses due to inflation. The increase in property operating expense was partially offset by the sale of the Fieldstone Properties in August 2022.

*General and Administrative Expenses*. General and administrative expenses were approximately $10.2 million and $9.1 million for the years ended December 31, 2022 and 2021, respectively. General and administrative expenses were comprised primarily of personnel expenses of affiliates of our Advisor, directors' and officers' insurance, franchise taxes, sales taxes, accounting and legal fees, and board of director fees.

*Asset Management Fees*. We incurred asset management fees of approximately $14.1 million and $15.7 million for the years ended December 31, 2022 and 2021, respectively. Asset management fees are paid to our Advisor for the management of our real estate assets, including our pro rata share of investments in unconsolidated entities, loans and other permitted investments. Asset management fees decreased during the year ended December 31, 2022, as compared to the year ended December 31, 2021, as a result of a reduction in our asset management fee from 1.0% per annum to 0.80% per annum of average invested assets, which became effective in March 2021, and due to the sale of three properties in 2022.

*Property Management Fees.* We incurred property management fees payable to our third-party property managers of approximately $14.7 million and $13.0 million for the years ended December 31, 2022 and 2021, respectively. The property management fees are based on a percentage of revenues under the property management agreement and the increase across periods is reflective of the increase in average occupancy and resident fees and service revenues over the same period as described above.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

*Impairment Provision.* As described above in "Liquidity and Capital Resources – Tenant Financial Difficulties," in March 2022 we entered into a purchase and sale agreement for the Hurst Specialty Hospital with an unrelated third party for a gross sales price of $8.5 million. In conjunction therewith, we determined that the carrying value of this property was not recoverable and during the year ended December 31, 2021, we recorded an impairment provision of approximately $9.8 million to write-down the value of our Hurst Specialty Hospital to its estimated sales proceeds expected from the sale of the Hurst Specialty Hospital. There was no impairment provision recorded during the year ended December 31, 2022.

*Depreciation and Amortization.* Depreciation and amortization expenses were approximately $54.2 million and $50.4 million for the years ended December 31, 2022 and 2021, respectively. Depreciation and amortization expenses are comprised of depreciation and amortization of the buildings, equipment, land improvements and in-place leases related to our real estate portfolio. The increase during the year ended December 31, 2022, as compared to the year ended December 31, 2021, is primarily due to investing approximately $17.8 million in capital improvements to maintain and improve our properties subsequent to December 31, 2021, and to a lesser extent, due to the consolidation of the Windsor Manor assets effective January 1, 2022.

*Gain on Sale of Real Estate.* Gain on the sale of real estate of the Fieldstone Properties was approximately $6.3 million during the year ended December 31, 2022. One of the Fieldstone Properties was indirectly owned through a consolidated joint venture. Of the aggregate gain on the sale of real estate for the year ended December 31, 2022, approximately $5.4 million was allocable to common stockholders and the balance was allocable to noncontrolling interests. We did not sell any properties from continuing operations during the year ended December 31, 2021.

*Interest and Other Income.* Interest and other income was approximately $4.7 million and $0.7 million for the years ended December 31, 2022 and 2021, respectively. Other income includes approximately $4.3 million and $0.5 million during the years ended December 31, 2022 and 2021, respectively, in CARES Act provider relief funds recorded as conditions of the grant were met. See "COVID-19" above and Item 8. "Financial Statements and Supplemental Data – Note 2. Summary of Significant Accounting Policies – Government Grant Income" for additional information.

*Interest Expense and Loan Cost Amortization*. Interest expense and loan cost amortization were approximately $21.8 million and $19.7 million for the years ended December 31, 2022 and 2021, respectively. The increase in interest expense and loan cost amortization for the year ended December 31, 2022, as compared to the year ended December 31, 2021, is primarily due to the rising interest rate environment. During the year ended December 31, 2022, we were able to partially mitigate the full impact from the rise in interest rates due to the interest rate caps in place throughout 2022 as part of our overall variable debt hedging strategy.

*Gain on Change of Control of a Joint Venture.* As described below in Item 8. "Financial Statements and Supplemental Data – Note 4. Acquisition," during the year ended December 31, 2022, we recognized a gain of approximately $8.4 million as part of acquiring the remaining 25% interest in the Windsor Manor Joint Venture from our joint venture partner, resulting in us owning a 100% controlling interest in the Windsor Manor Joint Venture and derecognizing our equity method investment in the Windsor Manor Joint Venture. We did not record such gains during the year ended December 31, 2021.

*Income Tax Expense.* We incurred income tax expense of approximately $0.5 million and $4.2 million for the years ended December 31, 2022 and 2021, respectively. The decrease in income tax expense during the year ended December 31, 2022, as compared to the year ended December 31, 2021, is primarily attributable to the tax effect of the valuation allowance on current year results and the increase in our valuation allowance against deferred tax assets in the prior year.

*Net income attributable to noncontrolling interests.* Net income attributable to non-controlling interests was approximately $1.0 million and $16,000 for the years ended December 31, 2022 and 2021, respectively. The increase in net income attributable to noncontrolling interests during the year ended December 31, 2022, as compared to the year ended December 31, 2021, was primarily due to the sale of one of the Fieldstone Properties by one of our consolidated joint ventures in August 2022, which resulted in a gain on sale of real estate of approximately $0.9 million attributable to noncontrolling interests.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Net Operating Income**

We generally expect to meet future cash needs for general and administrative expenses, debt service and distributions from NOI. We define NOI, a non-GAAP measure, as total revenues less the property operating expenses and property management fees from managed properties. We use NOI as a key performance metric for internal monitoring and planning purposes, including the preparation of annual operating budgets and monthly operating reviews, as well as to facilitate analysis of future investment and business decisions. It does not represent cash flows from operating activities in accordance with GAAP and should not be considered to be an alternative to net income or loss (determined in accordance with GAAP) as an indication of our operating performance or to be an alternative to cash flows from operating activities (determined in accordance with GAAP) as a measure of our liquidity. We believe the presentation of this non-GAAP measure is important to the understanding of our operating results for the periods presented because it is an indicator of the return on property investment and provides a method of comparing property performance over time. In addition, we have aggregated NOI on a "same-store" basis only for comparable properties that we have owned during the entirety of all periods presented. Non-same-store NOI includes NOI from the acquisition of the remaining 25% interest in the Windsor Manor Joint Venture effective January 1, 2022 and the subsequent transition of the Windsor Manor properties from unconsolidated to consolidated, as we did not consolidate those properties during the entirety of all periods presented. Non-same-store NOI also includes NOI from the Hurst Specialty Hospital sold in April 2022 and the two Fieldstone Properties sold in August 2022, as we did not own these properties during the entirety of all periods presented. The chart below presents a reconciliation of our net income to NOI for the years ended December 31, 2022 and 2021 (in thousands) and the amount invested in properties as of December 31, 2022 and 2021 (in millions), excluding one property classified as discontinued operations:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Change** |
| | **2022** | **2021** | $**%** |
| Net loss | $(412) | $(22866) |  |
| Adjusted to exclude: |  |  |  |
| &nbsp;&nbsp;&nbsp;General and administrative expenses | 10209 | 9116 |  |
| &nbsp;&nbsp;&nbsp;Asset management fees | 14074 | 15733 |  |
| &nbsp;&nbsp;&nbsp;Impairment provision |  | 9790 |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 54242 | 50417 |  |
| &nbsp;&nbsp;&nbsp;Gain on sale of real estate | (6282) |  |  |
| &nbsp;&nbsp;&nbsp;Other expenses, net of other income | 8742 | 18505 |  |
| &nbsp;&nbsp;&nbsp;Income tax expense | 540 | 4174 |  |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations |  | 10 |  |
| NOI | $81113 | $84879 | (4.4)% |
| Less: Non-same-store NOI | 3198 | 3582 |  |
| Same-store NOI | $77915 | $81297 | (4.2)% |
| Invested in operating properties, end of period | $1739 | $1768 |  |

---

Overall, our same-store NOI for the year ended December 31, 2022 decreased by approximately $3.4 million, as compared to the prior year. Same-store NOI was negatively impacted by reduced rents related to new leases which commenced in February 2022 at five seniors housing properties, as well as increased property operating expenses resulting from higher labor costs in a tight labor market and rising inflation levels.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Funds from Operations and Modified Funds from Operations**

Due to certain unique operating characteristics of real estate companies, as discussed below, the National Association of Real Estate Investment Trusts, ("NAREIT") promulgated a measure known as funds from operations ("FFO"), which we believe to be an appropriate supplemental measure to reflect the operating performance of a REIT. The use of FFO is recommended by the REIT industry as a supplemental performance measure. FFO is not equivalent to net income or loss as determined under GAAP.

We define FFO, a non-GAAP measure, consistent with the standards approved by the Board of Governors of NAREIT. NAREIT defines FFO as net income or loss computed in accordance with GAAP, excluding gains or losses from sales of property, real estate asset impairment write-downs, plus depreciation and amortization of real estate related assets, and after adjustments for unconsolidated partnerships and joint ventures. Our FFO calculation complies with NAREIT's policy described above.

The historical accounting convention used for real estate assets requires straight-line depreciation of buildings and improvements, which implies that the value of real estate assets diminishes predictably over time, especially if such assets are not adequately maintained or repaired and renovated as required by relevant circumstances and/or is requested or required by lessees for operational purposes in order to maintain the value of the property. We believe that, because real estate values historically rise and fall with market conditions, including inflation, interest rates, the business cycle, unemployment and consumer spending, presentations of operating results for a REIT using historical accounting for depreciation may be less informative. Historical accounting for real estate involves the use of GAAP. Any other method of accounting for real estate such as the fair value method cannot be construed to be any more accurate or relevant than the comparable methodologies of real estate valuation found in GAAP. Nevertheless, we believe that the use of FFO, which excludes the impact of real estate related depreciation and amortization, provides a more complete understanding of our performance to investors and to management, and when compared year over year, reflects the impact on our operations from trends in occupancy rates, rental rates, operating costs, general and administrative expenses, and interest costs, which may not be immediately apparent from net income or loss. However, FFO and MFFO, as described below, should not be construed to be more relevant or accurate than the current GAAP methodology in calculating net income or loss in its applicability in evaluating operating performance. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the non-GAAP FFO and MFFO measures and the adjustments to GAAP in calculating FFO and MFFO.

Changes in the accounting and reporting promulgations under GAAP (for acquisition fees and expenses for business combinations from a capitalization/depreciation model) to an expensed-as-incurred model that were put into effect in 2009, and other changes to GAAP accounting for real estate subsequent to the establishment of NAREIT's definition of FFO, have prompted an increase in cash-settled expenses, specifically acquisition fees and expenses, as items that are expensed under GAAP and accounted for as operating expenses. Our management believes these fees and expenses do not affect our overall long-term operating performance. Publicly registered, non-listed REITs typically have a significant amount of acquisition activity and are substantially more dynamic during their initial years of investment and operation. While other start up entities may also experience significant acquisition activity during their initial years, we believe that non-listed REITs are unique in that they have a limited life with targeted exit strategies within a relatively limited time frame after acquisition activity ceases. Due to the above factors and other unique features of publicly registered, non-listed REITs, the IPA has standardized a measure known as modified funds from operations ("MFFO") which the IPA has recommended as a supplemental measure for publicly registered non-listed REITs and which we believe to be another appropriate supplemental measure to reflect the operating performance of a non-listed REIT. MFFO is not equivalent to our net income or loss as determined under GAAP, and MFFO may not be a useful measure of the impact of long-term operating performance on value if we do not continue to operate with a limited life and targeted exit strategy, as currently intended. We believe that because MFFO excludes costs that we consider more reflective of investing activities and other non-operating items included in FFO and also excludes acquisition fees and expenses that affect our operations only in periods in which properties are acquired, MFFO can provide, on a going forward basis, an indication of the sustainability (that is, the capacity to continue to be maintained) of our operating performance after the period in which we acquired our properties and once our portfolio is in place. By providing MFFO, we believe we are presenting useful information that assists investors and analysts to better assess the sustainability of our operating performance after our properties have been acquired. We also believe that MFFO is a recognized measure of sustainable operating performance by the non-listed REIT industry.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

We define MFFO, a non-GAAP measure, consistent with the IPA's Guideline 2010-01, Supplemental Performance Measure for Publicly Registered, Non-Listed REITs: MFFO, or the Practice Guideline, issued by the IPA in November 2010. The Practice Guideline defines MFFO as FFO further adjusted for the following items, as applicable, included in the determination of GAAP net income or loss: acquisition fees and expenses; amounts relating to deferred rent receivables and amortization of above and below market leases and liabilities (which are adjusted from a GAAP accrual basis in order to reflect such payments on a cash basis of amounts expected to be received for such lease and rental payments); contingent purchase price consideration adjustments; accretion of discounts and amortization of premiums on debt investments; mark-to-market adjustments included in net income or loss; gains or losses included in net income from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or securities holdings where trading of such holdings is not a fundamental attribute of the business plan; and unrealized gains or losses resulting from consolidation from, or deconsolidation to, equity accounting and after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect MFFO on the same basis. The accretion of discounts and amortization of premiums on debt investments, unrealized gains and losses on hedges, foreign exchange, derivatives or securities holdings, unrealized gains and losses resulting from consolidations, as well as other listed cash flow adjustments are adjustments made to net income or loss in calculating the cash flows provided by operating activities and, in some cases, reflect gains or losses which are unrealized and may not ultimately be realized.

Our MFFO calculation complies with the IPA's Practice Guideline described above. In calculating MFFO, we exclude acquisition related expenses. Under GAAP, acquisition fees and expenses are characterized as operating expenses in determining operating net income or loss. These expenses are paid in cash by us. All paid and accrued acquisition fees and expenses will have negative effects on returns to investors, the potential for future distributions, and cash flows generated by us, unless earnings from operations or net sales proceeds from the disposition of other properties are generated to cover the purchase price of the property.

Our management uses MFFO and the adjustments used to calculate it in order to evaluate our performance against other non-listed REITs which have limited lives with short and defined acquisition periods and targeted exit strategies shortly thereafter. As noted above, MFFO may not be a useful measure of the impact of long-term operating performance on value if we do not continue to operate in this manner. We believe that our use of MFFO and the adjustments used to calculate it allow us to present our performance in a manner that reflects certain characteristics that are unique to non-listed REITs, such as their limited life, limited and defined acquisition period and targeted exit strategy, and hence that the use of such measures is useful to investors. For example, acquisition costs are funded from our subscription proceeds and other financing sources and not from operations.

By excluding expensed acquisition costs, the use of MFFO provides information consistent with management's analysis of the operating performance of the properties.

Presentation of this information is intended to provide useful information to investors as they compare the operating performance of different non-listed REITs, although it should be noted that not all REITs calculate FFO and MFFO the same way and as such comparisons with other REITs may not be meaningful. Furthermore, FFO and MFFO are not necessarily indicative of cash flows available to fund cash needs and should not be considered as an alternative to net income (or loss) or income (or loss) from continuing operations as an indication of our performance, as an alternative to cash flows from operations, as an indication of our liquidity, or indicative of funds available to fund our cash needs including our ability to make distributions to our stockholders. FFO and MFFO should be reviewed in conjunction with other GAAP measurements as an indication of our performance. MFFO is useful in assisting management and investors in assessing the sustainability of operating performance in future operating periods.

Neither the SEC, NAREIT nor any other regulatory body has passed judgment on the acceptability of the adjustments we use to calculate FFO or MFFO. In the future, the SEC, NAREIT or another regulatory body may decide to standardize the allowable adjustments across the non-listed REIT industry and we would have to adjust our calculation and characterization of FFO or MFFO.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

The following table presents a reconciliation of net income to FFO and MFFO for the years ended December 31, 2022, 2021 and 2020 (in thousands, except per share data):

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| | **2022** | **2021** | **2020** |
| Net (loss) income attributable to common stockholders | $(1453) | $(22882) | $3912 |
| Adjustments: |  |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | 54242 | 50417 | 51817 |
| &nbsp;&nbsp;&nbsp;Impairment provision: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations |  | 9790 |  |
| &nbsp;&nbsp;&nbsp;Gain on sale of real estate: <sup>(1)</sup> |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | (6282) |  | (1074) |
| &nbsp;&nbsp;&nbsp;Gain on change of control of a joint venture: <sup>(2)</sup>  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | (8376) |  |  |
| &nbsp;&nbsp;&nbsp;FFO adjustments attributable to noncontrolling interests: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | 821 | (184) | (192) |
| &nbsp;&nbsp;&nbsp;FFO adjustments from unconsolidated entities <sup>(3)</sup> |  | 947 | 266 |
| FFO attributable to common stockholders | 38952 | 38088 | 54729 |
| &nbsp;&nbsp;&nbsp;Straight-line rent adjustments: <sup>(4)</sup> |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | 1209 | 1231 | 1697 |
| &nbsp;&nbsp;&nbsp;Write-off of lease related costs: <sup>(5)</sup> |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations |  |  | 2468 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations |  |  | 103 |
| &nbsp;&nbsp;&nbsp;Amortization of premium for debt investments: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | (42) | (42) | (42) |
| &nbsp;&nbsp;&nbsp;Realized loss on extinguishment of debt: <sup>(6)</sup> |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | 28 | 43 | 35 |
| &nbsp;&nbsp;&nbsp;Unrealized gain on investment in short term securities: <sup>(7)</sup> |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations |  |  | 11 |
| &nbsp;&nbsp;&nbsp;MFFO adjustments attributable to noncontrolling interests: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | 12 | 1 | 9 |
| MFFO attributable to common stockholders | $40159 | $39321 | $59010 |
| Weighted average number of shares of common stock outstanding (basic and diluted) | 173960 | 173960 | 173960 |
| Net (loss) income per share (basic and diluted) | $(0.01) | $(0.13) | $0.02 |
| FFO per share (basic and diluted) | $0.22 | $0.22 | $0.31 |
| MFFO per share (basic and diluted) | $0.23 | $0.23 | $0.34 |

---

_______________

**FOOTNOTES:**

(1)Management believes that adjusting for the gain on sale of real estate is appropriate because the adjustment is not reflective of our ongoing operating performance and, as a result, the adjustment better aligns results with management's analysis of operating performance.

(2)Management believes that adjusting for the gain on change of control of a joint venture is appropriate because the adjustment is not reflective of our ongoing operating performance and, as a result, the adjustment better aligns results with management's analysis of operating performance.

(3)This amount represents our share of the FFO or MFFO adjustments allowable under the NAREIT or IPA definitions, respectively, calculated using the HLBV method relating to our previously unconsolidated equity method investment in the Windsor Manor Joint Venture. Effective January 1, 2022, we owned a 100% controlling interest in Windsor Manor Joint Venture.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

(4)Under GAAP, rental receipts are allocated to periods using various methodologies. This may result in income or expense recognition that is significantly different than underlying contract terms. By adjusting for these items (from a GAAP accrual basis in order to reflect such payments on a cash basis of amounts expected to be received for such lease and rental payments), MFFO provides useful supplemental information on the realized economic impact of lease terms and debt investments, providing insight on the contractual cash flows of such lease terms and debt investments, and aligns results with management's analysis of operating performance.

(5)Management believes that adjusting for write-offs of lease related assets is appropriate because they are non-cash adjustments that may not be reflective of our ongoing operating performance and, as a result, the adjustments better align results with management's analysis of operating performance. In 2020, we recorded write-offs totaling approximately $2.6 million for deferred rent from prior GAAP straight-line adjustments, unamortized lease costs and lease related intangibles.

(6)Management believes that adjusting for the realized loss on the extinguishment of debt, hedges or other derivatives is appropriate because the adjustments are not reflective of our ongoing operating performance and, as a result, the adjustments better align results with management's analysis of operating performance.

(7)Management believes that adjusting for the unrealized gain on investment in short term securities is appropriate because the adjustment is not reflective of our ongoing operating performance and, as a result, the adjustments better align results with management's analysis of operating performance.

**Related-Party Transactions** 

Our Advisor and its affiliates are entitled to reimbursement of certain costs incurred on our behalf in connection with our organization, acquisitions, dispositions and operating activities. To the extent that operating expenses payable or reimbursable by us in any four consecutive fiscal quarters ("Expense Year"), commencing with the Expense Year ending June 30, 2013, exceed the greater of 2% of average invested assets or 25% of net income, the Advisor shall reimburse us, within 60 days after the end of the Expense Year, the amount by which the total operating expenses paid or incurred by us exceed the greater of the 2% or 25% threshold. Notwithstanding the above, we may reimburse the Advisor for expenses in excess of this limitation if a majority of our independent directors determines that such excess expenses are justified based on unusual and non-recurring factors. For the Expense Year ended December 31, 2022, the Company did not incur operating expenses in excess of the limitation.

See Item 8. "Financial Statements and Supplemental Data – Note 12. Related Party Arrangements" in the accompanying consolidated financial statements for additional information.

**Critical Accounting Policies and Estimates** 

Below is a discussion of the accounting policies that management believes are critical. We consider these policies critical because they involve difficult management judgments and assumptions, require estimates about matters that are inherently uncertain and because they are important for understanding and evaluating our reported financial results. These judgments will affect the reported amounts of assets and liabilities and our disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. With different estimates or assumptions, materially different amounts could be reported in our financial statements. Additionally, other companies may utilize different estimates that may impact the comparability of our results of operations to those of companies in similar businesses. Our most sensitive estimates will involve the allocation of the purchase price of acquired properties and evaluating our real estate-related investments for impairment. See Item 8. "Financial Statements and Supplemental Data – Note 2. Summary of Significant Accounting Policies" in the accompanying consolidated financial statements for additional information.

*Basis of Presentation and Consolidation.* Our consolidated financial statements will include our accounts, the accounts of our wholly owned subsidiaries or subsidiaries for which we have a controlling interest, the accounts of variable interest entities ("VIEs") in which we are the primary beneficiary, and the accounts of other subsidiaries over which we have a controlling financial interest. All material intercompany accounts and transactions will be eliminated in consolidation.

In accordance with the guidance for the consolidation of a VIE, we are required to identify entities for which control is achieved through means other than voting rights and to determine the primary beneficiary of our VIEs. We qualitatively assess whether we are the primary beneficiary of a VIE and consider various factors including, but not limited to, the design of the entity, its organizational structure including decision-making ability and financial agreements, our ability and the rights of others to participate in policy making decisions, as well as our ability to replace the VIE manager and/or liquidate the entity.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

*Use of Estimates.* The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments, the valuation of contingent assets and liabilities, and the valuation of restricted common stock shares issued to the Advisor. Accordingly, actual results could differ from those estimates.

*Assets Held For Sale, net and Discontinued Operations.* The Company determines to classify a property as held for sale once management has the authority to approve and commits to a plan to sell the property, the property is available for immediate sale, there is an active program to locate a buyer, the sale of the property is probable and the transfer of the property is expected to occur within one year. Upon the determination to classify a property as held for sale, the Company ceases recording further depreciation and amortization relating to the associated assets and those assets are measured at the lower of its carrying amount or fair value less disposition costs and are presented separately in the consolidated balance sheets for all periods presented. In addition, the Company classifies assets held for sale as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on the Company's operations and financial results. For any disposal(s) qualifying as discontinued operations, the Company allocates interest expense and loan cost amortization that directly relates to either: (1) expense on mortgages and other notes payable collateralized by properties classified as discontinued operations; or (2) expense on the Company's Credit Facilities, which is allocated based on the value of the properties that are classified as discontinued operations since these properties are included in the Credit Facilities' unencumbered pool of assets and the related indebtedness is required to be repaid upon sale of the properties.

*Impairment of Real Estate Assets.* Real estate assets are reviewed on an ongoing basis to determine whether there are any impairment indicators. Management considers potential impairment indicators to primarily include (i) changes in a real estate asset's operating performance, such as a current period net operating loss combined with a history of net operating losses, or a projection or forecast that demonstrates continuing losses associated with the use of a real estate asset or (ii) a current expectation that, more likely than not, a real estate asset will be sold or otherwise disposed of significantly before the end of its previously estimated holding period. To assess if an asset group is potentially impaired, we compare the estimated current and projected undiscounted cash flows, including estimated net sales proceeds, of the asset group over its remaining useful life, or our estimated holding period if shorter, to the net carrying value of the asset group. Such cash flow projections consider factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition and other factors. In the event that the carrying value exceeds the undiscounted operating cash flows, we would recognize an impairment provision to adjust the carrying value of the asset group to the estimated fair value of the asset group. In March 2022, we received an unsolicited offer and entered into a purchase and sale agreement for the Hurst Specialty Hospital with an unrelated third party for a gross sales price of $8.5 million. In conjunction therewith, we determined that the carrying value of this property was not recoverable and during the year ended December 31, 2021, we recorded an impairment provision of approximately $9.8 million to write-down the value of our Hurst Specialty Hospital to its estimated sales proceeds expected from the sale of the Hurst Specialty Hospital.

When impairment indicators are present for real estate indirectly owned, through an investment in a joint venture or other similar investment structure accounted for under the equity method, we will compare the estimated fair value of our investment to the carrying value. An impairment charge will be recorded to the extent the fair value of our investment is less than the carrying amount and the decline in value is determined to be other than a temporary decline.

*Income Taxes.* To qualify as a REIT, we are subject to certain organizational and operational requirements, including a requirement to distribute to stockholders each year at least 90% of our annual REIT taxable income (which is computed without regard to the dividends-paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, we generally will not be subject to U.S. federal income tax on income that we distribute as dividends to our stockholders. If we fail to qualify as a REIT in any taxable year, we will be subject to U.S. federal income tax on our taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the IRS grants us relief under certain statutory provisions. Even if we qualify for taxation as a REIT, we may be subject to certain state and local taxes on our income and property, and U.S. federal income and excise taxes on our undistributed income.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

We have and will continue to form subsidiaries which may elect to be taxed as a TRS for U.S. federal income tax purposes. Under the provisions of the Internal Revenue Code and applicable state laws, a TRS will be subject to tax on its taxable income from its operations. We will account for federal and state income taxes with respect to a TRS using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities, the respective tax bases, operating losses and/or tax-credit carryforwards.

*Revenue Recognition.* Rental income and related revenues for operating leases are recognized based on the assessment of collectability of lease payments. When collectability is probable at commencement of the lease, lease income is recognized on an accrual basis and includes rental income that is recorded on the straight-line basis over the term of the lease. Collectability is reassessed during the lease term. When collectability of lease payments is no longer probable, lease income is recorded on a cash basis and limited to the amount of lease payments collected. In addition, lease related costs (the deferred rent from prior GAAP straight-line adjustments, unamortized lease costs and other lease related intangibles) are written-off when the Company determines that these assets are no longer realizable.

Rental income and related revenues recorded on an accrual basis include rental income that is recorded on the straight-line basis over the terms of the leases for new leases and the remaining terms of existing leases for those acquired as part of a property acquisition. The straight-line method records the periodic average amount of base rent earned over the term of a lease, taking into account contractual rent increases over the lease term. We record the difference between base rent revenues earned and amounts due per the respective lease agreements, as applicable, as an increase or decrease to deferred rent and lease incentives in the accompanying consolidated balance sheets.

Rental income and related revenues also includes tenant reimbursements that represent amounts tenants are required to reimburse us for expenses incurred on behalf of the tenants, in accordance with the terms of the leases and are recognized in the period in which the related reimbursable expenses are incurred, such as real estate taxes, common area maintenance, and similar items.

We account for our resident agreements as a single performance obligation under ASC 606 given our overall promise to provide a series of stand-ready goods and services to our residents each month. Resident fees and services are recorded in the period in which the goods are provided and the services are performed and generally consist of (1) monthly rent, which covers occupancy of the residents' unit as well as basic services, such as utilities, meals and certain housekeeping services, and (2) service level charges, such as assisted living care, memory care and ancillary services. Resident agreements are generally short-term in nature, billed monthly in advance and cancellable by the residents with a 30-day notice. Resident agreements may require the payment of upfront fees prior to moving into the community with any non-refundable portion of such fees being recorded as deferred revenue and amortized over the estimated resident stay.

**Impact of Accounting Pronouncements**

See Item 8. "Financial Statements and Supplemental Data – Note 2. Summary of Significant Accounting Policies" for additional information about the impact of accounting pronouncements.

**Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS**

We may be exposed to interest rate changes primarily as a result of the long-term debt we used to acquire properties and other permitted investments, as well as impacts of volatile credit markets and a rising interest rate environment. Our management objectives related to interest rate risk are to limit the impact of interest rate changes on earnings and on operating cash flows. To achieve our objectives, we borrow at fixed rates or variable rates with the lowest margins available, and in some cases, with the ability to convert from variable rates to fixed rates. With regard to variable rate financing, we assess interest rate cash flow risk by continually identifying and monitoring changes in interest rate exposures that may adversely impact expected future cash flows and by evaluating hedging opportunities.

In September 2022, we amended our revolving credit facility and term loan facilities loan agreements to, among other things, replace LIBOR with SOFR as the benchmark rate.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

The following is a schedule as of December 31, 2022 of our fixed and variable rate debt maturities for each of the next five years and thereafter (principal maturities only) (in thousands):

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Expected Maturities** | **Expected Maturities** | **Expected Maturities** | **Expected Maturities** | **Expected Maturities** | **Expected Maturities** | **Expected Maturities** | **Expected Maturities** | | | |
| | **2023** | **2023** | **2024**<sup>(3)</sup> | **2024**<sup>(3)</sup> | **2025** | **2026** | **2027** | **Thereafter** | **Total** | **Total** |<br>**Fair Value**<sup>(1)</sup> |
| Fixed rate debt | $| 23407 | $| 20675 | $— | $— | $— | $— | $| 44082 | $43000 |
| Weighted average interest rate on fixed rate debt | 4.65 | 4.65% | 3.25 | 3.25% | —% | —% | —% | —% | 3.99 | 3.99% |  |
| Variable rate debt | $| 647 | $| 565212 | $— | $— | $— | $— | $| 565859 | $566000 |
| Average interest rate on variable rate debt<sup>(2)</sup> | 1.55% + Variable Rate | 1.55% + Variable Rate | 1.55% + Variable Rate | 1.55% + Variable Rate | —% | —% | —% | —% | 1.55% + Variable Rate | 1.55% + Variable Rate |  |

---

_______________

**FOOTNOTES:**

(1)The estimated fair value of our fixed and variable rate debt was determined using discounted cash flows based on market interest rates as of December 31, 2022. We determined market rates through discussions with our existing lenders by pricing our loans with similar terms and current rates and spreads.

(2)Variable rates applicable to our variable rate debt include LIBOR and SOFR.

(3)In January 2023, the Company exercised its option to extend the maturity date for the $133.0 million outstanding under its Revolving Credit Facility by one year, extending the maturity date to May 2024. The variable rate debt maturities reflect the extended maturity date of the Revolving Credit Facility.

Throughout 2022, the Company had two interest rate caps in place, which expired on December 31, 2022. Prior to the expiration of these two interest rate caps, the Company's debt was comprised of approximately 7.2% in fixed rate debt, approximately 60.7% in variable rate debt with interest rate protection and approximately 32.1% of unhedged variable rate debt (primarily related to our Credit Facilities) based on debt outstanding as of December 31, 2022. After the expiration of the interest rate caps on December 31, 2022, the Company's debt was comprised of approximately 7.2% in fixed rate debt, approximately 2.5% in variable rate debt with interest rate protection and approximately 90.3% of unhedged variable rate debt. In February 2023, the Company purchased a short-term interest rate cap hedging the majority of its Credit Facilities and as of February 2023, the Company's debt was comprised of approximately 7.2% in fixed rate debt, approximately 71.5% in variable rate debt with interest rate protection and approximately 21.3% of unhedged variable rate debt. Overall, we believe longer term fixed rate debt could be beneficial in a rising interest rate or rising inflation rate environment and as such we continue to evaluate the need for additional interest rate protection on unhedged variable rate debt or variable rate debt with interest rate protection scheduled to mature.

Management estimates that a hypothetical one-percentage point increase in variable rates, compared to variable rates as of December 31, 2022 and considering the impact of our interest rate caps that were in place as of March 8, 2023, would increase interest expense by approximately $3.5 million over the next twelve months. This sensitivity analysis contains certain simplifying assumptions, and although it gives an indication of our exposure to changes in interest rates, it is not intended to predict future results and actual results will likely vary given that our sensitivity analysis on the effects of changes in LIBOR and SOFR does not factor in a potential change in variable rate debt levels or changes in our hedging strategy.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA**

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

---

| | |
|:---|:---|
| | Page |
| <u>[Report of Independent Registered Public Accounting Firm (PCAOB ID](#i7aa20ec61c924cc0a7c3ac74d325237b_106)238[)](#i7aa20ec61c924cc0a7c3ac74d325237b_106)</u> | [68](#i7aa20ec61c924cc0a7c3ac74d325237b_106) |
| <u>[Consolidated Balance Sheets](#i7aa20ec61c924cc0a7c3ac74d325237b_109)</u> | [70](#i7aa20ec61c924cc0a7c3ac74d325237b_109) |
| <u>[Consolidated Statements of Operations](#i7aa20ec61c924cc0a7c3ac74d325237b_112)</u> | [71](#i7aa20ec61c924cc0a7c3ac74d325237b_112) |
| <u>[Consolidated Statements of Comprehensive Income (Loss)](#i7aa20ec61c924cc0a7c3ac74d325237b_118)</u> | [72](#i7aa20ec61c924cc0a7c3ac74d325237b_118) |
| <u>[Consolidated Statements of Stockholders' Equity and Redeemable Noncontrolling Interest](#i7aa20ec61c924cc0a7c3ac74d325237b_121)</u> | [73](#i7aa20ec61c924cc0a7c3ac74d325237b_121) |
| <u>[Consolidated Statements of Cash Flows](#i7aa20ec61c924cc0a7c3ac74d325237b_124)</u> | [74](#i7aa20ec61c924cc0a7c3ac74d325237b_124) |
| <u>[Notes to Consolidated Financial Statements](#i7aa20ec61c924cc0a7c3ac74d325237b_127)</u> | [76](#i7aa20ec61c924cc0a7c3ac74d325237b_127) |
| <u>[Schedule II – Valuation and Qualifying Accounts](#i7aa20ec61c924cc0a7c3ac74d325237b_181)</u> | [98](#i7aa20ec61c924cc0a7c3ac74d325237b_181) |
| <u>[Schedule III – Real Estate and Accumulated Depreciation](#i7aa20ec61c924cc0a7c3ac74d325237b_184)</u> | [99](#i7aa20ec61c924cc0a7c3ac74d325237b_184) |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Report of Independent Registered Public Accounting Firm**

To the Board of Directors and Stockholders of CNL Healthcare Properties, Inc.

***Opinion on the Financial Statements***

We have audited the accompanying consolidated balance sheets of CNL Healthcare Properties, Inc. and its subsidiaries (the "Company") as of December 31, 2022 and 2021, and the related consolidated statements of operations, of comprehensive income (loss), of stockholders' equity and redeemable noncontrolling interest and of cash flows for each of the three years in the period ended December 31, 2022, including the related notes and financial statement schedules appearing under Item 8 as listed in the index appearing under Item 15(a)(2) (collectively referred to as the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.

***Basis for Opinion***

These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

***Critical Audit Matters***

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

*Analysis of Real Estate Assets for Indicators of Impairment*

As described in Notes 2 and 5 to the consolidated financial statements, the net carrying value of the Company's real estate investment properties was $1.3 billion as of December 31, 2022. Real estate assets are reviewed by management on an ongoing basis to determine whether there are any impairment indicators. Management considers potential impairment indicators to primarily include (i) changes in a real estate asset's operating performance, such as a current period net operating loss combined with a history of net operating losses, or a projection or forecast that demonstrates continuing losses associated with the use of a real estate asset or (ii) a current expectation that, more likely than not, a real estate asset will be sold or otherwise disposed of significantly before the end of its previously estimated holding period.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

The principal considerations for our determination that performing procedures relating to the analysis of real estate assets for indicators of impairment is a critical audit matter are (i) the significant judgment by management when determining impairment indicators, including the real estate assets' operating performance and the estimated holding period, and (ii) the high degree of auditor judgment and subjectivity in performing procedures related to management's determination of impairment indicators and the real estate assets' operating performance and the estimated holding period.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included, among others (i) evaluating the appropriateness of management's analysis of each real estate asset's operating performance and the reasonableness of management's determination of whether there were assets with net operating losses that are impairment indicators; (ii) testing the changes to the Company's leases for real estate assets related to the future minimum lease payment schedules and evaluating the impact to an asset's operating performance; (iii) reading the meeting minutes of the Board of Directors; (iv) inquiring of management about their judgments pertaining to the Company's evaluation of whether their plans have resulted in the determination that it is more likely than not there has been a change to the estimated holding period of an asset or group of assets; and (v) comparing management's determination of impairment indicators with evidence obtained in other areas of the audit.

/s/ PricewaterhouseCoopers LLP

Tampa, Florida

March 10, 2023

We have served as the Company's auditor since 2010.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| **ASSETS** | **2022** | **2021** |
| Real estate investment properties, net (including VIEs $30,906 and $42,612, respectively) | $1313438 | $1338856 |
| Assets held for sale |  | 8373 |
| Cash (including VIEs $646 and $1,597, respectively) | 69504 | 53161 |
| Restricted cash (including VIEs $9 and $59, respectively) | 4070 | 4520 |
| Other assets (including VIEs $554 and $544, respectively) | 36868 | 18700 |
| Deferred rent, lease incentives and intangibles, net | 13423 | 12970 |
| &nbsp;&nbsp;&nbsp;Total assets | $1437303 | $1436580 |
| **LIABILITIES AND EQUITY** |  |  |
| Liabilities: |  |  |
| Mortgages and other notes payable, net (including VIEs $21,142 and $28,855, respectively) | $61773 | $89400 |
| Credit facilities | 546100 | 499728 |
| Accounts payable and accrued liabilities (including VIEs $533 and $1,489, respectively) | 30270 | 29170 |
| Other liabilities (including VIEs $91 and $299, respectively) | 7469 | 6115 |
| Due to related parties | 1397 | 1406 |
| &nbsp;&nbsp;&nbsp;Total liabilities | 647009 | 625819 |
| Commitments and contingencies (Note 16) |  |  |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock, $0.01 par value per share, 200,000 shares authorized; none issued or outstanding | ― |  |
| &nbsp;&nbsp;&nbsp;Excess shares, $0.01 par value per share, 300,000 shares authorized; none issued or outstanding | ― |  |
| &nbsp;&nbsp;&nbsp;Common stock, $0.01 par value per share, 1,120,000 shares authorized, 186,626 shares issued and 173,960 shares outstanding | 1740 | 1740 |
| &nbsp;&nbsp;&nbsp;Capital in excess of par value | 1516926 | 1516926 |
| &nbsp;&nbsp;&nbsp;Accumulated income | 100408 | 101861 |
| &nbsp;&nbsp;&nbsp;Accumulated distributions | (829307) | (811493) |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | (16) | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 789751 | 809044 |
| &nbsp;&nbsp;&nbsp;Noncontrolling interest | 543 | 1717 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | 790294 | 810761 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and equity | $1437303 | $1436580 |

---

The abbreviation VIEs above means variable interest entities.

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| Revenues: |  |  |  |
| &nbsp;&nbsp;&nbsp;Rental income and related revenues | $26862 | $30101 | $26287 |
| &nbsp;&nbsp;&nbsp;Resident fees and services | 295799 | 265321 | 280854 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 322661 | 295422 | 307141 |
| Operating expenses: |  |  |  |
| &nbsp;&nbsp;&nbsp;Property operating expenses | 226845 | 197562 | 193427 |
| &nbsp;&nbsp;&nbsp;General and administrative expenses | 10209 | 9116 | 9413 |
| &nbsp;&nbsp;&nbsp;Asset management fees | 14074 | 15733 | 18051 |
| &nbsp;&nbsp;&nbsp;Property management fees | 14703 | 12981 | 13772 |
| &nbsp;&nbsp;&nbsp;Impairment provision |  | 9790 |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 54242 | 50417 | 51817 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 320073 | 295599 | 286480 |
| Gain on sale of real estate | 6282 |  | 1074 |
| Operating income (loss) | 8870 | (177) | 21735 |
| Other income (expense): |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest and other income | 4663 | 720 | 5655 |
| &nbsp;&nbsp;&nbsp;Interest expense and loan cost amortization | (21781) | (19696) | (24285) |
| &nbsp;&nbsp;&nbsp;Gain on change of control of a joint venture | 8376 |  |  |
| &nbsp;&nbsp;&nbsp;Equity in earnings of unconsolidated entity |  | 471 | 1050 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense | (8742) | (18505) | (17580) |
| Income (loss) before income taxes | 128 | (18682) | 4155 |
| Income tax expense | (540) | (4174) | (1098) |
| (Loss) income from continuing operations | (412) | (22856) | 3057 |
| (Loss) income from discontinued operations |  | (10) | 954 |
| Net (loss) income | (412) | (22866) | 4011 |
| Less: Amounts attributable to noncontrolling interests |  |  |  |
| &nbsp;&nbsp;&nbsp;Net income from continuing operations | 1041 | 16 | 99 |
| Net (loss) income attributable to common stockholders | $(1453) | $(22882) | $3912 |
| Net (loss) income per share of common stock (basic and diluted) |  |  |  |
| &nbsp;&nbsp;&nbsp;Continuing operations | $(0.01) | $(0.13) | $0.01 |
| &nbsp;&nbsp;&nbsp;Discontinued operations | $— | $— | $0.01 |
| Weighted average number of shares of common stock outstanding (basic and diluted) | 173960 | 173960 | 173960 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in thousands)

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| Net (loss) income | $(412) | $(22866) | $4011 |
| Other comprehensive (loss) income: |  |  |  |
| &nbsp;&nbsp;&nbsp;Unrealized (loss) gain on derivative financial instruments, net | (26) | 40 | 11 |
| &nbsp;&nbsp;&nbsp;Reclassification of interest rate caps upon derecognition |  |  | 2 |
| &nbsp;&nbsp;&nbsp;Unrealized gain (loss) on derivative financial instruments of equity method investments |  | 5 | (12) |
| Total other comprehensive (loss) income | (26) | 45 | 1 |
| Comprehensive (loss) income | (438) | (22821) | 4012 |
| Less: Comprehensive income attributable to noncontrolling interest | 1041 | 16 | 99 |
| Comprehensive (loss) income attributable to common stockholders | $(1479) | $(22837) | $3913 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND REDEEMABLE NONCONTROLLING INTEREST

(in thousands, except per share data)

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Redeemable<br>Noncontrolling<br>Interest** | **Common Stock** | **Common Stock** | **Capital in<br>Excess of<br>Par Value** | **Accumulated<br>Income (Loss)** | **Accumulated<br>Distributions** | **Accumulated<br>Other<br>Comprehensive<br>(Loss) Income** | **Total<br>Stockholders'<br>Equity** | **Non-<br>controlling<br>Interest** | **Total<br>Equity** |
| | **Redeemable<br>Noncontrolling<br>Interest** | **Number<br>of Shares** | **Par<br>Value** | **Capital in<br>Excess of<br>Par Value** | **Accumulated<br>Income (Loss)** | **Accumulated<br>Distributions** | **Accumulated<br>Other<br>Comprehensive<br>(Loss) Income** | **Total<br>Stockholders'<br>Equity** | **Non-<br>controlling<br>Interest** | **Total<br>Equity** |
| Balance at December 31, 2019 | $558 | 173960 | $1740 | $1516926 | $120831 | $(740239) | $(36) | $899222 | $1251 | $901031 |
| Net income | 44 |  |  |  | 3912 |  |  | 3912 | 55 | 4011 |
| Other comprehensive income |  |  |  |  |  |  | 1 | 1 |  | 1 |
| Distribution to noncontrolling interest | (30) |  |  |  |  |  |  |  | (92) | (122) |
| Cash distributions declared ($0.20480 per share) |  |  |  |  |  | (35627) |  | (35627) |  | (35627) |
| Contribution from noncontrolling interests |  |  |  |  |  |  |  |  | 75 | 75 |
| Balance at December 31, 2020 | $572 | 173960 | $1740 | $1516926 | $124743 | $(775866) | $(35) | $867508 | $1289 | $869369 |
| Net income (loss) | 22 |  |  |  | (22882) |  |  | (22882) | (6) | (22866) |
| Other comprehensive income |  |  |  |  |  |  | 45 | 45 |  | 45 |
| Distributions to noncontrolling interest | (89) |  |  |  |  |  |  |  | (71) | (160) |
| Cash distributions declared ($0.20480 per share) |  |  |  |  |  | (35627) |  | (35627) |  | (35627) |
| Reclassification of redeemable noncontrolling interest | (505) |  |  |  |  |  |  |  | 505 |  |
| Balance at December 31, 2021 | $— | 173960 | $1740 | $1516926 | $101861 | $(811493) | $10 | $809044 | $1717 | $810761 |
| Net (loss) income |  |  |  |  | (1453) |  |  | (1453) | 1041 | (412) |
| Other comprehensive loss |  |  |  |  |  |  | (26) | (26) |  | (26) |
| Distributions to noncontrolling interests |  |  |  |  |  |  |  |  | (2215) | (2215) |
| Cash distributions declared ($0.10240 per share) |  |  |  |  |  | (17814) |  | (17814) |  | (17814) |
| Balance at December 31, 2022 | $— | 173960 | $1740 | $1516926 | $100408 | $(829307) | $(16) | $789751 | $543 | $790294 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| Operating activities: |  |  |  |
| Net (loss) income | $(412) | $(22866) | $4011 |
| Net (loss) income from discontinued operations |  | (10) | 954 |
| Net (loss) income from continuing operations | (412) | (22856) | 3057 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 54242 | 50417 | 51817 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of loan costs | 2769 | 2193 | 2041 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of premium for debt investments | (42) | (42) | (42) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of discounts | (151) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Straight-line rent adjustments | 1209 | 1231 | 1697 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax expense |  | 3632 | 553 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment of debt | 28 | 43 | 35 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment provision |  | 9790 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Write-off of deferred rent and lease related costs |  |  | 2468 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of real estate | (6282) |  | (1074) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on change of control of a joint venture | (8376) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-cash operating activities | 984 | 1304 | 1212 |
| &nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | (640) | (1326) | 1299 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred rent and lease incentives |  | (250) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | 76 | 4718 | 505 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | 450 | (2108) | (1003) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Due to related parties | (9) | (374) | (495) |
| Net cash flows provided by operating activities – continuing operations | 43846 | 46372 | 62070 |
| Net cash flows (used in) provided by operating activities – discontinued operations |  | (10) | 1049 |
| Net cash flows provided by operating activities | 43846 | 46362 | 63119 |
| Investing activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition of joint venture interest, net of cash acquired | (1134) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net proceeds from sale of real estate | 36655 |  | 53712 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (17789) | (14186) | (12231) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of held-to-maturity securities | (24209) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other investing activities | 291 | 35 | 41 |
| Net cash (used in) provided by investing activities – continuing operations | (6186) | (14151) | 41522 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net proceeds from sale of real estate |  | 7402 | 28398 |
| Net cash provided by investing activities – discontinued operations |  | 7402 | 28398 |
| Net cash (used in) provided by investing activities | $(6186) | $(6749) | $69920 |

---

------

[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(in thousands)

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| Financing activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Distributions to stockholders | $(17814) | $(35627) | $(35627) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Draws under credit facilities | 45000 | 238000 | 40000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of loan costs | (328) | (2404) | (122) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principal payments on mortgages and other notes payable | (46294) | (247753) | (39737) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayments on credit facilities |  |  | (80000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Distributions to noncontrolling interests | (2215) | (160) | (122) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other financing activities | (116) | 1 | 43 |
| Net cash flows used in financing activities | (21767) | (47943) | (115565) |
| Net increase (decrease) in cash and restricted cash | 15893 | (8330) | 17474 |
| Cash and restricted cash at beginning of period, including assets held for sale | 57681 | 66011 | 48537 |
| Cash and restricted cash at end of period, including assets held for sale | $73574 | $57681 | $66011 |
| Supplemental disclosure of cash flow information (continuing operations): |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest, net | $17020 | $17615 | $23181 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for taxes, net | $801 | $690 | $737 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

1.&nbsp;&nbsp;&nbsp;&nbsp;<u>Organization</u>

CNL Healthcare Properties, Inc. (the "Company") is a Maryland corporation that elected to be taxed as a real estate investment trust ("REIT") for United States ("U.S.") federal income tax purposes. The Company has been and intends to continue to be organized and operate in a manner that allows it to remain qualified as a REIT for U.S. federal income tax purposes. The Company conducts substantially all of its operations either directly or indirectly through: (1) an operating partnership, CHP Partners, LP ("Operating Partnership"), in which the Company is the sole limited partner and its wholly-owned subsidiary, CHP GP, LLC, is the sole general partner; (2) a wholly-owned taxable REIT subsidiary ("TRS"), CHP TRS Holding, Inc.; (3) property owner and lender subsidiaries, which are single purpose entities; and (4) investments in joint ventures.

The Company is externally managed and advised by CNL Healthcare Corp. ("Advisor"), which is an affiliate of CNL Financial Group, LLC ("Sponsor"). The Sponsor is an affiliate of CNL Financial Group, Inc. ("CNL"). The Advisor is responsible for managing the Company's day-to-day operations, serving as a consultant in connection with policy decisions to be made by the board of directors, and for identifying, recommending and executing on possible strategic alternatives and dispositions on the Company's behalf pursuant to an advisory agreement among the Company, the Operating Partnership and the Advisor. Substantially all of the Company's operating, administrative and certain property management services are provided by affiliates of the Advisor. In addition, certain property management services are provided by third-party property managers.

In 2017, the Company began evaluating possible strategic alternatives to provide liquidity to the Company's stockholders. As part of executing under possible strategic alternatives, the Company's board of directors committed to a plan to sell 70 properties, including properties comprising its MOB/Healthcare portfolio. As of December 31, 2022, the Company had successfully completed the sale of the 70 properties.

As of December 31, 2022, the Company's seniors housing portfolio was geographically diversified with properties in 26 states and consisted of interests in 70 properties, including 69 seniors housing communities and one vacant land parcel. The Company has primarily leased its seniors housing properties to wholly-owned TRS entities and engaged independent third-party managers under management agreements to operate the properties under the RIDEA structures; however, the Company has also leased some of its properties to third-party tenants under triple-net or similar lease structures, where the tenant bears all or substantially all of the costs (including cost increases for real estate taxes, utilities, insurance and ordinary repairs). In addition, most of the Company's investments have been wholly owned, although, it has, to a lesser extent, invested through partnerships with other entities where it was believed to be appropriate and beneficial.

2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Summary of Significant Accounting Policies</u>

*Basis of Presentation and Consolidation* **—** The accompanying consolidated financial statements include the Company's accounts, the accounts of wholly owned subsidiaries or subsidiaries for which the Company has a controlling interest, the accounts of two variable interest entities ("VIEs") in which the Company is the primary beneficiary, and the accounts of other subsidiaries over which the Company has a controlling financial interest. All material intercompany accounts and transactions have been eliminated in consolidation.

In accordance with the guidance for the consolidation of a VIE, the Company is required to identify entities for which control is achieved through means other than voting rights and to determine the primary beneficiary of its VIEs. The Company qualitatively assesses whether it is the primary beneficiary of a VIE and considers various factors including, but not limited to, the design of the entity, its organizational structure including decision-making ability and financial agreements, its ability and the rights of others to participate in policy making decisions, as well as its ability to replace the VIE manager and/or liquidate the entity.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Summary of Significant Accounting Policies (Continued)</u>

*Government Grant Income* **—** On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law which provided, among other things, for the establishment of a Provider Relief Fund under the direction of the Department of Health and Human Services ("HHS"). Provider relief funds received under the CARES Act are deemed governmental grants provided that the recipient attests to and complies with certain terms and conditions. Grant income is recognized upon receipt of provider relief funds and when all the conditions of the grant have been met. During the years ended December 31, 2022, 2021 and 2020, the Company recorded approximately $4.3 million, $0.5 million and $5.3 million respectively, as other income in the accompanying consolidated statements of operations as all conditions of the grant had been met.

*Use of Estimates* **—** The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of revenues and expenses during the reporting periods and the disclosure of contingent liabilities. For example, significant assumptions are made in the analysis of real estate impairments, the valuation of contingent assets and liabilities, and the valuation of restricted common stock ("Restricted Stock") shares issued to the Advisor. Accordingly, actual results could differ from those estimates.

*Depreciation and Amortization* **—** Real estate costs related to the acquisition and improvement of properties are capitalized. Repair and maintenance costs are charged to expense as incurred and significant replacements and improvements are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Real estate assets are stated at cost less accumulated depreciation, which is computed using the straight-line method of accounting over the estimated useful lives of the related assets. Buildings and improvements are depreciated on the straight-line method over their estimated useful lives, which generally are the lesser of 39 and 15 years, respectively.

Amortization of intangible assets is computed using the straight-line method of accounting over the shorter of the respective lease term or estimated useful life. If a lease is terminated or modified prior to its scheduled expiration, the Company recognizes a loss on lease termination related to the unamortized lease-related costs not deemed to be recoverable.

*Impairment of Real Estate Assets* **—** Real estate assets are reviewed on an ongoing basis to determine whether there are any impairment indicators. Management considers potential impairment indicators to primarily include (i) changes in a real estate asset's operating performance, such as a current period net operating loss combined with a history of net operating losses, or a projection or forecast that demonstrates continuing losses associated with the use of a real estate asset or (ii) a current expectation that, more likely than not, a real estate asset will be sold or otherwise disposed of significantly before the end of its previously estimated holding period. To assess if an asset group is potentially impaired, management compares the estimated current and projected undiscounted cash flows, including estimated net sales proceeds, of the asset group over its remaining useful life to the net carrying value of the asset group. Such cash flow projections consider factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition and other factors. In the event that the carrying value exceeds the undiscounted operating cash flows, the Company would recognize an impairment provision to adjust the carrying value of the asset group to the estimated fair value.

When impairment indicators are present for real estate indirectly owned, through an investment in a joint venture or other similar investment structure accounted for under the equity method, the Company compares the estimated fair value of its investment to the carrying value. An impairment charge will be recorded to the extent the fair value of the investment is less than the carrying value and the decline in value is determined to be other than a temporary decline.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Summary of Significant Accounting Policies (Continued)</u>

*Assets Held For Sale, net and Discontinued Operations* — The Company determines to classify a property as held for sale once management has the authority to approve and commits to a plan to sell the property, the property is available for immediate sale, there is an active program to locate a buyer, the sale of the property is probable and the transfer of the property is expected to occur within one year. Upon the determination to classify a property as held for sale, the Company ceases recording further depreciation and amortization relating to the associated assets and those assets are measured at the lower of its carrying amount or fair value less disposition costs and are presented separately in the consolidated balance sheets for all periods presented. In addition, the Company classifies assets held for sale as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on the Company's operations and financial results.

For any disposal(s) qualifying as discontinued operations, the Company allocates interest expense and loan cost amortization that directly relates to either: (1) expense on mortgages and other notes payable collateralized by properties classified as discontinued operations; or (2) expense on the Company's credit facilities, which is allocated based on the value of the properties that are classified as discontinued operations if these properties are included in the credit facilities' unencumbered pool of assets and the related indebtedness is required to be repaid upon sale of the properties.

*Assets Reclassified from Held for Sale to Held and Used* **—** Upon management's determination to discontinue marketing properties for sale, the properties will no longer meet the held for sale criteria and are required to be reclassified as held and used at the lower of adjusted carrying value (carrying value of the properties prior to being classified as held for sale adjusted for any depreciation and/or amortization expense that would have been recognized had the properties been continuously classified as held and used) or its fair value at the date of the subsequent decision not to sell. If adjusted carrying value is determined to be lower, a catch-up depreciation and/or amortization adjustment will be recorded. The depreciation and/or amortization expenses that would have been recognized had the properties been continuously classified as held and used will be included as a component of depreciation and amortization expense in the accompanying consolidated statements of operations. If fair value is determined to be lower, the Company will record a loss on reclassification which will be included in income or loss from continuing operations in the accompanying consolidated statements of operations.

*Cash* ***—*** Cash consists of demand deposits at commercial banks. The Company also invests in cash equivalents consisting of highly liquid investments in money market funds with original maturities of three months or less. As of December 31, 2022, certain of the Company's cash deposits exceeded federally insured amounts. However, the Company continues to monitor the third-party depository institutions that hold the Company's cash, primarily with the goal of safeguarding principal. The Company attempts to limit cash investments to financial institutions with high credit standing; therefore, the Company believes it is not exposed to any significant credit risk on cash.

*Restricted Cash* **—** Certain amounts of cash are escrowed to fund capital expenditures, property taxes and/or insurance as required by loan or lease terms, and certain security deposits represent restricted use funds.

*Held-to-Maturity Securities* — From time to time, the Company may invest in U.S. Treasuries, which it has designated as held-to-maturity ("HTM") securities, because the Company has both the ability and the intent to hold them until maturity. All assets classified as HTM are included within other assets in the consolidated balance sheets and reported at stated cost plus any premiums or discounts. Premiums or discounts are amortized or accreted as interest and other income in the consolidated statement of operations.

The Company evaluates its HTM securities on a quarterly basis to assess whether a decline in the fair value of an HTM security below the Company's amortized cost basis is an other-than-temporary impairment ("OTTI"). The presence of OTTI is based upon a fair value decline below a security's amortized cost basis and a corresponding adverse change in expected cash flows due to credit related factors. Impairment is considered other-than-temporary if the Company does not expect to recover the security's amortized cost basis.

*Loan Costs* **—** Financing costs paid in connection with obtaining debt are deferred and amortized over the estimated life of the debt using the effective interest method. As of December 31, 2022 and 2021, the accumulated amortization of loan costs was approximately $8.9 million and $9.5 million, respectively.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Summary of Significant Accounting Policies (Continued)</u>

*Deferred Lease-Related Costs***—** The Company deferred lease-related costs that it incurred to obtain new or extend existing leases. The Company amortizes these costs using the straight-line method of accounting over the shorter of the respective lease term or estimated useful life. If a lease is terminated or modified prior to its scheduled expiration, the Company recognizes a loss on lease termination related to any unamortized deferred lease-related costs not deemed to be recoverable.

*Revenue Recognition* **—** Rental income and related revenues for operating leases are recognized based on the assessment of collectability of lease payments. When collectability is probable at commencement of the lease, lease income is recognized on an accrual basis and includes rental income that is recorded on the straight-line basis over the term of the lease. Collectability is reassessed during the lease term. When collectability of lease payments is no longer probable, lease income is recorded on a cash basis and limited to the amount of lease payments collected. In addition, lease related costs (the deferred rent from prior GAAP straight-line adjustments, unamortized lease costs and other lease related intangibles) are written-off when the Company determines that these assets are no longer realizable.

Rental income and related revenues recorded on an accrual basis include rental income that is recorded on the straight-line basis over the terms of the leases. The straight-line method records the periodic average amount of base rent earned over the term of a lease, taking into account contractual rent increases over the lease term. The Company records the difference between base rent revenues earned and amounts due per the respective lease agreements, as applicable, as an increase or decrease to deferred rent and lease incentives in the accompanying consolidated balance sheets. Rental income and related revenues also include amounts for which tenants are required to reimburse the Company related to expenses incurred on behalf of the tenants, in accordance with the terms of the leases. Tenant reimbursements are recognized in the period in which the related reimbursable expenses are incurred, such as real estate taxes, common area maintenance, and similar items.

Some of the Company's leases require the tenants to pay certain additional contractual amounts that are set aside by the Company for replacements of fixed assets and other improvements to the properties. These amounts are and will remain the property of the Company during and after the term of the lease. The amounts are recorded as capital improvement reserve income at the time such amounts are earned and are included in rental income and related revenues in the accompanying consolidated statements of operations. Additional percentage rent that is due contingent upon tenant performance thresholds, such as gross revenues, is deferred until the underlying performance thresholds have been achieved.

Resident fees and services are operating revenues relating to the Company's managed seniors housing properties, which are operated under RIDEA structures. Resident fees and services directly relate to the provision of monthly goods and services that are generally bundled together under a single resident agreement.

The Company accounts for its resident agreements as a single performance obligation given the Company's overall promise to provide a series of stand-ready goods and services to its residents each month. Resident fees and services are recorded in the period in which the goods are provided and the services are performed and generally consist of (1) monthly rent, which covers occupancy of the residents' unit as well as basic services, such as utilities, meals and certain housekeeping services, and (2) service level charges, such as assisted living care, memory care and ancillary services. Resident agreements are generally short-term in nature, billed monthly in advance and cancellable by the residents with a 30-day notice. Resident agreements may require the payment of upfront fees prior to moving into the community with any non-refundable portion of such fees being recorded as deferred revenue and amortized over the estimated resident stay.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Summary of Significant Accounting Policies (Continued)</u>

*Derivative Financial Instruments* — The Company and an unconsolidated equity method investment held by the Company use or have used derivative financial instruments to partially offset the effect of fluctuating interest rates on the cash flows associated with its variable-rate debt. Upon entry into a derivative, the Company or its unconsolidated equity method investment formally designates and documents the financial instrument as a hedge of a specific underlying exposure, as well as the risk management objectives and strategies for undertaking the hedge transaction. The Company or its unconsolidated equity method investment accounts for derivatives through the use of a fair value concept whereby the derivative positions are stated at fair value in other assets in the accompanying consolidated balance sheets. The fair value of derivatives used to hedge or modify risk fluctuates over time. As such, the fair value amounts should not be viewed in isolation, but rather in relation to the cash flows or fair value of the underlying hedged transaction and to the overall reduction in the exposure relating to adverse fluctuations in interest rates on the Company's or its unconsolidated equity method investment's variable-rate debt. Realized and unrealized gain (loss) on derivative financial instruments designated by either the Company or its unconsolidated equity method investment as cash flow hedges are reported as a component of other comprehensive income (loss), a component of stockholders' equity, in the accompanying consolidated statements of comprehensive income (loss) to the extent they are effective; reclassified into earnings on the same line item associated with the hedged transaction and in the same period the hedged transaction affects earnings.

Realized and unrealized gain (loss) on derivative financial instruments designated as cash flow hedges that are entered into by the Company's equity method investment are reported as a component of the Company's other comprehensive income (loss) in proportion to the Company's ownership percentage in the investment, with reclassifications being included in equity in earnings (loss) of unconsolidated entity in the accompanying consolidated statements of operations.

*Fair Value Measurements* **—** Fair value assumptions are based on the framework established in the fair value accounting guidance under GAAP. The framework specifies a hierarchy of valuation inputs which was established to increase consistency, clarity and comparability in fair value measurements and related disclosures. The guidance describes the following fair value hierarchy based upon three levels of inputs that may be used to measure fair value, two of which are considered observable and one that is considered unobservable:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 — Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 — Inputs, other than quoted prices included in Level 1, that are observable for the asset or liability either directly or indirectly; such as, quoted prices for similar assets or liabilities or other inputs that can be corroborated by observable market data.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 — Unobservable inputs for the asset or liability, which are typically based on the Company's own assumptions, as there is little, if any, related market activity.

When market data inputs are unobservable, the Company utilizes inputs that it believes reflects the Company's best estimate of the assumptions market participants would use in pricing the asset or liability. When inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement.

The estimated fair value of accounts payable and accrued liabilities approximates the carrying value as of December 31, 2022 and 2021 because of the relatively short maturities of the obligations.

*Mortgages and Other Notes Payable* **—** Mortgages and other notes payable are recorded at the stated principal amount and are generally collateralized by the Company's properties. Mortgages and other notes payable assumed in connection with an acquisition are recorded at fair market value as of the date of the acquisition.

*Net Income (Loss) per Share* **—** Net income (loss) per share is calculated based upon the weighted average number of shares of common stock outstanding during the period in which the Company was operational.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Summary of Significant Accounting Policies (Continued)</u>

*Share-Based Payments to Non-Employees* — In connection with the expense support agreement described in Note 12. "Related Party Arrangements," the Company may issue Restricted Stock to the Advisor on an annual basis in exchange for providing expense support in the event that cash distributions declared exceed MFFO as defined by the expense support agreement.

The Restricted Stock is forfeited if stockholders do not ultimately receive their original invested capital back with at least a 6% annualized return of investment upon a future liquidity or disposition event of the Company. Upon issuance of Restricted Stock, the Company measures the fair value at its then-current lowest aggregate fair value pursuant to ASC 505-50. On the date in which the Advisor satisfies the vesting criteria, the Company remeasures the fair value of the Restricted Stock pursuant to ASC 505-50 and records expense equal to the difference between the original fair value and that of the remeasurement date. In addition, given that performance is outside the control of the Advisor and involves both market conditions and counterparty performance conditions, the shares are treated as unissued for accounting purposes and the Company only includes the Restricted Stock in the calculation of diluted earnings per share to the extent their effect is dilutive and the vesting conditions have been satisfied as of the reporting date.

Pursuant to the expense support agreement, the Advisor shall be the record owner of the Restricted Stock until the shares of common stock are sold or otherwise disposed of, and shall be entitled to all of the rights of a stockholder of the Company including, without limitation, the right to vote such shares (to the extent permitted by the Company's articles of incorporation) and receive all distributions paid with respect to such shares. All distributions actually paid to the Advisor in connection with the Restricted Stock shall vest immediately and will not be subject to forfeiture. The Company recognizes expense related to the distributions on the Restricted Stock shares as declared.

*Segment Information* **—** Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and assess performance. The Company has determined that it operates in one operating segment, real estate ownership. The Company's chief operating decision maker evaluates the Company's operations from a number of different operational perspectives including, but not limited to, a property-by-property basis, by tenant or by operator.

The Company derives all significant revenues from a single reportable operating segment of business, healthcare real estate, regardless of the type (seniors housing, medical office, etc.) or ownership structure (leased or managed). Accordingly, the Company does not report segment information; nevertheless, management periodically evaluates whether the Company continues to have one single reportable segment of business.

*Redeemable Noncontrolling Interest* ***—*** The Company classified redeemable equity securities in accordance with Accounting Standard Update ("ASU") No. 2009-04, "Liabilities (Topic 480): Accounting for Redeemable Equity Instruments," which required that equity securities redeemable at the option of the holder be classified outside of permanent stockholders' equity. The Company classified redeemable equity securities as redeemable noncontrolling interest within the accompanying consolidated balance sheets and consolidated statements of stockholders' equity and redeemable noncontrolling interest during the year ended December 31, 2020. The Company evaluated the probability that the equity securities would become redeemable at each reporting period and, if determined probable, the Company measured the redemption value and recorded an adjustment to the carrying value of the equity securities as a component of redeemable noncontrolling interest. During the year ended December 31, 2021, the Company's redeemable equity securities were reclassified to noncontrolling interests due to the expiration of the redemption option. The Company did not have redeemable equity securities during the year ended December 31, 2022.

*Promoted Interest* ***—*** The Company accounts for promoted interests with third-party developers in a manner similar to redeemable noncontrolling interests discussed above. The Company records the initial carrying value of the promoted interest at its issuance date fair value. Subsequently, as the completed developments stabilize and it becomes probable that the promoted interest thresholds will be met, the Company records a liability equal to the estimated redemption value at the end of each reporting period based on the conditions that exist as of the balance sheet date. In connection with the measurement of this liability, the Company records, as a reduction to capital in excess of par value, an amount equal to the difference between the promoted interests' carrying value and the consideration paid or payable.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Summary of Significant Accounting Policies (Continued)</u>

*Income Taxes* — The Company has elected to be taxed as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended and related regulations beginning with the year ended December 31, 2012. In order to be taxed as a REIT, the Company is subject to certain organizational and operational requirements, including the requirement to make distributions to its stockholders each year of at least 90% of its annual REIT taxable income (which is computed without regard to the dividends-paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). If the Company qualifies for taxation as a REIT, the Company generally will not be subject to U.S. federal income tax on income that the Company distributes as dividends. If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to U.S. federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the IRS grants the Company relief under certain statutory provisions. Even if the Company qualifies for taxation as a REIT, it may be subject to certain state and local taxes on its income and property, and U.S. federal income and excise taxes on its undistributed income.

The Company has formed subsidiaries which elected to be taxed as a TRS for U.S. federal income tax purposes. Under the provisions of the Internal Revenue Code and applicable state laws, a TRS will be subject to tax on its taxable income from its operations. The Company will account for federal and state income taxes with respect to a TRS using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities, the respective tax bases, operating losses and/or tax-credit carryforwards. A valuation allowance is provided if the Company believes it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes the Company to change our judgment about the realizability of the related deferred tax asset, is included in the tax provision when such changes occur.

*Investment in Unconsolidated Entity* — The Company accounted for its investment in an unconsolidated joint venture under the equity method of accounting as the Company exercised significant influence, but did not maintain a controlling financial interest over these entities. The investment was recorded initially at cost and subsequently adjusted for cash contributions, distributions and equity in earnings (loss) of the unconsolidated entity. Based on the joint venture's structure and any preference the Company received on distributions and liquidation, the Company recorded its equity in earnings (loss) of the unconsolidated entity under the hypothetical liquidation at book value ("HLBV") method of accounting. Under this method, the Company recognized income or loss in each period as if the net book value of the assets in the venture were hypothetically liquidated at the end of each reporting period pursuant to the provisions of the joint venture agreement. In any given period, the Company could have recorded more or less equity in earnings (loss) than actual cash distributions received or an investment balance that was more or less than what the Company may have received in the event of an actual liquidation. The Company determined whether distributions were classified as returns on investment or returns of investment based on the nature of the distribution. As described in Note 4. "Acquisition," effective January 1, 2022, the Company acquired the remaining ownership interest in the Windsor Manor Joint Venture and consolidated the Windsor Manor Joint Venture. As of December 31, 2022, the Company did not have an investment in an unconsolidated entity.

*Reclassifications —* Certain amounts in the prior years' consolidated balance sheet and statements of cash flows have been reclassified to conform to the current year's presentation.

*Recently Adopted Accounting Pronouncements* **—** In Q1 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" ("ASU 2020-04"). ASU 2020-04 contains practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts. The guidance in ASU 2020-04 is optional and may be elected over time as reference rate reform activities occur. During the year ended December 31, 2020, the Company elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. The Company subsequently elected to apply additional expedients related to contract modifications, changes in critical terms, and updates to the designated hedged risks as qualifying changes have been made to applicable debt. Application of these expedients preserves the presentation of derivatives consistent with past presentation. Applications of this guidance did not have a material impact on its consolidated financial statements.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

3.&nbsp;&nbsp;&nbsp;&nbsp;<u>Revenue</u>

The following table presents disaggregated revenue related to the Company's resident fees and services during the years ended December 31, 2022, 2021 and 2020:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **Number of Units (Unaudited)** | **Number of Units (Unaudited)** | **Number of Units (Unaudited)** | **Revenues (in millions)** | **Revenues (in millions)** | **Revenues (in millions)** | **Percentage of Revenues** | **Percentage of Revenues** | **Percentage of Revenues** |
| | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** | **2022** | **2021** | **2020** |
| *Resident fees and services:* |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Independent living | 2223 | 2243 | 2256 | $74.1 | $69.6 | $72.6 | 25.0% | 26.2% | 25.9% |
| &nbsp;&nbsp;&nbsp;Assisted living | 3041 | 2960 | 2947 | 146.9 | 128.9 | 138.1 | 49.7 | 48.6 | 49.2 |
| &nbsp;&nbsp;&nbsp;Memory care | 932 | 904 | 904 | 60.6 | 53.2 | 57.7 | 20.5 | 20.1 | 20.5 |
| &nbsp;&nbsp;&nbsp;Other revenues |  |  |  | 14.2 | 13.6 | 12.5 | 4.8 | 5.1 | 4.4 |
|  | 6196 | 6107 | 6107 | $295.8 | $265.3 | $280.9 | 100.0% | 100.0% | 100.0% |

---

4. <u>Acquisition</u>

As of December 31, 2021, the Company held an interest in five properties through a 75% interest in an unconsolidated joint venture (the "Windsor Manor Joint Venture"), which was accounted for as an equity method investment. Effective January 1, 2022, the Company acquired the remaining 25% interest in the Windsor Manor Joint Venture from its joint venture partner for approximately $3.3 million. As a result, the Company obtained a 100% controlling interest in the Windsor Manor Joint Venture and consolidated the Windsor Manor Joint Venture. The acquisition was accounted for as an asset acquisition. As such, no goodwill was recognized in the acquisition.

As the Company previously held an equity method investment in the Windsor Manor Joint Venture, the acquisition resulted in a gain on change of control of a joint venture of approximately $8.4 million, representing the difference between the fair market value and the carrying value of the equity method investment on the acquisition date.

The following table summarizes the fair market value of the assets and liabilities recorded as part of the acquisition, adjusted on a relative fair value basis for the difference between the consideration transferred and the fair market value of the net assets acquired, of the Windsor Manor Joint Venture as of the acquisition date (in thousands):

---

| | |
|:---|:---|
| Equity method investment in unconsolidated joint venture | $4737 |
| Consideration paid for additional 25% interest in joint venture | 3310 |
| Total equity method investment and consideration paid | $8047 |
| Cash | $2097 |
| Restricted cash | 79 |
| Prepaid and other assets | 64 |
| Real estate assets | 29384 |
| Intangibles | 4281 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets acquired | 35905 |
| Accounts payable and accrued expenses | (953) |
| Other liabilities | (61) |
| Mortgages and notes payable | (18468) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total liabilities assumed | (19482) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net assets acquired | $16423 |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

5.&nbsp;&nbsp;&nbsp;&nbsp;<u>Real Estate Assets, net</u>

The gross carrying amount and accumulated depreciation of the Company's real estate assets as of December 31, 2022 and 2021 are as follows, excluding one asset held for sale (in thousands):

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| Land and land improvements | $136416 | $131312 |
| Building and building improvements | 1495552 | 1486630 |
| Furniture, fixtures and equipment | 105784 | 101063 |
| Less: accumulated depreciation | (424314) | (380149) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate investment properties, net | $1313438 | $1338856 |

---

In July 2022, the Company entered into a purchase and sale agreement (the "Fieldstone Sale Agreement") for the sale of its Fieldstone Memory Care and Fieldstone at Pear Orchard properties (the "Fieldstone Properties") with an unrelated third party buyer. The Fieldstone at Pear Orchard property was indirectly owned through a consolidated joint venture. The Company completed the sale of the Fieldstone Properties in August 2022 and recorded a gain of approximately $6.3 million, of which approximately $5.4 million was attributable to common stockholders. Additionally, the Company paid a disposition fee of approximately $0.1 million to the Advisor for the sale of these properties. The sale of the Fieldstone Properties did not cause a strategic shift in the Company's operations, and was not considered significant; therefore, these properties did not qualify as discontinued operations.

Depreciation expense on the Company's real estate investment properties, net was approximately $50.7 million, $50.0 million and $51.4 million for the years ended December 31, 2022, 2021 and 2020, respectively.

6.&nbsp;&nbsp;&nbsp;&nbsp;<u>Intangibles, net</u>

Effective January 1, 2022, as described in Note 4. "Acquisition," the Company acquired the remaining 25% interest in the Windsor Manor Joint Venture from its joint venture partner. In-place lease intangibles of approximately $4.3 million were included in the net assets acquired. The weighted-average amortization period on the in-place lease intangibles was approximately 1.3 years.

The gross carrying amount and accumulated amortization of the Company's intangible assets as of December 31, 2022 and 2021 are as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **As of December 31,** | **As of December 31,** |
| | **2022**<sup>(1)</sup> | **2021** |
| In-place lease intangibles | $5017 | $3944 |
| Less: accumulated amortization | (3769) | (3512) |
| &nbsp;&nbsp;&nbsp;Intangible assets, net | $1248 | $432 |

---

_______________

**FOOTNOTE:**

(1)Excludes approximately $3.2 million of gross in-place lease intangibles and accumulated amortization related to fully amortized intangibles as of December 31, 2022.

For the years ended December 31, 2022, 2021 and 2020, amortization on the Company's intangible assets was approximately $3.5 million, $0.4 million and $0.4 million, respectively, all of which was included in depreciation and amortization in the Company's consolidated statements of operations.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

6.&nbsp;&nbsp;&nbsp;&nbsp;<u>Intangibles, net (Continued)</u>

The estimated future amortization on the Company's intangibles for each of the next five years and thereafter, in the aggregate, as of December 31, 2022 is as follows (in thousands):

---

| | |
|:---|:---|
| 2023 | $1144 |
| 2024 | 73 |
| 2025 | 31 |
| 2026 |  |
| 2027 |  |
| Thereafter |  |
|  | $1248 |

---

7.&nbsp;&nbsp;&nbsp;&nbsp;<u>Assets Held For Sale and Discontinued Operations</u>

*Assets Held for Sale*

The Company received an unsolicited offer and entered into a purchase and sale agreement for the Hurst Specialty Hospital with an unrelated third party in March 2022 and classified this property as held for sale as of December 31, 2021 in the accompanying consolidated balance sheet. In conjunction therewith, the Company determined that the carrying value of this property was not recoverable and during the year ended December 31, 2021, recorded an impairment provision of approximately $9.8 million to write-down the carrying value of its Hurst Specialty Hospital to its estimated sales proceeds expected from the sale of the Hurst Specialty Hospital. As a result, the Hurst Specialty Hospital was carried at fair value as of December 31, 2021. The Level 3 unobservable inputs used in determining the fair value were based on estimated sales proceeds.

The Company sold the Hurst Specialty Hospital in April 2022, received net sales proceeds of $8.3 million and did not record a gain or loss on sale for financial reporting purposes. The sale of the Hurst Specialty Hospital did not cause a strategic shift in the Company's operations, and was not considered significant; therefore, this property did not qualify as discontinued operations and the Company recorded all operating results from the Hurst Specialty Hospital as income or loss from continuing operations for all periods presented.

Assets held for sale consisted of real estate held for sale, net as of December 31, 2021. The Company did not have any properties classified as held for sale as of December 31, 2022.

*Discontinued Operations*

During the years ended December 31, 2021 and 2020, the Company recorded (loss) income from discontinued operations of approximately $(0.01) million and $1.0 million, respectively, because it classified the revenues and expenses related to two properties as discontinued operations in the accompanying consolidated statements of operations. One of these properties was sold in January 2021 and the other was sold in February 2020. These two properties were identified for sale as part of the plan to sell the MOB/Healthcare portfolio described in Note 1. "Organization," and the Company determined that the sale of these properties represented a strategic shift in the Company's operations. The Company did not have any properties for which it had classified the revenues and expenses as discontinued operations during the year ended December 31, 2022.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

8.&nbsp;&nbsp;&nbsp;&nbsp;<u>Held-to-Maturity Securities</u>

The following presents the face value and carrying value of investments in short term securities by collateral type as of December 31, 2022 (in thousands):

---

| | |
|:---|:---|
| | **U.S. Treasuries** |
| Amortized cost basis | $24360 |
| Gross unrealized losses | (27) |
| Fair value | $24333 |

---

In determining the fair value of the Company's investments in short term securities, management judgment may be used to arrive at fair value that considers prices obtained from third-party pricing providers or broker quotes received using the bid price, which are both deemed indicative of market activity, and other applicable market data. The third-party pricing providers and brokers use pricing models that generally incorporate such factors as coupons, rate reset period, issuer, prepayment speeds, credit enhancements and expected life of the security. The Company categorizes the fair value measurement of these assets as Level 2.

As of December 31, 2022, the Company's investments in short term securities had an estimated weighted average life remaining of approximately eight months.

In evaluating investments in short term securities for other-than-temporary impairment, the Company determines whether there has been a significant adverse quarterly change in the cash flow expectations for a security. The Company compares the amortized cost of each security against the present value of expected future cash flows of the security. The Company also considers whether there has been a significant adverse change in the regulatory and/or economic environment as part of this analysis. If the amortized cost of the security is greater than the present value of expected future cash flows using the original yield as the discount rate, an other-than-temporary credit impairment has occurred and the credit loss is recognized in earnings. The Company did not record any other-than-temporary credit impairments during the year ended December 31, 2022, as expected cash flows were greater than amortized cost for all short term securities held.

The Company did not have HTM securities during the year ended or as of December 31, 2021.

9.&nbsp;&nbsp;&nbsp;&nbsp;<u>Operating Leases</u> 

As of December 31, 2022, the Company owned 15 seniors housing properties that have been leased to two tenants under triple-net operating leases. Under the terms of the Company's triple-net lease agreements, each tenant is responsible for the payment of property taxes, general liability insurance, utilities, repairs and maintenance, including structural and roof maintenance expenses. Each tenant is expected to pay real estate taxes directly to the taxing authorities and, therefore, such amounts are not included in the Company's consolidated financial statements. However, if the tenant does not pay the real estate taxes, the Company will be liable for such amounts. As of December 31, 2022, the total annualized property tax assessed on these properties was approximately $3.2 million.

As of December 31, 2022, the Company's triple-net operating leases had a weighted average remaining lease term of 4.7 years based on annualized base rents expiring between 2025 and 2032. Our tenants hold options to extend the lease terms at certain properties for five-year periods, which are generally subject to similar terms and conditions provided under the initial lease term, including rent increases. The Company's lease term is determined based on the non-cancellable lease term unless economic incentives make it reasonably certain that an extension option will be exercised, in which case the Company includes the extended lease term.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

9.&nbsp;&nbsp;&nbsp;&nbsp;<u>Operating Leases (Continued)</u>

The following are future minimum lease payments for the Company's 15 senior housing properties to be received under non-cancellable operating leases for the next five years and thereafter, in the aggregate, as of December 31, 2022 (in thousands):

---

| | |
|:---|:---|
| 2023 | $26888 |
| 2024 | 27337 |
| 2025 | 20708 |
| 2026 | 9287 |
| 2027 | 9556 |
| Thereafter | 43259 |
|  | $137035 |

---

The above future minimum lease payments to be received exclude straight-line rent adjustments and base rent attributable to any renewal options exercised by the tenants in the future. Several of our operating leases include options to extend the lease term. For purposes of determining the lease term, we exclude these extension periods unless it is reasonably certain at lease commencement that the extension options will be exercised.

10.&nbsp;&nbsp;&nbsp;&nbsp;<u>Variable Interest Entities</u>

As of December 31, 2022 and 2021, the Company had two subsidiaries classified as VIEs. These subsidiaries are joint ventures in which the equity interest consists of non-substantive protective voting rights. The Company determined it is the primary beneficiary and holds a controlling financial interest in each of these subsidiaries due to its power to direct the activities that most significantly impact the economic performance of the entities, as well as its obligation to absorb the losses and its right to receive benefits from these entities that could potentially be significant to these entities. As such, the transactions and accounts of these VIEs are included in the accompanying consolidated financial statements. As described above in Note 5. "Real Estate Assets, net," in August 2022, the Company sold the property owned by one of these subsidiaries, received net sales proceeds of $16.0 million and distributed approximately $2.0 million to the noncontrolling interest owner representing their pro rata share of the net sales proceeds in accordance with the terms of the joint venture agreement.

The aggregate carrying amount and major classifications of the consolidated assets that can be used to settle obligations of the VIEs and liabilities of the consolidated VIEs that are non-recourse to the Company as of December 31, 2022 and 2021 are as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **As of December 31,** | **As of December 31,** |
| | **2022** | **2021** |
| **Assets:** |  |  |
| Real estate investment properties, net | $30906 | $42612 |
| Cash | $646 | $1597 |
| Restricted cash | $9 | $59 |
| Other assets | $554 | $544 |
| **Liabilities:** |  |  |
| Mortgages and other notes payable, net | $21142 | $28855 |
| Accounts payable and accrued liabilities | $533 | $1489 |
| Other liabilities | $91 | $299 |

---

The Company's maximum exposure to loss as a result of its involvement with these VIEs is limited to its net investment in these entities which totaled approximately $9.7 million as of December 31, 2022. The Company's exposure is limited because of the non-recourse nature of the borrowings of the VIEs.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

11.&nbsp;&nbsp;&nbsp;&nbsp;<u>Indebtedness</u>

The following table provides details of the Company's indebtedness as of December 31, 2022 and 2021 (in thousands):

---

| | | |
|:---|:---|:---|
| | **As of December 31,** | **As of December 31,** |
| | **2022** | **2021** |
| Mortgages payable and other notes payable: |  |  |
| &nbsp;&nbsp;&nbsp;Fixed rate debt<sup>(1)</sup> | $44082 | $89766 |
| &nbsp;&nbsp;&nbsp;Variable rate debt<sup>(1)(2)(3)</sup> | 17859 |  |
| &nbsp;&nbsp;&nbsp;Premium<sup>(4)</sup> | 17 | 59 |
| &nbsp;&nbsp;&nbsp;Loan costs, net | (185) | (425) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total mortgages and other notes payable, net | 61773 | 89400 |
| Credit facilities: |  |  |
| &nbsp;&nbsp;&nbsp;Revolving Credit Facility<sup>(6)(7)</sup> | 133000 | 88000 |
| &nbsp;&nbsp;&nbsp;Term Loan Facility<sup>(5)(6)(7)</sup> | 265000 | 265000 |
| &nbsp;&nbsp;&nbsp;2021 Term Loan Facility<sup>(5)(6)(7)</sup> | 150000 | 150000 |
| &nbsp;&nbsp;&nbsp;Loan costs, net related to Term Loan Facilities | (1900) | (3272) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total credit facilities, net | 546100 | 499728 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total indebtedness, net | $607873 | $589128 |

---

_______________

**FOOTNOTES:**

(1)As of December 31, 2022 and 2021, the Company's mortgages and other notes payable are collateralized by seven properties with total carrying value of approximately $92.7 million and $135.4 million, respectively.

(2)In connection with the acquisition of the 25% interest in the Windsor Manor Joint Venture, the Company consolidated the net assets of the joint venture effective January 1, 2022, including the debt associated with the properties, at fair value. The debt collateralized by the five Windsor Manor properties pay interest at a rate of 2.50% plus 30-day LIBOR and matures in February 2024. The 30-day LIBOR was approximately 4.39% as of December 31, 2022.

(3)As of December 31, 2022, the Company had interest rate protection through an interest rate cap with a notional amount of $15.0 million. Refer to Note 13. "Derivative Financial Instruments" for additional information.

(4)Premium is reflective of the Company recording mortgage note payables assumed at fair value on the respective acquisition dates.

(5)As of December 31, 2021 and during the year ended December 31, 2022, the Company had interest rate protection through interest rate caps with notional amounts of $355.0 million. The interest rate caps expired on December 31, 2022. Refer to Note 13. "Derivative Financial Instruments" for additional information.

(6)As of December 31, 2022 and 2021, the Company had undrawn availability under the applicable revolving credit facility of approximately $117.0 million and $14.1 million, respectively, based on the value of the properties in the unencumbered pool of assets supporting the loan.

(7)Term SOFR (as defined by the agreements governing the Credit Facilities) was approximately 4.46% as of December 31, 2022. The 30-day LIBOR was approximately 0.10% as of December 31, 2021.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

11.&nbsp;&nbsp;&nbsp;&nbsp;<u>Indebtedness (Continued)</u>

In September 2021, the Company entered into a new term loan agreement (the "Term Loan Agreement"), which provided for an additional $150 million senior unsecured term loan facility (the "2021 Term Loan Facility") to complement and become part of the Company's existing credit facilities (collectively with the Revolving Credit Facility, the "Credit Facilities"). The 2021 Term Loan Facility has an initial term that is co-terminus with the Credit Facilities, maturing May 15, 2024, subject to one 12-month extension, and through September 2022, bore interest based on 30-day LIBOR plus a spread that varies with the Company's leverage ratio. The 2021 Term Loan Facility is pre-payable at any time in whole or part without fees or penalties, has a borrowing availability calculation that is subject to a similar borrowing base calculation as the Credit Facilities and contains similar affirmative, negative and financial covenants as the covenants in the Credit Facilities. Upon the execution of the Term Loan Agreement, the Company paid fees totaling approximately $0.9 million to unrelated third parties and a refinancing coordination fee to the Advisor of approximately $1.5 million. See Note 12. "Related Party Arrangements" for additional information regarding the financing coordination fee. In October 2021, the Company refinanced secured indebtedness of approximately $238.0 million, consisting of debt collateralized by 22 properties, in advance of its scheduled maturity of January 2022 using proceeds from the unsecured 2021 Term Loan Facility and available borrowings under its Revolving Credit Facility.

In June 2022, the Company refinanced secured indebtedness of approximately $44.5 million, consisting of debt collateralized by five properties, in advance of its scheduled maturity of September 2022 using available borrowings under its Revolving Credit Facility. In September 2022, the Company amended the agreements under its Credit Facilities to transition its benchmark rate from LIBOR to SOFR effective September 2022.

The following is a schedule of future principal payments for the Company's total indebtedness for the next five years and thereafter, in the aggregate, as of December 31, 2022 (in thousands):

---

| | |
|:---|:---|
| 2023<sup>(1)</sup> | $157054 |
| 2024 | 452887 |
| 2025 |  |
| 2026 |  |
| 2027 |  |
| Thereafter |  |
|  | $609941 |

---

_______________

**FOOTNOTE:**

(1)Amounts include $133 million outstanding under the Company's Revolving Credit Facility and a mortgage loan maturing in June 2023 of approximately $23 million. Refer to Note 18. "Subsequent Events" for information on the extension of the maturity date of the Revolving Credit Facility and the repayment of the $23 million mortgage loan in advance of its scheduled maturity.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

11.&nbsp;&nbsp;&nbsp;&nbsp;<u>Indebtedness (Continued)</u>

The following table details the Company's mortgages and other notes payable as of December 31, 2022 and 2021 (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Property and Loan<br>Type** | **Interest Rate at December 31, 2022** | **Payment Terms** | **Maturity Date**<sup>(1)</sup> | **December 31,** | **December 31,** |
| **Property and Loan<br>Type** | **Interest Rate at December 31, 2022** | **Payment Terms** | **Maturity Date**<sup>(1)</sup> | **2022** | **2021** |
| Primrose I Communities; Mortgage Loan | 4.11%<br>per annum | Monthly principal and interest payments based on a 30-year amortization schedule | 9/1/2022 | $— | $45019 |
| Watercrest at Mansfield; Mortgage Loan <sup>(2)</sup> | 4.68%<br>per annum | Monthly principal and interest payments based on a total payment of $143,330 | 6/1/2023 | 22854 | 23473 |
| Watercrest at Katy;<br>Mortgage Loan | 3.25%<br>per annum | Monthly principal and interest payments based on a 25-year amortization schedule | 11/15/2024 | 21228 | 21274 |
|  | Total fixed rate debt | Total fixed rate debt |  | 44082 | 89766 |
| Windsor Manor Communities; <br>Mortgage Loan <sup>(3)</sup> | 30-Day LIBOR plus 2.50% per annum | Monthly principal and interest payments based on a 25-year amortization schedule | 2/28/2024 | 17859 |  |
|  | Total variable rate debt | Total variable rate debt |  | 17859 |  |
|  | Total mortgages and other notes payable | Total mortgages and other notes payable |  | $61941 | $89766 |

---

_______________

**FOOTNOTES:**

(1)Represents the initial maturity date (or, as applicable, the maturity date as extended).

(2)The balance for this loan excludes a remaining premium of $0.02 million related to the mortgage note payable assumed being recorded at fair value on the acquisition date. The Company repaid this loan on March 1, 2023. Refer to Note 18. "Subsequent Events" for additional information.

(3)In connection with the acquisition of the 25% interest in the Windsor Manor Joint Venture, the Company consolidated the net assets of the joint venture effective January 1, 2022, including the debt associated with the properties, at fair value.

The following table provides the details of the fair market value and carrying value of the Company's indebtedness as of December 31, 2022 and 2021 (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** |
| | **Fair <br>Value** | **Carrying<br>Value** | **Fair <br>Value** | **Carrying<br>Value** |
| Mortgages and other notes payable, net | $60.8 | $61.8 | $90.4 | $89.4 |
| Credit facilities, net | $548.0 | $546.1 | $503.0 | $499.7 |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

11.&nbsp;&nbsp;&nbsp;&nbsp;<u>Indebtedness (Continued)</u>

These fair market values are based on current rates and spreads the Company would expect to obtain for similar borrowings. Since this methodology includes inputs that are less observable by the public and are not necessarily reflected in active markets, the measurement of the estimated fair values related to the Company's mortgage notes payable is categorized as Level 3 on the three-level valuation hierarchy.

Generally, the loan agreements for the Company's mortgage loans contain customary financial covenants and ratios; including (but not limited to) the following: debt service coverage ratio, minimum occupancy levels, limitations on incurrence of additional indebtedness, etc. The loan agreements also contain customary events of default and remedies for the lenders. As of December 31, 2022, the Company was in compliance with all financial covenants related to its mortgage loans.

The Credit Facilities contain affirmative, negative, and financial covenants which are customary for loans of this type, including (but not limited to): (i) maximum leverage, (ii) minimum fixed charge coverage ratio, (iii) minimum consolidated net worth, (iv) restrictions on payments of cash distributions except if required by REIT requirements, (v) maximum secured indebtedness, (vi) maximum secured recourse debt, (vii) minimum unsecured interest coverage, (viii) maximum unsecured indebtedness ratio, and (ix) limitations on certain types of investments and with respect to the pool of properties supporting borrowings under the Credit Facilities, minimum weighted average occupancy, and remaining lease terms, as well as property type, MSA, operator, and asset value concentration limits. The limitations on distributions generally include a limitation on the extent of allowable distributions, which are not to exceed the greater of 95% of adjusted FFO (as defined per the Credit Facilities) and the minimum amount of distributions required to maintain the Company's REIT status. As of December 31, 2022, the Company was in compliance with all financial covenants related to its Credit Facilities.

12.&nbsp;&nbsp;&nbsp;&nbsp;<u>Related Party Arrangements</u>

The Company is externally advised and has no direct employees. Certain of the Company's executive officers are executive officers of or are on the board of managers of the Advisor.

In connection with services provided to the Company, affiliates are entitled to the following fees:

*Advisor* — The Advisor and certain affiliates are entitled to receive fees and compensation in connection with the acquisition, management and sale of the Company's assets, as well as the refinancing of debt obligations of the Company or its subsidiaries. In addition, the Advisor and its affiliates are entitled to reimbursement of actual costs incurred on behalf of the Company in connection with the Company's organizational, offering, acquisition and operating activities. Pursuant to the advisory agreement, as amended, the Advisor receives investment services fees equal to 1.85% of the purchase price of properties (including its proportionate share of properties acquired through joint ventures) for services rendered in connection with the selection, evaluation, structure and purchase of assets. In addition, the Advisor is entitled to receive a monthly asset management fee based on the average real estate asset value (as defined in the advisory agreement) of the Company's properties, including its proportionate share of properties owned through joint ventures. In May 2022, the Company extended its advisory agreement with the Advisor through June 2023. The Advisor earns an asset management fee equal to 0.8% per annum of average invested assets, which was reduced in May 2021 from 1.0% per annum. The Advisor will also receive a financing coordination fee for services rendered with respect to refinancing of any debt obligations of the Company or its subsidiaries equal to 1.0% of the gross amount of the refinancing.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

12.&nbsp;&nbsp;&nbsp;&nbsp;<u>Related Party Arrangements (Continued)</u>

The Company will pay the Advisor, if a substantial amount of services are provided as determined by the Company's independent directors, a disposition fee in an amount equal to 0.8% of (a) the gross market capitalization of the Company upon the occurrence of a listing on a national securities exchange, (b) the gross consideration paid to the Company or its stockholders upon the occurrence of any other liquidity event of the Company (including the sale of the Company or a portion thereof), or (c) the gross sales price upon the sale or transfer of one or more of its properties. The disposition fee was decreased from 1.0% to 0.8% effective May 2021. The Company will not pay its Advisor a disposition fee in connection with the sale of investments that are securities. A disposition fee in the form of a usual and customary brokerage fee may be paid to an affiliate or related party of the Advisor, provided that when added to the sum of all brokerage and real estate fees and commissions paid to unaffiliated parties, the disposition fee to the Advisor may not exceed the lesser of (i) a competitive real estate or brokerage commission or (ii) an amount equal to 6% of the gross sales price.

Under the advisory agreement and the Company's articles of incorporation, the Advisor will be entitled to receive certain subordinated incentive fees upon (a) sales of assets and/or (b) a listing (which would also include the receipt by the Company's stockholders of securities that are approved for trading on a national securities exchange in exchange for shares of the Company's common stock as a result of a merger, share acquisition or similar transaction). However, once a listing occurs, the Advisor will not be entitled to receive an incentive fee on subsequent sales of assets. The incentive fees are calculated pursuant to formulas set forth in the expense support agreement, the advisory agreement and the Company's articles of incorporation. All incentive fees payable to the Advisor are subordinated to the return to investors of their invested capital plus a 6% cumulative, non-compounded annual return on their invested capital. Upon termination or non-renewal of the advisory agreement by the Advisor for good reason (as defined in the advisory agreement) or by the Company other than for cause (as defined in the advisory agreement), a listing or sale of assets after such termination or non-renewal will entitle the Advisor to receive a pro-rated portion of the applicable subordinated incentive fee.

In addition, the Advisor or its affiliates may be entitled to receive fees that are usual and customary for comparable services in connection with the financing, development, construction or renovation of a property, subject to approval of the Company's board of directors, including a majority of its independent directors.

Pursuant to the advisory agreement, the Advisor shall reimburse the Company the amount by which the total operating expenses paid or incurred by the Company exceed, in any four consecutive fiscal quarters commencing with the Expense Year ending June 30, 2013, the greater of 2% of average invested assets or 25% of net income (as defined in the advisory agreement) ("Limitation"), unless a majority of the Company's independent directors determines that such excess expenses are justified based on unusual and non-recurring factors ("Expense Cap Test"). In performing the Expense Cap Test, the Company uses operating expenses on a GAAP basis after making adjustments for the benefit of expense support under the Expense Support Agreement. The Company did not incur operating expenses in excess of the Limitation during the Expense Years ended December 31, 2022, 2021 and 2020.

*Amended and Restated Expense Support Agreement* — Pursuant to the Amended and Restated Expense Support Agreement, the Company's Advisor agreed to forgo the payment of fees in cash and accept Restricted Stock for services in an amount equal to the positive excess, if any, of (a) Aggregate Stockholder Cash Distributions declared for the applicable year, over (b) aggregate MFFO, each as defined in the Amended and Restated Expense Support Agreement. The Restricted Stock is subordinated and forfeited to the extent that stockholders do not receive their invested capital plus a 6% cumulative non-compounded annual return upon ultimate liquidity of the Company. Any amounts settled, and for which restricted stock shares were issued pursuant to the Amended and Restated Expense Support Agreement, have been permanently settled and the Company has no further obligation to pay such amounts.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

12.&nbsp;&nbsp;&nbsp;&nbsp;<u>Related Party Arrangements (Continued)</u>

Under the terms of the Amended and Restated Expense Support Agreement, for each quarter within a calendar expense support year, the Company will record a proportional estimate of the cumulative year-to-date period based on an estimate of expense support amounts for the calendar expense support year. Moreover, in exchange for services rendered and in consideration of the expense support provided under the expense support agreement, the Company will issue, within 90 days following the determination date, a number of shares of Restricted Stock equal to the quotient of the expense support amounts provided by the Advisor for the preceding calendar year divided by the Company's then-current estimated NAV per share of common stock. The terms of the Amended and Restated Expense Support Agreement automatically renew for consecutive one-year periods, subject to the right of the Advisor to terminate their respective agreements upon 30 days' written notice to the Company.

No expense support was received for the years ended December 31, 2022, 2021 and 2020.

*CNL Capital Markets LLC* — CNL Capital Markets LLC, an affiliate of CNL, receives a sliding flat annual rate (payable monthly) based on the average number of investor accounts that will be open over the term of the agreement. For each of the years ended December 31, 2022, 2021 and 2020, the Company incurred approximately $0.9 million in such fees. These amounts are included in general and administrative expenses in the accompanying consolidated statements of operations.

*Co-Venture Partners* —The Company incurs operating expenses which, in general, relate to administration of the Company and its subsidiaries on an ongoing basis.

The expenses and fees incurred by and reimbursable to the Company's related parties, including amounts included in income from discontinued operations, for the years ended December 31, 2022, 2021 and 2020, and related amounts unpaid as of December 31, 2022 and 2021 are as follows (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Unpaid amounts as of** <sup>(1)</sup> | **Unpaid amounts as of** <sup>(1)</sup> |
| | **2022** | **2021** | **2020** | **December 31,<br>2022** | **December 31,<br>2021** |
| Reimbursable expenses: |  |  |  |  |  |
| Operating expenses <sup>(2)</sup> | $3056 | $2972 | $3517 | $238 | $214 |
|  | 3056 | 2972 | 3517 | 238 | 214 |
| Investment services fee <sup>(3)</sup> | 60 |  |  |  |  |
| Disposition fee <sup>(4)</sup> | 195 |  | 143 |  |  |
| Financing coordination fees <sup>(5)</sup> |  | 1500 | 61 |  |  |
| Asset management fees | 14074 | 15740 | 18190 | 1159 | 1192 |
|  | $17385 | $20212 | $21911 | $1397 | $1406 |

---

_______________

**FOOTNOTES:** 

(1)Amounts are recorded as due to related parties in the accompanying consolidated balance sheets.

(2)Amounts are recorded as general and administrative expenses in the accompanying consolidated statements of operations unless such amounts represent prepaid expenses, which are capitalized in the accompanying consolidated balance sheets.

(3)For the year ended December 31, 2022, the Company incurred approximately $0.1 million in investment services fees, all of which was capitalized and included in real estate assets, net in the accompanying consolidated balance sheets. For the years ended December 31, 2021 and 2020, the Company did not incur any investment services fees.

(4)Amounts are recorded as a reduction to gain on sale of real estate in the accompanying consolidated statements of operations.

(5)For the years ended December 31, 2021 and 2020, the Company incurred financing coordination fees of approximately $1.5 million and $0.1 million, respectively, all of which were capitalized as loan costs and reflected in mortgages and other notes payable, net in the accompanying consolidated balance sheets. The Company did not incur any financing coordination fees for the year ended December 31, 2022.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

12.&nbsp;&nbsp;&nbsp;&nbsp;<u>Related Party Arrangements (Continued)</u>

No amounts were settled or paid in the form of Restricted Stock in accordance with the expense support agreements for the years ended December 31, 2022, 2021 and 2020. As of December 31, 2022, approximately $13.6 million of asset management fees had been settled in exchange for approximately 1.3 million shares of Restricted Stock. The number of Restricted Stock shares granted to the Advisor in lieu of payment in cash was determined by dividing the expense support amount for the respective determination date by the then-current NAV per share. At grant date, no fair value was assigned to the Restricted Stock shares as the shares were valued at zero, which represented the lowest possible value estimated at vesting. In addition, the Restricted Stock shares were treated as unissued for financial reporting purposes because the vesting criteria had not been met as of December 31, 2022.

Cash distributions paid on Restricted Stock shares for the years ended December 31, 2022, 2021 and 2020 were $0.136 million, $0.273 million and $0.273 million, respectively. The cash distributions on Restricted Stock shares were recognized as compensation expense as declared and included in general and administrative expense in the accompanying consolidated statements of operations.

13.&nbsp;&nbsp;&nbsp;&nbsp;<u>Derivative Financial Instruments</u>

The following summarizes the terms of the Company's, or its equity method investment's, interest rate caps and the corresponding asset as of December 31, 2022 and 2021 (in thousands):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Notional Amount**<sup>(1)</sup> | **Strike** | **Trade** | **Forward** | **Maturity<br>Date** | **Fair Value Asset as of December 31,** | **Fair Value Asset as of December 31,** |
| **Notional Amount**<sup>(1)</sup> | **Strike** | **Trade** | **Forward** | **Maturity<br>Date** | **2022** | **2021** |
| $130000 | 1.0% | 10/7/2021 | 10/7/2021 | 12/31/2022 | $— | $63 |
| $225000 | 2.0% | 12/22/2021 | 12/31/2021 | 12/31/2022 | $— | $28 |
| $15000 | 3.5% | 12/28/2022 | 12/28/2022 | 7/1/2023 | $99 | $— |

---

_______________

**FOOTNOTE:**

<sup>(1)</sup> Amounts related to the interest rate caps held by the Company are recorded at fair value and included in other assets in the accompanying consolidated balance sheets.

Although the Company has determined that the majority of the inputs used to value its interest rate caps fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its interest rate caps utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by the Company and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its interest rate cap positions and has determined that the credit valuation adjustments on the overall valuation adjustments are not significant to the overall valuation of its interest rate caps. As a result, the Company determined that its interest rate cap valuation in its entirety is classified in Level 2 of the fair value hierarchy. Determining fair value requires management to make certain estimates and judgments. Changes in assumptions could have a positive or negative impact on the estimated fair values of such instruments which could, in turn, impact the Company's results of operations.

See Note 18. "Subsequent Events" for information regarding interest rate caps purchased after December 31, 2022.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

14.&nbsp;&nbsp;&nbsp;&nbsp;<u>Equity</u>

**Stockholders' Equity:**

*Distributions* — In March 2022, the Board approved a reduction in the quarterly distribution rate from $0.0512 per share to $0.0256 per share starting with the first quarter 2022 distribution. For the years ended December 31, 2022, 2021 and 2020, the Company declared cash distributions of $17.8 million, $35.6 million and $35.6 million, respectively, and all of which were paid in cash to stockholders.

The tax composition of the Company's distributions declared for the years ended December 31, 2022, 2021 and 2020 were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| Ordinary income | —% | 43.82% | 21.88% |
| Capital gain | —% | —% | 0.62% |
| Unrecaptured Sec. 1250 gain | —% | —% | 11.15% |
| Return of capital | 100.00% | 56.18% | 66.35% |

---

*Other comprehensive income (loss)* — The following table reflects the effect of derivative financial instruments held by the Company, or its equity method investment, and included in the consolidated statements of comprehensive income (loss) for the years ended December 31, 2022, 2021 and 2020 (in thousands):

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Derivative financial instruments** | **Gain (loss) recognized in other comprehensive loss on derivative financial instruments**  | **Gain (loss) recognized in other comprehensive loss on derivative financial instruments**  | **Gain (loss) recognized in other comprehensive loss on derivative financial instruments**  | **Location of gain (loss) reclassified into earnings** | **Gain (loss) reclassified from accumulated other comprehensive income (loss) into earnings**  | **Gain (loss) reclassified from accumulated other comprehensive income (loss) into earnings**  | **Gain (loss) reclassified from accumulated other comprehensive income (loss) into earnings**  |
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
|  | **2022** | **2021** | **2020** |  | **2022** | **2021** | **2020** |
| Interest rate caps | $(26) | $40 | $11 | Interest expense and loan cost amortization | $(82) | $(32) | $(44) |
| Reclassification of interest rate caps upon derecognition |  |  | 2 | Interest expense and loan cost amortization |  |  | (2) |
| Interest rate cap held by unconsolidated joint venture |  | 5 | (12) | Equity in earnings of unconsolidated entity |  | (5) | (3) |
| &nbsp;&nbsp;&nbsp;Total | $(26) | $45 | $1 |  | $(82) | $(37) | $(49) |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

15.&nbsp;&nbsp;&nbsp;&nbsp;<u>Income Taxes</u> 

For the years ended December 31, 2022, 2021 and 2020, the Company recorded net current tax expense and deferred tax assets related to deferred income at its TRS entities. The components of the income tax expense for the years ended December 31, 2022, 2021 and 2020, excluding amounts related to discontinued operations, were as follows (in thousands):

---

| | | | |
|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** | **2020** |
| Current: |  |  |  |
| &nbsp;&nbsp;&nbsp;Federal | $(10) | $(10) | $51 |
| &nbsp;&nbsp;&nbsp;State | (530) | (532) | (596) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current expense | (540) | (542) | (545) |
| Deferred: |  |  |  |
| &nbsp;&nbsp;&nbsp;Federal |  | (3379) | (552) |
| &nbsp;&nbsp;&nbsp;State |  | (253) | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deferred expense |  | (3632) | (553) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | $(540) | $(4174) | $(1098) |

---

Deferred income taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets as of December 31, 2022 and 2021 are as follows:

---

| | | |
|:---|:---|:---|
| | **2022** | **2021** |
| Carryforwards of net operating loss | $18647 | $10847 |
| Prepaid rent | 1044 | 985 |
| Valuation allowance | (19691) | (11832) |
| &nbsp;&nbsp;&nbsp;Deferred tax assets, net | $— | $— |

---

A reconciliation of the income tax expense computed at the statutory U.S. federal tax rate on income before income taxes is as follows (in thousands):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2022** | **2021** | **2021** | **2020** | **2020** |
| Tax (expense) benefit computed at federal statutory rate | $(27) | (21.00)% | $3923 | 21.00% | $(873) | (21.00)% |
| Impact of REIT election | 5714 | 4465.61 | 1575 | 8.43 | 303 | 7.28 |
| State income tax expense net of federal benefit | 630 | 492.27 | 706 | 3.78 | (160) | (3.84) |
| Effect of change in valuation allowance | (6857) | (5358.79) | (10378) | (55.55) | (368) | (8.86) |
| &nbsp;&nbsp;&nbsp;Income tax expense | $(540) | (421.91)% | $(4174) | (22.34)% | $(1098) | (26.42)% |

---

The Company's TRS entities had net operating loss carryforwards for federal and state purposes of approximately $70.8 million and $39.5 million as of December 31, 2022 and 2021, respectively, to offset future taxable income. If not utilized, the federal net operating loss carryforwards will begin to expire in 2032, and the state net operating loss carryforwards are currently subject to expiration. The Company has $56.6 million net operating loss carry-forwards with an indefinite carryforward period. The Company analyzed its material tax positions and determined that it has not taken any uncertain tax positions. The tax years 2019 and forward remain subject to examination by taxing authorities.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

YEAR ENDED DECEMBER 31, 2022

16.&nbsp;&nbsp;&nbsp;&nbsp;<u>Commitments and Contingencies</u>

From time to time, the Company may be a party to legal proceedings in the ordinary course of, or incidental to the normal course of, its business, including proceedings to enforce its contractual or statutory rights. While the Company cannot predict the outcome of these legal proceedings with certainty, based upon currently available information, the Company does not believe the final outcome of any pending or threatened legal proceeding will have a material adverse effect on its results of operations or financial condition.

As a result of the Company's completed seniors housing developments continuing to move towards or achieving stabilization, the Company monitors the lease-up of these properties to determine whether the established performance metrics have been met as of each reporting period. As of December 31, 2022, the Company had one remaining promoted interest agreement with third-party developers pursuant to which certain operating targets have been established that, upon meeting such targets, the developer will be entitled to additional payments based on enumerated percentages of the assumed net proceeds of a deemed sale, subject to achievement of an established internal rate of return on the Company's investment in the development. The established performance metrics were not met or probable of being met as of December 31, 2022.

The Company's Advisor has approximately 1.3 million contingently issuable Restricted Stock shares for financial reporting purposes that were issued pursuant to the Advisor expense support agreement. Refer to Note 12. "Related Party Arrangements" for information on distributions declared related to these Restricted Stock shares.

17.&nbsp;&nbsp;&nbsp;&nbsp;<u>Concentration of Credit Risk</u>

For the years ended December 31, 2022, 2021 and 2020, the Company had a geographical concentration accounting for 10% or more of its total revenues, excluding the properties classified as discontinued operations, as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Type of<br>Concentration** | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
| | **Type of<br>Concentration** | **2022** | **2021** | **2020** |
| State of Texas <sup>(1)</sup> | Geographical | 20.6% | 21.3% | 21.0% |

---

_______________

**FOOTNOTE:**

<sup>(1)</sup> Includes rental income and related revenues and resident fees and services. Adverse economic developments in this geographical area could significantly impact the Company's results of operations and cash flows from operations, which in turn would impact its ability to pay debt service and make distributions to stockholders.

18.&nbsp;&nbsp;&nbsp;&nbsp;<u>Subsequent Events</u>

In January 2023, the Company exercised its one-year extension option for the $133.0 million outstanding under its Revolving Credit Facility, which extended the maturity date to May 2024. In February 2023, the Company purchased a short-term interest rate cap with a notional value of $420.0 million and a strike of 3.5%, to hedge the majority of its Credit Facilities. The interest rate cap matures in August 2023. In March 2023, the Company repaid a mortgage loan of approximately $23 million, which was collateralized by the Watercrest at Mansfield property and scheduled to mature in June 2023.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS

YEARS ENDED DECEMBER 31, 2022, 2021 AND 2020 (in thousands)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Year** | **Description** | **Balance at <br>Beginning of Year** | **Charged to <br>Costs and Expenses** | **Charged to <br>Other Accounts** | **Balance at <br>End of Year** |
| 2020 | Deferred tax asset valuation allowance | $(1108) | $— | $(356) | $(1464) |
|  | Allowance for doubtful accounts | (1927) | (2252) | 1156 | (3023) |
|  |  | $(3035) | $(2252) | $800 | $(4487) |
| 2021 | Deferred tax asset valuation allowance | $(1464) | $(3632) | $(6736) | $(11832) |
|  | Allowance for doubtful accounts | (3023) | (1278) | 1161 | (3140) |
|  |  | $(4487) | $(4910) | $(5575) | $(14972) |
| 2022 | Deferred tax asset valuation allowance | $(11832) | $— | $(7859) | $(19691) |
|  | Allowance for doubtful account | (3140) | (902) | 2439 | (1603) |
|  |  | $(14972) | $(902) | $(5420) | $(21294) |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION

AS OF DECEMBER 31, 2022 (in thousands)

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Initial Costs** | **Initial Costs** | **Costs Capitalized Subsequent to Acquisition** | **Costs Capitalized Subsequent to Acquisition** | **Costs Capitalized Subsequent to Acquisition** | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | | | | **Life on which depreciation in latest income statement is computed** |
|<br>**Property/Location** |<br>**Encum-<br>brances** | **Land & Land Improvements** | **Building and Building Improvements** | **Land & Land Improvements** | **Building and Building Improvements** | **Construction in Process** | **Land & Land Improvements** | **Building and Building Improvements** | **Construction in Process** | **Total** |<br>**Accumulated Depreciation** |<br>**Date of Construction** |<br>**Date Acquired** | **Life on which depreciation in latest income statement is computed** |
| Primrose Retirement Community of CasperCasper, Wyoming | $— | $1910 | $16310 | $61 | $337 | $— | $1971 | $16647 | $— | $18618 | $(4818) | 2004 | 2/16/2012 | (1) |
| Primrose Retirement Community of Grand IslandGrand Island, Nebraska |  | 719 | 12140 | 83 | 1 |  | 802 | 12141 |  | 12943 | (3653) | 2005 | 2/16/2012 | (1) |
| Primrose Retirement Community of MansfieldMansfield, Ohio |  | 650 | 16720 | 229 | 79 |  | 879 | 16799 |  | 17678 | (5084) | 2007 | 2/16/2012 | (1) |
| Primrose Retirement Community of MarionMarion, Ohio |  | 889 | 16305 | 110 | 7 |  | 999 | 16312 |  | 17311 | (4826) | 2006 | 2/16/2012 | (1) |
| Sweetwater Retirement CommunityBillings, Montana |  | 1578 | 14205 | 19 | 30 |  | 1597 | 14235 |  | 15832 | (4099) | 2006 | 2/16/2012 | (1) |
| HarborChase of Villages CrossingLady Lake, Florida ("The Villages") |  | 2165 |  | 1024 | 15544 |  | 3189 | 15544 |  | 18733 | (3814) | 2013 | 8/29/2012 | (1) |
| Primrose Retirement Community CottagesAberdeen, South Dakota |  | 311 | 3794 |  |  |  | 311 | 3794 |  | 4105 | (1052) | 2005 | 12/19/2012 | (1) |
| Primrose Retirement Community of Council BluffsCouncil Bluffs, Iowa ("Omaha") |  | 1144 | 11117 | 46 | 16 |  | 1190 | 11133 |  | 12323 | (3174) | 2008 | 12/19/2012 | (1) |
| Primrose Retirement Community of DecaturDecatur, Illinois |  | 513 | 16706 | 105 | 184 |  | 618 | 16890 |  | 17508 | (4607) | 2009 | 12/19/2012 | (1) |
| Primrose Retirement Community of LimaLima, Ohio |  | 944 | 17115 | 8 | 15 |  | 952 | 17130 |  | 18082 | (4662) | 2006 | 12/19/2012 | (1) |
| Primrose Retirement Community of ZanesvilleZanesville, Ohio |  | 1184 | 17292 |  | 74 |  | 1184 | 17366 |  | 18550 | (4737) | 2008 | 12/19/2012 | (1) |
| Capital Health of Symphony ManorBaltimore, Maryland |  | 2319 | 19444 | 7 | 305 |  | 2326 | 19749 |  | 22075 | (5281) | 2011 | 12/21/2012 | (1) |
| Curry House Assisted Living & Memory CareCadillac, Michigan |  | 995 | 11072 | 15 | 457 |  | 1010 | 11529 |  | 12539 | (3005) | 1966 | 12/21/2012 | (1) |
| Tranquillity at FredericktowneFrederick, Maryland |  | 808 | 14291 | 41 | 6529 |  | 849 | 20820 |  | 21669 | (5889) | 2000 | 12/21/2012 | (1) |
| Brookridge Heights Assisted Living & Memory CareMarquette, Michigan |  | 595 | 11339 | 119 | 5086 |  | 714 | 16425 |  | 17139 | (4801) | 1998 | 12/21/2012 | (1) |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION (CONTINUED)

AS OF DECEMBER 31, 2022 (in thousands)

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Initial Costs** | **Initial Costs** | **Costs Capitalized Subsequent to Acquisition** | **Costs Capitalized Subsequent to Acquisition** | **Costs Capitalized Subsequent to Acquisition** | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | | | | **Life on which depreciation in latest income statement is computed** |
|<br>**Property/Location** |<br>**Encum-<br>brances** | **Land & Land Improvements** | **Building and Building Improvements** | **Land & Land Improvements** | **Building and Building Improvements** | **Construction in Process** | **Land & Land Improvements** | **Building and Building Improvements** | **Construction in Process** | **Total** |<br>**Accumulated Depreciation** |<br>**Date of Construction** |<br>**Date Acquired** | **Life on which depreciation in latest income statement is computed** |
| Woodholme Gardens Assisted Living & Memory CarePikesville, Maryland ("Baltimore") | $— | $1603 | $13472 | $54 | $111 | $— | $1657 | $13583 | $— | $15240 | $(3676) | 2010 | 12/21/2012 | (1) |
| HarborChase of JasperJasper, Alabama |  | 355 | 6358 | 23 | 68 |  | 378 | 6426 |  | 6804 | (1611) | 1998 | 7/31/2013 | (1) |
| Raider RanchLubbock, Texas |  | 4992 | 48818 | 658 | 13297 |  | 5650 | 62115 |  | 67765 | (14625) | 2009 | 8/29/2013 | (1) |
| Town VillageOklahoma City, Oklahoma |  | 1020 | 19847 | 103 | 1665 |  | 1123 | 21512 |  | 22635 | (5465) | 2004 | 8/29/2013 | (1) |
| Prestige Senior Living Beaverton HillsBeaverton, Oregon |  | 1387 | 10324 | 13 | 85 |  | 1400 | 10409 |  | 11809 | (2534) | 2000 | 12/2/2013 | (1) |
| Prestige Senior Living High DesertBend, Oregon |  | 835 | 11252 | 17 | 430 |  | 852 | 11682 |  | 12534 | (2906) | 2003 | 12/2/2013 | (1) |
| MorningStar of BillingsBillings, Montana |  | 4067 | 41373 | 54 | 589 |  | 4121 | 41962 |  | 46083 | (10778) | 2009 | 12/2/2013 | (1) |
| MorningStar of BoiseBoise, Idaho |  | 1663 | 35752 | 292 | 355 |  | 1955 | 36107 |  | 38062 | (8792) | 2007 | 12/2/2013 | (1) |
| Prestige Senior Living Huntington TerraceGresham, Oregon ("Portland") |  | 1236 | 12083 | 2 | 127 |  | 1238 | 12210 |  | 13448 | (3028) | 2000 | 12/2/2013 | (1) |
| MorningStar of Idaho FallsIdaho Falls, Idaho |  | 2006 | 40397 | 64 | 420 |  | 2070 | 40817 |  | 42887 | (10124) | 2009 | 12/2/2013 | (1) |
| Prestige Senior Living Arbor PlaceMedford, Oregon |  | 355 | 14083 | 11 | 934 |  | 366 | 15017 |  | 15383 | (3492) | 2003 | 12/2/2013 | (1) |
| Prestige Senior Living Orchard HillsSalem, Oregon |  | 545 | 15544 | 134 | 228 |  | 679 | 15772 |  | 16451 | (3795) | 2002 | 12/2/2013 | (1) |
| Prestige Senior Living Southern HillsSalem, Oregon |  | 653 | 10753 | 55 | 170 |  | 708 | 10923 |  | 11631 | (2652) | 2001 | 12/2/2013 | (1) |
| MorningStar of SparksSparks, Nevada |  | 3986 | 47968 | 16 | 566 |  | 4002 | 48534 |  | 52536 | (12048) | 2009 | 12/2/2013 | (1) |
| Prestige Senior Living Five RiversTillamook, Oregon |  | 1298 | 14064 | 18 | 571 |  | 1316 | 14635 |  | 15951 | (3685) | 2002 | 12/2/2013 | (1) |
| Prestige Senior Living RiverwoodTualatin, Oregon ("Portland") |  | 1028 | 7429 | 12 | 224 |  | 1040 | 7653 |  | 8693 | (1920) | 1999 | 12/2/2013 | (1) |
| Prestige Senior Living Auburn MeadowsAuburn, Washington ("Seattle") |  | 2537 | 17261 |  | 1555 |  | 2537 | 18816 |  | 21353 | (4387) | 2003/2010 | 2/3/2014 | (1) |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION (CONTINUED)

AS OF DECEMBER 31, 2022 (in thousands)

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Initial Costs** | **Initial Costs** | **Costs Capitalized Subsequent to Acquisition** | **Costs Capitalized Subsequent to Acquisition** | **Costs Capitalized Subsequent to Acquisition** | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | | | | **Life on which depreciation in latest income statement is computed** |
|<br>**Property/Location** |<br>**Encum-<br>brances** | **Land & Land Improvements** | **Building and Building Improvements** | **Land & Land Improvements** | **Building and Building Improvements** | **Construction in Process** | **Land & Land Improvements** | **Building and Building Improvements** | **Construction in Process** | **Total** |<br>**Accumulated Depreciation** |<br>**Date of Construction** |<br>**Date Acquired** | **Life on which depreciation in latest income statement is computed** |
| Prestige Senior Living BridgewoodVancouver, Washington ("Portland") | $— | $1603 | $18172 | $10 | $474 | $— | $1613 | $18646 | $— | $20259 | $(4344) | 2001 | 2/3/2014 | (1) |
| Prestige Senior Living Monticello ParkLongview, Washington |  | 1981 | 23056 | 1 | 73 |  | 1982 | 23129 |  | 25111 | (5516) | 2001/2010 | 2/3/2014 | (1) |
| Prestige Senior Living RosemontYelm, Washington |  | 668 | 14564 | 14 | 165 |  | 682 | 14729 |  | 15411 | (3461) | 2004 | 2/3/2014 | (1) |
| Wellmore of Tega CayTega Cay, South Carolina ("Charlotte") |  | 2445 |  | 2755 | 23457 |  | 5200 | 23457 |  | 28657 | (5883) | 2015 | 2/7/2014 | (1) |
| Isle at Cedar RidgeCedar Park, Texas ("Austin") |  | 1525 | 16277 |  | 670 |  | 1525 | 16947 |  | 18472 | (4157) | 2011 | 2/28/2014 | (1) |
| Prestige Senior Living West HillsCorvallis, Oregon |  | 842 | 12603 | 11 | 419 |  | 853 | 13022 |  | 13875 | (3142) | 2002 | 3/3/2014 | (1) |
| HarborChase of PlainfieldPlainfield, Illinois |  | 1596 | 21832 | 123 | 351 |  | 1719 | 22183 |  | 23902 | (5219) | 2010 | 3/28/2014 | (1) |
| Legacy Ranch Alzheimer's Special Care CenterMidland, Texas |  | 917 | 9982 | 34 | 212 |  | 951 | 10194 |  | 11145 | (2427) | 2012 | 3/28/2014 | (1) |
| The Springs Alzheimer's Special Care CenterSan Angelo, Texas |  | 595 | 9658 | 9 | 206 |  | 604 | 9864 |  | 10468 | (2369) | 2012 | 3/28/2014 | (1) |
| Isle at Watercrest - BryanBryan, Texas |  | 3223 | 40581 | 45 | 2575 |  | 3268 | 43156 |  | 46424 | (10379) | 2011 | 4/21/2014 | (1) |
| Isle at Watercrest - MansfieldMansfield, Texas ("Dallas/Fort Worth") |  | 997 | 24635 |  | 363 |  | 997 | 24998 |  | 25995 | (5715) | 2011 | 5/5/2014 | (1) |
| Watercrest at KatyKaty, Texas ("Houston") | 21228 | 4000 |  | 127 | 33996 |  | 4127 | 33996 |  | 38123 | (5559) | 2016 | 6/27/2014 | (1) |
| Watercrest at MansfieldMansfield, Texas ("Dallas/Fort Worth") | 22854 | 2191 | 42740 | 24 | 990 |  | 2215 | 43730 |  | 45945 | (10001) | 2010 | 6/30/2014 | (1) |
| HarborChase of Shorewood Shorewood, Wisconsin ("Milwaukee") |  | 2200 |  | 304 | 19868 |  | 2504 | 19868 |  | 22372 | (3748) | 2015 | 7/8/2014 | (1) |
| Fairfield Village of Layton Layton, Utah ("Salt Lake City") |  | 5217 | 54167 | 344 | 648 |  | 5561 | 54815 |  | 60376 | (12535) | 2010 | 11/20/2014 | (1) |
| Primrose Retirement Center of Anderson Anderson, Indiana ("Muncie") |  | 1342 | 19083 |  | 33 |  | 1342 | 19116 |  | 20458 | (4094) | 2008 | 5/29/2015 | (1) |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION (CONTINUED)

AS OF DECEMBER 31, 2022 (in thousands)

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Initial Costs** | **Initial Costs** | **Costs Capitalized Subsequent to Acquisition** | **Costs Capitalized Subsequent to Acquisition** | **Costs Capitalized Subsequent to Acquisition** | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | | | | **Life on which depreciation in latest income statement is computed** |
|<br>**Property/Location** |<br>**Encum-<br>brances** | **Land & Land Improvements** | **Building and Building Improvements** | **Land & Land Improvements** | **Building and Building Improvements** | **Construction in Process** | **Land & Land Improvements** | **Building and Building Improvements** | **Construction in Process** | **Total** |<br>**Accumulated Depreciation** |<br>**Date of Construction** |<br>**Date Acquired** | **Life on which depreciation in latest income statement is computed** |
| Primrose Retirement Center of Lancaster Lancaster, Ohio ("Columbus") | $— | $2840 | $21884 | $51 | $345 | $— | $2891 | $22229 | $— | $25120 | $(5179) | 2007 | 5/29/2015 | (1) |
| Primrose Retirement Center of Wausau Wausau, Wisconsin ("Green Bay") |  | 1089 | 18653 | 3 | 15 |  | 1092 | 18668 |  | 19760 | (3837) | 2008 | 5/29/2015 | (1) |
| Superior Residences of Panama City Panama City Beach, Florida |  | 2099 | 19367 | 14 | 116 |  | 2113 | 19483 |  | 21596 | (4107) | 2015 | 7/15/2015 | (1) |
| The Hampton at Meadows Place Fort Bend, Texas ("Houston") |  | 715 | 24281 | 11 | 383 |  | 726 | 24664 |  | 25390 | (4790) | 2007/2013/ 2014 | 7/31/2015 | (1) |
| The Pavilion at Great Hills Austin, Texas |  | 1783 | 29318 | 53 | 284 |  | 1836 | 29602 |  | 31438 | (5809) | 2010 | 7/31/2015 | (1) |
| The Beacon at Gulf Breeze Gulf Breeze, Florida ("Pensacola") |  | 824 | 24106 | 89 | 381 |  | 913 | 24487 |  | 25400 | (4943) | 2008 | 7/31/2015 | (1) |
| Parc at Piedmont Marietta, Georgia ("Atlanta") |  | 3529 | 43080 | 36 | 1582 |  | 3565 | 44662 |  | 48227 | (8866) | 2001/2011 | 7/31/2015 | (1) |
| Parc at Duluth Duluth, Georgia ("Atlanta") |  | 5951 | 42458 | 70 | 2726 |  | 6021 | 45184 |  | 51205 | (8755) | 2003/2012 | 7/31/2015 | (1) |
| Waterstone on Augusta Greenville, South Carolina |  | 2253 |  | 2116 | 20882 |  | 4369 | 20882 |  | 25251 | (3876) | 2017 | 8/31/2015 | (1) |
| Wellmore of Lexington Lexington, South Carolina ("Columbia") |  | 2300 |  | 3204 | 43101 |  | 5504 | 43101 |  | 48605 | (7239) | 2017 | 9/14/2015 | (1) |
| Palmilla Senior Living Albuquerque, New Mexico |  | 4701 | 38321 | 33 | 225 |  | 4734 | 38546 |  | 43280 | (7650) | 2013 | 9/30/2015 | (1) |
| Cedar Lake Assisted Living and Memory Care Lake Zurich, Illinois ("Chicago") |  | 2412 | 25126 | 38 | 105 |  | 2450 | 25231 |  | 27681 | (5001) | 2014 | 9/30/2015 | (1) |
| The Shores of Lake Phalen Maplewood, Minnesota ("St. Paul") |  | 2724 | 25093 | 10 | 108 |  | 2734 | 25201 |  | 27935 | (4907) | 2012 | 11/10/2015 | (1) |
| Dogwood Forest of Grayson Grayson, Georgia |  | 1788 |  | 112 | 22084 |  | 1900 | 22084 |  | 23984 | (3182) | 2017 | 11/24/2015 | (1) |
| Park Place Senior Living at WingHaven O'Fallon, Missouri ("St. Louis") |  | 1283 | 48221 | 151 | 1093 |  | 1434 | 49314 |  | 50748 | (9248) | 2006/2014 | 12/17/2015 | (1) |
| Hearthside Senior Living of Collierville Collierville, Tennessee ("Memphis") |  | 1756 | 13379 | 57 | 39 |  | 1813 | 13418 |  | 15231 | (2631) | 2014 | 12/29/2015 | (1) |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES

SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION (CONTINUED)

AS OF DECEMBER 31, 2022 (in thousands)

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Initial Costs** | **Initial Costs** | **Costs Capitalized Subsequent to Acquisition** | **Costs Capitalized Subsequent to Acquisition** | **Costs Capitalized Subsequent to Acquisition** | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | **Gross Amounts at which Carried at Close of Period** <sup>(2)</sup> | | | | **Life on which depreciation in latest income statement is computed** |
|<br>**Property/Location** |<br>**Encum-<br>brances** | **Land & Land Improvements** | **Building and Building Improvements** | **Land & Land Improvements** | **Building and Building Improvements** | **Construction in Process** | **Land & Land Improvements** | **Building and Building Improvements** | **Construction in Process** | **Total** |<br>**Accumulated Depreciation** |<br>**Date of Construction** |<br>**Date Acquired** | **Life on which depreciation in latest income statement is computed** |
| Albuquerque, New Mexico – Vacant Land Albuquerque, New Mexico | $— | $1056 | $— | $— | $— | $— | $1056 | $— | $— | $1056 | $— |  | 9/7/2017 | (1) |
| Finton Assisted LivingVinton, Iowa | 2679 | 1083 | 3439 |  |  |  | 1083 | 3439 |  | 4522 | (117) | 2007 | 8/31/2012 | (1) |
| Webster City Assisted LivingWebster City, Iowa | 2435 | 912 | 3794 |  | 1 |  | 912 | 3795 |  | 4707 | (123) | 2007 | 8/31/2012 | (1) |
| Nevada Assisted LivingNevada, Iowa | 5439 | 1749 | 7196 |  |  |  | 1749 | 7196 |  | 8945 | (240) | 2011 | 8/31/2012 | (1) |
| Grinnell Assisted LivingGrinnell, Iowa | 5196 | 1690 | 4454 | 13 | 5 |  | 1703 | 4459 |  | 6162 | (167) | 2005 | 4/2/2013 | (1) |
| Indianola Assisted LivingIndianola, Iowa | 2110 | 986 | 3369 | 6 | 1 |  | 992 | 3370 |  | 4362 | (114) | 2004 | 4/2/2013 | (1) |
|  | $61941 | $123155 | $1267517 | $13261 | $228035 | $— | $136416 | $1495552 | $— | $1631968 | $(338350) |  |  |  |

---

Transactions in real estate and accumulated depreciation as of December 31, 2022 are as follows:

---

| | | | |
|:---|:---|:---|:---|
| Balance December 31, 2019 | $1712827 | Balance December 31, 2019 | $(226529) |
| 2020 Improvements | 3020 | 2020 Depreciation | (42430) |
| 2020 Dispositions | (75313) | 2020 Accumulated depreciation on dispositions | 6565 |
| Balance December 31, 2020 | 1640534 | Balance December 31, 2020 | (262394) |
| 2021 Improvements | 6385 | 2021 Depreciation | (42215) |
| 2021 Dispositions | (6764) | 2021 Accumulated depreciation on dispositions | 842 |
| 2021 Impairments | (9673) | Balance December 31, 2021 | (303767) |
| Balance December 31, 2021 | 1630482 | 2022 Depreciation | (43781) |
| 2022 Acquisitions <sup>(3)</sup> | 28672 | 2022 Accumulated depreciation on dispositions | 9198 |
| 2022 Improvements | 11339 | Balance December 31, 2022 | $(338350) |
| 2022 Dispositions | (38525) |  |  |
| Balance December 31, 2022 | $1631968 |  |  |

---

_______________

**FOOTNOTES:**

(1)Buildings and building improvements are depreciated over 39 and 15 years, respectively. Tenant improvements are depreciated over the terms of their respective leases.

(2)The aggregate cost for federal income tax purposes is approximately $1.8 billion.

(3)Represents the consolidation of the five properties held by the Windsor Manor Joint Venture, effective January 1, 2022, as described in Note 4. "Acquisition."

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE**

There were no changes in or disagreements with our independent registered accountants during the period ended December 31, 2022.

**Item 9A. CONTROLS AND PROCEDURES**

*Evaluation of Disclosure Controls and Procedures* 

Pursuant to Rule 13a-15(b) under the Exchange Act, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our management, including our principal executive officer and principal financial officer, concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report.

*Management's Report on Internal Control Over Financial Reporting* 

Management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended). The Company's internal control over financial reporting is designed to provide reasonable assurance to the Company's management and board of directors regarding the preparation and fair presentation of published financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Based on management's assessment, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022 using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in "Internal Control Integrated Framework (2013).

Pursuant to rules established by the SEC, this annual report does not include an attestation report of the Company's independent registered public accounting firm regarding internal control over financial reporting.

*Changes in Internal Control over Financial Reporting* 

During the most recent fiscal quarter, there was no change in our internal controls over financial reporting (as defined under Rule 13a-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

**Item 9B. OTHER INFORMATION**

None.

**Item 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS**

None.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**PART III**

**Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE**

**Directors and Executive Officers**

Our directors and executive officers as of March 8, 2023 were as follows:

---

| | | |
|:---|:---|:---|
| **Name** | **Age** | **Position** |
| James M. Seneff, Jr. | 76 | Director and Chairman of the Board |
| Stephen H. Mauldin | 54 | Director, Vice Chairman of the Board, President and Chief Executive Officer |
| James Chandler Martin | 72 | Independent Director and Audit Committee Financial Expert |
| Michael P. Haggerty | 70 | Independent Director |
| J. Douglas Holladay | 76 | Independent Director |
| Ixchell C. Duarte | 56 | Chief Financial Officer, Senior Vice President and Treasurer |
|  |  | (Principal Financial and Principal Accounting Officer) |
| John R. McRae | 52 | Senior Vice President |
| Tracey B. Bracco | 43 | General Counsel, Senior Vice President and Secretary |

---

***James M. Seneff, Jr****. Chairman of the Board and Director.* On December 7, 2017, Mr. Seneff was re-appointed to serve as chairman of the board and director of the Company. Mr. Seneff previously served as chairman of the board of directors from May 2011 to June 2016, and as a director since inception in June 2010 to June 2016. Mr. Seneff has served as the chairman of its advisor, CNL Healthcare Corp., since its inception in June 2010. In December 2017, Mr. Seneff was appointed as director and chairman of the board of CNL Strategic Capital, LLC, a public, non-traded operating company formed to acquire debt and equity of private U.S. businesses. Mr. Seneff served as chairman of the board of directors and a director of CNL Lifestyle Properties, Inc., a public, non-traded REIT (2003 to 2017), a director of the managing member of its former advisor, CNL Lifestyle Company, LLC (2003 to December 2010), and a director of its successor advisor, CNL Lifestyle Advisor Corporation (December 2010 to 2017). He served as chairman of the board of directors and a director of CNL Growth Properties, Inc., a public, non-traded REIT, from August 2009 and December 2008, respectively, to June 2016, and has served as a manager of its advisor, CNL Global Growth Advisors, LLC, from 2008 to 2017. Mr. Seneff also served as chairman of the board of directors and a director of Global Income Trust, Inc., another public, non-traded REIT, from April 2009 until its dissolution in December 2015, and served as manager of its advisor until December 2016. Mr. Seneff is the sole member of CNL Holdings, LLC ("CNL Holdings") and has served as the chairman, chief executive officer and/or president of several of CNL Holdings' subsidiaries, including chief executive officer and president (2008 to 2013), and as chairman from 2013 to present of CNL Financial Group, LLC, our sponsor, and as executive chairman (January 2011 to present), chairman (1988 to January 2011), chief executive officer (1995 to January 2011) and president (1980 to 1995) of CNL Financial Group, Inc., a diversified real estate company. Mr. Seneff also has served on the board of directors of the following CNL Holdings' affiliates: CNL Hotels & Resorts, Inc., a public, non-traded REIT (1996 to April 2007), and its advisor, CNL Hospitality Corp. (1997 to June 2006 (became self-advised)); CNL Retirement Properties, Inc., a public, non-traded REIT, and its advisor, CNL Retirement Corp. (1997 to October 2006); CNL Restaurant Properties, Inc., a public, non-traded REIT, and its advisor (1994 to 2005 (became self-advised)); Trustreet Properties, Inc. ("Trustreet"), a publicly traded REIT (2005 to February 2007); National Retail Properties, Inc., a publicly traded REIT (1994 to 2005); CNL Securities Corp., a FINRA-registered broker-dealer and the managing dealer of our offerings (1979 to 2013); and CNL Capital Markets Corp. (1990 to 2017). Mr. Seneff was also the chairman and a principal stockholder of CNLBancshares, Inc. (1999 to 2015), which owned CNLBank until it merged into Valley National Bank in 2015. Mr. Seneff received his B.A. in business administration from Florida State University.

**As a result of these professional and other experiences, Mr. Seneff possesses particular knowledge of real estate acquisitions, ownership and dispositions in a variety of public and private real estate investment vehicles, which strengthens the board's collective knowledge, capabilities and experience. Mr. Seneff is principally responsible for overseeing the formulation of our strategic objectives.**

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

***Stephen H. Mauldin***, *Vice Chairman of the Board and Director.* Mr. Mauldin has served as vice chairman of the Board and a director since June 2016, as our president since September 2011 and as our chief executive officer since April 2012. Mr. Mauldin is primarily responsible for executive leadership of the Company and the formulation and execution of our strategic objectives. Mr. Mauldin has also served as president and chief executive officer of our Advisor since September 2011 and January 2018 respectively and as chief operating officer from September 2011 to July 2018. Mr. Mauldin has served as a director of CNL Healthcare Properties II, Inc., a public, non-traded REIT, from November 2015, as vice chairman of its board of directors from November 2015 to December 2017, as chairman of its board of directors from January 2018 and as its chief executive officer and president since July 2015 until its dissolution in March 2020. Mr. Mauldin has served as manager and president of its advisor since July 2015, and as chief executive officer of its advisor since January 2018. Mr. Mauldin also served as chief operating officer of its advisor from July 2015 to July 2018. Mr. Mauldin also served as president (from September 2011), chief executive officer (from April 2012) and chief operating officer (September 2011 to April 2012) of CNL Lifestyle Properties, Inc., a public-non-traded REIT, until its dissolution in December 2017, as well as president and chief operating officer of CNL Lifestyle Advisor Corporation, its advisor, from September 2011 to December 31, 2017. Mr. Mauldin also served as president of CNL Growth Properties, Inc., a public, non-traded REIT, from March 2016 and as chief executive officer from August 2016 until its dissolution in October 2017. Mr. Mauldin served on the board of directors of Burroughs & Chapin Company, Inc., a South Carolina based real estate investment trust, since May 2021. Immediately prior to joining the Company, Mr. Mauldin served as a management consultant to Crosland, LLC, a privately held real estate development and asset management company headquartered in Charlotte, North Carolina, from March 2011 through August 2011. He previously served as Crosland's chief executive officer, president and a member of its board of directors from July 2010 until March 2011. Mr. Mauldin originally joined Crosland, LLC in August 2006 and served as its chief financial officer from July 2009 to July 2010 and as president of Crosland's mixed-use and multi-used development division prior to his appointment as chief financial officer. Prior to joining Crosland, LLC, from 1998 to August 2006, Mr. Mauldin was a co-founder and served as a partner of Crutchfield Capital, LLC, a privately held investment and operating company with a focus on small and medium-sized companies in the southeastern United States. From 1996 to 1998, Mr. Mauldin held various positions in the capital markets group and the office of the chairman of Security Capital Group, Inc., which prior to its sale in 2002, owned controlling interests in 18 public and private real estate operating companies (eight of which were NYSE-listed) with a total market capitalization of over $26 billion. Mr. Mauldin graduated with a B.S. in finance from the University of Tampa and received an M.B.A. with majors in real estate, finance, managerial economics and accounting/information systems from the J.L. Kellogg Graduate School of Management at Northwestern University.

**As a result of these professional and other experiences, Mr. Mauldin possesses particular knowledge of real estate investment, including acquisition, development, financing, operation, and disposition, which strengthens the Board's collective knowledge, capabilities and experience.**

***J. Chandler Martin****, Independent Director and Audit Committee Financial Expert*. Mr. Martin has been an independent director and has served as our audit committee financial expert since July 2012. Mr. Martin served as independent director and audit committee financial expert of CNL Healthcare Properties II, Inc., a public-non-traded REIT, from January 2016 to September 2018. Mr. Martin served as Corporate Treasurer of Bank of America, a banking and financial services company, from 2005 until his retirement in March 2008. During his 27 years at Bank of America, Mr. Martin held a number of line and risk management roles, including leadership roles in commercial real estate risk management, capital markets risk management, and private equity investing. As corporate treasurer, he was responsible for funding, liquidity, and interest rate risk management. From 2003 to 2005, Mr. Martin was Bank of America's enterprise market and operational risk executive, and from 1999 until 2003, he served as the risk management executive for Bank of America's global corporate and investment banking. From April 2008 through July 2008, following his retirement, Mr. Martin served as a member of the Counterparty Risk Management Policy Group III ("CPMPG III"), co-chaired its Risk Monitoring and Risk Management Working Group, and participated in the production of CPMPG III's report: "Containing Systemic Risk: The Road to Reform," a forward-looking and integrated framework of risk management best practices. Mr. Martin returned to Bank of America in October 2008 to assist with the integration process for enterprise risk management following Bank of America's acquisition of Merrill Lynch. After working on the transition, Mr. Martin served as Bank of America's enterprise credit and market risk executive until July 2009. Between October 2011 until its acquisition in October 2016, Mr. Martin served as a director of CommunityOne Bancorporation, a community bank holding company headquartered in Asheboro, North Carolina. Until May 2021, he also served on the board of directors of Burroughs & Chapin Company, Inc., a South Carolina based real estate investment trust, having served on the audit, personnel and compensation committees. He also serves on the board of directors of Wings Capital Partners LLC, a California based aviation finance company. He serves as a member of the advisory board of Corrum Capital Management, an alternative investment management firm. Mr. Martin attained an M.B.A. from Samford University and a B.A. in economics from Emory University.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**As a result of these professional and other experiences, Mr. Martin possesses particular knowledge of, among other things, systems of internal controls, risk management best practices, sound corporate governance, and the relationship between liquidity, leverage and capital adequacy, which strengthens the board of directors' collective knowledge, capabilities and experience.**

***Michael P. Haggerty***, *Independent Director*. Mr. Haggerty joined the board of directors as an independent director in April 2012. Mr. Haggerty was a partner at Jackson Walker, LLC, a Dallas-based law firm, for more than 37 years, where he headed the Firm's finance group. Mr. Haggerty's commercial real estate practice included the negotiation, structuring, and documentation of interim and permanent financing of office buildings, shopping centers, retirement facilities, restaurants, industrial properties, and multi-family residential projects. The credit facilities involved both single asset and portfolio transactions; multi-state transactions; partnerships, corporations, REITs, conduits, and pension funds; equity participations; loan participations; letters of credit; multi-creditor facilities; and commercial and residential mortgage warehouse lines of credit. In January 2016, Mr. Haggerty left Jackson Walker, LLC to become the executor of the Estate of Bert Fields, Jr. The estate owns extensive oil and gas properties, the controlling ownership interest of North Dallas Bank & Trust and a ranching operation. Mr. Haggerty is a director of North Dallas Bank & Trust Co., serving on the executive, audit, investment, marketing and compensation committees. Mr. Haggerty attained a B.B.A. from the University of Georgia and a J.D. from the University of Virginia School of Law. Since 1978, Mr. Haggerty has been admitted to practice law in the states of both Texas and Georgia.

**As a result of these professional and other experiences, Mr. Haggerty possesses particular knowledge of real estate and commercial law, which strengthens the board of directors' collective knowledge, capabilities and experience.**

***J. Douglas Holladay*,** *Independent Director*. Mr. Holladay has been an independent director since April 2012. Mr. Holladay has served as a general partner of Elgin Capital Partners, a private energy company based in Denver from 2008 to the present. From 1999 to 2008, Mr. Holladay was co-founder of a middle market private equity fund, Park Avenue Equity Partners. Mr. Holladay served as a guest columnist for the online Washington Post and is an adjunct professor at Georgetown University. From 2009 to 2013, Mr. Holladay served on the board of directors of Miraval, a privately held luxury resort and spa located in Arizona. From July 2004 to April 2007, Mr. Holladay served as a director of CNL Hotels & Resorts, Inc., a public non-traded REIT affiliated with CNL. Previously, Mr. Holladay held senior positions at Goldman, Sachs & Co., the U.S. State Department and the White House. While a diplomat, Mr. Holladay was accorded the personal rank of ambassador. Between 2000 and 2009, Mr. Holladay served as a director for Sunrise Senior Living, Inc., a public company that provides senior living services in the United States, Canada and the United Kingdom. Mr. Holladay attained an M.Litt. in political and economic history from Oxford University, an M.A. in theology from Princeton Theological Seminary, and an A.B. in political science from the University of North Carolina, Chapel Hill. He holds honorary doctorates from Morehouse College and Nyack College.

**As a result of these professional and other experiences, Mr. Holladay possesses particular knowledge of real estate investment and finance and the capital markets, which strengthens the board of directors' collective knowledge, capabilities and experience.**

***Ixchell C. Duarte****, Chief Financial Officer, Senior Vice President and Treasurer.* Ms. Duarte has served as our chief financial officer and treasurer since February 2018 and as a senior vice president since March 2012. She previously served as the Company's chief accounting officer from March 2012 to June 2017 and as a vice president from February 2012 to March 2012. Ms. Duarte has served as senior vice president and chief accounting officer of our Advisor since November 2013. Ms. Duarte served as chief financial officer and treasurer of CNL Healthcare Properties II, Inc., a public, non-traded REIT from February 2018 and served as senior vice president from June 2016 through its dissolution in March 2020, and previously served as chief accounting officer from January 2016 to June 2017. Ms. Duarte has served as senior vice president and chief accounting officer of its advisor, CHP II Advisors, LLC, since July 2015. Ms. Duarte served as senior vice president and chief accounting officer of CNL Lifestyle Properties, Inc., a public, non-traded REIT from March 2012 until its dissolution in December 2017. Ms. Duarte served as senior vice president and chief accounting officer of its advisor from November 2013 to December 2017. Ms. Duarte served as senior vice president and chief accounting officer of CNL Growth Properties, Inc., a public non-traded REIT from June 2012 until its dissolution in October 2017. Ms. Duarte served as senior vice president of its advisor from November 2013 to December 2017. She also served as senior vice president and chief accounting officer of Global Income Trust, Inc., another public non-traded REIT, from June 2012 until its dissolution in December 2015 and served as a senior vice president of its advisor from November 2013 to December 2016. Prior to rejoining CNL affiliates in January 2012, Ms. Duarte served as controller at GE Capital, Franchise Finance from February 2007 through January 2012. Ms. Duarte served as senior vice president and chief accounting officer of Trustreet Properties, Inc., a publicly traded REIT (NYSE-listed), from February 2005 until the sale of

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

Trustreet to GE Capital in February 2007. Ms. Duarte served as vice president and controller of CNL Restaurant Properties, Inc. from November 1999 through February 2005 and held various positions with CNL affiliates from September 1995 to February 2005, including director of accounting, controller, chief financial officer, secretary and treasurer. Prior to joining CNL's affiliates, Ms. Duarte worked in the New York City audit practice of KPMG, LLP and for the Orlando, FL audit practice of Coopers & Lybrand. She received a B.S. in accounting from the Wharton School of the University of Pennsylvania and is a certified public accountant and a chartered global management accountant.

***John R. McRae,*** *Senior Vice President.* Mr. McRae has served as the Company's senior vice president since July 2022. Mr. McRae has served as the Advisor's chief investment officer since 2015. Mr. McRae has served as vice president of CNL Growth Properties III Member, LLC, the managing member of the newly dissolved CNL Growth Properties III, LLC, since October 2017. Mr. McRae served as senior vice president of CNL Growth Properties II Member, LLC, the managing member of CNL Growth Properties II, LLC from April 2015 until its dissolution in December 2020. Mr. McRae served as senior vice president of CNL Healthcare Properties II, Inc., a public, nontraded real estate investment trust, from January 2016 until its dissolution in March 2020 and has served as senior vice president of its advisor since April 2016. In addition, Mr. McRae was responsible for domestic investment activities for CNL Growth Properties, Inc., and Global Income Trust, Inc. from 2008 to 2017. Mr. McRae also served as vice president of CNL Financial Group Investment Management, LLC from October 2011 until his appointment as chief investment officer in March 2015. Mr. McRae oversees all aspects of the real estate investment process including the structuring of joint venture arrangements, project financing, property underwriting and sourcing new investment opportunities. Mr. McRae has over 25 years of diversified real estate experience encompassing all functions of commercial real estate including development, leasing, financing and management. Prior to joining CNL, Mr. McRae served as senior vice president at Trammell Crow Company. Mr. McRae received a B.S. in business from the University of Florida.

***Tracey B. Bracco****, General Counsel, Senior Vice President and Secretary.* Ms. Bracco has served as our general counsel, senior vice president and secretary since March 2018. She previously served as assistant general counsel and assistant secretary of the Company from June 2014 until March 2018 and as vice president from March 2013 to March 2018. Ms. Bracco has also served as vice president of our advisor since November 2013. Ms. Bracco also has served as general counsel and secretary of CNL Healthcare Properties II, Inc., a public, non-traded REIT, from August 23, 2016 and as its vice president since January 2016, until its dissolution in March 2020. Ms. Bracco has also served as vice president of CHP II Advisors, LLC, the advisor to CNL Healthcare Properties II, Inc., since its inception on July 9, 2015. Ms. Bracco has served as group general counsel, fund management of CNL Financial Group Investment Management, LLC since May 2018, and previously served as deputy general counsel, real estate (March 2016 to May 2018) and previously served as assistant general counsel (April 2013 to March 2016), where she oversees CNL's non-traded REITS, as well as supervising the acquisition and asset management functions relating to fund management for CNL. Ms. Bracco serves as general counsel of CNL Strategic Capital, LLC, a public, non-traded operating company formed to acquire debt and equity of private U.S. businesses. Ms. Bracco served as assistant general counsel and assistant secretary of CNL Lifestyle Properties, Inc., a public, non-traded REIT, from June 2014 and as vice president since March 2013 until its dissolution in December 2017 and as vice president of its advisor since November 2013. Prior to joining CNL Lifestyle Properties, Inc., Ms. Bracco spent six years in private legal practice, primarily at the law firm of Lowndes, Drosdick, Doster, Kantor & Reed, P.A., in Orlando, Florida. Ms. Bracco is licensed to practice law in Florida and is a member of the Florida Bar Association and the Association of Corporate Counsel. She received a B.S. in Journalism from the University of Florida and her J.D. from Boston University School of Law.

**Corporate Governance:** 

**Board Leadership Structure and Risk Oversight** 

**Separate CEO and Chairman** 

The Company currently operates under a leadership structure in which the positions of chairman of the Board and chief executive officer have been separated, such that each position is held by a different person. Although the Board has no mandatory policy with respect to the separation of the offices of chairman and the chief executive officer, the Board believes that it is appropriate to have these as separate positions at this time on account of the varying strengths, experiences and relationships of each of these individuals in the real estate industry. Mr. Seneff serves as the chairman of the Board and has unique knowledge, experience and relationships with the board of directors and management and within a broad spectrum of the real estate market. Mr. Mauldin serves as our president and chief executive officer, in addition to his position of vice chairman of the Board.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Board Structure and Director Independence** 

Under our organizational documents, we must have at least three but not more than eleven directors. The Board of Directors has currently set the number of directors at five. A majority of these directors must be "independent." An "Independent Director" is defined under our Third Articles of Amendment and Restatement ("Charter") as one who is not, and within the last two years has not been, directly or indirectly associated with the Sponsor or the Advisor by virtue of (i) ownership of an interest in the Sponsor, the Advisor or any of their affiliates, (ii) employment by the Sponsor, the Advisor or any of their affiliates, (iii) service as an officer or director of the Sponsor, the Advisor or any of their affiliates, (iv) performance of services, other than as a director, for the Company, (v) service as a director or trustee of more than three REITs sponsored by the Sponsor or advised by the Advisor, or (vi) maintenance of a material business or professional relationship with the Sponsor, Advisor or any of their affiliates. An indirect relationship shall include circumstances in which a director's spouse, parents, children, siblings, mothers- or fathers-in-law, sons- or daughters-in-law or brothers- or sisters-in-law is or has been associated with the Sponsor, the Advisor, any of their affiliates or the Company. A business or professional relationship is considered material if the gross revenue derived by the director from the Sponsor, the Advisor and any of their affiliates exceeds five percent of either the director's annual gross revenue during either of the last two years or the director's net worth on a fair market value basis. The Board annually reviews business and charitable relationships of directors in order to make a determination as to the independence of each director. Only those directors whom the Board determines have no material relationship with us or our affiliates that would impair their independent judgment are considered independent directors. The Board has considered the independence of each director and nominee for election as a director in accordance with the elements of independence set forth in our Charter and the elements of independence in the listing standards of the New York Stock Exchange ("NYSE"), even though our shares are not listed on the NYSE. After performing such a review, based upon information solicited from each nominee, the Board has affirmatively determined that each of Messrs. Martin, Haggerty and Holladay has no material relationship with the Company (either directly or as a partner, stockholder or officer of an organization that has a relationship with the Company) other than as a director of the Company and each satisfies the elements of independence set forth in our Charter and in the listing standards of the NYSE, as currently in effect. There are no familial relationships between any of our directors and executive officers.

We believe that our Board leadership structure is effective for the Company and provides for appropriate oversight of the Company's risk management, by providing balanced leadership through the separated chairman and chief executive officer positions, and by having strong independent leaders on the Board who are fully engaged and provide significant input into Board deliberations and decisions. Below is additional information about our risk oversight procedures.

**Board Meetings and Attendance**

The Board of Directors held seven meetings in 2022. All directors attended 100% of the meetings of the Board. Although the Company does not have a policy on director attendance at the annual meetings of stockholders, directors are encouraged to do so.

**Committees of the Board**

**Audit Committee**

The Company has a standing Audit Committee, the members of which are selected by the Board each year. The Audit Committee, which is composed entirely of Independent Directors, is chaired by an Independent Director. The current membership of the Audit Committee and other descriptive information is summarized below.

---

| | |
|:---|:---|
| **Independent Directors** | **Position** |
| J. Chandler Martin | C, E |
| Michael P. Haggerty | M |
| J. Douglas Holladay | M |
| **Number of 2022 Meetings** | 4 |

---

_______________

**FOOTNOTES:**

C – Committee Chair

E – Audit Committee Financial Expert

M – Committee Member

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

The Audit Committee operates under a written charter adopted by the Board, which can be found in the Corporate Governance section of the Investor Relations page of our website, CNLHealthcareProperties.com.

The Audit Committee assists the Board by providing oversight responsibilities relating to the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The integrity of financial reporting;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The annual independent audit process;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The independence, qualifications and performance of our independent auditor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our systems of internal control over financial reporting and disclosure controls and procedures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The performance of our internal audit department;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Compliance with management's audit, accounting and financial reporting policies and procedures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our policies and procedures for risk assessment and risk management; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The process to estimate the Company's NAV per share on an annual basis.

In addition, the Audit Committee engages and is responsible for the compensation and oversight of the Company's independent auditors and internal auditors. In performing these functions, the Audit Committee meets periodically with the independent auditors, management and internal auditors (including private sessions) to review the results of their work. During the year ended December 31, 2022, the Audit Committee held a total of four meetings, including four meetings with the Company's independent auditors, internal auditors and management to discuss the annual and quarterly financial reports prior to the filing of such reports with the SEC (the Commission"). Each member of the Audit Committee attended 100% of the meetings.

The Board has determined that each member of the Audit Committee is independent under our Charter and the listing standards of the NYSE, as currently in effect. In addition, the Audit Committee determined that Mr. Martin is an "audit committee financial expert" under the rules and regulations of the Commission for purposes of Section 407 of the Sarbanes-Oxley Act of 2002.

**Other Board Committees**

In August 2013, the Board initiated a process to estimate the Company's NAV per share and created the Valuation Committee, charged with oversight of the Company's valuation process (the "Valuation Committee").

In April 2018, the Board appointed a special committee comprised solely of independent directors (the "Special Committee") to review and evaluate the possible strategic alternatives and to act as independent and disinterested directors for purposes of Maryland law with respect to the review of possible strategic alternatives and all matters pertaining thereto.

Currently, the Company does not have a nominating committee or a compensation committee. The Board is of the view that it is not necessary to have a nominating committee at this time because the Board is composed of only five members, a majority of whom are "independent" (as defined under our Charter and the listing standards of the NYSE, as currently in effect). The Board does not have a compensation committee because the Company is externally advised and does not have any employees. We do not separately compensate our executive officers for their services as officers. At such time, if any, as the Company's shares of common stock are listed on a national securities exchange such as the NYSE or the NASDAQ Stock Market, or the Company has employees to whom it directly provides compensation, the Board will form a compensation committee, the members of which will be selected by the full Board annually.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Risk Oversight** 

The Audit Committee focuses on the adequacy of the Company's enterprise risk management and risk mitigation processes. The Audit Committee meets regularly to discuss the strategic direction and the issues and opportunities facing the Company in light of trends and developments in the REIT industry and general business environment. Throughout the year, the Board provides guidance to management regarding the Company's strategy and helps to refine its operating plans to implement the Company's strategy. Annually, Internal Audit presents the results of the enterprise risk assessment to the Audit Committee. The risk assessment approach includes reviewing the categories of risk the Company faces, including any fraud and business risks, as well as the likelihood of occurrence, the potential impact of those risks and mitigating measures. The involvement of the Audit Committee in setting the Company's business strategy is critical to the determination of the types and appropriate levels of risk undertaken by the Company. The Board's role in risk oversight of the Company is consistent with the Company's leadership structure, with the president and chief executive officer and other members of senior management having responsibility for assessing and managing the Company's risk exposure, and the Board and the Audit Committee providing oversight of risk management efforts.

**Committee Charters and Other Corporate Governance Documents** 

The Board has adopted corporate governance policies and procedures that the Board believes are in the best interest of the Company and its stockholders as well as compliant with the Sarbanes-Oxley Act of 2002 and the rules and regulations of the Commission, more particularly:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A majority of the Board and all of the members of the Audit Committee are independent, as discussed above in "Board Structure and Director Independence."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Board has adopted a charter for the Audit Committee; and one member of the Audit Committee is an "audit committee financial expert" as defined in Commission rules.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Audit Committee hires, determines compensation of, and decides the scope of services performed by the Company's independent auditors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company has adopted a Code of Business Conduct that applies to all directors, managers, officers and employees of the Company, as well as all directors, managers, officers and employees of the Advisor. The Code of Business Conduct sets forth the basic principles to guide their day-to-day activities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company has adopted a Whistleblower Policy that applies to the Company and all employees of the Advisor, and establishes procedures for the anonymous submission of employee complaints or concerns regarding financial statement disclosures, accounting, internal accounting controls or auditing matters.

The Audit Committee Charter, and the Whistleblower Policy and the Code of Business Conduct are available in the Corporate Governance section of the Forms and Literature page of our website, CNLHealthcareProperties.com, and will be sent to any stockholder who requests them from CNL Client Services, 450 South Orange Avenue, Orlando, Florida 32801, (866) 650-0650.

**Item 11. EXECUTIVE COMPENSATION**

**Board of Directors Report on Compensation**

*The following report of the Board should not be deemed "filed" with the Commission or incorporated by reference into any other filing the Company makes under the Securities Act or the Exchange Act except to the extent the Company specifically incorporates this report by reference therein.*

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

The Board reviewed and discussed with management the Compensation Discussion and Analysis set forth below ("CD&A"). Based on the Board's review of the CD&A and the Board's discussions of the CD&A with management, the Board approved including the CD&A in this Annual Report on Form 10-K for filing with the Commission.

---

| |
|:---|
| **Board of Directors** |
| James M. Seneff, Jr. |
| Stephen H. Mauldin |
| J. Chandler Martin |
| Michael P. Haggerty |
| J. Douglas Holladay |

---

**Compensation Discussion and Analysis**

The Company has no employees and all of its executive officers are officers of the Advisor and/or one or more of the Advisor's affiliates and are compensated by those entities, in part, for their service rendered to the Company. The Company does not separately compensate its executive officers for their service as officers. The Company did not pay any annual salary or bonus or long-term compensation to its executive officers for services rendered in all capacities to the Company during the year ended December 31, 2022. See "Certain Relationships and Related Transactions" for a description of the fees paid and expenses reimbursed to the Advisor and its affiliates.

If the Company determines to compensate named executive officers in the future, the board of directors will review all forms of compensation and approve all stock option grants, warrants, stock appreciation rights and other current or deferred compensation payable with respect to the current or future value of the Company's shares.

**Compensation of Directors**

Two of our directors, Messrs. Seneff and Mauldin, are employed by and receive compensation from affiliates of our Advisor. We do not separately compensate them for their services as directors to the Company. Below is information regarding the compensation program in effect during 2022 for our independent directors.

---

| | |
|:---|:---|
| Annual Board Retainer | $45000 |
| Annual Audit Committee Chair Retainer | $10000 |
| Annual Special Committee Retainer | $35000 |
| Annual Special Committee Chair Retainer | $45000 |
| Board and Committee Meeting Attendance Fees | $2,000 for each Board and Committee Meeting attended |
| Other Fees | $2,000 per day for other meetings and Company related business outside of normally scheduled Board and Committee meetings, however, no compensation is paid for attending Annual Meetings of Stockholders. |

---

In addition to the above Annual retainers and fees, we pay for or reimburse our independent directors for their meeting-related expenses. The purpose of our independent director compensation program is to allow us to continue to attract and retain qualified Board members and recognize the significant commitment required of our directors.

The following table gives information regarding the compensation we provided to our directors in 2022.

---

| | | |
|:---|:---|:---|
| **Name** | **Fees Earned or <br>Paid in Cash** | **Total <br>Compensation** |
| James M. Seneff, Jr. (Chairman) | $— | $— |
| Stephen H. Mauldin |  |  |
| J. Chandler Martin | 130000 | 130000 |
| Michael P. Haggerty | 110000 | 110000 |
| J. Douglas Holladay | 110000 | 110000 |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS**

The following table sets forth information regarding the shares of the Company's common stock beneficially owned by each director and nominee, by each executive officer and by all executive officers and directors as a group, based upon information furnished by such stockholders, directors and officers. Unless otherwise noted below, such persons have sole investment and voting power over the shares. The address of the named officers and directors is CNL Center at City Commons, 450 South Orange Avenue, 14<sup>th</sup> Floor, Orlando, Florida 32801.

The number of shares of our common stock beneficially owned by any director or executive officer did not exceed 1% of the total shares outstanding at March 8, 2023.

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **Number of Shares** | **Percent of Shares** | |
| J. Chandler Martin |  | 0.0% |  |
| Michael P. Haggerty |  | 0.0% |  |
| J. Douglas Holladay |  | 0.0% |  |
| James M. Seneff, Jr <sup>(1)</sup> | 1370820 | 0.8% |  |
| Stephen H. Mauldin | 6133 | 0.0% | <sup>(2)</sup> |
| Ixchell C. Duarte |  | 0.0% |  |
| John R. McRae |  | 0.0% |  |
| Tracey B. Bracco |  | 0.0% |  |
| All directors and executive officers as a group (8 persons) | 1376953 | 0.8% |  |

---

_______________

**FOOTNOTES:**

(1)Represents shares held of record by the Advisor.

(2)The number of shares of our common stock beneficially owned by any director or executive officer did not exceed 0.1% of the total shares outstanding as of March 8, 2023.

**Five Percent Stockholders** 

There are no persons who are known to us to be the beneficial owners of more than 5% of our outstanding common stock as of December 31, 2022 or March 8, 2023.

**Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE**

The Company is externally advised and has no direct employees. In addition, certain directors and officers hold similar positions with the Managing Dealer, our Advisor and their affiliates. In connection with services provided to the Company, affiliates are entitled to certain fees as described in Item 8. "Financial Statements and Supplementary Data–Note 12. Related Party Arrangements."

In order to reduce or eliminate certain potential conflicts of interest, our charter and our advisory agreement contain restrictions and conflict resolution procedures relating to transactions we enter into with our Advisor and other related parties. The types of transactions covered by these policies include the compensation paid to our Advisor, decisions to renew our advisory agreement, acquisitions or leases of assets and any other transaction in which our Advisor or any of our directors have an interest.

Our board of directors monitors and reviews issues involving potential conflicts of interest and related party transactions. Our independent directors are responsible for reviewing our fees and expenses, including those payable to our Advisor and other related parties, at least annually or with sufficient frequency to determine that our total fees and expenses are fair and reasonable in light of our investment performance, among other factors. Our independent directors are also responsible for reviewing, at least annually, the performance of our Advisor and determining that compensation to be paid to the Advisor is reasonable in relation to the nature and quality of services performed and our performance. In addition, a majority of our independent directors, must approve each transaction with our Advisor or its affiliates.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

During 2022, the Company's Total Operating Expenses incurred represented approximately 1.3% of Average Invested Assets, as each term is defined in the Company's Charter. During 2022, the Company's Total Operating Expenses incurred represented approximately 57.0% of Net Income, as each term is defined in the Company's Charter.

**Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES**

***Auditor Fees***

PricewaterhouseCoopers LLP serves as the Company's principal accounting firm and audited the Company's consolidated financial statements for the years ended December 31, 2022 and 2021.

The following table presents fees for professional audit services rendered by PricewaterhouseCoopers LLP for the audit of our annual financial statements for the years ended December 31, 2022 and 2021, and fees billed for other services rendered (for audit and non-audit services and all "out-of-pocket" costs incurred in connection with these services) by PricewaterhouseCoopers LLP during these periods.

---

| | | |
|:---|:---|:---|
| | **Years Ended December 31,** | **Years Ended December 31,** |
| | **2022** | **2021** |
| Audit fees | $819800 | $755040 |
| Audit-related fees |  |  |
| Tax fees | 636842 | 373834 |
| All other fees |  |  |
| &nbsp;&nbsp;&nbsp;Total Fees | $1456642 | $1128874 |

---

*Audit Fees* – Consists of professional services rendered in connection with the annual audit of the Company's consolidated financial statements included in the Company's Annual Report on Form 10-K and quarterly reviews of the Company's interim financial statements included in the Company's quarterly reports on Form 10-Q. Audit fees also include fees for services performed by PricewaterhouseCoopers that are closely related to the audit and in many cases could only be provided by the Company's independent auditors. Such services include consents related to the Company's registration statements, assistance with, and review of, other documents filed with the Commission and accounting advice on completed transactions.

*Audit-Related Fees –* There were no professional services rendered by PricewaterhouseCoopers that would be classified as audit-related fees during the years ended December 31, 2022 and 2021.

*Tax Fees –* Consists of services related to corporate tax compliance, including preparation of corporate tax returns, review of the tax treatments for certain expenses, tax due diligence or other consulting fees.

*All Other Fees* – There were no professional services rendered by PricewaterhouseCoopers that would be classified as other fees during the years ended December 31, 2022 and 2021.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**PART IV**

**Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULE**

(a)List of Documents Filed as a Part of This Report.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Index to Consolidated Financial Statements:

**CNL Healthcare Properties, Inc.**

Report of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm

Consolidated Balance Sheets as of December 31, 2022 and 2021

Consolidated Statements of Operations for the years ended December 31, 2022, 2021 and 2020

Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2022, 2021, 2020

Consolidated Statements of Stockholders' Equity and Redeemable Noncontrolling Interest for the years ended December 31, 2022, 2021 and 2020

Consolidated Statements of Cash Flows for the years ended December 31, 2022, 2021 and 2020

Notes to Consolidated Financial Statements

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Index to Financial Statement Schedules:

Schedule II – Valuation and Qualifying Accounts for the years ended December 31, 2022, 2021 and 2020

Schedule III – Real Estate and Accumulated Depreciation as of December 31, 2022

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)Index to Exhibits (refer below).

**Item 16. FORM 10-K SUMMARY**

None.

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**EXHIBIT INDEX**

**Exhibits**

CNL Healthcare Properties, Inc. was formerly known as CNL Healthcare Trust, Inc., CNL Properties Trust, Inc., and CNL Diversified Lifestyle Properties, Inc.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 1.1 | <u>[Form of Managing Dealer Agreement](https://www.sec.gov/Archives/edgar/data/1496454/000119312515016298/d852727dex11.htm)</u>*<u>[(Previously filed as Exhibit 1.1 to the Pre-effective Amendment No. 2 to the Registration Statement on Form S-11 (File No. 333-196108) filed January 21, 2015 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312515016298/d852727dex11.htm)</u>* |
| 1.2 | <u>[Form of Participating Broker Agreement](https://www.sec.gov/Archives/edgar/data/1496454/000119312515016298/d852727dex12.htm)</u>*<u>[(Previously filed as Exhibit 1.2 to the Pre-effective Amendment No. 2 to the Registration Statement on Form S-11 (File No. 333-196108) filed January 21, 2015 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312515016298/d852727dex12.htm)</u>* |
| 3.1 | <u>[Third Articles of Amendment and Restatement of CNL Healthcare Properties, Inc.](https://www.sec.gov/Archives/edgar/data/1496454/000119312516656499/d217853dex31.htm)</u>*<u>[(Previously filed as Exhibit 3.1 to the Current Report on Form 8-K filed July 25, 2016 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312516656499/d217853dex31.htm)</u>* |
| 3.2 | <u>[Third Amended and Restated Bylaws of CNL Healthcare Properties, Inc., effective June 27, 2013](https://www.sec.gov/Archives/edgar/data/1496454/000119312513280695/d562746dex32.htm)</u>*<u>[(Previously filed as Exhibit 3.2 to the Current Report on Form 8-K filed July 2, 2013 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312513280695/d562746dex32.htm)</u>* |
| 4.1 | <u>[Statement regarding restrictions on transferability of shares of common stock (to appear on stock certificate or to be sent upon request and without charge to stockholders issued shares without certificates)](https://www.sec.gov/Archives/edgar/data/1496454/000119312510232662/dex45.htm)</u>*<u>[(Previously filed as Exhibit 4.5 to the Pre-effective Amendment One to the Registration Statement on Form S-11 (File No. 333-168129) filed October 20, 2010 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312510232662/dex45.htm)</u>* |
| 4.2 | <u>[Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.](chp-12312022xex42.htm)</u>*<u>[(Filed herewith.)](chp-12312022xex42.htm)</u>* |
| 10.1 | <u>[Amended and Restated Limited Partnership Agreement of CNL Properties Trust, LP dated June 8, 2011](https://www.sec.gov/Archives/edgar/data/1496454/000119312511162992/dex101.htm)</u>*<u>[(Previously filed as Exhibit 10.1 to Pre-effective Amendment Three to the Registration Statement on Form S-11 (File No. 333-168129) filed June 10, 2011 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312511162992/dex101.htm)</u>* |
| 10.2 | <u>[Advisory Agreement dated June 8, 2011, between CNL Properties Trust, Inc., CNL Properties Trust LP, and CNL Properties Corp.](https://www.sec.gov/Archives/edgar/data/1496454/000119312511162992/dex103.htm)</u>*<u>[(Previously filed as Exhibit 10.3 to Pre-effective Amendment Three to the Registration Statement on Form S-11 (File No. 333-168129) filed June 10, 2011 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312511162992/dex103.htm)</u>* |
| 10.2.1 | <u>[First Amendment to Advisory Agreement dated October 5, 2011, by and between CNL Properties Trust, Inc., CNL Properties Corp., and CNL Properties Trust, LP](https://www.sec.gov/Archives/edgar/data/1496454/000119312511264694/d240033dex101.htm)</u>*<u>[(Previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed October 5, 2011 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312511264694/d240033dex101.htm)</u>* |
| 10.2.2 | <u>[Second Amendment to Advisory Agreement dated March 20, 2013, by and among CNL Healthcare Properties, Inc., CHP Partners, LP and CNL Healthcare Corp](https://www.sec.gov/Archives/edgar/data/1496454/000119312513126660/d510144dex101.htm)</u>*<u>[. (Previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed March 26, 2013 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312513126660/d510144dex101.htm)</u>* |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 10.2.3 | <u>[Third Amendment to Advisory Agreement dated May 26, 2021, by and among CNL Healthcare Properties, Inc., CHP Partners, LP, and CNL Healthcare Corp.](https://www.sec.gov/Archives/edgar/data/0001496454/000119312521175173/d140695dex101.htm)</u>*<u>[(previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed May 27, 2021 and incorporated herein by reference).](https://www.sec.gov/Archives/edgar/data/0001496454/000119312521175173/d140695dex101.htm)</u>* |
| 10.3 | <u>[First Amended and Restated Property Management and Leasing Agreement dated June 28, 2012, by and between CNL Healthcare Trust, Inc., CHT Partners, LP, its various subsidiaries and CNL Healthcare Manager Corp](https://www.sec.gov/Archives/edgar/data/1496454/000119312512291932/d376199dex101.htm)</u>*<u>[. (Previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed July 2, 2012 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312512291932/d376199dex101.htm)</u>* |
| 10.3.1 | <u>[First Amendment to First Amended and Restated Property Management and Leasing Agreement dated April 1, 2013, by and between CNL Healthcare Properties, Inc. and CHP Partners, LP, and CNL Healthcare Manager Corp.](https://www.sec.gov/Archives/edgar/data/1496454/000119312515016298/d852727dex1031.htm)</u>*<u>[(Previously filed as Exhibit 10.3.1 to Pre-effective Amendment Two to Form S-11 (File No. 333-196108) filed January 21, 2015 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312515016298/d852727dex1031.htm)</u>* |
| 10.4 | <u>[Service Agreement dated as of June 8, 2011, by and between CNL Capital Markets Corp. and CNL Properties Trust, Inc.](https://www.sec.gov/Archives/edgar/data/1496454/000119312511162992/dex105.htm)</u>*<u>[(Previously filed as Exhibit 10.5 to Pre-effective Amendment Three to the Registration Statement on Form S-11 (File No. 333-168129) filed June 10, 2011 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312511162992/dex105.htm)</u>* |
| 10.4.1 | <u>[Second Addendum to Service Agreement dated March 20, 2013, by and between CNL Capital Markets Corp. and CNL Healthcare Properties, Inc](https://www.sec.gov/Archives/edgar/data/1496454/000119312513126660/d510144dex103.htm)</u>*<u>[. (Previously filed as Exhibit 10.3 to the Current Report on Form 8-K filed March 26, 2013 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312513126660/d510144dex103.htm)</u>* |
| 10.5 | <u>[Expense Support and Restricted Stock Agreement effective April 1, 2013, by and between CNL Healthcare Properties, Inc. and CNL Healthcare Corp.](https://www.sec.gov/Archives/edgar/data/1496454/000119312513126660/d510144dex102.htm)</u>*<u>[(Previously filed as Exhibit 10.2 to the Current Report on Form 8-K filed March 26, 2013 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312513126660/d510144dex102.htm)</u>* |
| 10.5.1 | <u>[First Amendment to Expense Support and Restricted Stock Agreement dated November 7, 2013, by and between CNL Healthcare Properties, Inc. and CNL Healthcare Corp.](https://www.sec.gov/Archives/edgar/data/1496454/000119312513126660/d510144dex101.htm)</u>*<u>[(Previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed November 26, 2013 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312513126660/d510144dex101.htm)</u>* |
| 10.5.2 | <u>[Second Amendment to Expense Support and Restricted Stock Agreement effective as of April 3, 2014, by and between CNL Healthcare Properties, Inc. and CNL Healthcare Corp](https://www.sec.gov/Archives/edgar/data/1496454/000119312514129923/d701446dex104.htm)</u>*<u>[. (Previously filed as Exhibit 10.4 to the Current Report on Form 8-K filed April 3, 2014 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312514129923/d701446dex104.htm)</u>* |
| 10.5.3 | <u>[Third Amendment to Expense Support and Restricted Stock Agreement effective as of January 1, 2016, by and between CNL Healthcare Properties, Inc. and CNL Healthcare Corp.](https://www.sec.gov/Archives/edgar/data/1496454/000156459016014918/chp-ex1053_629.htm)</u>*<u>[(Previously filed as Exhibit 10.5.3 to the Form 10-K filed March 16, 2016 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000156459016014918/chp-ex1053_629.htm)</u>* |
| 10.5.4 | <u>[Fourth Amendment to Expense Support and Restricted Stock Agreement effective as of January 1, 2017, by and between CNL Healthcare Properties, Inc. and CNL Healthcare Corp.](http://www.sec.gov/Archives/edgar/data/1496454/000119312517040624/d343088dex1054.htm)</u>*<u>[(Previously filed as Exhibit 10.5.4 to the Current Report on Form 8-K filed February 13, 2017 and incorporated herein by reference.)](http://www.sec.gov/Archives/edgar/data/1496454/000119312517040624/d343088dex1054.htm)</u>* |
| 10.6 | <u>[Expense Support and Restricted Stock Agreement effective July 1, 2013, by and among CNL Healthcare Properties, Inc. and CNL Healthcare Manager Corp.](https://www.sec.gov/Archives/edgar/data/1496454/000119312513348452/d590440dex101.htm)</u>*<u>[(Previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed August 27, 2013 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312513348452/d590440dex101.htm)</u>* |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 10.6.1 | <u>[First Amendment to Expense Support and Restricted Stock Agreement dated November 7, 2013, by and between CNL Healthcare Properties, Inc. and CNL Healthcare Manager Corp.](https://www.sec.gov/Archives/edgar/data/1496454/000119312513454236/d636929dex102.htm)</u>*<u>[(Previously filed as Exhibit 10.2 to the Current Report on Form 8-K filed November 26, 2013 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312513454236/d636929dex102.htm)</u>* |
| 10.6.2 | <u>[Second Amendment to Expense Support and Restricted Stock Agreement effective as of April 3, 2014, by and between CNL Healthcare Properties, Inc. and CNL Healthcare Manager Corp.](https://www.sec.gov/Archives/edgar/data/1496454/000119312514129923/d701446dex105.htm)</u>*<u>[(Previously filed as Exhibit 10.5 to the Current Report on Form 8-K filed April 3, 2014 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312514129923/d701446dex105.htm)</u>* |
| 10.6.3 | <u>[Third Amendment to Expense Support and Restricted Stock Agreement effective as of January 1, 2016, by and between CNL Healthcare Properties Inc. and CNL Healthcare Manager Corp.](https://www.sec.gov/Archives/edgar/data/1496454/000156459016014918/chp-ex1063_630.htm)</u>*<u>[(Previously filed as Exhibit 10.6.3 to the Form 10-K filed March 16, 2016 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000156459016014918/chp-ex1063_630.htm)</u>* |
| 10.6.4 | <u>[Fourth Amendment to Expense Support and Restricted Stock Agreement effective as of January 1, 2017, by and between CNL Healthcare Properties Inc. and CNL Healthcare Manager Corp.](https://www.sec.gov/Archives/edgar/data/1496454/000119312517040624/d343088dex1064.htm)</u>*<u>[(Previously filed as Exhibit 10.6.4 to the Current Report on Form 8-K filed February 13, 2017 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312517040624/d343088dex1064.htm)</u>* |
| 10.7 | <u>[Form of Indemnification Agreement dated April 13, 2012, between CNL Healthcare Trust, Inc. and certain executive offices and senior management dated July 27, 2012](https://www.sec.gov/Archives/edgar/data/1496454/000119312512170575/d337662dex991.htm)</u>*<u>[(Previously filed as Exhibit 99.1 to the Current Report on Form 8-K filed April 19, 2012 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312512170575/d337662dex991.htm)</u>* |
| 10.8 | <u>[Credit Agreement dated as of May 15, 2019 by and between CHP Partners, LP, as borrower, and KeyBank National Association, as agent for itself and the other lenders](http://www.sec.gov/Archives/edgar/data/1496454/000119312519148037/d747699dex101.htm)</u>*<u>[(Previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed May 15, 2019 and incorporated herein by reference.)](http://www.sec.gov/Archives/edgar/data/1496454/000119312519148037/d747699dex101.htm)</u>* |
| 10.8.1 | <u>[Credit Agreement First Amendment by and among CHP Partners, LP, Keybank National Association and certain other lenders dated March 21, 2022](http://www.sec.gov/Archives/edgar/data/1496454/000119312522081522/d293847dex101.htm)</u>*<u>[(previously filed as Exhibit 10.2 to the Current Report on Form 8-K filed March 22, 2022 and incorporated herein by reference).](http://www.sec.gov/Archives/edgar/data/1496454/000119312522081522/d293847dex101.htm)</u>* |
| 10.8.2 | <u>[Credit Agreement](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)[Second Amendment](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)[by and](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)[among](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)[CHP Partners, LP,](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)[Keybank](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)[National](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)[Association and certain other lenders dated September 6, 2022](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)</u>*<u>[(previously](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)[filed as Exhibit 10.2 to the Current Report on Form 8-K filed](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)[September 8, 2022](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)[and incorporated herein by](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)[reference).](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex102.htm)</u>* |
| 10.9 | <u>[Guaranty Agreement dated as of May 15, 2019 by CNL Healthcare Properties, Inc. and certain of its subsidiaries](https://www.sec.gov/Archives/edgar/data/1496454/000119312519148037/d747699dex104.htm)</u>*<u>[(Previously filed as Exhibit 10.4 to the Current Report on Form 8-K filed May 15, 2019 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312519148037/d747699dex104.htm)</u>* |
| 10.10 | <u>[Term Note dated May 15, 2019 by CHP Partners, LP in favor of KeyBank National Association](https://www.sec.gov/Archives/edgar/data/1496454/000119312519148037/d747699dex103.htm)</u>*<u>[(Previously filed as Exhibit 10.3 to the Current Report on Form 8-K filed May 15, 2019 and incorporated herein by reference.)](https://www.sec.gov/Archives/edgar/data/1496454/000119312519148037/d747699dex103.htm)</u>* |
| 10.11 | <u>[Term Loan Agreement by and among CHP Partners, LP, KeyBank National Association and certain other Lenders dated Sept. 24, 2021](https://www.sec.gov/Archives/edgar/data/0001496454/000119312521285277/d191048dex101.htm)</u>*<u>[(previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed Sept. 28, 2021 and incorporated herein by this reference).](https://www.sec.gov/Archives/edgar/data/0001496454/000119312521285277/d191048dex101.htm)</u>* |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 10.11.1 | <u>[Term Loan First Amendment by and among CHP Partners, LP, Keybank National Association and certain other lenders dated March 21, 2022](http://www.sec.gov/Archives/edgar/data/1496454/000119312522081522/d293847dex101.htm)</u>*<u>[(previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed March 22, 2022 and incorporated herein by reference).](http://www.sec.gov/Archives/edgar/data/1496454/000119312522081522/d293847dex101.htm)</u>* |
| 10.11.2 | <u>[Term Loan Second Amendment by and among CHP Partners, LP, Keybank National Association and certain other lenders dated September 6, 2022](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex101.htm)</u>*<u>[(previously filed as Exhibit 10.1 to the Current Report on Form 8-K filed September 8, 2022 and incorporated herein by reference).](http://www.sec.gov/Archives/edgar/data/1496454/000119312522240878/d359004dex101.htm)</u>* |
| 10.12 | <u>[Term Note made by CHP Partners, LP in favor of KeyBank National Association dated Sept. 24, 2021](https://www.sec.gov/Archives/edgar/data/0001496454/000119312521285277/d191048dex102.htm)</u>*<u>[(previously filed as Exhibit 10.2 to the Current Report on Form 8-K filed Sept. 28, 2021 and incorporated herein by this reference).](https://www.sec.gov/Archives/edgar/data/0001496454/000119312521285277/d191048dex102.htm)</u>* |
| 10.13 | <u>[Guaranty by and among the Guarantors in favor of the Lenders referred to in the Term Loan Agreement dated Sept. 24, 2021](https://www.sec.gov/Archives/edgar/data/0001496454/000119312521285277/d191048dex103.htm)</u>*<u>[(previously filed as Exhibit 10.3 to the Current Report on Form 8-K filed Sept. 28, 2021 and incorporated herein by this reference).](https://www.sec.gov/Archives/edgar/data/0001496454/000119312521285277/d191048dex103.htm)</u>* |
| 10.14 | <u>[Schedule of Omitted Documents](chp-12312022xex1014.htm)</u>*<u>[(Filed herewith.)](chp-12312022xex1014.htm)</u>* |
| 21.1 | <u>[Subsidiaries of the Registrant](chp-12312022xex211.htm)</u>*<u>[(Filed herewith.)](chp-12312022xex211.htm)</u>* |
| 23.1 | <u>[Consent of Independent Registered Public Accounting Firm - PricewaterhouseCoopers LLP.](chp-12312022xex231.htm)</u>*<u>[(Filed herewith.)](chp-12312022xex231.htm)</u>* |
| 31.1 | <u>[Certification of Chief Executive Officer of CNL Healthcare Properties, Inc., Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](chp-12312022xex311.htm)</u>*<u>[(Filed herewith.)](chp-12312022xex311.htm)</u>* |
| 31.2 | <u>[Certification of Chief Financial Officer of CNL Healthcare Properties, Inc., Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](chp-12312022xex312.htm)</u>*<u>[(Filed herewith.)](chp-12312022xex312.htm)</u>* |
| 32.1 | <u>[Certification of Chief Executive Officer and Chief Financial Officer of CNL Healthcare Properties, Inc., Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](chp-12312022xex321.htm)</u>*<u>[(Filed herewith.)](chp-12312022xex321.htm)</u>* |
| 101 | The following materials from CNL Healthcare Properties, Inc. Quarterly Report on Form 10-K for the year ended December 31, 2022, formatted in iXBRL (Inline eXtensible Business Reporting Language); (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Comprehensive Loss, (iv) Consolidated Statements of Stockholders' Equity and Redeemable Noncontrolling Interest, (v) Consolidated Statements of Cash Flows, and (vi) Notes to the Consolidated Financial Statements. |
| 104 | Cover Page Interactive Data File included as Exhibit 101 (embedded within the Inline XBRL document) |

---

------

<u>[**Table of Contents**](#i7aa20ec61c924cc0a7c3ac74d325237b_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on the 10<sup>th</sup> day of March 2023.

---

| | |
|:---|:---|
| CNL HEALTHCARE PROPERTIES, INC. | CNL HEALTHCARE PROPERTIES, INC. |
| By: | /s/ Stephen H. Mauldin |
|  | STEPHEN H. MAULDIN |
|  | Chief Executive Officer and President |
|  | (Principal Executive Officer) |
| By: | /s/ Ixchell C. Duarte |
|  | IXCHELL C. DUARTE |
|  | Chief Financial Officer, Senior Vice President and Treasurer |
|  | (Principal Financial Officer and Principal Accounting Officer) |

---

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| Signature | Title | Date |
| /s/ James M. Seneff, Jr. | Chairman of the Board | March 10, 2023 |
| JAMES M. SENEFF, JR. |  |  |
| /s/ Michael P. Haggerty | Independent Director | March 10, 2023 |
| MICHAEL P. HAGGERTY |  |  |
| /s/ J. Douglas Holladay | Independent Director | March 10, 2023 |
| J. DOUGLAS HOLLADAY |  |  |
| /s/ J. Chandler Martin | Independent Director | March 10, 2023 |
| J. CHANDLER MARTIN |  |  |
|  | Vice Chairman of the Board, Chief Executive Officer and President |  |
| /s/ Stephen H. Mauldin | Vice Chairman of the Board, Chief Executive Officer and President | March 10, 2023 |
| STEPHEN H. MAULDIN | (Principal Executive Officer) |  |
| /s/ Ixchell C. Duarte | Chief Financial Officer, Senior Vice President and Treasurer | March 10, 2023 |
| IXCHELL C. DUARTE | (Principal Financial Officer and Principal Accounting Officer) |  |

---

## Exhibit 4.2

**EXHIBIT 4.2**

**DESCRIPTION OF THE REGISTRANT'S SECURITIES**

**REGISTERED PURSUANT TO SECTION 12 OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

As of December 31, 2022, CNL Healthcare Properties, Inc. (the "Company") had Common Stock registered under Section 12 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Common Stock is not listed on a national securities exchange.

The following is a description of the material rights of the Common Stock and related provisions of the Company's Third Articles of Amendment and Restatement, as amended (the "Articles"), Third Amended and Restated Bylaws (the "Bylaws"), and applicable Delaware law. This description is qualified in its entirety by, and should be read in conjunction with, the Articles, Bylaws, and applicable Delaware law.

**Authorized Capital Stock**

The Articles authorize the Company to issue up to 1,620,000,000 common shares, par value $0.01 per share ("Common Stock"), 300,000,000 excess shares, par value $0.01 per share ("Excess Shares"), and 200,000,000 preferred shares, $0.01 par value per share ("Preferred Stock"). As of December 31, 2022, the Company had 173,960,540 shares of Common Stock and no Excess Shares or shares of Preferred Stock outstanding.

**Dividend Rights**

The holders of shares of Common Stock are entitled to receive dividends when declared by the Company's board of directors subject to any preferential rights with respect to the payment of, or provision for, full cumulative dividends on and any required redemptions of shares of Preferred Stock then outstanding, if any.

**Voting Rights**

The holders of shares of Common Stock are entitled to one vote per share on all matters to be voted on by such holders. Holders of shares of Common Stock are not entitled to cumulative voting rights.

**Liquidation Rights**

In the event of any voluntary or involuntary liquidation, dissolution or winding up, or any distribution of the assets of the Company in liquidation, the aggregate assets available for distribution to holders of Common Stock shall be determined in accordance with applicable law. Subject to the liquidation rights of the Excess Shares, each holder of Common Stock shall be entitled to receive, ratably with each other holder of Common Stock, that portion of such aggregate assets available for distribution to the Common Stock as the number of the outstanding shares of Common Stock held by such holder bears to the total number of outstanding shares of Common Stock.

**Other Rights and Preferences**

Holders of shares of Common Stock do not have preemptive rights, and there are no conversion rights or redemption or sinking fund provisions with respect to such shares of Common Stock. The rights, preferences and privileges of holders of shares of Common Stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of Preferred Stock or Excess Shares which are outstanding or which the Company may designate and issue in the future.

**Fully Paid and Nonassessable**

All of the outstanding shares of Common Stock are fully paid and nonassessable.

------

**Transfer Agent**

The transfer agent for the Common Stock is DST Systems, Inc.

**Restriction of Ownership**

To qualify as a REIT under the Internal Revenue Code (the "Code"), among other things, (i) not more than 50% of the value of the Company's outstanding stock may be owned, directly or indirectly (applying certain attribution rules), by five or fewer individuals (as defined in the Code to include certain entities) during the last half of a taxable year; (ii) the Company's stock must be beneficially owned (without reference to any attribution rules) by 100 or more Persons during at least 335 days of a taxable year of 12 months or during a proportionate part of a shorter taxable year; and (iii) certain other requirements must be satisfied.

To ensure that the Company satisfies these requirements, among other purposes, the Articles restrict the direct or indirect ownership (applying certain attribution rules) of shares of Common Stock and Preferred Stock by any Person to no more than 9.8%, by number or value, of the outstanding shares of such Common Stock or 9.8%, by number or value of any series of Preferred Stock (the "Ownership Limitation"). It is the responsibility of each Person owning or deemed to own more than 5% of the outstanding shares of Common Stock or any series of outstanding Preferred Stock to give the Company written notice of such ownership. In addition, to the extent deemed necessary by the board of directors, the Company can demand that each stockholder disclose to the Company in writing all information regarding the beneficial and constructive ownership (as such terms are defined in the Articles) of the Common Stock and Preferred Stock. However, the Articles generally provide that the board of directors, upon a receipt of a ruling from the Internal Revenue Service or an opinion of counsel or other evidence, representations or undertakings acceptable to the board of directors, may, in its sole discretion, waive the application of certain transfer restrictions or the 9.8% ownership limit to a Person if the board of directors determines that such Person's ownership of Common Stock and/or Preferred Stock will not jeopardize the Company's status as a REIT under the Code. In addition, the restrictions on transfer, ownership limitations and information requirements will not apply if the board of directors determines that it is no longer in the Company's best interest to attempt to qualify, or to continue to qualify, as a REIT under the Code.

Subject to the board of directors' ability to waive certain of the following restrictions in certain circumstances (as described above), transfers of shares of Common Stock or Preferred Stock or other events that would create a direct or indirect ownership of such stock that would (i) violate the ownership limit; (ii) result in the Company's disqualification as a REIT under the Code, including any transfer that results in (A) the Common Stock and/or Preferred Stock being beneficially owned by fewer than 100 Persons or (B) the Company being "closely held" within the meaning of Section 856(h) of the Code; or (iii) potentially jeopardize the Company's status as a REIT under the Code, will be null and void and of no effect with respect to the shares in excess of the applicable limit and, accordingly, the intended transferee (or "prohibited owner") will not acquire any right or interest in such shares. Any shares owned or transferred in excess of an applicable limitation will be automatically exchanged for Excess Shares and will be transferred by operation of law to an unaffiliated trust for the exclusive benefit of one or more qualified charitable organizations. As soon as practicable after the transfer of shares to the trust, the trustee of the trust will be required to sell the excess shares to a Person or entity who could own the shares without violating the applicable limit and distribute to the prohibited owner an amount equal to the lesser of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.the proceeds of the sale;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.the price paid for the stock in excess of the applicable limit by the prohibited owner or, in the event that the original violative transfer was a gift or an event other than a transfer, the market price of the shares on the date of the transfer or other event; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.the pro rata amount of the prohibited owner's initial capital investment in the Company properly allocated to such excess shares.

------

All dividends and other distributions received with respect to the Excess Shares prior to their sale by the trust and any proceeds from the sale by the trust in excess of the amount distributable to the prohibited owner will be distributed to the beneficiary of the trust. In connection with any liquidation, however, the trust must distribute to the prohibited owner the amounts received upon such liquidation, but the prohibited owner is not entitled to receive amounts in excess of the price paid for such shares by the prohibited owner or, in the event that the original violative transfer was a gift or an event other than a transfer, the market price of the shares on the date of the transfer or other event. In addition to the foregoing transfer restrictions, the Company has the right, for a period of 90 days during the time any Excess Shares are held by the trust, to purchase all or any portion of such Excess Shares for the lesser of the price paid for such shares by the prohibited owner (or, in the event that the original violative transfer was a gift or an event other than a transfer, the market price of the shares on the date of the transfer or other event) or the market price of our stock on the date the Company exercises its option to purchase, which amount will be paid to the prohibited owner. In all instances, the market price will be determined in the manner set forth in the Articles.

The term "Person" means an individual, corporation, partnership, trust, joint venture, limited liability company or other entity or association.

The ownership limits may have the effect of delaying, deferring or preventing a change of control of the Company.

**Anti-Takeover Effects of the Articles, Bylaws and Maryland Law**

There are provisions in the Articles and bylaws and under Maryland law, where the Company is organized as a corporation, that may discourage a third party from making a proposal to acquire the Company, even if some of the Company's stockholders might consider the proposal to be in their best interests. These provisions include the following:

The Articles authorize the Company's board of directors to issue up to 200,000,000 shares of Preferred Stock without stockholder approval. In addition, without stockholder approval, the board of directors may designate new classes or series of common stock. The board of directors may determine the relative rights, preferences and privileges of each class or series of common stock or Preferred Stock so issued. Because the board of directors has the power to establish the preferences and rights of each class or series of common stock or Preferred Stock, it may afford the holders of any series or class of stock preferences, powers and rights senior to the rights of holders of Common Stock outstanding. The issuance of common stock or Preferred Stock could have the effect of delaying or preventing a change in control.

To maintain the Company's qualification as a REIT for federal income tax purposes, not more than 50% in value of the Company's outstanding stock may be owned, directly or indirectly, by or for five or fewer individuals at any time during the last half of any taxable year. As described above under Restriction of Ownership, to maintain this qualification, and/or to address other concerns about concentrations of ownership of the Company's stock, the Articles generally prohibit ownership (directly, indirectly by virtue of the attribution provisions of the Code, or beneficially as defined in Section 13 of the Securities Exchange Act) by any single stockholder of more than 9.8% of the issued and outstanding shares of any class or series of the Company's stock. As described above, under the Articles, the board of directors may in its sole discretion waive or modify the ownership limit for one or more Persons, but it is not required to do so even if such waiver would not affect the Company's qualification as a REIT. These ownership limits may prevent or delay a change in control and, as a result, could adversely affect the Company's stockholders' ability to realize a premium for their shares of common stock.

The Bylaws generally require notice at least 120 days and not more than 150 days before the anniversary of the prior annual meeting of stockholders in order for a stockholder to (i) nominate a director, or (ii) propose new business other than pursuant to the notice of the meeting by, or on behalf of, the directors. Further, the Bylaws generally require notice at least 60 days and not more than 90 days prior to a special meeting of stockholders called for the purpose of electing one or more directors. These provisions may prevent or delay a change in control by restricting the ability of an acquiror to take steps to exert control or influence over the board of directors.

------

As a Maryland corporation, the Company is subject to the provisions of the Maryland General Corporation Law. Maryland law imposes restrictions on some business combinations and requires compliance with statutory procedures before some mergers and acquisitions may occur, which may delay or prevent offers to acquire the Company or increase the difficulty of completing any offers, even if they are in the Company's stockholders' best interests. The Maryland Business Combination Act provides that certain business combinations (including mergers, consolidations, share exchanges or, in certain circumstances, asset transfers or issuances or reclassifications of equity securities) between a Maryland corporation and any Person who beneficially owns 10% or more of the voting power of such corporation's outstanding voting stock or an affiliate of such corporation who, at any time within the two-year period prior to the date in question, was the beneficial owner of 10% or more of the voting power of the then-outstanding voting stock of such corporation (an "Interested Stockholder") or an affiliate thereof, are prohibited for five years after the most recent date on which the Interested Stockholder became an Interested Stockholder. Thereafter, any such business combination must be recommended by the board of directors of such corporation and approved by the affirmative vote of at least (i) 80% of the votes entitled to be cast by holders of outstanding shares of voting stock of the corporation and (ii) two-thirds of the votes entitled to be cast by holders of voting stock of such corporation other than shares held by the Interested Stockholder with whom (or with whose affiliate) the business combination is to be effected, unless, among other conditions, the corporation's common stockholders receive a minimum price (as determined by statute) for their shares and the consideration is received in cash or in the same form as previously paid by the Interested Stockholder for its shares. In addition, other provisions of the Maryland General Corporation Law permit the board of directors to make elections and to take actions without stockholder approval (such as classifying the Company's board or directors such that the entire board of directors is not up for re-election annually) that, if made or taken, could have the effect of discouraging or delaying a change in control.

## Exhibit 10.14

**EXHIBIT 10.14**

**Schedule of Omitted Documents**

**of CNL Healthcare Properties, Inc.**

The following management agreements were not filed as exhibits to this annual report on Form 10-K pursuant to Instruction 2 of Item 601 of Regulation S-K.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Management Agreement dated December 2, 2013, by and between Morningstar Senior Management, LLC and CHP Boise ID Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Management Agreement dated December 2, 2013, by and between Morningstar Senior Management, LLC and CHP Idaho Falls ID Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Management Agreement dated December 2, 2013, by and between Morningstar Senior Management, LLC and CHP Sparks NV Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.Management Services Agreement dated December 1, 2013, by and between Prestige Senior Living, L.L.C. and CHP Beaverton OR Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.Management Services Agreement dated December 1, 2013, by and between Prestige Senior Living, L.L.C. and CHP Bend-High Desert OR Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.Management Services Agreement dated December 1, 2013, by and between Prestige Senior Living, L.L.C. and CHP Tillamook-Five Rivers OR Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.Management Services Agreement dated December 1, 2013, by and between Prestige Senior Living, L.L.C. and CHP Tualatin-Riverwood OR Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.Management Services Agreement dated December 1, 2013, by and between Prestige Senior Living, L.L.C. and CHP Salem-Southern Hills OR Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.Management Services Agreement dated December 1, 2013, by and between Prestige Senior Living, L.L.C. and CHP Salem-Orchard Heights OR Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.Management Services Agreement dated December 1, 2013, by and between Prestige Senior Living, L.L.C. and CHP Gresham-Huntington Terrace OR Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.Management Services Agreement dated December 1, 2013, by and between Prestige Senior Living, L.L.C. and CHP Medford-Arbor Place OR Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.Management Services Agreement dated February 1, 2014, by and between Prestige Senior Living, L.L.C. and CHP Vancouver-Bridgewood WA Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.Management Services Agreement dated February 1, 2014, by and between Prestige Senior Living, L.L.C. and CHP Longview-Monticello Park WA Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.Management Services Agreement dated February 1, 2014, by and between Prestige Senior Living, L.L.C. and CHP Yelm-Rosemont WA Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.Management Agreement dated March 28, 2014, by and between CHP Park at Plainfield IL Tenant Corp. and Harbor Plainfield Management, LLC.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16.Management Services Agreement dated February 1, 2014, between Prestige Senior Living, L.L.C. and CHP Auburn WA Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17.Management Services Agreement dated March 1, 2014, by and between Prestige Senior Living, L.L.C. and CHP Corvallis-West Hills OR Tenant Corp.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18.Management Services Agreement made as of May 5, 2014, by and between CHP Isle at Watercrest-Mansfield TX Tenant Corp. and Integrated Senior Living, LLC.

The following promissory, revolving and term notes were not filed as exhibits to this annual report on Form 10-K pursuant to Instruction 2 of Item 601 of Regulation S-K.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Revolving Note executed by CHP Partners, LP in favor of KeyBank National Association in the original principal amount of $41,504,855, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Revolving Note executed by CHP Partners, LP in favor of SunTrust Bank in the original principal amount of $41,262,137, dated May 15, 2019.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Revolving Note executed by CHP Partners, LP in favor of Fifth Third Bank in the original principal amount of $41,262,136, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.Revolving Note executed by CHP Partners, LP in favor of Capital One, National Association in the original principal amount of $24,271,845, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.Revolving Note executed by CHP Partners, LP in favor of Cadence Bank, N.A. in the original principal amount of $16,990,291, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.Revolving Note executed by CHP Partners, LP in favor of Comerica Bank in the original principal amount of $14,563,107, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.Revolving Note executed by CHP Partners, LP in favor of Capital Bank, a division of First Tennessee Bank National Association, a national banking association, successor by merger to Capital Bank Corporation, a North Carolina banking corporation, successor by conversion to Capital Bank, N.A., a national banking association, in the original principal amount of $12,135,922, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.Revolving Note executed by CHP Partners, LP in favor of First Financial Bank in the original principal amount of $12,135,922, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.Revolving Note executed by CHP Partners, LP in favor of Synovus Bank in the original principal amount of $12,135,922, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.Revolving Note executed by CHP Partners, LP in favor of BankUnited, N.A. in the original principal amount of $12,135,922, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.Revolving Note executed by CHP Partners, LP in favor of Eastern Bank in the original principal amount of $7,281,553, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.Revolving Note executed by CHP Partners, LP in favor of City National Bank of Florida in the original principal amount of $7,281,553, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.Revolving Note executed by CHP Partners, LP in favor of Seaside National Bank & Trust, N.A. in the original principal amount of $7,038,835, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.Term Note executed by CHP Partners, LP in favor of KeyBank National Association in the original principal amount of $43,995,145, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.Term Note executed by CHP Partners, LP in favor of SunTrust Bank in the original principal amount of $43,737,863, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16.Term Note executed by CHP Partners, LP in favor of Fifth Third Bank in the original principal amount of $43,737,864, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17.Term Note executed by CHP Partners, LP in favor of Capital One, National Association in the original principal amount of $25,728,155, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18.Term Note executed by CHP Partners, LP in favor of Cadence Bank, N.A. in the original principal amount of $18,009,709, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.Term Note executed by CHP Partners, LP in favor of Comerica Bank in the original principal amount of $15,436,893, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20.Term Note executed by CHP Partners, LP in favor of Capital Bank, a division of First Tennessee Bank National Association, a national banking association, successor by merger to Capital Bank Corporation, a North Carolina banking corporation, successor by conversion to Capital Bank, N.A., a national banking association, in the original principal amount of $12,864,078, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.Term Note executed by CHP Partners, LP in favor of First Financial Bank in the original principal amount of $12,864,078, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22.Term Note executed by CHP Partners, LP in favor of Synovus Bank in the original principal amount of $12,864,078, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.Term Note executed by CHP Partners, LP in favor of BankUnited, N.A. in the original principal amount of $12,864,078, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24.Term Note executed by CHP Partners, LP in favor of Eastern Bank in the original principal amount of $7,718,447, dated May 15, 2019.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25.Term Note executed by CHP Partners, LP in favor of City National Bank of Florida in the original principal amount of $7,718,447, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26.Term Note executed by CHP Partners, LP in favor of Seaside National Bank & Trust, N.A. in the original principal amount of $7,461,165, dated May 15, 2019.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.Term Note by CHP Partners, LP in the principal amount of $32.5 million in favor of Fifth Third Bank, National Association dated Sept. 25, 2021.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28.Term Note by CHP Partners, LP in the principal amount of $32.5 million in favor of Capital One, National Association dated Sept. 25, 2021.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29.Term Note by CHP Partners, LP in the principal amount of $25 million in favor of First Horizon dated Sept. 25, 2021.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30.Term Note by CHP Partners, LP in the principal amount of $10 million in favor of Comerica Bank dated Sept. 25, 2021.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31.Term Note by CHP Partners, LP in the principal amount of $10 million in favor of Eastern Bank dated Sept. 25, 2021.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32.Term Note by CHP Partners, LP in the principal amount of $5 million in favor of First Financial Bank dated Sept. 25, 2021.

The following guaranty agreements have not been filed as exhibits to this annual report on Form 10-K pursuant to Instruction 2 of Item 601 of Regulation S-K.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Guaranty Agreement, dated May 15, 2019, by CNL Healthcare Properties, Inc. and certain of its subsidiaries, as guarantors, in favor of KeyBank National Association and the other lenders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Guaranty Agreement, dated September 5, 2019, by CHP Columbia SC Owner, LLC and CHP SL Development Holding, LLC, as guarantors, in favor of KeyBank National Association and the other lenders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Guaranty Agreement, dated January 2, 2020, by CHP Tega Cay SC Owner, LLC, CHP Albuquerque NM Owner, LLC, CHP Grayson GA Owner, LLC, CHP Albuquerque NM Tenant Corp., CHP Grayson GA Tenant Corp. and CHP TRS Development Holding, LLC, as guarantors, in favor of KeyBank National Association and the other lenders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.Guaranty Agreement, dated March 4, 2020, by CHT Decatur IL Senior Living, LLC and CHT Zanesville OH Senior Living, LLC, as guarantors, in favor of KeyBank National Association and the other lenders.

## Exhibit 21.1

**EXHIBIT 21.1**

**CNL Healthcare Properties, Inc.**

**Subsidiaries of the Registrant** 

***All entities were formed in Delaware and do business under the name listed, unless otherwise noted.***

1. CHP Albuquerque NM Owner, LLC

2. CHP Albuquerque NM Tenant Corp. (d/b/a Palmilla Senior Living)

3. CHP Albuquerque NM Land Owner, LLC

4. CHP Anderson IN Senior Living Owner, LLC

5. CHP Auburn WA Owner, LLC

6. CHP Auburn WA Tenant Corp. (d/b/a Prestige Senior Living Auburn Meadows)

7. CHP Austin TX Holding GP, LLC

8. CHP Austin TX Holding, LP

9. CHP Austin TX Owner GP, LLC

10. CHP Austin TX Senior Living Owner, LP

11. CHP Austin TX Tenant Corp. (d/b/a The Pavilion at Great Hills)

12. CHP Batesville Healthcare Owner, LLC

13. CHP Beaverton OR Owner, LLC

14. CHP Beaverton OR Tenant Corp. (d/b/a Prestige Senior Living Beaverton Hills)

15. CHP Bend-High Desert OR Owner, LLC

16. CHP Bend-High Desert OR Tenant Corp. (d/b/a Prestige Senior Living High Desert)

17. CHP Billings MT Owner, LLC

18. CHP Billings MT Tenant Corp. (d/b/a MorningStar of Billings)

19. CHP Boise ID Owner, LLC

20. CHP Boise ID Tenant Corp. (d/b/a MorningStar of Boise)

21. CHP Broadway Healthcare Owner, LLC

22. CHP Cascadia Partners I, LLC

23. CHP Collierville TN Owner, LLC

24. CHP Collierville TN Tenant Corp. (d/b/a Hearthside Senior Living of Collierville)

25. CHP Columbia SC Owner, LLC

26. CHP Corvallis-West Hills OR Owner, LLC

27. CHP Corvallis-West Hills OR Tenant Corp. (d/b/a Prestige Senior Living West Hills)

28. CHP Duluth GA Senior Living Owner, LLC

29. CHP Duluth GA Tenant, LLC

30. CHP GP, LLC

31. CHP Grayson GA Owner, LLC

32. CHP Grayson GA Tenant Corp.

33. CHP Greenville SC Owner, LLC

34. CHP Greenville SC Tenant Corp.

35. CHP Gresham-Huntington Terrace OR Owner, LLC

36. CHP Gresham-Huntington Terrace OR Tenant Corp. (d/b/a Prestige Senior Living Huntington Terrace)

37. CHP Gulf Breeze FL Senior Living Owner, LLC

38. CHP Gulf Breeze FL Tenant Corp. (d/b/a The Beacon at Gulf Breeze)

39. CHP Hospital Holding, LLC

------

40. CHP Hurst TX Surgical Owner, LLC

41. CHP Idaho Falls ID Owner, LLC

42. CHP Idaho Falls ID Tenant Corp. (d/b/a MorningStar of Idaho Falls)

43. CHP IP Holding Company

44. CHP Isle at Cedar Ridge TX Owner, LLC

45. CHP Isle at Cedar Ridge TX Tenant Corp. (d/b/a Isle at Cedar Ridge)

46. CHP Isle at Watercrest-Bryan TX Owner, LLC

47. CHP Isle at Watercrest-Bryan TX Tenant Corp. (d/b/a Isle at Watercrest-Bryan and Watercrest at Bryan)

48. CHP Isle at Watercrest-Mansfield TX Owner, LLC

49. CHP Isle at Watercrest-Mansfield TX Tenant Corp. (d/b/a Isle at Watercrest-Mansfield)

50. CHP Jasper AL Owner, LLC

51. CHP Jasper AL Tenant Corp. (d/b/a Harborchase of Jasper)

52. CHP Jonesboro Healthcare Owner, LLC

53. CHP JV SL Development Holding, LLC

54. CHP Katy TX Member, LLC

55. CHP Lake Zurich IL Owner, LLC

56. CHP Lake Zurich IL Tenant Corp. (d/b/a Cedar Lake Assisted Living & Memory Care)

57. CHP Lancaster OH Senior Living Owner, LLC

58. CHP Layton UT Owner, LLC

59. CHP Layton UT Tenant Corp. (d/b/a Fairfield Village of Layton and Fairfield Village Rehabilitation)

60. CHP Legacy Ranch TX Owner, LLC

61. CHP Legacy Ranch TX Tenant Corp. (d/b/a Legacy Ranch)

62. CHP Longview-Monticello Park WA Owner, LLC

63. CHP Longview-Monticello Park WA Tenant Corp. (d/b/a Prestige Senior Living Monticello Park)

64. CHP Magnolia Healthcare Owner, LLC

65. CHP Maplewood MN Owner, LLC

66. CHP Maplewood MN Tenant Corp. (d/b/a The Shores of Lake Phalen)

67. CHP Marietta GA Senior Living Owner, LLC

68. CHP Marietta GA Tenant, LLC

69. CHP Meadows Place TX Holding GP, LLC

70. CHP Meadows Place TX Holding, LP

71. CHP Meadows Place TX Owner GP, LLC

72. CHP Meadows Place TX Senior Living Owner, LP

73. CHP Meadows Place TX Tenant Corp. (d/b/a The Hampton at Meadows Place)

74. CHP Medford-Arbor Place OR Owner, LLC

75. CHP Medford-Arbor Place OR Tenant Corp. (d/b/a Prestige Senior Living Arbor Place Memory Care and Prestige Senior Living Arbor Place)

76. CHP Mine Creek Healthcare Owner, LLC

77. CHP O'Fallon MO Owner, LLC

78. CHP O'Fallon MO Tenant Corp. (d/b/a Park Place II)

79. CHP Panama City FL Owner, LLC

80. CHP Panama City FL Tenant Corp.

81. CHP Park at Plainfield IL Owner, LLC

------

82. CHP Park at Plainfield IL Tenant Corp. (d/b/a HarborChase of Plainfield)

83. CHP Partners, LP

84. CHP Raider Ranch TX Owner, LLC

85. CHP Raider Ranch TX Tenant Corp. (d/b/a The Isle at Raider Ranch)

86. CHP Salem-Orchard Heights OR Owner, LLC

87. CHP Salem-Orchard Heights OR Tenant Corp. (d/b/a Prestige Senior Living Orchard Heights Memory Care and Prestige Senior Living Orchard Heights)

88. CHP Salem-Southern Hills OR Owner, LLC

89. CHP Salem-Southern Hills OR Tenant Corp. (d/b/a Prestige Senior Living Southern Hills)

90. CHP Senior Living Net Lease Holding, LLC

91. CHP Shorewood WI Owner, LLC

92. CHP Shorewood WI Tenant Corp.

93. CHP SL Development Holding, LLC

94. CHP SL Owner Holding I, LLC

95. CHP SL Owner Holding II, LLC

96. CHP South Bay Partners I, LLC

97. CHP Sparks NV Owner, LLC

98. CHP Sparks NV Tenant Corp. (Morningstar of Sparks)

99. CHP Springs TX Owner, LLC

100. CHP Springs TX Tenant Corp. (d/b/a The Springs)

101. CHP Tega Cay SC Owner, LLC

102. CHP Tillamook-Five Rivers OR Owner, LLC

103. CHP Tillamook-Five Rivers OR Tenant Corp. (d/b/a Prestige Senior Living Five Rivers)

104. CHP Town Village OK Owner, LLC

105. CHP Town Village OK Tenant Corp.

106. CHP TRS Development Holding, LLC

107. CHP TRS Holding, Inc.

108. CHP Tualatin-Riverwood OR Owner, LLC

109. CHP Tualatin-Riverwood OR Tenant Corp. (d/b/a Prestige Senior Living Riverwood)

110. CHP Vancouver-Bridgewood WA Owner, LLC

111. CHP Vancouver-Bridgewood WA Tenant Corp. (d/b/a Prestige Senior Living Bridgewood)

112. CHP Watercrest at Katy TX Owner, LLC (d/b/a Watercrest at Katy)

113. CHP Watercrest at Katy TX TRS Corp.

114. CHP Watercrest at Mansfield Holding, LLC

115. CHP Watercrest at Mansfield TX Owner, LLC (d/b/a Watercrest at Mansfield)

116. CHP Watercrest at Mansfield TX TRS Corp. (d/b/a Watercrest at Mansfield)

117. CHP Wausau WI Senior Living Owner, LLC

118. CHP Yakima WA II JV Member, LLC

119. CHP Yakima WA II Owner, LLC

120. CHP Yakima WA II Tenant Corp. (d/b/a Fieldstone OrchardWest)

121. CHP Yakima WA Owner, LLC

122. CHP Yakima WA Tenant Corp. (d/b/a Fieldstone Memory Care)

123. CHP Yelm-Rosemont WA Owner, LLC

------

124. CHP Yelm-Rosemont WA Tenant Corp. (d/b/a Prestige Senior Living Rosemont)

125. CHT Aberdeen SD Senior Living, LLC

126. CHT Billings MT Senior Living, LLC

127. CHT Brookridge Heights MI Owner, LLC

128. CHT Brookridge Heights MI Tenant Corp.

129. CHT Casper WY Senior Living, LLC

130. CHT Council Bluffs IA Senior Living, LLC

131. CHT Curry House MI Owner, LLC

132. CHT Curry House MI Tenant Corp.

133. CHT Decatur IL Senior Living, LLC

134. CHT GCI Partners I, LLC

135. CHT Grand Island NE Senior Living, LLC

136. CHT Harborchase Assisted Living Owner, LLC

137. CHT Harborchase TRS Tenant Corp. (d/b/a Harborchase of Villages Crossing)

138. CHT Lima OH Senior Living, LLC

139. CHT Mansfield OH Senior Living, LLC

140. CHT Marion OH Senior Living, LLC

141. CHT Symphony Manor MD Owner, LLC

142. CHT Symphony Manor MD Tenant Corp.

143. CHT Tranquility at Fredericktowne MD Owner, LLC

144. CHT Tranquility at Fredericktowne MD Tenant Corp.

145. CHT Windsor Manor AL Holding, LLC

146. CHT Windsor Manor TRS Corp.

147. CHT Woodholme Gardens MD Owner, LLC

148. CHT Woodholme Gardens MD Tenant Corp.

149. CHT Zanesville OH Senior Living, LLC

150. Grinnell IA Assisted Living Owner, LLC

151. Grinnell IA Assisted Living Tenant, LLC

152. Indianola IA Assisted Living Owner, LLC

153. Indianola IA Assisted Living Tenant, LLC

154. Nevada IA Assisted Living Owner, LLC

155. Nevada IA Assisted Living Tenant, LLC

156. Vinton IA Assisted Living Owner, LLC

157. Vinton IA Assisted Living Tenant, LLC

158. Webster City IA Assisted Living Owner, LLC

159. Webster City IA Assisted Living Tenant, LLC

## Exhibit 23.1

**EXHIBIT 23.1**

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Post-Effective Amendment No. 4 to the Form S-11 Registration Statement on Form S-3 (No. 333-196108) of CNL Healthcare Properties, Inc. of our report dated March 10, 2023 relating to the financial statements and financial statement schedules, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Tampa, Florida

March 10, 2023

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**OF CNL HEALTHCARE PROPERTIES, INC.**

**PURSUANT TO RULE 13a-14(a), AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Stephen H. Mauldin, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this annual report on Form 10-K of CNL Healthcare Properties, Inc. (the "Registrant");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The Registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The Registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: March 10, 2023 | By: | /s/ Stephen H. Mauldin |
|  |  | Stephen H. Mauldin |
|  |  | Chief Executive Officer and President<br>(Principal Executive Officer) |

---

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**OF CNL HEALTHCARE PROPERTIES, INC.**

**PURSUANT TO RULE 13a-14(a), AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Ixchell C. Duarte, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this annual report on Form 10-K of CNL Healthcare Properties, Inc. (the "Registrant");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The Registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The Registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: March 10, 2023 | By: | /s/ Ixchell C. Duarte |
|  |  | Ixchell C. Duarte |
|  |  | Chief Financial Officer, Senior Vice President and Treasurer<br>(Principal Financial Officer and Principal Accounting Officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION**

**PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the annual report of CNL Healthcare Properties, Inc. (the "Company") on Form 10-K for the period ended December 31, 2022, as filed with the United States Securities and Exchange Commission on the date hereof (the "Report"), I, Stephen H. Mauldin, Chief Executive Officer and President and Ixchell C. Duarte, Chief Financial Officer, Senior Vice President and Treasurer of the Company, each certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: March 10, 2023 | By: | /s/ Stephen H. Mauldin |
|  |  | Stephen H. Mauldin |
|  |  | Chief Executive Officer and President |
| Date: March 10, 2023 | By: | /s/ Ixchell C. Duarte |
|  |  | Ixchell C. Duarte |
|  |  | Chief Financial Officer, Senior Vice President and Treasurer |

---